Index Sample Index Original Filename Sample Name Sample ID Sample Comment Sample Type Acquisition Date & Time Rack Number Plate Number Vial Number Dilution Factor Injection Volume Operator Name Acq. Method Name IS Component Name Component Index Component Comment IS Comment Mass Info IS Mass Info IS Name Component Group Name Conc. Units Failed Query IS Failed Query Peak Comment IS Peak Comment Actual Concentration IS Actual Concentration Concentration Ratio Expected RT IS Expected RT Integration Type IS Integration Type Area IS Area Corrected Area IS Corrected Area Area Ratio Height IS Height Corrected Height IS Corrected Height Height Ratio Area / Height IS Area / Height Corrected Area/Height IS Corrected Area/Height Region Height IS Region Height Quality IS Quality Retention Time IS Retention Time Start Time IS Start Time End Time IS End Time Total Width IS Total Width Width at 50% IS Width at 50% Signal / Noise IS Signal / Noise Baseline Delta / Height IS Baseline Delta / Height Modified Relative RT Used Calculated Concentration Accuracy SF Peak Width Confidence SF Model Source SF Candidate Model Quality SF Asymmetry SF Saturated SF Integration Quality SF Group Confidence SF Num Peaks Score_IMPAQT MSSimScore_IMPAQT HeightScore_IMPAQT RTminScore_IMPAQT RankScore_IMPAQT MSSim_IMPAQT MSSimSita_IMPAQT RTminDiff_IMPAQT RankSum_IMPAQT CosSimilarity_IMPAQT CosSimilaritySita_IMPAQT Height_IMPAQT InterfereTrans_IMPAQT InterfereTransAll_IMPAQT LScore_IMPAQT LRTminScore_IMPAQT LSNScore_IMPAQT LSNAllScore_IMPAQT HLSimScore_IMPAQT HLSim_IMPAQT HLSimSita_IMPAQT BaseLine_IMPAQT BaseLineUnitNum_IMPAQT BaseLineMaxCount_IMPAQT Symbol Description 1 1 C20140527_SFK016_02 C20140527_SFK016_02 TB526482.[MT7]-TSNVQTC[CAM]LTK[MT7].3y3_1.heavy 480.597 / 505.347 12709.0 23.411399841308594 50 20 10 10 10 10.243128839632178 9.762642017455178 0.0 3 0.9906256349223673 12.736543528551318 12709.0 37.83277997666277 0.0 - - - - - - - 713.8571428571429 25 7 KIAA0947 KIAA0947 3 1 C20140527_SFK016_02 C20140527_SFK016_02 TB526482.[MT7]-TSNVQTC[CAM]LTK[MT7].3b4_1.heavy 480.597 / 546.3 16993.0 23.411399841308594 50 20 10 10 10 10.243128839632178 9.762642017455178 0.0 3 0.9906256349223673 12.736543528551318 16993.0 32.477403587464636 0.0 - - - - - - - 615.75 33 8 KIAA0947 KIAA0947 5 1 C20140527_SFK016_02 C20140527_SFK016_02 TB526482.[MT7]-TSNVQTC[CAM]LTK[MT7].3y4_1.heavy 480.597 / 665.377 7997.0 23.411399841308594 50 20 10 10 10 10.243128839632178 9.762642017455178 0.0 3 0.9906256349223673 12.736543528551318 7997.0 31.724586628324943 0.0 - - - - - - - 230.94117647058823 15 17 KIAA0947 KIAA0947 7 1 C20140527_SFK016_02 C20140527_SFK016_02 TB526482.[MT7]-TSNVQTC[CAM]LTK[MT7].3y5_1.heavy 480.597 / 766.425 4927.0 23.411399841308594 50 20 10 10 10 10.243128839632178 9.762642017455178 0.0 3 0.9906256349223673 12.736543528551318 4927.0 38.384617672047575 0.0 - - - - - - - 224.35714285714286 9 14 KIAA0947 KIAA0947 9 2 C20140527_SFK016_02 C20140527_SFK016_02 TB328461.[MT7]-LMQADLGGTEILAPLQNIYR.2b3_1.heavy 1180.64 / 517.292 1214.0 49.1127986907959 41 15 10 6 10 2.110264092567681 38.382715447880464 0.03479766845703125 3 0.9516541370689358 5.590070668744956 1214.0 18.450104094378904 0.0 - - - - - - - 112.36842105263158 2 19 VWA5A von Willebrand factor A domain containing 5A 11 2 C20140527_SFK016_02 C20140527_SFK016_02 TB328461.[MT7]-LMQADLGGTEILAPLQNIYR.2y10_1.heavy 1180.64 / 1200.71 820.0 49.1127986907959 41 15 10 6 10 2.110264092567681 38.382715447880464 0.03479766845703125 3 0.9516541370689358 5.590070668744956 820.0 9.45 0.0 - - - - - - - 0.0 1 0 VWA5A von Willebrand factor A domain containing 5A 13 2 C20140527_SFK016_02 C20140527_SFK016_02 TB328461.[MT7]-LMQADLGGTEILAPLQNIYR.2b5_1.heavy 1180.64 / 703.357 3215.0 49.1127986907959 41 15 10 6 10 2.110264092567681 38.382715447880464 0.03479766845703125 3 0.9516541370689358 5.590070668744956 3215.0 66.91037473976405 0.0 - - - - - - - 90.82352941176471 6 17 VWA5A von Willebrand factor A domain containing 5A 15 2 C20140527_SFK016_02 C20140527_SFK016_02 TB328461.[MT7]-LMQADLGGTEILAPLQNIYR.2y7_1.heavy 1180.64 / 903.505 3313.0 49.1127986907959 41 15 10 6 10 2.110264092567681 38.382715447880464 0.03479766845703125 3 0.9516541370689358 5.590070668744956 3313.0 65.40933379597502 0.0 - - - - - - - 70.42857142857143 6 21 VWA5A von Willebrand factor A domain containing 5A 17 3 C20140527_SFK016_02 C20140527_SFK016_02 TB526486.[MT7]-ASGGTSEFITGK[MT7].2b8_1.heavy 721.89 / 881.412 8423.0 27.395000457763672 42 12 10 10 10 1.2581273938130701 54.6797797735033 0.0 3 0.8822069234436893 3.559952816591935 8423.0 107.2714268359097 0.0 - - - - - - - 188.8181818181818 16 11 VWA5A von Willebrand factor A domain containing 5A 19 3 C20140527_SFK016_02 C20140527_SFK016_02 TB526486.[MT7]-ASGGTSEFITGK[MT7].2y5_1.heavy 721.89 / 709.437 5579.0 27.395000457763672 42 12 10 10 10 1.2581273938130701 54.6797797735033 0.0 3 0.8822069234436893 3.559952816591935 5579.0 52.853191429850085 0.0 - - - - - - - 243.0 11 9 VWA5A von Willebrand factor A domain containing 5A 21 3 C20140527_SFK016_02 C20140527_SFK016_02 TB526486.[MT7]-ASGGTSEFITGK[MT7].2b7_1.heavy 721.89 / 734.344 4376.0 27.395000457763672 42 12 10 10 10 1.2581273938130701 54.6797797735033 0.0 3 0.8822069234436893 3.559952816591935 4376.0 41.10921201457836 0.0 - - - - - - - 291.6666666666667 8 15 VWA5A von Willebrand factor A domain containing 5A 23 3 C20140527_SFK016_02 C20140527_SFK016_02 TB526486.[MT7]-ASGGTSEFITGK[MT7].2y11_1.heavy 721.89 / 1227.63 1969.0 27.395000457763672 42 12 10 10 10 1.2581273938130701 54.6797797735033 0.0 3 0.8822069234436893 3.559952816591935 1969.0 21.096369653554518 0.0 - - - - - - - 200.41666666666666 3 12 VWA5A von Willebrand factor A domain containing 5A 25 4 C20140527_SFK016_02 C20140527_SFK016_02 TB526346.[MT7]-LAQQIANC[CAM]K[MT7].3y3_1.heavy 445.255 / 565.288 66730.0 26.762800216674805 48 18 10 10 10 3.0207234099830202 26.381762865171922 0.0 3 0.9865308373071346 10.621929067878375 66730.0 233.1828996282528 0.0 - - - - - - - 741.3333333333334 133 9 MID1 midline 1 (Opitz/BBB syndrome) 27 4 C20140527_SFK016_02 C20140527_SFK016_02 TB526346.[MT7]-LAQQIANC[CAM]K[MT7].3b4_1.heavy 445.255 / 585.348 79754.0 26.762800216674805 48 18 10 10 10 3.0207234099830202 26.381762865171922 0.0 3 0.9865308373071346 10.621929067878375 79754.0 179.14369372855828 0.0 - - - - - - - 710.4 159 10 MID1 midline 1 (Opitz/BBB syndrome) 29 4 C20140527_SFK016_02 C20140527_SFK016_02 TB526346.[MT7]-LAQQIANC[CAM]K[MT7].3y4_1.heavy 445.255 / 636.326 49402.0 26.762800216674805 48 18 10 10 10 3.0207234099830202 26.381762865171922 0.0 3 0.9865308373071346 10.621929067878375 49402.0 198.2957308584687 0.0 - - - - - - - 251.25 98 12 MID1 midline 1 (Opitz/BBB syndrome) 31 4 C20140527_SFK016_02 C20140527_SFK016_02 TB526346.[MT7]-LAQQIANC[CAM]K[MT7].3b3_1.heavy 445.255 / 457.289 59842.0 26.762800216674805 48 18 10 10 10 3.0207234099830202 26.381762865171922 0.0 3 0.9865308373071346 10.621929067878375 59842.0 123.35519321089626 0.0 - - - - - - - 733.7272727272727 119 11 MID1 midline 1 (Opitz/BBB syndrome) 33 5 C20140527_SFK016_02 C20140527_SFK016_02 TB526341.[MT7]-FLDIIDAVK[MT7].2y4_1.heavy 661.402 / 576.347 23894.0 45.104000091552734 35 5 10 10 10 0.5425281143727976 95.23073686803082 0.0 3 0.6956071905923051 2.17749275727261 23894.0 19.347368421052636 1.0 - - - - - - - 319.8181818181818 47 11 ZBTB41 zinc finger and BTB domain containing 41 35 5 C20140527_SFK016_02 C20140527_SFK016_02 TB526341.[MT7]-FLDIIDAVK[MT7].2b3_1.heavy 661.402 / 520.289 19140.0 45.104000091552734 35 5 10 10 10 0.5425281143727976 95.23073686803082 0.0 3 0.6956071905923051 2.17749275727261 19140.0 24.715328043936488 1.0 - - - - - - - 776.0 38 7 ZBTB41 zinc finger and BTB domain containing 41 37 5 C20140527_SFK016_02 C20140527_SFK016_02 TB526341.[MT7]-FLDIIDAVK[MT7].2y5_1.heavy 661.402 / 689.431 3705.0 45.104000091552734 35 5 10 10 10 0.5425281143727976 95.23073686803082 0.0 3 0.6956071905923051 2.17749275727261 3705.0 7.324959218821651 1.0 - - - - - - - 243.0 16 16 ZBTB41 zinc finger and BTB domain containing 41 39 5 C20140527_SFK016_02 C20140527_SFK016_02 TB526341.[MT7]-FLDIIDAVK[MT7].2y7_1.heavy 661.402 / 917.542 34267.0 45.104000091552734 35 5 10 10 10 0.5425281143727976 95.23073686803082 0.0 3 0.6956071905923051 2.17749275727261 34267.0 121.91616103673724 0.0 - - - - - - - 290.7142857142857 68 7 ZBTB41 zinc finger and BTB domain containing 41 41 6 C20140527_SFK016_02 C20140527_SFK016_02 TB526487.[MT7]-ASGGTSEFITGK[MT7].3b5_1.heavy 481.596 / 518.269 29765.0 27.395000457763672 47 17 10 10 10 2.8228852867240835 27.369129703055993 0.0 3 0.9773889387655429 8.19181548507898 29765.0 80.74787091065421 0.0 - - - - - - - 319.25 59 12 VWA5A von Willebrand factor A domain containing 5A 43 6 C20140527_SFK016_02 C20140527_SFK016_02 TB526487.[MT7]-ASGGTSEFITGK[MT7].3y4_1.heavy 481.596 / 562.368 50338.0 27.395000457763672 47 17 10 10 10 2.8228852867240835 27.369129703055993 0.0 3 0.9773889387655429 8.19181548507898 50338.0 89.81438974385489 0.0 - - - - - - - 766.1428571428571 100 7 VWA5A von Willebrand factor A domain containing 5A 45 6 C20140527_SFK016_02 C20140527_SFK016_02 TB526487.[MT7]-ASGGTSEFITGK[MT7].3b8_1.heavy 481.596 / 881.412 25497.0 27.395000457763672 47 17 10 10 10 2.8228852867240835 27.369129703055993 0.0 3 0.9773889387655429 8.19181548507898 25497.0 326.01894834736714 0.0 - - - - - - - 141.9 50 10 VWA5A von Willebrand factor A domain containing 5A 47 6 C20140527_SFK016_02 C20140527_SFK016_02 TB526487.[MT7]-ASGGTSEFITGK[MT7].3b7_1.heavy 481.596 / 734.344 98049.0 27.395000457763672 47 17 10 10 10 2.8228852867240835 27.369129703055993 0.0 3 0.9773889387655429 8.19181548507898 98049.0 580.5218231707317 0.0 - - - - - - - 226.06666666666666 196 15 VWA5A von Willebrand factor A domain containing 5A 49 7 C20140527_SFK016_02 C20140527_SFK016_02 TB526748.[MT7]-TIGILTK[MT7]PDLMDR.3y6_1.heavy 587.678 / 746.35 57883.0 36.81570053100586 50 20 10 10 10 6.573892104506755 15.21168866331783 0.0 3 0.9928383809304997 14.574619743010386 57883.0 93.57728468093457 0.0 - - - - - - - 755.25 115 8 MX2 myxovirus (influenza virus) resistance 2 (mouse) 51 7 C20140527_SFK016_02 C20140527_SFK016_02 TB526748.[MT7]-TIGILTK[MT7]PDLMDR.3b4_1.heavy 587.678 / 529.347 27349.0 36.81570053100586 50 20 10 10 10 6.573892104506755 15.21168866331783 0.0 3 0.9928383809304997 14.574619743010386 27349.0 42.9066675169386 0.0 - - - - - - - 758.0 54 10 MX2 myxovirus (influenza virus) resistance 2 (mouse) 53 7 C20140527_SFK016_02 C20140527_SFK016_02 TB526748.[MT7]-TIGILTK[MT7]PDLMDR.3y4_1.heavy 587.678 / 534.27 58762.0 36.81570053100586 50 20 10 10 10 6.573892104506755 15.21168866331783 0.0 3 0.9928383809304997 14.574619743010386 58762.0 56.950640905054684 0.0 - - - - - - - 737.5714285714286 117 7 MX2 myxovirus (influenza virus) resistance 2 (mouse) 55 7 C20140527_SFK016_02 C20140527_SFK016_02 TB526748.[MT7]-TIGILTK[MT7]PDLMDR.3y12_2.heavy 587.678 / 758.438 23505.0 36.81570053100586 50 20 10 10 10 6.573892104506755 15.21168866331783 0.0 3 0.9928383809304997 14.574619743010386 23505.0 17.231282759366728 0.0 - - - - - - - 241.8 47 5 MX2 myxovirus (influenza virus) resistance 2 (mouse) 57 8 C20140527_SFK016_02 C20140527_SFK016_02 TB526880.[MT7]-SQASTSC[CAM]LPAPPAESVAR.3y7_1.heavy 658.334 / 729.389 12597.0 28.203899383544922 47 17 10 10 10 3.6720692608877776 27.23260180986442 0.0 3 0.9738391631626488 7.613514644558607 12597.0 11.123779761745558 1.0 - - - - - - - 206.75 25 8 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 59 8 C20140527_SFK016_02 C20140527_SFK016_02 TB526880.[MT7]-SQASTSC[CAM]LPAPPAESVAR.3b4_1.heavy 658.334 / 518.269 5782.0 28.203899383544922 47 17 10 10 10 3.6720692608877776 27.23260180986442 0.0 3 0.9738391631626488 7.613514644558607 5782.0 7.202299870641894 1.0 - - - - - - - 708.0714285714286 11 14 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 61 8 C20140527_SFK016_02 C20140527_SFK016_02 TB526880.[MT7]-SQASTSC[CAM]LPAPPAESVAR.3y8_1.heavy 658.334 / 826.442 20960.0 28.203899383544922 47 17 10 10 10 3.6720692608877776 27.23260180986442 0.0 3 0.9738391631626488 7.613514644558607 20960.0 32.454193548387096 1.0 - - - - - - - 206.6 41 5 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 63 8 C20140527_SFK016_02 C20140527_SFK016_02 TB526880.[MT7]-SQASTSC[CAM]LPAPPAESVAR.3y10_1.heavy 658.334 / 994.532 36654.0 28.203899383544922 47 17 10 10 10 3.6720692608877776 27.23260180986442 0.0 3 0.9738391631626488 7.613514644558607 36654.0 46.77962732370448 0.0 - - - - - - - 252.55555555555554 73 9 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 65 9 C20140527_SFK016_02 C20140527_SFK016_02 TB526613.[MT7]-TWRNDLISATK[MT7].3y10_2.heavy 531.638 / 674.379 8129.0 30.9158992767334 39 13 10 10 6 2.179885021023985 45.87397914823312 0.0 5 0.9223035015918878 4.398542393778774 8129.0 14.455334728033474 2.0 - - - - - - - 793.6 18 10 ITIH2 inter-alpha (globulin) inhibitor H2 67 9 C20140527_SFK016_02 C20140527_SFK016_02 TB526613.[MT7]-TWRNDLISATK[MT7].3b6_1.heavy 531.638 / 930.491 7077.0 30.9158992767334 39 13 10 10 6 2.179885021023985 45.87397914823312 0.0 5 0.9223035015918878 4.398542393778774 7077.0 57.02060656365727 0.0 - - - - - - - 233.1875 14 16 ITIH2 inter-alpha (globulin) inhibitor H2 69 9 C20140527_SFK016_02 C20140527_SFK016_02 TB526613.[MT7]-TWRNDLISATK[MT7].3b5_1.heavy 531.638 / 817.407 10041.0 30.9158992767334 39 13 10 10 6 2.179885021023985 45.87397914823312 0.0 5 0.9223035015918878 4.398542393778774 10041.0 40.038488641842775 1.0 - - - - - - - 263.0 41 16 ITIH2 inter-alpha (globulin) inhibitor H2 71 9 C20140527_SFK016_02 C20140527_SFK016_02 TB526613.[MT7]-TWRNDLISATK[MT7].3y4_1.heavy 531.638 / 550.332 53649.0 30.9158992767334 39 13 10 10 6 2.179885021023985 45.87397914823312 0.0 5 0.9223035015918878 4.398542393778774 53649.0 84.55832520187127 0.0 - - - - - - - 328.0 107 7 ITIH2 inter-alpha (globulin) inhibitor H2 73 10 C20140527_SFK016_02 C20140527_SFK016_02 TB526355.[MT7]-C[CAM]QEELGSLK[MT7].3y3_1.heavy 451.242 / 491.331 11307.0 27.073299407958984 44 18 10 6 10 4.575623146777893 21.854946701722795 0.0391998291015625 3 0.9846731619415937 9.95588389762881 11307.0 11.816430054203666 0.0 - - - - - - - 307.8333333333333 22 6 KIAA0947 KIAA0947 75 10 C20140527_SFK016_02 C20140527_SFK016_02 TB526355.[MT7]-C[CAM]QEELGSLK[MT7].3b4_1.heavy 451.242 / 691.284 26093.0 27.073299407958984 44 18 10 6 10 4.575623146777893 21.854946701722795 0.0391998291015625 3 0.9846731619415937 9.95588389762881 26093.0 128.42076313377052 0.0 - - - - - - - 248.42857142857142 52 14 KIAA0947 KIAA0947 77 10 C20140527_SFK016_02 C20140527_SFK016_02 TB526355.[MT7]-C[CAM]QEELGSLK[MT7].3y4_1.heavy 451.242 / 548.352 25767.0 27.073299407958984 44 18 10 6 10 4.575623146777893 21.854946701722795 0.0391998291015625 3 0.9846731619415937 9.95588389762881 25767.0 42.114178683385575 0.0 - - - - - - - 621.4285714285714 51 7 KIAA0947 KIAA0947 79 10 C20140527_SFK016_02 C20140527_SFK016_02 TB526355.[MT7]-C[CAM]QEELGSLK[MT7].3y5_1.heavy 451.242 / 661.437 3479.0 27.073299407958984 44 18 10 6 10 4.575623146777893 21.854946701722795 0.0391998291015625 3 0.9846731619415937 9.95588389762881 3479.0 19.067777514231498 2.0 - - - - - - - 237.0909090909091 14 11 KIAA0947 KIAA0947 81 11 C20140527_SFK016_02 C20140527_SFK016_02 TB328479.[MT7]-ILNLVSDPESGIVVNGQLVGAK[MT7].3b4_1.heavy 837.486 / 598.404 8018.0 44.70560073852539 46 16 10 10 10 1.4091708991756835 46.63210920574421 0.0 3 0.9641186864750675 6.495625637669414 8018.0 28.911485288963114 0.0 - - - - - - - 263.9166666666667 16 12 ITIH2 inter-alpha (globulin) inhibitor H2 83 11 C20140527_SFK016_02 C20140527_SFK016_02 TB328479.[MT7]-ILNLVSDPESGIVVNGQLVGAK[MT7].3b5_1.heavy 837.486 / 697.473 7227.0 44.70560073852539 46 16 10 10 10 1.4091708991756835 46.63210920574421 0.0 3 0.9641186864750675 6.495625637669414 7227.0 32.629443127962084 0.0 - - - - - - - 263.8666666666667 14 15 ITIH2 inter-alpha (globulin) inhibitor H2 85 11 C20140527_SFK016_02 C20140527_SFK016_02 TB328479.[MT7]-ILNLVSDPESGIVVNGQLVGAK[MT7].3y4_1.heavy 837.486 / 518.342 8809.0 44.70560073852539 46 16 10 10 10 1.4091708991756835 46.63210920574421 0.0 3 0.9641186864750675 6.495625637669414 8809.0 35.584828691175666 1.0 - - - - - - - 692.375 17 8 ITIH2 inter-alpha (globulin) inhibitor H2 87 11 C20140527_SFK016_02 C20140527_SFK016_02 TB328479.[MT7]-ILNLVSDPESGIVVNGQLVGAK[MT7].3b7_1.heavy 837.486 / 899.532 15509.0 44.70560073852539 46 16 10 10 10 1.4091708991756835 46.63210920574421 0.0 3 0.9641186864750675 6.495625637669414 15509.0 23.201283565933746 0.0 - - - - - - - 705.75 31 8 ITIH2 inter-alpha (globulin) inhibitor H2 89 12 C20140527_SFK016_02 C20140527_SFK016_02 TB526608.[MT7]-TSGGLLSEAPNEK[MT7].3y3_1.heavy 530.957 / 534.3 33716.0 28.35580062866211 47 17 10 10 10 3.3114393759740812 24.14995167053679 0.0 3 0.9766440375391262 8.059619929587706 33716.0 37.57351451467972 0.0 - - - - - - - 739.125 67 8 GLTSCR2 glioma tumor suppressor candidate region gene 2 91 12 C20140527_SFK016_02 C20140527_SFK016_02 TB526608.[MT7]-TSGGLLSEAPNEK[MT7].3b5_1.heavy 530.957 / 560.316 86520.0 28.35580062866211 47 17 10 10 10 3.3114393759740812 24.14995167053679 0.0 3 0.9766440375391262 8.059619929587706 86520.0 47.24666239425788 0.0 - - - - - - - 1348.8 173 5 GLTSCR2 glioma tumor suppressor candidate region gene 2 93 12 C20140527_SFK016_02 C20140527_SFK016_02 TB526608.[MT7]-TSGGLLSEAPNEK[MT7].3y4_1.heavy 530.957 / 631.353 102288.0 28.35580062866211 47 17 10 10 10 3.3114393759740812 24.14995167053679 0.0 3 0.9766440375391262 8.059619929587706 102288.0 85.33647576866409 0.0 - - - - - - - 1151.4 204 10 GLTSCR2 glioma tumor suppressor candidate region gene 2 95 12 C20140527_SFK016_02 C20140527_SFK016_02 TB526608.[MT7]-TSGGLLSEAPNEK[MT7].3b8_1.heavy 530.957 / 889.475 10270.0 28.35580062866211 47 17 10 10 10 3.3114393759740812 24.14995167053679 0.0 3 0.9766440375391262 8.059619929587706 10270.0 30.10706896106911 0.0 - - - - - - - 244.35714285714286 20 14 GLTSCR2 glioma tumor suppressor candidate region gene 2 97 13 C20140527_SFK016_02 C20140527_SFK016_02 TB526607.[MT7]-ASVSGPNSPSETRR.3y6_1.heavy 530.277 / 745.395 4236.0 16.84910011291504 48 18 10 10 10 6.468837374902587 15.458728393447345 0.0 3 0.9863000534733583 10.531879126438671 4236.0 9.738225855283076 0.0 - - - - - - - 255.7058823529412 8 17 MID1 midline 1 (Opitz/BBB syndrome) 99 13 C20140527_SFK016_02 C20140527_SFK016_02 TB526607.[MT7]-ASVSGPNSPSETRR.3y11_2.heavy 530.277 / 594.292 6044.0 16.84910011291504 48 18 10 10 10 6.468837374902587 15.458728393447345 0.0 3 0.9863000534733583 10.531879126438671 6044.0 24.98140620644052 1.0 - - - - - - - 185.8235294117647 15 17 MID1 midline 1 (Opitz/BBB syndrome) 101 13 C20140527_SFK016_02 C20140527_SFK016_02 TB526607.[MT7]-ASVSGPNSPSETRR.3b5_1.heavy 530.277 / 546.3 16606.0 16.84910011291504 48 18 10 10 10 6.468837374902587 15.458728393447345 0.0 3 0.9863000534733583 10.531879126438671 16606.0 42.9110796460177 0.0 - - - - - - - 266.2142857142857 33 14 MID1 midline 1 (Opitz/BBB syndrome) 103 13 C20140527_SFK016_02 C20140527_SFK016_02 TB526607.[MT7]-ASVSGPNSPSETRR.3y13_2.heavy 530.277 / 687.342 10562.0 16.84910011291504 48 18 10 10 10 6.468837374902587 15.458728393447345 0.0 3 0.9863000534733583 10.531879126438671 10562.0 70.468919052975 0.0 - - - - - - - 205.64705882352942 21 17 MID1 midline 1 (Opitz/BBB syndrome) 105 14 C20140527_SFK016_02 C20140527_SFK016_02 TB526890.[MT7]-LWAY[MT7]LTINQLLAER.3y7_1.heavy 664.722 / 843.468 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITIH2 inter-alpha (globulin) inhibitor H2 107 14 C20140527_SFK016_02 C20140527_SFK016_02 TB526890.[MT7]-LWAY[MT7]LTINQLLAER.3y8_1.heavy 664.722 / 956.552 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITIH2 inter-alpha (globulin) inhibitor H2 109 14 C20140527_SFK016_02 C20140527_SFK016_02 TB526890.[MT7]-LWAY[MT7]LTINQLLAER.3y5_1.heavy 664.722 / 601.367 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITIH2 inter-alpha (globulin) inhibitor H2 111 14 C20140527_SFK016_02 C20140527_SFK016_02 TB526890.[MT7]-LWAY[MT7]LTINQLLAER.3y9_1.heavy 664.722 / 1057.6 N/A N/A - - - - - - - - - 0.0 - - - - - - - ITIH2 inter-alpha (globulin) inhibitor H2 113 15 C20140527_SFK016_02 C20140527_SFK016_02 TB526752.[MT7]-GTYTSLQQEVEVK[MT7].3y3_1.heavy 590.656 / 519.326 96379.0 31.647199630737305 47 17 10 10 10 5.753942859773071 17.37938704590193 0.0 3 0.9727213571562788 7.455190892132345 96379.0 41.3193768128951 0.0 - - - - - - - 950.0 192 1 KIF3C kinesin family member 3C 115 15 C20140527_SFK016_02 C20140527_SFK016_02 TB526752.[MT7]-GTYTSLQQEVEVK[MT7].3b5_1.heavy 590.656 / 654.321 62480.0 31.647199630737305 47 17 10 10 10 5.753942859773071 17.37938704590193 0.0 3 0.9727213571562788 7.455190892132345 62480.0 86.25854977950817 0.0 - - - - - - - 257.85714285714283 124 7 KIF3C kinesin family member 3C 117 15 C20140527_SFK016_02 C20140527_SFK016_02 TB526752.[MT7]-GTYTSLQQEVEVK[MT7].3b3_1.heavy 590.656 / 466.242 23739.0 31.647199630737305 47 17 10 10 10 5.753942859773071 17.37938704590193 0.0 3 0.9727213571562788 7.455190892132345 23739.0 15.18788155920076 1.0 - - - - - - - 475.0 95 1 KIF3C kinesin family member 3C 119 15 C20140527_SFK016_02 C20140527_SFK016_02 TB526752.[MT7]-GTYTSLQQEVEVK[MT7].3y5_1.heavy 590.656 / 747.437 30765.0 31.647199630737305 47 17 10 10 10 5.753942859773071 17.37938704590193 0.0 3 0.9727213571562788 7.455190892132345 30765.0 55.58787859518685 0.0 - - - - - - - 760.0 61 8 KIF3C kinesin family member 3C 121 16 C20140527_SFK016_02 C20140527_SFK016_02 TB328073.[MT7]-VNEDPK[MT7].2b3_1.heavy 495.279 / 487.263 11010.0 16.974599838256836 48 18 10 10 10 4.070416774701195 24.567508816671705 0.0 3 0.9899929848308126 12.326712260610918 11010.0 48.85304592022466 0.0 - - - - - - - 326.5 22 14 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 123 16 C20140527_SFK016_02 C20140527_SFK016_02 TB328073.[MT7]-VNEDPK[MT7].2y5_1.heavy 495.279 / 746.38 7731.0 16.974599838256836 48 18 10 10 10 4.070416774701195 24.567508816671705 0.0 3 0.9899929848308126 12.326712260610918 7731.0 81.93538461538462 0.0 - - - - - - - 121.76923076923077 15 13 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 125 16 C20140527_SFK016_02 C20140527_SFK016_02 TB328073.[MT7]-VNEDPK[MT7].2b4_1.heavy 495.279 / 602.29 113498.0 16.974599838256836 48 18 10 10 10 4.070416774701195 24.567508816671705 0.0 3 0.9899929848308126 12.326712260610918 113498.0 537.9018803418803 0.0 - - - - - - - 297.07142857142856 226 14 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 127 16 C20140527_SFK016_02 C20140527_SFK016_02 TB328073.[MT7]-VNEDPK[MT7].2y3_1.heavy 495.279 / 503.295 3982.0 16.974599838256836 48 18 10 10 10 4.070416774701195 24.567508816671705 0.0 3 0.9899929848308126 12.326712260610918 3982.0 17.974973544630885 1.0 - - - - - - - 206.8235294117647 7 17 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 129 17 C20140527_SFK016_02 C20140527_SFK016_02 TB328074.[MT7]-TILDDLR.2y5_1.heavy 495.291 / 631.341 54714.0 37.391700744628906 47 17 10 10 10 3.247267991738073 30.795117697223333 0.0 3 0.9791223885641236 8.526356157779322 54714.0 231.1617909664358 0.0 - - - - - - - 226.4 109 10 ITIH2 inter-alpha (globulin) inhibitor H2 131 17 C20140527_SFK016_02 C20140527_SFK016_02 TB328074.[MT7]-TILDDLR.2b4_1.heavy 495.291 / 587.352 135276.0 37.391700744628906 47 17 10 10 10 3.247267991738073 30.795117697223333 0.0 3 0.9791223885641236 8.526356157779322 135276.0 158.98452670352032 0.0 - - - - - - - 251.66666666666666 270 3 ITIH2 inter-alpha (globulin) inhibitor H2 133 17 C20140527_SFK016_02 C20140527_SFK016_02 TB328074.[MT7]-TILDDLR.2y6_1.heavy 495.291 / 744.425 68015.0 37.391700744628906 47 17 10 10 10 3.247267991738073 30.795117697223333 0.0 3 0.9791223885641236 8.526356157779322 68015.0 280.14088910967183 0.0 - - - - - - - 249.28571428571428 136 14 ITIH2 inter-alpha (globulin) inhibitor H2 135 17 C20140527_SFK016_02 C20140527_SFK016_02 TB328074.[MT7]-TILDDLR.2b5_1.heavy 495.291 / 702.379 297532.0 37.391700744628906 47 17 10 10 10 3.247267991738073 30.795117697223333 0.0 3 0.9791223885641236 8.526356157779322 297532.0 941.2402337745305 0.0 - - - - - - - 387.8888888888889 595 9 ITIH2 inter-alpha (globulin) inhibitor H2 137 18 C20140527_SFK016_02 C20140527_SFK016_02 TPX_ECO57.AQTFTLVAK.2y7.peptide 489.78 / 779.47 1242650.0 30.507099151611328 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1242650.0 1017.5381516864334 0.0 - - - - - - - 252.92307692307693 2485 13 139 18 C20140527_SFK016_02 C20140527_SFK016_02 TPX_ECO57.AQTFTLVAK.2y6.peptide 489.78 / 678.42 483346.0 30.507099151611328 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 483346.0 890.9529091575839 0.0 - - - - - - - 314.4166666666667 966 12 141 18 C20140527_SFK016_02 C20140527_SFK016_02 TPX_ECO57.AQTFTLVAK.2y5.peptide 489.78 / 531.35 486925.0 30.507099151611328 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 486925.0 660.8020764568677 0.0 - - - - - - - 367.7 973 10 143 19 C20140527_SFK016_02 C20140527_SFK016_02 TB525736.[MT7]-VLYTIR.2b3_1.heavy 454.788 / 520.325 9830.0 31.606300354003906 48 20 10 10 8 13.391923983557215 7.467186949595991 0.0 4 0.9973982460887787 24.18995475989818 9830.0 17.05747223955084 1.0 - - - - - - - 302.0 21 6 GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 145 19 C20140527_SFK016_02 C20140527_SFK016_02 TB525736.[MT7]-VLYTIR.2y4_1.heavy 454.788 / 552.314 21283.0 31.606300354003906 48 20 10 10 8 13.391923983557215 7.467186949595991 0.0 4 0.9973982460887787 24.18995475989818 21283.0 46.599414315036164 1.0 - - - - - - - 771.5 42 12 GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 147 19 C20140527_SFK016_02 C20140527_SFK016_02 TB525736.[MT7]-VLYTIR.2y5_1.heavy 454.788 / 665.398 73774.0 31.606300354003906 48 20 10 10 8 13.391923983557215 7.467186949595991 0.0 4 0.9973982460887787 24.18995475989818 73774.0 216.46263473053892 2.0 - - - - - - - 327.07142857142856 149 14 GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 149 19 C20140527_SFK016_02 C20140527_SFK016_02 TB525736.[MT7]-VLYTIR.2b4_1.heavy 454.788 / 621.373 12121.0 31.606300354003906 48 20 10 10 8 13.391923983557215 7.467186949595991 0.0 4 0.9973982460887787 24.18995475989818 12121.0 38.92258289703316 0.0 - - - - - - - 286.3636363636364 24 11 GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 151 20 C20140527_SFK016_02 C20140527_SFK016_02 TB397692.[MT7]-C[CAM]RGQQEITNR.2y4_1.heavy 703.358 / 503.294 N/A 15.629633585611979 45 20 10 5 10 6.018416045769342 16.615667517750822 0.04549980163574219 3 0.9908657610537353 12.90312936541246 810.0 20.59121911611182 1.0 - - - - - - - 0.0 1 0 MX2 myxovirus (influenza virus) resistance 2 (mouse) 153 20 C20140527_SFK016_02 C20140527_SFK016_02 TB397692.[MT7]-C[CAM]RGQQEITNR.2y8_1.heavy 703.358 / 945.475 1288.0 15.629633585611979 45 20 10 5 10 6.018416045769342 16.615667517750822 0.04549980163574219 3 0.9908657610537353 12.90312936541246 1288.0 31.329729729729728 0.0 - - - - - - - 52.857142857142854 2 7 MX2 myxovirus (influenza virus) resistance 2 (mouse) 155 20 C20140527_SFK016_02 C20140527_SFK016_02 TB397692.[MT7]-C[CAM]RGQQEITNR.2b9_1.heavy 703.358 / 1231.6 663.0 15.629633585611979 45 20 10 5 10 6.018416045769342 16.615667517750822 0.04549980163574219 3 0.9908657610537353 12.90312936541246 663.0 10.80022113022113 0.0 - - - - - - - 0.0 1 0 MX2 myxovirus (influenza virus) resistance 2 (mouse) 157 20 C20140527_SFK016_02 C20140527_SFK016_02 TB397692.[MT7]-C[CAM]RGQQEITNR.2b6_1.heavy 703.358 / 903.422 1104.0 15.629633585611979 45 20 10 5 10 6.018416045769342 16.615667517750822 0.04549980163574219 3 0.9908657610537353 12.90312936541246 1104.0 31.777297297297295 0.0 - - - - - - - 122.83333333333333 2 6 MX2 myxovirus (influenza virus) resistance 2 (mouse) 159 21 C20140527_SFK016_02 C20140527_SFK016_02 ODP2_ECOLI.AEAPAAAPAAK.2y7.peptide 484.26 / 599.35 957534.0 16.033899307250977 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 957534.0 4022.180281855428 0.0 - - - - - - - 678.25 1915 8 161 21 C20140527_SFK016_02 C20140527_SFK016_02 ODP2_ECOLI.AEAPAAAPAAK.2y8.peptide 484.26 / 696.4 1492810.0 16.033899307250977 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1492810.0 8482.365857572742 0.0 - - - - - - - 276.0 2985 6 163 21 C20140527_SFK016_02 C20140527_SFK016_02 ODP2_ECOLI.AEAPAAAPAAK.2y6.peptide 484.26 / 528.31 785825.0 16.033899307250977 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 785825.0 845.8852771113457 0.0 - - - - - - - 314.5 1571 8 165 22 C20140527_SFK016_02 C20140527_SFK016_02 TB526469.[MT7]-LIEPIPDSHIR.3y6_1.heavy 478.613 / 724.374 46740.0 32.2843017578125 48 18 10 10 10 6.372337767942627 15.692827913653737 0.0 3 0.9884920969588762 11.493357253871586 46740.0 85.30835734870317 0.0 - - - - - - - 283.8888888888889 93 9 MID1 midline 1 (Opitz/BBB syndrome) 167 22 C20140527_SFK016_02 C20140527_SFK016_02 TB526469.[MT7]-LIEPIPDSHIR.3y4_1.heavy 478.613 / 512.294 29899.0 32.2843017578125 48 18 10 10 10 6.372337767942627 15.692827913653737 0.0 3 0.9884920969588762 11.493357253871586 29899.0 68.64728745491568 0.0 - - - - - - - 714.8888888888889 59 9 MID1 midline 1 (Opitz/BBB syndrome) 169 22 C20140527_SFK016_02 C20140527_SFK016_02 TB526469.[MT7]-LIEPIPDSHIR.3b3_1.heavy 478.613 / 500.32 69353.0 32.2843017578125 48 18 10 10 10 6.372337767942627 15.692827913653737 0.0 3 0.9884920969588762 11.493357253871586 69353.0 104.01032933734484 0.0 - - - - - - - 473.0 138 2 MID1 midline 1 (Opitz/BBB syndrome) 171 22 C20140527_SFK016_02 C20140527_SFK016_02 TB526469.[MT7]-LIEPIPDSHIR.3y5_1.heavy 478.613 / 627.321 15139.0 32.2843017578125 48 18 10 10 10 6.372337767942627 15.692827913653737 0.0 3 0.9884920969588762 11.493357253871586 15139.0 98.27923528189389 0.0 - - - - - - - 212.91666666666666 30 12 MID1 midline 1 (Opitz/BBB syndrome) 173 23 C20140527_SFK016_02 C20140527_SFK016_02 TB397799.[MT7]-LIQTC[CAM]QHVEVNASR.3y7_1.heavy 600.317 / 774.41 27443.0 26.074199676513672 41 16 10 5 10 4.320765639650863 23.144046296406035 0.040599822998046875 3 0.9602193805486281 6.167033019980401 27443.0 33.86547152612234 0.0 - - - - - - - 317.0 54 10 MID1 midline 1 (Opitz/BBB syndrome) 175 23 C20140527_SFK016_02 C20140527_SFK016_02 TB397799.[MT7]-LIQTC[CAM]QHVEVNASR.3y6_1.heavy 600.317 / 675.342 37829.0 26.074199676513672 41 16 10 5 10 4.320765639650863 23.144046296406035 0.040599822998046875 3 0.9602193805486281 6.167033019980401 37829.0 39.26067368789769 0.0 - - - - - - - 306.0 75 5 MID1 midline 1 (Opitz/BBB syndrome) 177 23 C20140527_SFK016_02 C20140527_SFK016_02 TB397799.[MT7]-LIQTC[CAM]QHVEVNASR.3y8_1.heavy 600.317 / 911.469 11480.0 26.074199676513672 41 16 10 5 10 4.320765639650863 23.144046296406035 0.040599822998046875 3 0.9602193805486281 6.167033019980401 11480.0 17.875241312533618 0.0 - - - - - - - 240.4 22 5 MID1 midline 1 (Opitz/BBB syndrome) 179 23 C20140527_SFK016_02 C20140527_SFK016_02 TB397799.[MT7]-LIQTC[CAM]QHVEVNASR.3y5_1.heavy 600.317 / 546.299 16400.0 26.074199676513672 41 16 10 5 10 4.320765639650863 23.144046296406035 0.040599822998046875 3 0.9602193805486281 6.167033019980401 16400.0 14.886117810254355 0.0 - - - - - - - 182.0 32 3 MID1 midline 1 (Opitz/BBB syndrome) 181 24 C20140527_SFK016_02 C20140527_SFK016_02 TB328487.[MT7]-DVVYGPQPQPLENQLLSEETK[MT7].4y5_1.heavy 668.856 / 737.38 48275.0 38.203399658203125 48 18 10 10 10 4.963240412136472 20.14812737168097 0.0 3 0.9893125607881781 11.927185933704093 48275.0 146.43117488971933 0.0 - - - - - - - 288.9166666666667 96 12 GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 183 24 C20140527_SFK016_02 C20140527_SFK016_02 TB328487.[MT7]-DVVYGPQPQPLENQLLSEETK[MT7].4b4_1.heavy 668.856 / 621.336 34027.0 38.203399658203125 48 18 10 10 10 4.963240412136472 20.14812737168097 0.0 3 0.9893125607881781 11.927185933704093 34027.0 75.46170992933988 0.0 - - - - - - - 760.3333333333334 68 9 GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 185 24 C20140527_SFK016_02 C20140527_SFK016_02 TB328487.[MT7]-DVVYGPQPQPLENQLLSEETK[MT7].4b5_1.heavy 668.856 / 678.358 52399.0 38.203399658203125 48 18 10 10 10 4.963240412136472 20.14812737168097 0.0 3 0.9893125607881781 11.927185933704093 52399.0 81.35188011099252 0.0 - - - - - - - 803.4285714285714 104 7 GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 187 24 C20140527_SFK016_02 C20140527_SFK016_02 TB328487.[MT7]-DVVYGPQPQPLENQLLSEETK[MT7].4y6_1.heavy 668.856 / 850.464 21560.0 38.203399658203125 48 18 10 10 10 4.963240412136472 20.14812737168097 0.0 3 0.9893125607881781 11.927185933704093 21560.0 67.06505511674334 0.0 - - - - - - - 726.375 43 8 GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 189 25 C20140527_SFK016_02 C20140527_SFK016_02 TB328093.[MT7]-AQFLIK[MT7].2y4_1.heavy 504.328 / 664.451 13895.0 32.87310028076172 40 16 6 10 8 5.867121194047283 17.044134029728056 0.0 4 0.9606374719045959 6.199917451633546 13895.0 43.19188679153632 0.0 - - - - - - - 717.4285714285714 27 7 KCNG1 potassium voltage-gated channel, subfamily G, member 1 191 25 C20140527_SFK016_02 C20140527_SFK016_02 TB328093.[MT7]-AQFLIK[MT7].2y5_1.heavy 504.328 / 792.51 5665.0 32.87310028076172 40 16 6 10 8 5.867121194047283 17.044134029728056 0.0 4 0.9606374719045959 6.199917451633546 5665.0 47.882516465164194 2.0 - - - - - - - 214.0 25 11 KCNG1 potassium voltage-gated channel, subfamily G, member 1 193 25 C20140527_SFK016_02 C20140527_SFK016_02 TB328093.[MT7]-AQFLIK[MT7].2b4_1.heavy 504.328 / 604.357 10047.0 32.87310028076172 40 16 6 10 8 5.867121194047283 17.044134029728056 0.0 4 0.9606374719045959 6.199917451633546 10047.0 12.11400637703257 0.0 - - - - - - - 778.5714285714286 20 14 KCNG1 potassium voltage-gated channel, subfamily G, member 1 195 25 C20140527_SFK016_02 C20140527_SFK016_02 TB328093.[MT7]-AQFLIK[MT7].2y3_1.heavy 504.328 / 517.383 11650.0 32.87310028076172 40 16 6 10 8 5.867121194047283 17.044134029728056 0.0 4 0.9606374719045959 6.199917451633546 11650.0 15.731894602520764 1.0 - - - - - - - 726.6 44 10 KCNG1 potassium voltage-gated channel, subfamily G, member 1 197 26 C20140527_SFK016_02 C20140527_SFK016_02 TB397493.[MT7]-DISVQAIAC[CAM]R.3b4_1.heavy 426.232 / 559.321 15035.0 31.11639976501465 45 15 10 10 10 3.125099982091501 25.329903726871493 0.0 3 0.9500686316508924 5.499861914667814 15035.0 41.57189030865303 0.0 - - - - - - - 345.53846153846155 30 13 C2CD2 C2 calcium-dependent domain containing 2 199 26 C20140527_SFK016_02 C20140527_SFK016_02 TB397493.[MT7]-DISVQAIAC[CAM]R.3y4_1.heavy 426.232 / 519.271 38369.0 31.11639976501465 45 15 10 10 10 3.125099982091501 25.329903726871493 0.0 3 0.9500686316508924 5.499861914667814 38369.0 59.047142684915386 1.0 - - - - - - - 781.0 76 10 C2CD2 C2 calcium-dependent domain containing 2 201 26 C20140527_SFK016_02 C20140527_SFK016_02 TB397493.[MT7]-DISVQAIAC[CAM]R.3b3_1.heavy 426.232 / 460.252 66681.0 31.11639976501465 45 15 10 10 10 3.125099982091501 25.329903726871493 0.0 3 0.9500686316508924 5.499861914667814 66681.0 144.89273037542662 0.0 - - - - - - - 765.9230769230769 133 13 C2CD2 C2 calcium-dependent domain containing 2 203 26 C20140527_SFK016_02 C20140527_SFK016_02 TB397493.[MT7]-DISVQAIAC[CAM]R.3y5_1.heavy 426.232 / 590.308 49986.0 31.11639976501465 45 15 10 10 10 3.125099982091501 25.329903726871493 0.0 3 0.9500686316508924 5.499861914667814 49986.0 100.97197590988593 0.0 - - - - - - - 767.0 99 7 C2CD2 C2 calcium-dependent domain containing 2 205 27 C20140527_SFK016_02 C20140527_SFK016_02 TB526467.[MT7]-ASVSGPNSPSETR.2y8_1.heavy 716.861 / 887.422 3999.0 18.10832452774048 41 15 10 6 10 14.48462603066503 6.903871718074914 0.03349876403808594 3 0.9528208604224581 5.659328815231551 3999.0 34.92307459786246 0.0 - - - - - - - 171.27272727272728 7 11 MID1 midline 1 (Opitz/BBB syndrome) 207 27 C20140527_SFK016_02 C20140527_SFK016_02 TB526467.[MT7]-ASVSGPNSPSETR.2y12_1.heavy 716.861 / 1217.58 1647.0 18.10832452774048 41 15 10 6 10 14.48462603066503 6.903871718074914 0.03349876403808594 3 0.9528208604224581 5.659328815231551 1647.0 9.44527920104212 0.0 - - - - - - - 126.76923076923077 3 13 MID1 midline 1 (Opitz/BBB syndrome) 209 27 C20140527_SFK016_02 C20140527_SFK016_02 TB526467.[MT7]-ASVSGPNSPSETR.2y9_1.heavy 716.861 / 944.443 8410.0 18.10832452774048 41 15 10 6 10 14.48462603066503 6.903871718074914 0.03349876403808594 3 0.9528208604224581 5.659328815231551 8410.0 85.06181504031593 0.0 - - - - - - - 161.83333333333334 16 12 MID1 midline 1 (Opitz/BBB syndrome) 211 27 C20140527_SFK016_02 C20140527_SFK016_02 TB526467.[MT7]-ASVSGPNSPSETR.2y10_1.heavy 716.861 / 1031.48 10939.0 18.10832452774048 41 15 10 6 10 14.48462603066503 6.903871718074914 0.03349876403808594 3 0.9528208604224581 5.659328815231551 10939.0 181.72819881482013 0.0 - - - - - - - 183.875 21 8 MID1 midline 1 (Opitz/BBB syndrome) 213 28 C20140527_SFK016_02 C20140527_SFK016_02 TB328086.[MT7]-DLIVMLR.2y4_1.heavy 502.308 / 518.312 42049.0 40.92530059814453 48 18 10 10 10 4.681184819449267 21.362113195044675 0.0 3 0.9824312591933898 9.297242526007434 42049.0 143.28196281268112 0.0 - - - - - - - 244.07142857142858 84 14 LOC100287399;LOC100288966;POTED;POTEB;POTEC;POTEE;POTEI;POTEJ;POTEF POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member E;POTE ankyrin domain family, member I;POTE ankyrin domain family, member J;POTE ankyrin domain family, member F 215 28 C20140527_SFK016_02 C20140527_SFK016_02 TB328086.[MT7]-DLIVMLR.2y5_1.heavy 502.308 / 631.396 27622.0 40.92530059814453 48 18 10 10 10 4.681184819449267 21.362113195044675 0.0 3 0.9824312591933898 9.297242526007434 27622.0 87.83043060576745 0.0 - - - - - - - 267.1818181818182 55 11 LOC100287399;LOC100288966;POTED;POTEB;POTEC;POTEE;POTEI;POTEJ;POTEF POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member E;POTE ankyrin domain family, member I;POTE ankyrin domain family, member J;POTE ankyrin domain family, member F 217 28 C20140527_SFK016_02 C20140527_SFK016_02 TB328086.[MT7]-DLIVMLR.2b4_1.heavy 502.308 / 585.373 33844.0 40.92530059814453 48 18 10 10 10 4.681184819449267 21.362113195044675 0.0 3 0.9824312591933898 9.297242526007434 33844.0 193.71479531850264 0.0 - - - - - - - 191.35 67 20 LOC100287399;LOC100288966;POTED;POTEB;POTEC;POTEE;POTEI;POTEJ;POTEF POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member E;POTE ankyrin domain family, member I;POTE ankyrin domain family, member J;POTE ankyrin domain family, member F 219 28 C20140527_SFK016_02 C20140527_SFK016_02 TB328086.[MT7]-DLIVMLR.2y6_1.heavy 502.308 / 744.48 45399.0 40.92530059814453 48 18 10 10 10 4.681184819449267 21.362113195044675 0.0 3 0.9824312591933898 9.297242526007434 45399.0 311.5646145473172 0.0 - - - - - - - 162.92307692307693 90 13 LOC100287399;LOC100288966;POTED;POTEB;POTEC;POTEE;POTEI;POTEJ;POTEF POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member E;POTE ankyrin domain family, member I;POTE ankyrin domain family, member J;POTE ankyrin domain family, member F 221 29 C20140527_SFK016_02 C20140527_SFK016_02 TB397791.[MT7]-GTYTSLQQEVEVK[MT7].2y8_1.heavy 885.48 / 1116.64 1489.0 31.647199630737305 45 15 10 10 10 1.3284193346209023 46.60553973789765 0.0 3 0.9522417159355826 5.624633726864743 1489.0 9.016665394499148 0.0 - - - - - - - 240.92857142857142 2 14 KIF3C kinesin family member 3C 223 29 C20140527_SFK016_02 C20140527_SFK016_02 TB397791.[MT7]-GTYTSLQQEVEVK[MT7].2b7_1.heavy 885.48 / 895.464 3970.0 31.647199630737305 45 15 10 10 10 1.3284193346209023 46.60553973789765 0.0 3 0.9522417159355826 5.624633726864743 3970.0 21.230303030303034 0.0 - - - - - - - 184.14285714285714 7 14 KIF3C kinesin family member 3C 225 29 C20140527_SFK016_02 C20140527_SFK016_02 TB397791.[MT7]-GTYTSLQQEVEVK[MT7].2b5_1.heavy 885.48 / 654.321 3374.0 31.647199630737305 45 15 10 10 10 1.3284193346209023 46.60553973789765 0.0 3 0.9522417159355826 5.624633726864743 3374.0 11.702582317017923 0.0 - - - - - - - 234.54545454545453 6 11 KIF3C kinesin family member 3C 227 29 C20140527_SFK016_02 C20140527_SFK016_02 TB397791.[MT7]-GTYTSLQQEVEVK[MT7].2y3_1.heavy 885.48 / 519.326 4764.0 31.647199630737305 45 15 10 10 10 1.3284193346209023 46.60553973789765 0.0 3 0.9522417159355826 5.624633726864743 4764.0 21.588 0.0 - - - - - - - 239.1764705882353 9 17 KIF3C kinesin family member 3C 229 30 C20140527_SFK016_02 C20140527_SFK016_02 TB328207.[MT7]-WTNFPGLQQLFLK[MT7].3y3_1.heavy 627.361 / 551.367 11063.0 50.75724983215332 39 13 10 6 10 1.223455090140397 48.280613175104065 0.033298492431640625 3 0.9158559233450141 4.224324008390564 11063.0 104.6863556876206 0.0 - - - - - - - 253.52173913043478 22 23 FRYL FRY-like 231 30 C20140527_SFK016_02 C20140527_SFK016_02 TB328207.[MT7]-WTNFPGLQQLFLK[MT7].3b6_1.heavy 627.361 / 847.422 5150.0 50.75724983215332 39 13 10 6 10 1.223455090140397 48.280613175104065 0.033298492431640625 3 0.9158559233450141 4.224324008390564 5150.0 108.02893309222424 0.0 - - - - - - - 116.56521739130434 10 23 FRYL FRY-like 233 30 C20140527_SFK016_02 C20140527_SFK016_02 TB328207.[MT7]-WTNFPGLQQLFLK[MT7].3b4_1.heavy 627.361 / 693.348 10275.0 50.75724983215332 39 13 10 6 10 1.223455090140397 48.280613175104065 0.033298492431640625 3 0.9158559233450141 4.224324008390564 10275.0 84.51985248447204 0.0 - - - - - - - 151.72727272727272 20 22 FRYL FRY-like 235 30 C20140527_SFK016_02 C20140527_SFK016_02 TB328207.[MT7]-WTNFPGLQQLFLK[MT7].3b3_1.heavy 627.361 / 546.279 4572.0 50.75724983215332 39 13 10 6 10 1.223455090140397 48.280613175104065 0.033298492431640625 3 0.9158559233450141 4.224324008390564 4572.0 33.84410393071286 0.0 - - - - - - - 176.56 9 25 FRYL FRY-like 237 31 C20140527_SFK016_02 C20140527_SFK016_02 TB328204.[MT7]-VENDPHFIIYLPK[MT7].3y3_1.heavy 625.02 / 501.352 12217.0 39.93100070953369 46 20 10 6 10 15.173499775294028 6.590437373111717 0.034801483154296875 3 0.9914142959349412 13.309544573127141 12217.0 18.182177923808233 0.0 - - - - - - - 1723.0 24 7 ITIH2 inter-alpha (globulin) inhibitor H2 239 31 C20140527_SFK016_02 C20140527_SFK016_02 TB328204.[MT7]-VENDPHFIIYLPK[MT7].3b4_1.heavy 625.02 / 602.29 75103.0 39.93100070953369 46 20 10 6 10 15.173499775294028 6.590437373111717 0.034801483154296875 3 0.9914142959349412 13.309544573127141 75103.0 50.91069563085399 0.0 - - - - - - - 2662.8571428571427 150 7 ITIH2 inter-alpha (globulin) inhibitor H2 241 31 C20140527_SFK016_02 C20140527_SFK016_02 TB328204.[MT7]-VENDPHFIIYLPK[MT7].3b5_1.heavy 625.02 / 699.343 5639.0 39.93100070953369 46 20 10 6 10 15.173499775294028 6.590437373111717 0.034801483154296875 3 0.9914142959349412 13.309544573127141 5639.0 10.830299432902788 0.0 - - - - - - - 644.6153846153846 11 13 ITIH2 inter-alpha (globulin) inhibitor H2 243 31 C20140527_SFK016_02 C20140527_SFK016_02 TB328204.[MT7]-VENDPHFIIYLPK[MT7].3y5_1.heavy 625.02 / 777.499 9868.0 39.93100070953369 46 20 10 6 10 15.173499775294028 6.590437373111717 0.034801483154296875 3 0.9914142959349412 13.309544573127141 9868.0 13.068504867807937 0.0 - - - - - - - 690.7272727272727 19 11 ITIH2 inter-alpha (globulin) inhibitor H2 245 32 C20140527_SFK016_02 C20140527_SFK016_02 TB526864.[MT7]-SLGWVEMTEEELAPGR.3b6_1.heavy 649.992 / 816.437 26615.0 45.20177459716797 32 18 0 6 8 2.7694003848675655 28.86798544038541 0.0384979248046875 4 0.9856081604619171 10.275003485190927 26615.0 -0.5208414872798457 0.0 - - - - - - - 279.125 53 24 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 247 32 C20140527_SFK016_02 C20140527_SFK016_02 TB526864.[MT7]-SLGWVEMTEEELAPGR.3b4_1.heavy 649.992 / 588.326 20360.0 45.20177459716797 32 18 0 6 8 2.7694003848675655 28.86798544038541 0.0384979248046875 4 0.9856081604619171 10.275003485190927 20360.0 -1.9147335423197518 0.0 - - - - - - - 709.9375 40 16 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 249 32 C20140527_SFK016_02 C20140527_SFK016_02 TB526864.[MT7]-SLGWVEMTEEELAPGR.3b5_1.heavy 649.992 / 687.395 19786.0 45.20177459716797 32 18 0 6 8 2.7694003848675655 28.86798544038541 0.0384979248046875 4 0.9856081604619171 10.275003485190927 19786.0 -0.775921568627453 0.0 - - - - - - - 263.90909090909093 39 22 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 251 32 C20140527_SFK016_02 C20140527_SFK016_02 TB526864.[MT7]-SLGWVEMTEEELAPGR.3y5_1.heavy 649.992 / 513.314 21063.0 45.20177459716797 32 18 0 6 8 2.7694003848675655 28.86798544038541 0.0384979248046875 4 0.9856081604619171 10.275003485190927 21063.0 -0.9001282051282047 1.0 - - - - - - - 740.3333333333334 254 15 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 253 33 C20140527_SFK016_02 C20140527_SFK016_02 TB526761.[MT7]-LFLDC[CAM]EEEQWK[MT7].3b6_1.heavy 595.63 / 922.446 22329.0 39.77730178833008 50 20 10 10 10 10.582621531270721 9.449454438534795 0.0 3 0.9977649570514413 26.099880038558766 22329.0 148.10051020408162 0.0 - - - - - - - 258.3636363636364 44 11 KIF3C kinesin family member 3C 255 33 C20140527_SFK016_02 C20140527_SFK016_02 TB526761.[MT7]-LFLDC[CAM]EEEQWK[MT7].3b4_1.heavy 595.63 / 633.373 71297.0 39.77730178833008 50 20 10 10 10 10.582621531270721 9.449454438534795 0.0 3 0.9977649570514413 26.099880038558766 71297.0 111.25961677977153 0.0 - - - - - - - 359.3333333333333 142 6 KIF3C kinesin family member 3C 257 33 C20140527_SFK016_02 C20140527_SFK016_02 TB526761.[MT7]-LFLDC[CAM]EEEQWK[MT7].3b5_1.heavy 595.63 / 793.404 22525.0 39.77730178833008 50 20 10 10 10 10.582621531270721 9.449454438534795 0.0 3 0.9977649570514413 26.099880038558766 22525.0 93.08801020408163 0.0 - - - - - - - 392.0 45 11 KIF3C kinesin family member 3C 259 33 C20140527_SFK016_02 C20140527_SFK016_02 TB526761.[MT7]-LFLDC[CAM]EEEQWK[MT7].3b3_1.heavy 595.63 / 518.346 39860.0 39.77730178833008 50 20 10 10 10 10.582621531270721 9.449454438534795 0.0 3 0.9977649570514413 26.099880038558766 39860.0 43.89668136221327 0.0 - - - - - - - 741.4285714285714 79 7 KIF3C kinesin family member 3C 261 34 C20140527_SFK016_02 C20140527_SFK016_02 TB525733.[MT7]-LLPSGK[MT7].2y4_1.heavy 451.799 / 532.321 214827.0 26.7337007522583 42 18 10 6 8 1.7289318330609709 42.866303183906254 0.038799285888671875 4 0.9806117292673597 8.848886803080326 214827.0 158.33479517388653 0.0 - - - - - - - 425.0 429 1 HMCN2;ST5 hemicentin 2;suppression of tumorigenicity 5 263 34 C20140527_SFK016_02 C20140527_SFK016_02 TB525733.[MT7]-LLPSGK[MT7].2y4_2.heavy 451.799 / 266.664 4994.0 26.7337007522583 42 18 10 6 8 1.7289318330609709 42.866303183906254 0.038799285888671875 4 0.9806117292673597 8.848886803080326 4994.0 48.42368226557225 0.0 - - - - - - - 308.1 9 10 HMCN2;ST5 hemicentin 2;suppression of tumorigenicity 5 265 34 C20140527_SFK016_02 C20140527_SFK016_02 TB525733.[MT7]-LLPSGK[MT7].2y5_1.heavy 451.799 / 645.405 58328.0 26.7337007522583 42 18 10 6 8 1.7289318330609709 42.866303183906254 0.038799285888671875 4 0.9806117292673597 8.848886803080326 58328.0 91.33810626185958 1.0 - - - - - - - 276.0 218 5 HMCN2;ST5 hemicentin 2;suppression of tumorigenicity 5 267 34 C20140527_SFK016_02 C20140527_SFK016_02 TB525733.[MT7]-LLPSGK[MT7].2y3_1.heavy 451.799 / 435.268 25180.0 26.7337007522583 42 18 10 6 8 1.7289318330609709 42.866303183906254 0.038799285888671875 4 0.9806117292673597 8.848886803080326 25180.0 36.24633502645371 0.0 - - - - - - - 758.7142857142857 50 7 HMCN2;ST5 hemicentin 2;suppression of tumorigenicity 5 269 35 C20140527_SFK016_02 C20140527_SFK016_02 TB526868.[MT7]-AEDHFSVIDFNQNIR.3y7_1.heavy 650.326 / 906.443 64768.0 36.898399353027344 47 17 10 10 10 3.688878335836937 27.108511286076855 0.0 3 0.9752843380616943 7.833893732949172 64768.0 73.84572712680578 0.0 - - - - - - - 261.25 129 8 ITIH2 inter-alpha (globulin) inhibitor H2 271 35 C20140527_SFK016_02 C20140527_SFK016_02 TB526868.[MT7]-AEDHFSVIDFNQNIR.3y6_1.heavy 650.326 / 791.416 36178.0 36.898399353027344 47 17 10 10 10 3.688878335836937 27.108511286076855 0.0 3 0.9752843380616943 7.833893732949172 36178.0 50.14477098405611 0.0 - - - - - - - 815.8333333333334 72 12 ITIH2 inter-alpha (globulin) inhibitor H2 273 35 C20140527_SFK016_02 C20140527_SFK016_02 TB526868.[MT7]-AEDHFSVIDFNQNIR.3b4_1.heavy 650.326 / 597.275 61799.0 36.898399353027344 47 17 10 10 10 3.688878335836937 27.108511286076855 0.0 3 0.9752843380616943 7.833893732949172 61799.0 49.422192759812816 0.0 - - - - - - - 385.0 123 2 ITIH2 inter-alpha (globulin) inhibitor H2 275 35 C20140527_SFK016_02 C20140527_SFK016_02 TB526868.[MT7]-AEDHFSVIDFNQNIR.3y8_1.heavy 650.326 / 1019.53 56631.0 36.898399353027344 47 17 10 10 10 3.688878335836937 27.108511286076855 0.0 3 0.9752843380616943 7.833893732949172 56631.0 76.61205848696758 0.0 - - - - - - - 780.0 113 11 ITIH2 inter-alpha (globulin) inhibitor H2 277 36 C20140527_SFK016_02 C20140527_SFK016_02 TB328358.[MT7]-IQPSGGTNINEALLR.3b6_1.heavy 576.324 / 684.38 55005.0 34.113800048828125 50 20 10 10 10 7.847587788154336 12.74276920494557 0.0 3 0.9956928259999147 18.797935555196915 55005.0 67.88255604847738 0.0 - - - - - - - 324.6666666666667 110 3 ITIH2 inter-alpha (globulin) inhibitor H2 279 36 C20140527_SFK016_02 C20140527_SFK016_02 TB328358.[MT7]-IQPSGGTNINEALLR.3y6_1.heavy 576.324 / 715.41 264198.0 34.113800048828125 50 20 10 10 10 7.847587788154336 12.74276920494557 0.0 3 0.9956928259999147 18.797935555196915 264198.0 219.43414695627592 0.0 - - - - - - - 325.0 528 1 ITIH2 inter-alpha (globulin) inhibitor H2 281 36 C20140527_SFK016_02 C20140527_SFK016_02 TB328358.[MT7]-IQPSGGTNINEALLR.3b8_1.heavy 576.324 / 899.47 89762.0 34.113800048828125 50 20 10 10 10 7.847587788154336 12.74276920494557 0.0 3 0.9956928259999147 18.797935555196915 89762.0 156.51817792276123 0.0 - - - - - - - 216.6 179 5 ITIH2 inter-alpha (globulin) inhibitor H2 283 36 C20140527_SFK016_02 C20140527_SFK016_02 TB328358.[MT7]-IQPSGGTNINEALLR.3y5_1.heavy 576.324 / 601.367 89437.0 34.113800048828125 50 20 10 10 10 7.847587788154336 12.74276920494557 0.0 3 0.9956928259999147 18.797935555196915 89437.0 57.09913091029915 0.0 - - - - - - - 920.75 178 4 ITIH2 inter-alpha (globulin) inhibitor H2 285 37 C20140527_SFK016_02 C20140527_SFK016_02 TB328356.[MT7]-DLLLQLEDETLK[MT7].2y4_1.heavy 859.495 / 634.389 13362.0 47.7515983581543 47 17 10 10 10 10.477502135257721 9.544259567697072 0.0 3 0.9711771309732451 7.251787591019393 13362.0 70.68701581540057 0.0 - - - - - - - 213.47619047619048 26 21 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 287 37 C20140527_SFK016_02 C20140527_SFK016_02 TB328356.[MT7]-DLLLQLEDETLK[MT7].2b4_1.heavy 859.495 / 599.388 34697.0 47.7515983581543 47 17 10 10 10 10.477502135257721 9.544259567697072 0.0 3 0.9711771309732451 7.251787591019393 34697.0 157.83030823765122 0.0 - - - - - - - 252.58823529411765 69 17 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 289 37 C20140527_SFK016_02 C20140527_SFK016_02 TB328356.[MT7]-DLLLQLEDETLK[MT7].2y6_1.heavy 859.495 / 878.459 20082.0 47.7515983581543 47 17 10 10 10 10.477502135257721 9.544259567697072 0.0 3 0.9711771309732451 7.251787591019393 20082.0 111.86919611401729 0.0 - - - - - - - 207.22727272727272 40 22 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 291 37 C20140527_SFK016_02 C20140527_SFK016_02 TB328356.[MT7]-DLLLQLEDETLK[MT7].2b5_1.heavy 859.495 / 727.447 26497.0 47.7515983581543 47 17 10 10 10 10.477502135257721 9.544259567697072 0.0 3 0.9711771309732451 7.251787591019393 26497.0 120.85810342717258 0.0 - - - - - - - 238.55555555555554 52 18 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 293 38 C20140527_SFK016_02 C20140527_SFK016_02 TB328491.[MT7]-C[CAM]QGC[CAM]ASLQQNLNEYVEALITLK[MT7].4y4_1.heavy 710.869 / 618.431 3721.0 53.66550064086914 44 14 10 10 10 1.8302650727061602 42.561953092050665 0.0 3 0.9311472543186985 4.676035595924454 3721.0 46.202416666666664 0.0 - - - - - - - 133.56521739130434 7 23 KIAA0947 KIAA0947 295 38 C20140527_SFK016_02 C20140527_SFK016_02 TB328491.[MT7]-C[CAM]QGC[CAM]ASLQQNLNEYVEALITLK[MT7].4b5_1.heavy 710.869 / 721.288 1613.0 53.66550064086914 44 14 10 10 10 1.8302650727061602 42.561953092050665 0.0 3 0.9311472543186985 4.676035595924454 1613.0 25.0015 0.0 - - - - - - - 95.10526315789474 3 19 KIAA0947 KIAA0947 297 38 C20140527_SFK016_02 C20140527_SFK016_02 TB328491.[MT7]-C[CAM]QGC[CAM]ASLQQNLNEYVEALITLK[MT7].4y3_1.heavy 710.869 / 505.347 6916.0 53.66550064086914 44 14 10 10 10 1.8302650727061602 42.561953092050665 0.0 3 0.9311472543186985 4.676035595924454 6916.0 74.52170731707317 1.0 - - - - - - - 197.6818181818182 13 22 KIAA0947 KIAA0947 299 38 C20140527_SFK016_02 C20140527_SFK016_02 TB328491.[MT7]-C[CAM]QGC[CAM]ASLQQNLNEYVEALITLK[MT7].4b6_1.heavy 710.869 / 808.32 2140.0 53.66550064086914 44 14 10 10 10 1.8302650727061602 42.561953092050665 0.0 3 0.9311472543186985 4.676035595924454 2140.0 16.71875 0.0 - - - - - - - 72.38095238095238 4 21 KIAA0947 KIAA0947 301 39 C20140527_SFK016_02 C20140527_SFK016_02 TB328351.[MT7]-NIC[CAM]FNIDSEPGK[MT7].2b3_1.heavy 841.427 / 532.267 3533.0 33.34214973449707 41 17 10 6 8 8.883993706675108 11.256198878761435 0.039096832275390625 4 0.9710072226211867 7.230403820226224 3533.0 10.013511697513895 0.0 - - - - - - - 223.72727272727272 7 11 ITIH2 inter-alpha (globulin) inhibitor H2 303 39 C20140527_SFK016_02 C20140527_SFK016_02 TB328351.[MT7]-NIC[CAM]FNIDSEPGK[MT7].2y8_1.heavy 841.427 / 1003.52 3533.0 33.34214973449707 41 17 10 6 8 8.883993706675108 11.256198878761435 0.039096832275390625 4 0.9710072226211867 7.230403820226224 3533.0 7.676845794392523 1.0 - - - - - - - 238.69230769230768 7 13 ITIH2 inter-alpha (globulin) inhibitor H2 305 39 C20140527_SFK016_02 C20140527_SFK016_02 TB328351.[MT7]-NIC[CAM]FNIDSEPGK[MT7].2y5_1.heavy 841.427 / 661.364 6745.0 33.34214973449707 41 17 10 6 8 8.883993706675108 11.256198878761435 0.039096832275390625 4 0.9710072226211867 7.230403820226224 6745.0 39.398364485981304 0.0 - - - - - - - 249.66666666666666 13 15 ITIH2 inter-alpha (globulin) inhibitor H2 307 39 C20140527_SFK016_02 C20140527_SFK016_02 TB328351.[MT7]-NIC[CAM]FNIDSEPGK[MT7].2b5_1.heavy 841.427 / 793.378 1820.0 33.34214973449707 41 17 10 6 8 8.883993706675108 11.256198878761435 0.039096832275390625 4 0.9710072226211867 7.230403820226224 1820.0 19.26308411214953 0.0 - - - - - - - 276.4166666666667 3 12 ITIH2 inter-alpha (globulin) inhibitor H2 309 40 C20140527_SFK016_02 C20140527_SFK016_02 ODP2_ECOLI.EAAPAAAPAAAAAK.2y7.peptide 590.82 / 599.35 2283450.0 18.85759925842285 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2283450.0 12923.554157784465 0.0 - - - - - - - 754.0 4566 8 311 40 C20140527_SFK016_02 C20140527_SFK016_02 ODP2_ECOLI.EAAPAAAPAAAAAK.2y9.peptide 590.82 / 741.43 1361430.0 18.85759925842285 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1361430.0 8367.24944527736 0.0 - - - - - - - 760.4444444444445 2722 9 313 40 C20140527_SFK016_02 C20140527_SFK016_02 ODP2_ECOLI.EAAPAAAPAAAAAK.2y11.peptide 590.82 / 909.52 1532680.0 18.85759925842285 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1532680.0 6732.731817813163 0.0 - - - - - - - 1131.0 3065 10 315 41 C20140527_SFK016_02 C20140527_SFK016_02 TB328219.[MT7]-ERDFAYVAR.3y6_1.heavy 424.227 / 726.393 8099.0 25.32349967956543 48 18 10 10 10 4.232368661124605 23.62743135269045 0.0 3 0.9801186210976259 8.73809879113685 8099.0 40.56580649292795 0.0 - - - - - - - 279.55555555555554 16 9 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 317 41 C20140527_SFK016_02 C20140527_SFK016_02 TB328219.[MT7]-ERDFAYVAR.3b5_1.heavy 424.227 / 763.385 7880.0 25.32349967956543 48 18 10 10 10 4.232368661124605 23.62743135269045 0.0 3 0.9801186210976259 8.73809879113685 7880.0 47.75361698930655 1.0 - - - - - - - 218.71428571428572 41 7 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 319 41 C20140527_SFK016_02 C20140527_SFK016_02 TB328219.[MT7]-ERDFAYVAR.3y4_1.heavy 424.227 / 508.288 26815.0 25.32349967956543 48 18 10 10 10 4.232368661124605 23.62743135269045 0.0 3 0.9801186210976259 8.73809879113685 26815.0 56.01763698630137 0.0 - - - - - - - 306.3 53 10 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 321 41 C20140527_SFK016_02 C20140527_SFK016_02 TB328219.[MT7]-ERDFAYVAR.3y5_1.heavy 424.227 / 579.325 9522.0 25.32349967956543 48 18 10 10 10 4.232368661124605 23.62743135269045 0.0 3 0.9801186210976259 8.73809879113685 9522.0 23.488442563421902 0.0 - - - - - - - 339.1 19 10 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 323 42 C20140527_SFK016_02 C20140527_SFK016_02 TB526778.[MT7]-QAVIYESEQTLIK[MT7].3y3_1.heavy 604.012 / 517.383 62673.0 35.15380096435547 48 20 10 10 8 6.774981395152347 14.760188134472557 0.0 4 0.9906092756438977 12.725427323420682 62673.0 7.253812918349288 2.0 - - - - - - - 753.0 209 1 CXorf23 chromosome X open reading frame 23 325 42 C20140527_SFK016_02 C20140527_SFK016_02 TB526778.[MT7]-QAVIYESEQTLIK[MT7].3b4_1.heavy 604.012 / 556.357 144912.0 35.15380096435547 48 20 10 10 8 6.774981395152347 14.760188134472557 0.0 4 0.9906092756438977 12.725427323420682 144912.0 129.58828806723383 0.0 - - - - - - - 323.0 289 1 CXorf23 chromosome X open reading frame 23 327 42 C20140527_SFK016_02 C20140527_SFK016_02 TB526778.[MT7]-QAVIYESEQTLIK[MT7].3b5_1.heavy 604.012 / 719.421 43753.0 35.15380096435547 48 20 10 10 8 6.774981395152347 14.760188134472557 0.0 4 0.9906092756438977 12.725427323420682 43753.0 64.0709802313896 1.0 - - - - - - - 269.25 227 4 CXorf23 chromosome X open reading frame 23 329 42 C20140527_SFK016_02 C20140527_SFK016_02 TB526778.[MT7]-QAVIYESEQTLIK[MT7].3y4_1.heavy 604.012 / 618.431 62243.0 35.15380096435547 48 20 10 10 8 6.774981395152347 14.760188134472557 0.0 4 0.9906092756438977 12.725427323420682 62243.0 63.47026471918065 0.0 - - - - - - - 722.0 124 7 CXorf23 chromosome X open reading frame 23 331 43 C20140527_SFK016_02 C20140527_SFK016_02 TB527047.[MT7]-VDQDTLDC[CAM]DNPEEEQFALEVLPDVLEK[MT7].4b7_1.heavy 862.919 / 931.449 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL1RAPL2 interleukin 1 receptor accessory protein-like 2 333 43 C20140527_SFK016_02 C20140527_SFK016_02 TB527047.[MT7]-VDQDTLDC[CAM]DNPEEEQFALEVLPDVLEK[MT7].4b4_1.heavy 862.919 / 602.29 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL1RAPL2 interleukin 1 receptor accessory protein-like 2 335 43 C20140527_SFK016_02 C20140527_SFK016_02 TB527047.[MT7]-VDQDTLDC[CAM]DNPEEEQFALEVLPDVLEK[MT7].4b5_1.heavy 862.919 / 703.338 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL1RAPL2 interleukin 1 receptor accessory protein-like 2 337 43 C20140527_SFK016_02 C20140527_SFK016_02 TB527047.[MT7]-VDQDTLDC[CAM]DNPEEEQFALEVLPDVLEK[MT7].4y6_1.heavy 862.919 / 844.49 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL1RAPL2 interleukin 1 receptor accessory protein-like 2 339 44 C20140527_SFK016_02 C20140527_SFK016_02 TB525892.[MT7]-NLTDAIAR.2b4_1.heavy 509.294 / 588.311 34686.0 27.559600830078125 50 20 10 10 10 11.306976175435718 8.844097524256654 0.0 3 0.9972265829017016 23.429032296127065 34686.0 63.82295747831607 0.0 - - - - - - - 731.5454545454545 69 11 EDC4 enhancer of mRNA decapping 4 341 44 C20140527_SFK016_02 C20140527_SFK016_02 TB525892.[MT7]-NLTDAIAR.2y6_1.heavy 509.294 / 646.352 26966.0 27.559600830078125 50 20 10 10 10 11.306976175435718 8.844097524256654 0.0 3 0.9972265829017016 23.429032296127065 26966.0 24.07809437757464 0.0 - - - - - - - 265.6666666666667 53 9 EDC4 enhancer of mRNA decapping 4 343 44 C20140527_SFK016_02 C20140527_SFK016_02 TB525892.[MT7]-NLTDAIAR.2b5_1.heavy 509.294 / 659.348 21420.0 27.559600830078125 50 20 10 10 10 11.306976175435718 8.844097524256654 0.0 3 0.9972265829017016 23.429032296127065 21420.0 27.735995601759296 0.0 - - - - - - - 316.27272727272725 42 11 EDC4 enhancer of mRNA decapping 4 345 44 C20140527_SFK016_02 C20140527_SFK016_02 TB525892.[MT7]-NLTDAIAR.2y7_1.heavy 509.294 / 759.436 27836.0 27.559600830078125 50 20 10 10 10 11.306976175435718 8.844097524256654 0.0 3 0.9972265829017016 23.429032296127065 27836.0 45.68220293322459 0.0 - - - - - - - 761.0 55 10 EDC4 enhancer of mRNA decapping 4 347 45 C20140527_SFK016_02 C20140527_SFK016_02 TB525891.[MT7]-ALAEGQQR.2y5_1.heavy 508.784 / 617.3 14064.0 16.890899658203125 50 20 10 10 10 7.792818165926457 12.832328160464833 0.0 3 0.9934358193030333 15.224192051218848 14064.0 158.06442477876107 0.0 - - - - - - - 175.88235294117646 28 17 EDC4 enhancer of mRNA decapping 4 349 45 C20140527_SFK016_02 C20140527_SFK016_02 TB525891.[MT7]-ALAEGQQR.2b4_1.heavy 508.784 / 529.31 10732.0 16.890899658203125 50 20 10 10 10 7.792818165926457 12.832328160464833 0.0 3 0.9934358193030333 15.224192051218848 10732.0 49.44008033640871 0.0 - - - - - - - 240.57894736842104 21 19 EDC4 enhancer of mRNA decapping 4 351 45 C20140527_SFK016_02 C20140527_SFK016_02 TB525891.[MT7]-ALAEGQQR.2y6_1.heavy 508.784 / 688.337 25304.0 16.890899658203125 50 20 10 10 10 7.792818165926457 12.832328160464833 0.0 3 0.9934358193030333 15.224192051218848 25304.0 81.41254872126493 0.0 - - - - - - - 157.14285714285714 50 14 EDC4 enhancer of mRNA decapping 4 353 45 C20140527_SFK016_02 C20140527_SFK016_02 TB525891.[MT7]-ALAEGQQR.2y7_1.heavy 508.784 / 801.421 26829.0 16.890899658203125 50 20 10 10 10 7.792818165926457 12.832328160464833 0.0 3 0.9934358193030333 15.224192051218848 26829.0 225.55353982300886 0.0 - - - - - - - 179.23529411764707 53 17 EDC4 enhancer of mRNA decapping 4 355 46 C20140527_SFK016_02 C20140527_SFK016_02 TB525894.[MT7]-ATEELRR.2b4_1.heavy 509.792 / 575.279 6032.0 16.974599838256836 41 13 10 10 8 1.9501519431072067 39.95998652124645 0.0 4 0.9295521291337092 4.6221629991961155 6032.0 48.65288712422008 0.0 - - - - - - - 197.4375 12 16 MX2 myxovirus (influenza virus) resistance 2 (mouse) 357 46 C20140527_SFK016_02 C20140527_SFK016_02 TB525894.[MT7]-ATEELRR.2b6_1.heavy 509.792 / 844.464 7354.0 16.974599838256836 41 13 10 10 8 1.9501519431072067 39.95998652124645 0.0 4 0.9295521291337092 4.6221629991961155 7354.0 37.55170832702116 0.0 - - - - - - - 195.94117647058823 14 17 MX2 myxovirus (influenza virus) resistance 2 (mouse) 359 46 C20140527_SFK016_02 C20140527_SFK016_02 TB525894.[MT7]-ATEELRR.2y6_1.heavy 509.792 / 803.437 2758.0 16.974599838256836 41 13 10 10 8 1.9501519431072067 39.95998652124645 0.0 4 0.9295521291337092 4.6221629991961155 2758.0 13.427906976744186 1.0 - - - - - - - 196.08333333333334 5 12 MX2 myxovirus (influenza virus) resistance 2 (mouse) 361 46 C20140527_SFK016_02 C20140527_SFK016_02 TB525894.[MT7]-ATEELRR.2b5_1.heavy 509.792 / 688.363 2068.0 16.974599838256836 41 13 10 10 8 1.9501519431072067 39.95998652124645 0.0 4 0.9295521291337092 4.6221629991961155 2068.0 5.5933551831497255 0.0 - - - - - - - 233.3125 4 16 MX2 myxovirus (influenza virus) resistance 2 (mouse) 363 47 C20140527_SFK016_02 C20140527_SFK016_02 TB526877.[MT7]-YSWLLQEQSETATK[MT7].3y6_1.heavy 658.014 / 780.422 7656.0 37.432899475097656 44 14 10 10 10 1.1964281980989921 55.05920514648939 0.0 3 0.9494622282107475 5.466484429833971 7656.0 20.898810810810808 0.0 - - - - - - - 808.7142857142857 15 7 MX2 myxovirus (influenza virus) resistance 2 (mouse) 365 47 C20140527_SFK016_02 C20140527_SFK016_02 TB526877.[MT7]-YSWLLQEQSETATK[MT7].3b4_1.heavy 658.014 / 694.368 24964.0 37.432899475097656 44 14 10 10 10 1.1964281980989921 55.05920514648939 0.0 3 0.9494622282107475 5.466484429833971 24964.0 37.06071894845665 0.0 - - - - - - - 333.0 49 7 MX2 myxovirus (influenza virus) resistance 2 (mouse) 367 47 C20140527_SFK016_02 C20140527_SFK016_02 TB526877.[MT7]-YSWLLQEQSETATK[MT7].3y4_1.heavy 658.014 / 564.347 14645.0 37.432899475097656 44 14 10 10 10 1.1964281980989921 55.05920514648939 0.0 3 0.9494622282107475 5.466484429833971 14645.0 37.82192192192193 0.0 - - - - - - - 777.0 29 11 MX2 myxovirus (influenza virus) resistance 2 (mouse) 369 47 C20140527_SFK016_02 C20140527_SFK016_02 TB526877.[MT7]-YSWLLQEQSETATK[MT7].3b3_1.heavy 658.014 / 581.284 13980.0 37.432899475097656 44 14 10 10 10 1.1964281980989921 55.05920514648939 0.0 3 0.9494622282107475 5.466484429833971 13980.0 28.13992277992278 0.0 - - - - - - - 758.5 27 12 MX2 myxovirus (influenza virus) resistance 2 (mouse) 371 48 C20140527_SFK016_02 C20140527_SFK016_02 TB525744.[MT7]-LFIPER.2y5_1.heavy 459.78 / 661.367 115752.0 34.19919967651367 50 20 10 10 10 86.92848404678288 1.1503709180776962 0.0 2 0.9997984485753443 86.92849064471292 115752.0 104.59845942333891 0.0 - - - - - - - 170.33333333333334 231 3 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 373 48 C20140527_SFK016_02 C20140527_SFK016_02 TB525744.[MT7]-LFIPER.2b5_1.heavy 459.78 / 744.441 7164.0 34.19919967651367 50 20 10 10 10 86.92848404678288 1.1503709180776962 0.0 2 0.9997984485753443 86.92849064471292 7164.0 98.86388522238164 0.0 - - - - - - - 179.0 14 12 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 375 49 C20140527_SFK016_02 C20140527_SFK016_02 TB328422.[MT7]-LTEEC[CAM]DLLIEIIQQR.3y7_1.heavy 673.03 / 899.531 104952.0 51.23540115356445 47 17 10 10 10 3.119436278324154 32.05707412421411 0.0 3 0.9714738760501186 7.28959080715858 104952.0 310.9497838409644 0.0 - - - - - - - 174.05882352941177 209 17 MID1 midline 1 (Opitz/BBB syndrome) 377 49 C20140527_SFK016_02 C20140527_SFK016_02 TB328422.[MT7]-LTEEC[CAM]DLLIEIIQQR.3y6_1.heavy 673.03 / 786.447 140502.0 51.23540115356445 47 17 10 10 10 3.119436278324154 32.05707412421411 0.0 3 0.9714738760501186 7.28959080715858 140502.0 518.2344733663186 0.0 - - - - - - - 185.2941176470588 281 17 MID1 midline 1 (Opitz/BBB syndrome) 379 49 C20140527_SFK016_02 C20140527_SFK016_02 TB328422.[MT7]-LTEEC[CAM]DLLIEIIQQR.3b6_1.heavy 673.03 / 892.384 183594.0 51.23540115356445 47 17 10 10 10 3.119436278324154 32.05707412421411 0.0 3 0.9714738760501186 7.28959080715858 183594.0 742.1763074039363 0.0 - - - - - - - 183.83333333333334 367 12 MID1 midline 1 (Opitz/BBB syndrome) 381 49 C20140527_SFK016_02 C20140527_SFK016_02 TB328422.[MT7]-LTEEC[CAM]DLLIEIIQQR.3b7_1.heavy 673.03 / 1005.47 128281.0 51.23540115356445 47 17 10 10 10 3.119436278324154 32.05707412421411 0.0 3 0.9714738760501186 7.28959080715858 128281.0 728.3643453504533 0.0 - - - - - - - 199.27777777777777 256 18 MID1 midline 1 (Opitz/BBB syndrome) 383 50 C20140527_SFK016_02 C20140527_SFK016_02 TB526988.[MT7]-NQFNFPFVETYTVEEVK[MT7].4b7_1.heavy 595.558 / 1039.51 N/A N/A - - - - - - - - - 0.0 - - - - - - - CERKL ceramide kinase-like 385 50 C20140527_SFK016_02 C20140527_SFK016_02 TB526988.[MT7]-NQFNFPFVETYTVEEVK[MT7].4b5_1.heavy 595.558 / 795.391 N/A N/A - - - - - - - - - 0.0 - - - - - - - CERKL ceramide kinase-like 387 50 C20140527_SFK016_02 C20140527_SFK016_02 TB526988.[MT7]-NQFNFPFVETYTVEEVK[MT7].4y3_1.heavy 595.558 / 519.326 N/A N/A - - - - - - - - - 0.0 - - - - - - - CERKL ceramide kinase-like 389 50 C20140527_SFK016_02 C20140527_SFK016_02 TB526988.[MT7]-NQFNFPFVETYTVEEVK[MT7].4b3_1.heavy 595.558 / 534.279 N/A N/A - - - - - - - - - 0.0 - - - - - - - CERKL ceramide kinase-like 391 51 C20140527_SFK016_02 C20140527_SFK016_02 OPPA_ECOLI.LAIAASSLWK.2y7.peptide 530.31 / 762.41 N/A N/A - - - - - - - - - 0.0 - - - - - - - 393 51 C20140527_SFK016_02 C20140527_SFK016_02 OPPA_ECOLI.LAIAASSLWK.2y8.peptide 530.31 / 875.5 N/A N/A - - - - - - - - - 0.0 - - - - - - - 395 51 C20140527_SFK016_02 C20140527_SFK016_02 OPPA_ECOLI.LAIAASSLWK.2y6.peptide 530.31 / 691.38 N/A N/A - - - - - - - - - 0.0 - - - - - - - 397 52 C20140527_SFK016_02 C20140527_SFK016_02 TB328428.[MT7]-RNVTLQNIIDRFQK[MT7].4y8_2.heavy 509.052 / 589.344 92451.0 38.83509826660156 37 7 10 10 10 0.6037717937328816 75.16395492264598 0.0 3 0.728896903760361 2.3144932047132705 92451.0 387.2755988795518 0.0 - - - - - - - 243.57142857142858 184 14 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 399 52 C20140527_SFK016_02 C20140527_SFK016_02 TB328428.[MT7]-RNVTLQNIIDRFQK[MT7].4b4_1.heavy 509.052 / 615.37 23441.0 38.83509826660156 37 7 10 10 10 0.6037717937328816 75.16395492264598 0.0 3 0.728896903760361 2.3144932047132705 23441.0 94.43374285714285 0.0 - - - - - - - 674.8571428571429 46 7 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 401 52 C20140527_SFK016_02 C20140527_SFK016_02 TB328428.[MT7]-RNVTLQNIIDRFQK[MT7].4y3_1.heavy 509.052 / 566.342 17843.0 38.83509826660156 37 7 10 10 10 0.6037717937328816 75.16395492264598 0.0 3 0.728896903760361 2.3144932047132705 17843.0 68.21344243964421 0.0 - - - - - - - 218.41666666666666 35 12 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 403 52 C20140527_SFK016_02 C20140527_SFK016_02 TB328428.[MT7]-RNVTLQNIIDRFQK[MT7].4b3_1.heavy 509.052 / 514.322 10059.0 38.83509826660156 37 7 10 10 10 0.6037717937328816 75.16395492264598 0.0 3 0.728896903760361 2.3144932047132705 10059.0 49.885473282442746 0.0 - - - - - - - 256.75 20 16 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 405 53 C20140527_SFK016_02 C20140527_SFK016_02 TB526987.[MT7]-NQFNFPFVETYTVEEVK[MT7].3y6_1.heavy 793.742 / 848.485 N/A N/A - - - - - - - - - 0.0 - - - - - - - CERKL ceramide kinase-like 407 53 C20140527_SFK016_02 C20140527_SFK016_02 TB526987.[MT7]-NQFNFPFVETYTVEEVK[MT7].3b3_1.heavy 793.742 / 534.279 N/A N/A - - - - - - - - - 0.0 - - - - - - - CERKL ceramide kinase-like 409 53 C20140527_SFK016_02 C20140527_SFK016_02 TB526987.[MT7]-NQFNFPFVETYTVEEVK[MT7].3y5_1.heavy 793.742 / 747.437 N/A N/A - - - - - - - - - 0.0 - - - - - - - CERKL ceramide kinase-like 411 53 C20140527_SFK016_02 C20140527_SFK016_02 TB526987.[MT7]-NQFNFPFVETYTVEEVK[MT7].3b7_1.heavy 793.742 / 1039.51 N/A N/A - - - - - - - - - 0.0 - - - - - - - CERKL ceramide kinase-like 413 54 C20140527_SFK016_02 C20140527_SFK016_02 TB328427.[MT7]-RNVTLQNIIDRFQK[MT7].3y6_1.heavy 678.4 / 950.554 4980.0 38.83509826660156 32 14 0 10 8 2.9616328274832333 23.14734781796866 0.0 4 0.9361320266595353 4.857153082174255 4980.0 15.253315371950308 1.0 - - - - - - - 280.7857142857143 9 14 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 415 54 C20140527_SFK016_02 C20140527_SFK016_02 TB328427.[MT7]-RNVTLQNIIDRFQK[MT7].3y3_1.heavy 678.4 / 566.342 3931.0 38.83509826660156 32 14 0 10 8 2.9616328274832333 23.14734781796866 0.0 4 0.9361320266595353 4.857153082174255 3931.0 6.115111950327922 0.0 - - - - - - - 742.6 7 10 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 417 54 C20140527_SFK016_02 C20140527_SFK016_02 TB328427.[MT7]-RNVTLQNIIDRFQK[MT7].3b5_1.heavy 678.4 / 728.453 1573.0 38.83509826660156 32 14 0 10 8 2.9616328274832333 23.14734781796866 0.0 4 0.9361320266595353 4.857153082174255 1573.0 4.302735368956744 4.0 - - - - - - - 631.0 3 9 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 419 54 C20140527_SFK016_02 C20140527_SFK016_02 TB328427.[MT7]-RNVTLQNIIDRFQK[MT7].3b7_1.heavy 678.4 / 970.555 5242.0 38.83509826660156 32 14 0 10 8 2.9616328274832333 23.14734781796866 0.0 4 0.9361320266595353 4.857153082174255 5242.0 20.370339157630582 1.0 - - - - - - - 276.5 54 18 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 421 55 C20140527_SFK016_02 C20140527_SFK016_02 TB328326.[MT7]-ALLLYGADIESK[MT7].2y4_1.heavy 790.961 / 620.374 8113.0 39.9483757019043 39 13 10 6 10 1.870551026538782 42.62531204231968 0.034698486328125 3 0.9034054987034703 3.9384622345927336 8113.0 22.304199380142837 0.0 - - - - - - - 306.76190476190476 16 21 LOC100287399;LOC100288966;POTEH;POTED;POTEB;POTEC;POTEG;POTEE;POTEM;POTEI;POTEJ;POTEF POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member H;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member G;POTE ankyrin domain family, member E;POTE ankyrin domain family, member M;POTE ankyrin domain family, member I;POTE ankyrin domain family, member J;POTE ankyrin domain family, member F 423 55 C20140527_SFK016_02 C20140527_SFK016_02 TB328326.[MT7]-ALLLYGADIESK[MT7].2y8_1.heavy 790.961 / 1026.52 19259.0 39.9483757019043 39 13 10 6 10 1.870551026538782 42.62531204231968 0.034698486328125 3 0.9034054987034703 3.9384622345927336 19259.0 67.25655220414697 0.0 - - - - - - - 654.0 38 8 LOC100287399;LOC100288966;POTEH;POTED;POTEB;POTEC;POTEG;POTEE;POTEM;POTEI;POTEJ;POTEF POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member H;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member G;POTE ankyrin domain family, member E;POTE ankyrin domain family, member M;POTE ankyrin domain family, member I;POTE ankyrin domain family, member J;POTE ankyrin domain family, member F 425 55 C20140527_SFK016_02 C20140527_SFK016_02 TB328326.[MT7]-ALLLYGADIESK[MT7].2y3_1.heavy 790.961 / 507.289 3488.0 39.9483757019043 39 13 10 6 10 1.870551026538782 42.62531204231968 0.034698486328125 3 0.9034054987034703 3.9384622345927336 3488.0 1.5331868131868134 2.0 - - - - - - - 235.83333333333334 7 18 LOC100287399;LOC100288966;POTEH;POTED;POTEB;POTEC;POTEG;POTEE;POTEM;POTEI;POTEJ;POTEF POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member H;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member G;POTE ankyrin domain family, member E;POTE ankyrin domain family, member M;POTE ankyrin domain family, member I;POTE ankyrin domain family, member J;POTE ankyrin domain family, member F 427 55 C20140527_SFK016_02 C20140527_SFK016_02 TB328326.[MT7]-ALLLYGADIESK[MT7].2y7_1.heavy 790.961 / 863.459 15013.0 39.9483757019043 39 13 10 6 10 1.870551026538782 42.62531204231968 0.034698486328125 3 0.9034054987034703 3.9384622345927336 15013.0 62.691648351648354 0.0 - - - - - - - 294.8333333333333 30 18 LOC100287399;LOC100288966;POTEH;POTED;POTEB;POTEC;POTEG;POTEE;POTEM;POTEI;POTEJ;POTEF POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member H;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member G;POTE ankyrin domain family, member E;POTE ankyrin domain family, member M;POTE ankyrin domain family, member I;POTE ankyrin domain family, member J;POTE ankyrin domain family, member F 429 56 C20140527_SFK016_02 C20140527_SFK016_02 TB525915.[MT7]-LDEFSK[MT7].2b3_1.heavy 513.789 / 502.263 9782.0 28.451849937438965 46 20 10 6 10 4.377048207879258 18.033621710682944 0.033000946044921875 3 0.9939019247907086 15.795924080701656 9782.0 14.782282108135767 0.0 - - - - - - - 1171.0 19 8 KIAA0947 KIAA0947 431 56 C20140527_SFK016_02 C20140527_SFK016_02 TB525915.[MT7]-LDEFSK[MT7].2y4_1.heavy 513.789 / 654.358 16338.0 28.451849937438965 46 20 10 6 10 4.377048207879258 18.033621710682944 0.033000946044921875 3 0.9939019247907086 15.795924080701656 16338.0 29.64204909284952 0.0 - - - - - - - 776.6153846153846 32 13 KIAA0947 KIAA0947 433 56 C20140527_SFK016_02 C20140527_SFK016_02 TB525915.[MT7]-LDEFSK[MT7].2y5_1.heavy 513.789 / 769.385 24663.0 28.451849937438965 46 20 10 6 10 4.377048207879258 18.033621710682944 0.033000946044921875 3 0.9939019247907086 15.795924080701656 24663.0 41.61342982628429 0.0 - - - - - - - 741.5 49 8 KIAA0947 KIAA0947 435 56 C20140527_SFK016_02 C20140527_SFK016_02 TB525915.[MT7]-LDEFSK[MT7].2y3_1.heavy 513.789 / 525.315 12176.0 28.451849937438965 46 20 10 6 10 4.377048207879258 18.033621710682944 0.033000946044921875 3 0.9939019247907086 15.795924080701656 12176.0 19.65143351568863 0.0 - - - - - - - 662.0 24 11 KIAA0947 KIAA0947 437 57 C20140527_SFK016_02 C20140527_SFK016_02 TB526388.[MT7]-ELLGFVNYK[MT7].3y3_1.heavy 457.602 / 568.321 66181.0 40.462501525878906 50 20 10 10 10 8.596876914057189 11.632131179694447 0.0 3 0.9915815513436879 13.441297416721097 66181.0 -1.7355157342657357 0.0 - - - - - - - 320.5 132 6 MX2 myxovirus (influenza virus) resistance 2 (mouse) 439 57 C20140527_SFK016_02 C20140527_SFK016_02 TB526388.[MT7]-ELLGFVNYK[MT7].3b4_1.heavy 457.602 / 557.341 103162.0 40.462501525878906 50 20 10 10 10 8.596876914057189 11.632131179694447 0.0 3 0.9915815513436879 13.441297416721097 103162.0 -7.044178900648685 0.0 - - - - - - - 183.33333333333334 206 3 MX2 myxovirus (influenza virus) resistance 2 (mouse) 441 57 C20140527_SFK016_02 C20140527_SFK016_02 TB526388.[MT7]-ELLGFVNYK[MT7].3b5_1.heavy 457.602 / 704.41 38903.0 40.462501525878906 50 20 10 10 10 8.596876914057189 11.632131179694447 0.0 3 0.9915815513436879 13.441297416721097 38903.0 -3.5430783242258634 0.0 - - - - - - - 229.0 77 6 MX2 myxovirus (influenza virus) resistance 2 (mouse) 443 57 C20140527_SFK016_02 C20140527_SFK016_02 TB526388.[MT7]-ELLGFVNYK[MT7].3b3_1.heavy 457.602 / 500.32 25447.0 40.462501525878906 50 20 10 10 10 8.596876914057189 11.632131179694447 0.0 3 0.9915815513436879 13.441297416721097 25447.0 -3.088228155339806 0.0 - - - - - - - 234.11111111111111 50 9 MX2 myxovirus (influenza virus) resistance 2 (mouse) 445 58 C20140527_SFK016_02 C20140527_SFK016_02 TB525916.[MT7]-ANLNALDR.2y5_1.heavy 515.792 / 588.31 20415.0 26.540649890899658 44 18 10 6 10 7.375994792711523 13.557493302301879 0.03859901428222656 3 0.9808864747744961 8.912464117991655 20415.0 20.960027528621946 1.0 - - - - - - - 294.8 40 5 LOC100287399;POTEH;POTEB;POTEA;POTEC;POTEG;POTEE;POTEM;POTEI;POTEJ;POTEF POTE ankyrin domain family member B-like;POTE ankyrin domain family, member H;POTE ankyrin domain family, member B;POTE ankyrin domain family, member A;POTE ankyrin domain family, member C;POTE ankyrin domain family, member G;POTE ankyrin domain family, member E;POTE ankyrin domain family, member M;POTE ankyrin domain family, member I;POTE ankyrin domain family, member J;POTE ankyrin domain family, member F 447 58 C20140527_SFK016_02 C20140527_SFK016_02 TB525916.[MT7]-ANLNALDR.2b4_1.heavy 515.792 / 557.316 17784.0 26.540649890899658 44 18 10 6 10 7.375994792711523 13.557493302301879 0.03859901428222656 3 0.9808864747744961 8.912464117991655 17784.0 29.759285195623544 1.0 - - - - - - - 736.6 55 10 LOC100287399;POTEH;POTEB;POTEA;POTEC;POTEG;POTEE;POTEM;POTEI;POTEJ;POTEF POTE ankyrin domain family member B-like;POTE ankyrin domain family, member H;POTE ankyrin domain family, member B;POTE ankyrin domain family, member A;POTE ankyrin domain family, member C;POTE ankyrin domain family, member G;POTE ankyrin domain family, member E;POTE ankyrin domain family, member M;POTE ankyrin domain family, member I;POTE ankyrin domain family, member J;POTE ankyrin domain family, member F 449 58 C20140527_SFK016_02 C20140527_SFK016_02 TB525916.[MT7]-ANLNALDR.2b5_1.heavy 515.792 / 628.354 21362.0 26.540649890899658 44 18 10 6 10 7.375994792711523 13.557493302301879 0.03859901428222656 3 0.9808864747744961 8.912464117991655 21362.0 41.13546088284795 0.0 - - - - - - - 710.25 42 12 LOC100287399;POTEH;POTEB;POTEA;POTEC;POTEG;POTEE;POTEM;POTEI;POTEJ;POTEF POTE ankyrin domain family member B-like;POTE ankyrin domain family, member H;POTE ankyrin domain family, member B;POTE ankyrin domain family, member A;POTE ankyrin domain family, member C;POTE ankyrin domain family, member G;POTE ankyrin domain family, member E;POTE ankyrin domain family, member M;POTE ankyrin domain family, member I;POTE ankyrin domain family, member J;POTE ankyrin domain family, member F 451 58 C20140527_SFK016_02 C20140527_SFK016_02 TB525916.[MT7]-ANLNALDR.2y7_1.heavy 515.792 / 815.437 33358.0 26.540649890899658 44 18 10 6 10 7.375994792711523 13.557493302301879 0.03859901428222656 3 0.9808864747744961 8.912464117991655 33358.0 444.7733333333333 0.0 - - - - - - - 236.5 66 8 LOC100287399;POTEH;POTEB;POTEA;POTEC;POTEG;POTEE;POTEM;POTEI;POTEJ;POTEF POTE ankyrin domain family member B-like;POTE ankyrin domain family, member H;POTE ankyrin domain family, member B;POTE ankyrin domain family, member A;POTE ankyrin domain family, member C;POTE ankyrin domain family, member G;POTE ankyrin domain family, member E;POTE ankyrin domain family, member M;POTE ankyrin domain family, member I;POTE ankyrin domain family, member J;POTE ankyrin domain family, member F 453 59 C20140527_SFK016_02 C20140527_SFK016_02 TB525918.[MT7]-NTNPGIK[MT7].2y4_1.heavy 516.308 / 558.373 75870.0 17.98259925842285 50 20 10 10 10 9.036671391353863 11.066021510495371 0.0 3 0.997474246922742 24.551355335474764 75870.0 172.10153661464585 0.0 - - - - - - - 316.9230769230769 151 13 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 455 59 C20140527_SFK016_02 C20140527_SFK016_02 TB525918.[MT7]-NTNPGIK[MT7].2y5_1.heavy 516.308 / 672.416 10645.0 17.98259925842285 50 20 10 10 10 9.036671391353863 11.066021510495371 0.0 3 0.997474246922742 24.551355335474764 10645.0 51.65701232404426 0.0 - - - - - - - 197.2941176470588 21 17 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 457 59 C20140527_SFK016_02 C20140527_SFK016_02 TB525918.[MT7]-NTNPGIK[MT7].2y6_1.heavy 516.308 / 773.464 13645.0 17.98259925842285 50 20 10 10 10 9.036671391353863 11.066021510495371 0.0 3 0.997474246922742 24.551355335474764 13645.0 85.90681864235054 0.0 - - - - - - - 198.21052631578948 27 19 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 459 59 C20140527_SFK016_02 C20140527_SFK016_02 TB525918.[MT7]-NTNPGIK[MT7].2b5_1.heavy 516.308 / 628.317 7469.0 17.98259925842285 50 20 10 10 10 9.036671391353863 11.066021510495371 0.0 3 0.997474246922742 24.551355335474764 7469.0 24.376239019879797 0.0 - - - - - - - 279.45 14 20 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 461 60 C20140527_SFK016_02 C20140527_SFK016_02 TB525710.[MT7]-ELAELR.2y4_1.heavy 437.759 / 488.283 15956.0 27.559600830078125 44 14 10 10 10 2.0053481551920687 41.89659120553571 0.0 3 0.94882100194547 5.431835660393164 15956.0 22.39438596491228 0.0 - - - - - - - 705.3636363636364 31 11 EDC4;FASLG;ROS1;QRICH2;ProSAPiP1 enhancer of mRNA decapping 4;Fas ligand (TNF superfamily, member 6);c-ros oncogene 1 , receptor tyrosine kinase;glutamine rich 2;ProSAPiP1 protein 463 60 C20140527_SFK016_02 C20140527_SFK016_02 TB525710.[MT7]-ELAELR.2b3_1.heavy 437.759 / 458.273 21530.0 27.559600830078125 44 14 10 10 10 2.0053481551920687 41.89659120553571 0.0 3 0.94882100194547 5.431835660393164 21530.0 11.925020215372 1.0 - - - - - - - 777.1111111111111 43 9 EDC4;FASLG;ROS1;QRICH2;ProSAPiP1 enhancer of mRNA decapping 4;Fas ligand (TNF superfamily, member 6);c-ros oncogene 1 , receptor tyrosine kinase;glutamine rich 2;ProSAPiP1 protein 465 60 C20140527_SFK016_02 C20140527_SFK016_02 TB525710.[MT7]-ELAELR.2y5_1.heavy 437.759 / 601.367 37704.0 27.559600830078125 44 14 10 10 10 2.0053481551920687 41.89659120553571 0.0 3 0.94882100194547 5.431835660393164 37704.0 93.59668186721763 0.0 - - - - - - - 296.7142857142857 75 7 EDC4;FASLG;ROS1;QRICH2;ProSAPiP1 enhancer of mRNA decapping 4;Fas ligand (TNF superfamily, member 6);c-ros oncogene 1 , receptor tyrosine kinase;glutamine rich 2;ProSAPiP1 protein 467 60 C20140527_SFK016_02 C20140527_SFK016_02 TB525710.[MT7]-ELAELR.2b4_1.heavy 437.759 / 587.316 61092.0 27.559600830078125 44 14 10 10 10 2.0053481551920687 41.89659120553571 0.0 3 0.94882100194547 5.431835660393164 61092.0 41.540445751016634 0.0 - - - - - - - 437.0 122 1 EDC4;FASLG;ROS1;QRICH2;ProSAPiP1 enhancer of mRNA decapping 4;Fas ligand (TNF superfamily, member 6);c-ros oncogene 1 , receptor tyrosine kinase;glutamine rich 2;ProSAPiP1 protein 469 61 C20140527_SFK016_02 C20140527_SFK016_02 TB525711.[MT7]-AQGSPK[MT7].2y4_1.heavy 438.263 / 532.321 N/A N/A - - - - - - - - - 0.0 - - - - - - - CERKL ceramide kinase-like 471 61 C20140527_SFK016_02 C20140527_SFK016_02 TB525711.[MT7]-AQGSPK[MT7].2y5_1.heavy 438.263 / 660.38 N/A N/A - - - - - - - - - 0.0 - - - - - - - CERKL ceramide kinase-like 473 61 C20140527_SFK016_02 C20140527_SFK016_02 TB525711.[MT7]-AQGSPK[MT7].2b4_1.heavy 438.263 / 488.259 N/A N/A - - - - - - - - - 0.0 - - - - - - - CERKL ceramide kinase-like 475 61 C20140527_SFK016_02 C20140527_SFK016_02 TB525711.[MT7]-AQGSPK[MT7].2y3_1.heavy 438.263 / 475.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - CERKL ceramide kinase-like 477 62 C20140527_SFK016_02 C20140527_SFK016_02 TB525911.[MT7]-LTQMLK[MT7].2y4_1.heavy 511.32 / 663.398 10849.0 31.89240074157715 48 20 10 10 8 4.802413831666406 20.82286189928382 0.0 4 0.9922917190741862 14.04766803384464 10849.0 18.461533613445376 1.0 - - - - - - - 809.0 21 8 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 479 62 C20140527_SFK016_02 C20140527_SFK016_02 TB525911.[MT7]-LTQMLK[MT7].2y5_1.heavy 511.32 / 764.446 33594.0 31.89240074157715 48 20 10 10 8 4.802413831666406 20.82286189928382 0.0 4 0.9922917190741862 14.04766803384464 33594.0 31.356032995563794 0.0 - - - - - - - 1713.0 67 9 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 481 62 C20140527_SFK016_02 C20140527_SFK016_02 TB525911.[MT7]-LTQMLK[MT7].2b4_1.heavy 511.32 / 618.34 13133.0 31.89240074157715 48 20 10 10 8 4.802413831666406 20.82286189928382 0.0 4 0.9922917190741862 14.04766803384464 13133.0 32.15222145132297 1.0 - - - - - - - 341.1666666666667 32 12 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 483 62 C20140527_SFK016_02 C20140527_SFK016_02 TB525911.[MT7]-LTQMLK[MT7].2y3_1.heavy 511.32 / 535.339 23602.0 31.89240074157715 48 20 10 10 8 4.802413831666406 20.82286189928382 0.0 4 0.9922917190741862 14.04766803384464 23602.0 23.70683122380477 0.0 - - - - - - - 697.8888888888889 47 9 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 485 63 C20140527_SFK016_02 C20140527_SFK016_02 TB526582.[MT7]-ALLLYGADIESK[MT7].3b6_1.heavy 527.643 / 775.483 16595.0 39.939701080322266 48 18 10 10 10 5.144473031838619 19.438336906639453 0.0 3 0.9891101036187556 11.815594781794285 16595.0 -2.9558524173028005 0.0 - - - - - - - 187.36363636363637 33 11 LOC100287399;LOC100288966;POTEH;POTED;POTEB;POTEC;POTEG;POTEE;POTEM;POTEI;POTEJ;POTEF POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member H;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member G;POTE ankyrin domain family, member E;POTE ankyrin domain family, member M;POTE ankyrin domain family, member I;POTE ankyrin domain family, member J;POTE ankyrin domain family, member F 487 63 C20140527_SFK016_02 C20140527_SFK016_02 TB526582.[MT7]-ALLLYGADIESK[MT7].3y3_1.heavy 527.643 / 507.289 106054.0 39.939701080322266 48 18 10 10 10 5.144473031838619 19.438336906639453 0.0 3 0.9891101036187556 11.815594781794285 106054.0 -9.002886247877754 0.0 - - - - - - - 314.4 212 5 LOC100287399;LOC100288966;POTEH;POTED;POTEB;POTEC;POTEG;POTEE;POTEM;POTEI;POTEJ;POTEF POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member H;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member G;POTE ankyrin domain family, member E;POTE ankyrin domain family, member M;POTE ankyrin domain family, member I;POTE ankyrin domain family, member J;POTE ankyrin domain family, member F 489 63 C20140527_SFK016_02 C20140527_SFK016_02 TB526582.[MT7]-ALLLYGADIESK[MT7].3b4_1.heavy 527.643 / 555.399 101144.0 39.939701080322266 48 18 10 10 10 5.144473031838619 19.438336906639453 0.0 3 0.9891101036187556 11.815594781794285 101144.0 -18.730370370370366 0.0 - - - - - - - 261.6666666666667 202 6 LOC100287399;LOC100288966;POTEH;POTED;POTEB;POTEC;POTEG;POTEE;POTEM;POTEI;POTEJ;POTEF POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member H;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member G;POTE ankyrin domain family, member E;POTE ankyrin domain family, member M;POTE ankyrin domain family, member I;POTE ankyrin domain family, member J;POTE ankyrin domain family, member F 491 63 C20140527_SFK016_02 C20140527_SFK016_02 TB526582.[MT7]-ALLLYGADIESK[MT7].3b8_1.heavy 527.643 / 961.547 18658.0 39.939701080322266 48 18 10 10 10 5.144473031838619 19.438336906639453 0.0 3 0.9891101036187556 11.815594781794285 18658.0 -1.5200000000000031 0.0 - - - - - - - 266.57142857142856 37 7 LOC100287399;LOC100288966;POTEH;POTED;POTEB;POTEC;POTEG;POTEE;POTEM;POTEI;POTEJ;POTEF POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member H;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member G;POTE ankyrin domain family, member E;POTE ankyrin domain family, member M;POTE ankyrin domain family, member I;POTE ankyrin domain family, member J;POTE ankyrin domain family, member F 493 64 C20140527_SFK016_02 C20140527_SFK016_02 TB328225.[MT7]-DYLTVLQQR.2y4_1.heavy 640.36 / 544.32 13169.0 36.602699279785156 48 18 10 10 10 5.645306899224791 17.71382881127896 0.0 3 0.9829223673090582 9.430365626190092 13169.0 16.351941116289645 0.0 - - - - - - - 309.0 26 3 USP25 ubiquitin specific peptidase 25 495 64 C20140527_SFK016_02 C20140527_SFK016_02 TB328225.[MT7]-DYLTVLQQR.2y8_1.heavy 640.36 / 1020.58 20268.0 36.602699279785156 48 18 10 10 10 5.645306899224791 17.71382881127896 0.0 3 0.9829223673090582 9.430365626190092 20268.0 59.585992217898834 0.0 - - - - - - - 639.8888888888889 40 9 USP25 ubiquitin specific peptidase 25 497 64 C20140527_SFK016_02 C20140527_SFK016_02 TB328225.[MT7]-DYLTVLQQR.2y6_1.heavy 640.36 / 744.436 23560.0 36.602699279785156 48 18 10 10 10 5.645306899224791 17.71382881127896 0.0 3 0.9829223673090582 9.430365626190092 23560.0 38.17243129457739 0.0 - - - - - - - 262.1818181818182 47 11 USP25 ubiquitin specific peptidase 25 499 64 C20140527_SFK016_02 C20140527_SFK016_02 TB328225.[MT7]-DYLTVLQQR.2y7_1.heavy 640.36 / 857.52 9259.0 36.602699279785156 48 18 10 10 10 5.645306899224791 17.71382881127896 0.0 3 0.9829223673090582 9.430365626190092 9259.0 24.98618048233898 0.0 - - - - - - - 655.625 18 8 USP25 ubiquitin specific peptidase 25 501 65 C20140527_SFK016_02 C20140527_SFK016_02 TB328228.[MT7]-RQEIAEQK[MT7].2b3_1.heavy 645.374 / 558.312 880.0 16.353300094604492 44 18 10 10 6 3.9428250644562723 25.362525185679345 0.0 5 0.9825296631179248 9.323466666736774 880.0 1.77351191851446 10.0 - - - - - - - 311.7368421052632 3 19 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 503 65 C20140527_SFK016_02 C20140527_SFK016_02 TB328228.[MT7]-RQEIAEQK[MT7].2y4_1.heavy 645.374 / 619.353 N/A 16.353300094604492 44 18 10 10 6 3.9428250644562723 25.362525185679345 0.0 5 0.9825296631179248 9.323466666736774 704.0 6.017094017094017 4.0 - - - - - - - 0.0 1 0 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 505 65 C20140527_SFK016_02 C20140527_SFK016_02 TB328228.[MT7]-RQEIAEQK[MT7].2b7_1.heavy 645.374 / 999.534 1232.0 16.353300094604492 44 18 10 10 6 3.9428250644562723 25.362525185679345 0.0 5 0.9825296631179248 9.323466666736774 1232.0 23.285084745762717 1.0 - - - - - - - 150.375 2 16 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 507 65 C20140527_SFK016_02 C20140527_SFK016_02 TB328228.[MT7]-RQEIAEQK[MT7].2b6_1.heavy 645.374 / 871.475 2230.0 16.353300094604492 44 18 10 10 6 3.9428250644562723 25.362525185679345 0.0 5 0.9825296631179248 9.323466666736774 2230.0 66.52203389830507 0.0 - - - - - - - 103.0 4 4 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 509 66 C20140527_SFK016_02 C20140527_SFK016_02 TB526581.[MT7]-C[CAM]GADIPSQEADK[MT7].3y6_1.heavy 526.927 / 821.412 4764.0 21.55780029296875 50 20 10 10 10 17.984275667063358 5.560412988060527 0.0 3 0.9986250641526762 33.27908516388193 4764.0 33.800721091939224 0.0 - - - - - - - 204.26315789473685 9 19 MX2 myxovirus (influenza virus) resistance 2 (mouse) 511 66 C20140527_SFK016_02 C20140527_SFK016_02 TB526581.[MT7]-C[CAM]GADIPSQEADK[MT7].3b4_1.heavy 526.927 / 548.226 78281.0 21.55780029296875 50 20 10 10 10 17.984275667063358 5.560412988060527 0.0 3 0.9986250641526762 33.27908516388193 78281.0 226.26604782139484 0.0 - - - - - - - 698.375 156 8 MX2 myxovirus (influenza virus) resistance 2 (mouse) 513 66 C20140527_SFK016_02 C20140527_SFK016_02 TB526581.[MT7]-C[CAM]GADIPSQEADK[MT7].3b5_1.heavy 526.927 / 661.31 33112.0 21.55780029296875 50 20 10 10 10 17.984275667063358 5.560412988060527 0.0 3 0.9986250641526762 33.27908516388193 33112.0 182.86392312264712 0.0 - - - - - - - 256.0 66 17 MX2 myxovirus (influenza virus) resistance 2 (mouse) 515 66 C20140527_SFK016_02 C20140527_SFK016_02 TB526581.[MT7]-C[CAM]GADIPSQEADK[MT7].3y4_1.heavy 526.927 / 606.321 14468.0 21.55780029296875 50 20 10 10 10 17.984275667063358 5.560412988060527 0.0 3 0.9986250641526762 33.27908516388193 14468.0 51.64215297450424 0.0 - - - - - - - 268.05555555555554 28 18 MX2 myxovirus (influenza virus) resistance 2 (mouse) 517 67 C20140527_SFK016_02 C20140527_SFK016_02 TB397535.[MT7]-SVQTEK[MT7].2b3_1.heavy 490.287 / 459.268 1695.0 15.735699653625488 43 15 10 10 8 8.313157786683902 12.029123296586645 0.0 4 0.9509614731611727 5.5501244800779 1695.0 4.272713926005776 1.0 - - - - - - - 602.1818181818181 3 11 KIAA0947 KIAA0947 519 67 C20140527_SFK016_02 C20140527_SFK016_02 TB397535.[MT7]-SVQTEK[MT7].2y4_1.heavy 490.287 / 649.364 2326.0 15.735699653625488 43 15 10 10 8 8.313157786683902 12.029123296586645 0.0 4 0.9509614731611727 5.5501244800779 2326.0 13.151228544713817 0.0 - - - - - - - 178.6 4 15 KIAA0947 KIAA0947 521 67 C20140527_SFK016_02 C20140527_SFK016_02 TB397535.[MT7]-SVQTEK[MT7].2y5_1.heavy 490.287 / 748.432 2050.0 15.735699653625488 43 15 10 10 8 8.313157786683902 12.029123296586645 0.0 4 0.9509614731611727 5.5501244800779 2050.0 14.284508740204943 1.0 - - - - - - - 194.83333333333334 5 18 KIAA0947 KIAA0947 523 67 C20140527_SFK016_02 C20140527_SFK016_02 TB397535.[MT7]-SVQTEK[MT7].2y3_1.heavy 490.287 / 521.305 3548.0 15.735699653625488 43 15 10 10 8 8.313157786683902 12.029123296586645 0.0 4 0.9509614731611727 5.5501244800779 3548.0 26.20674630058834 0.0 - - - - - - - 181.3 7 20 KIAA0947 KIAA0947 525 68 C20140527_SFK016_02 C20140527_SFK016_02 TB397681.[MT7]-ASPLSSDSPVK[MT7].3y3_1.heavy 459.261 / 487.336 61466.0 25.722999572753906 44 14 10 10 10 1.2929434593818907 53.46880315965646 0.0 3 0.9357647035071083 4.8430937708890776 61466.0 32.005545035161745 0.0 - - - - - - - 847.5 122 4 C2CD2 C2 calcium-dependent domain containing 2 527 68 C20140527_SFK016_02 C20140527_SFK016_02 TB397681.[MT7]-ASPLSSDSPVK[MT7].3b4_1.heavy 459.261 / 513.315 39592.0 25.722999572753906 44 14 10 10 10 1.2929434593818907 53.46880315965646 0.0 3 0.9357647035071083 4.8430937708890776 39592.0 10.6853146116359 1.0 - - - - - - - 328.0 80 1 C2CD2 C2 calcium-dependent domain containing 2 529 68 C20140527_SFK016_02 C20140527_SFK016_02 TB397681.[MT7]-ASPLSSDSPVK[MT7].3y4_1.heavy 459.261 / 574.368 20562.0 25.722999572753906 44 14 10 10 10 1.2929434593818907 53.46880315965646 0.0 3 0.9357647035071083 4.8430937708890776 20562.0 34.39306427901904 0.0 - - - - - - - 859.2857142857143 41 7 C2CD2 C2 calcium-dependent domain containing 2 531 68 C20140527_SFK016_02 C20140527_SFK016_02 TB397681.[MT7]-ASPLSSDSPVK[MT7].3y3_2.heavy 459.261 / 244.172 45935.0 25.722999572753906 44 14 10 10 10 1.2929434593818907 53.46880315965646 0.0 3 0.9357647035071083 4.8430937708890776 45935.0 17.867120996604875 0.0 - - - - - - - 1531.0 91 1 C2CD2 C2 calcium-dependent domain containing 2 533 69 C20140527_SFK016_02 C20140527_SFK016_02 TB328336.[MT7]-IYGNQDTSSQLK[MT7].2y6_1.heavy 821.438 / 807.469 2138.0 25.17319965362549 37 14 10 5 8 1.4805269132091265 46.5867529792882 0.048000335693359375 4 0.9368533440827975 4.885116333503818 2138.0 22.98561412720081 0.0 - - - - - - - 160.5 4 8 ITIH2 inter-alpha (globulin) inhibitor H2 535 69 C20140527_SFK016_02 C20140527_SFK016_02 TB328336.[MT7]-IYGNQDTSSQLK[MT7].2y10_1.heavy 821.438 / 1221.62 1069.0 25.17319965362549 37 14 10 5 8 1.4805269132091265 46.5867529792882 0.048000335693359375 4 0.9368533440827975 4.885116333503818 1069.0 6.493925233644859 1.0 - - - - - - - 214.0 2 9 ITIH2 inter-alpha (globulin) inhibitor H2 537 69 C20140527_SFK016_02 C20140527_SFK016_02 TB328336.[MT7]-IYGNQDTSSQLK[MT7].2b4_1.heavy 821.438 / 592.321 1069.0 25.17319965362549 37 14 10 5 8 1.4805269132091265 46.5867529792882 0.048000335693359375 4 0.9368533440827975 4.885116333503818 1069.0 4.246028037383177 0.0 - - - - - - - 203.3 2 10 ITIH2 inter-alpha (globulin) inhibitor H2 539 69 C20140527_SFK016_02 C20140527_SFK016_02 TB328336.[MT7]-IYGNQDTSSQLK[MT7].2b6_1.heavy 821.438 / 835.407 1176.0 25.17319965362549 37 14 10 5 8 1.4805269132091265 46.5867529792882 0.048000335693359375 4 0.9368533440827975 4.885116333503818 1176.0 16.10130841121495 0.0 - - - - - - - 142.66666666666666 2 3 ITIH2 inter-alpha (globulin) inhibitor H2 541 70 C20140527_SFK016_02 C20140527_SFK016_02 TB525728.[MT7]-GLC[CAM]IER.2y4_1.heavy 446.246 / 577.276 5359.0 25.765300750732422 46 20 10 10 6 10.583766570450901 9.448432118598745 0.0 5 0.996621890112948 21.227710186602923 5359.0 10.593063222229786 2.0 - - - - - - - 365.3333333333333 14 12 KIAA0947 KIAA0947 543 70 C20140527_SFK016_02 C20140527_SFK016_02 TB525728.[MT7]-GLC[CAM]IER.2b3_1.heavy 446.246 / 475.246 9646.0 25.765300750732422 46 20 10 10 6 10.583766570450901 9.448432118598745 0.0 5 0.996621890112948 21.227710186602923 9646.0 33.14266666666667 0.0 - - - - - - - 807.5714285714286 19 7 KIAA0947 KIAA0947 545 70 C20140527_SFK016_02 C20140527_SFK016_02 TB525728.[MT7]-GLC[CAM]IER.2y5_1.heavy 446.246 / 690.36 6236.0 25.765300750732422 46 20 10 10 6 10.583766570450901 9.448432118598745 0.0 5 0.996621890112948 21.227710186602923 6236.0 40.858202601699375 0.0 - - - - - - - 221.27272727272728 12 11 KIAA0947 KIAA0947 547 70 C20140527_SFK016_02 C20140527_SFK016_02 TB525728.[MT7]-GLC[CAM]IER.2b4_1.heavy 446.246 / 588.33 N/A 25.765300750732422 46 20 10 10 6 10.583766570450901 9.448432118598745 0.0 5 0.996621890112948 21.227710186602923 4969.0 2.6462438964730155 4.0 - - - - - - - 2185.5714285714284 16 7 KIAA0947 KIAA0947 549 71 C20140527_SFK016_02 C20140527_SFK016_02 TB328335.[MT7]-K[MT7]QPTQFDEDSR.3y7_1.heavy 546.949 / 896.375 4270.0 19.679150104522705 45 18 10 7 10 4.119618415771788 24.274092866745658 0.028200149536132812 3 0.9879489238155376 11.23084268546364 4270.0 83.6727816550349 0.0 - - - - - - - 142.2 8 15 SETBP1 SET binding protein 1 551 71 C20140527_SFK016_02 C20140527_SFK016_02 TB328335.[MT7]-K[MT7]QPTQFDEDSR.3y6_1.heavy 546.949 / 768.316 8954.0 19.679150104522705 45 18 10 7 10 4.119618415771788 24.274092866745658 0.028200149536132812 3 0.9879489238155376 11.23084268546364 8954.0 80.31630629780003 0.0 - - - - - - - 169.52380952380952 17 21 SETBP1 SET binding protein 1 553 71 C20140527_SFK016_02 C20140527_SFK016_02 TB328335.[MT7]-K[MT7]QPTQFDEDSR.3y4_1.heavy 546.949 / 506.22 7828.0 19.679150104522705 45 18 10 7 10 4.119618415771788 24.274092866745658 0.028200149536132812 3 0.9879489238155376 11.23084268546364 7828.0 12.465598122828393 0.0 - - - - - - - 730.0769230769231 15 13 SETBP1 SET binding protein 1 555 71 C20140527_SFK016_02 C20140527_SFK016_02 TB328335.[MT7]-K[MT7]QPTQFDEDSR.3y5_1.heavy 546.949 / 621.247 7294.0 19.679150104522705 45 18 10 7 10 4.119618415771788 24.274092866745658 0.028200149536132812 3 0.9879489238155376 11.23084268546364 7294.0 40.617394133496006 0.0 - - - - - - - 193.96153846153845 14 26 SETBP1 SET binding protein 1 557 72 C20140527_SFK016_02 C20140527_SFK016_02 TB525727.[MT7]-GLDGLK[MT7].2y4_1.heavy 445.781 / 576.347 30372.0 26.685400009155273 48 18 10 10 10 12.329821994097156 8.11041716967808 0.0 3 0.9816500891578559 9.096598773934447 30372.0 69.33991581074581 1.0 - - - - - - - 274.0 60 5 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 559 72 C20140527_SFK016_02 C20140527_SFK016_02 TB525727.[MT7]-GLDGLK[MT7].2y5_1.heavy 445.781 / 689.431 16135.0 26.685400009155273 48 18 10 10 10 12.329821994097156 8.11041716967808 0.0 3 0.9816500891578559 9.096598773934447 16135.0 28.69336483077234 1.0 - - - - - - - 303.125 32 8 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 561 72 C20140527_SFK016_02 C20140527_SFK016_02 TB525727.[MT7]-GLDGLK[MT7].2b4_1.heavy 445.781 / 487.263 14659.0 26.685400009155273 48 18 10 10 10 12.329821994097156 8.11041716967808 0.0 3 0.9816500891578559 9.096598773934447 14659.0 20.844815010095807 2.0 - - - - - - - 777.75 29 8 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 563 72 C20140527_SFK016_02 C20140527_SFK016_02 TB525727.[MT7]-GLDGLK[MT7].2y3_1.heavy 445.781 / 461.32 150488.0 26.685400009155273 48 18 10 10 10 12.329821994097156 8.11041716967808 0.0 3 0.9816500891578559 9.096598773934447 150488.0 154.43065549881828 0.0 - - - - - - - 105.0 300 1 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 565 73 C20140527_SFK016_02 C20140527_SFK016_02 TB526992.[MT7]-VNMYC[CAM]VTDDQLIC[CAM]ALC[CAM]K[MT7].3y6_1.heavy 797.719 / 908.481 5049.0 43.26057529449463 42 16 10 6 10 2.259863142255341 35.27899067857279 0.034099578857421875 3 0.9651319859088822 6.589898153726028 5049.0 18.18307692307692 0.0 - - - - - - - 231.84615384615384 10 13 MID1 midline 1 (Opitz/BBB syndrome) 567 73 C20140527_SFK016_02 C20140527_SFK016_02 TB526992.[MT7]-VNMYC[CAM]VTDDQLIC[CAM]ALC[CAM]K[MT7].3b4_1.heavy 797.719 / 652.325 4768.0 43.26057529449463 42 16 10 6 10 2.259863142255341 35.27899067857279 0.034099578857421875 3 0.9651319859088822 6.589898153726028 4768.0 -6.811428571428571 0.0 - - - - - - - 205.14285714285714 9 14 MID1 midline 1 (Opitz/BBB syndrome) 569 73 C20140527_SFK016_02 C20140527_SFK016_02 TB526992.[MT7]-VNMYC[CAM]VTDDQLIC[CAM]ALC[CAM]K[MT7].3b5_1.heavy 797.719 / 812.355 4488.0 43.26057529449463 42 16 10 6 10 2.259863142255341 35.27899067857279 0.034099578857421875 3 0.9651319859088822 6.589898153726028 4488.0 37.18628571428572 0.0 - - - - - - - 166.375 8 16 MID1 midline 1 (Opitz/BBB syndrome) 571 73 C20140527_SFK016_02 C20140527_SFK016_02 TB526992.[MT7]-VNMYC[CAM]VTDDQLIC[CAM]ALC[CAM]K[MT7].3y5_1.heavy 797.719 / 795.397 9046.0 43.26057529449463 42 16 10 6 10 2.259863142255341 35.27899067857279 0.034099578857421875 3 0.9651319859088822 6.589898153726028 9046.0 21.751838888559313 0.0 - - - - - - - 648.625 18 8 MID1 midline 1 (Opitz/BBB syndrome) 573 74 C20140527_SFK016_02 C20140527_SFK016_02 TB526062.[MT7]-NDLISATK[MT7].2y4_1.heavy 575.34 / 550.332 35557.0 25.847999572753906 48 18 10 10 10 2.952303694093501 26.30947604445363 0.0 3 0.9840262347653934 9.751668081643423 35557.0 43.1252205177373 0.0 - - - - - - - 255.28571428571428 71 7 ITIH2 inter-alpha (globulin) inhibitor H2 575 74 C20140527_SFK016_02 C20140527_SFK016_02 TB526062.[MT7]-NDLISATK[MT7].2y5_1.heavy 575.34 / 663.416 14799.0 25.847999572753906 48 18 10 10 10 2.952303694093501 26.30947604445363 0.0 3 0.9840262347653934 9.751668081643423 14799.0 55.37603812768425 0.0 - - - - - - - 298.0 29 12 ITIH2 inter-alpha (globulin) inhibitor H2 577 74 C20140527_SFK016_02 C20140527_SFK016_02 TB526062.[MT7]-NDLISATK[MT7].2b4_1.heavy 575.34 / 600.347 16289.0 25.847999572753906 48 18 10 10 10 2.952303694093501 26.30947604445363 0.0 3 0.9840262347653934 9.751668081643423 16289.0 34.32475037328627 0.0 - - - - - - - 362.0 32 14 ITIH2 inter-alpha (globulin) inhibitor H2 579 74 C20140527_SFK016_02 C20140527_SFK016_02 TB526062.[MT7]-NDLISATK[MT7].2y6_1.heavy 575.34 / 776.5 11025.0 25.847999572753906 48 18 10 10 10 2.952303694093501 26.30947604445363 0.0 3 0.9840262347653934 9.751668081643423 11025.0 26.382872320502035 0.0 - - - - - - - 780.2857142857143 22 7 ITIH2 inter-alpha (globulin) inhibitor H2 581 75 C20140527_SFK016_02 C20140527_SFK016_02 TB526796.[MT7]-DVPRPILLGASAPLK[MT7].4b7_1.heavy 459.539 / 935.58 2955.0 36.55950164794922 45 15 10 10 10 8.171608568908017 12.237492674390685 0.0 3 0.9538663648221072 5.723604224956824 2955.0 38.434435088601234 0.0 - - - - - - - 182.0 5 3 VWA5A von Willebrand factor A domain containing 5A 583 75 C20140527_SFK016_02 C20140527_SFK016_02 TB526796.[MT7]-DVPRPILLGASAPLK[MT7].4b7_2.heavy 459.539 / 468.293 36117.0 36.55950164794922 45 15 10 10 10 8.171608568908017 12.237492674390685 0.0 3 0.9538663648221072 5.723604224956824 36117.0 51.84361386315677 0.0 - - - - - - - 218.71428571428572 72 7 VWA5A von Willebrand factor A domain containing 5A 585 75 C20140527_SFK016_02 C20140527_SFK016_02 TB526796.[MT7]-DVPRPILLGASAPLK[MT7].4y3_1.heavy 459.539 / 501.352 108022.0 36.55950164794922 45 15 10 10 10 8.171608568908017 12.237492674390685 0.0 3 0.9538663648221072 5.723604224956824 108022.0 240.10774342976976 0.0 - - - - - - - 750.7142857142857 216 7 VWA5A von Willebrand factor A domain containing 5A 587 75 C20140527_SFK016_02 C20140527_SFK016_02 TB526796.[MT7]-DVPRPILLGASAPLK[MT7].4b9_2.heavy 459.539 / 553.346 71248.0 36.55950164794922 45 15 10 10 10 8.171608568908017 12.237492674390685 0.0 3 0.9538663648221072 5.723604224956824 71248.0 199.64407858363583 1.0 - - - - - - - 232.375 144 8 VWA5A von Willebrand factor A domain containing 5A 589 76 C20140527_SFK016_02 C20140527_SFK016_02 TB526795.[MT7]-DVPRPILLGASAPLK[MT7].3b9_2.heavy 612.383 / 553.346 30643.0 36.602699279785156 48 18 10 10 10 4.17094806560395 19.518457750569166 0.0 3 0.9871801774252146 10.88820535662977 30643.0 44.729313301675674 0.0 - - - - - - - 797.5714285714286 61 7 VWA5A von Willebrand factor A domain containing 5A 591 76 C20140527_SFK016_02 C20140527_SFK016_02 TB526795.[MT7]-DVPRPILLGASAPLK[MT7].3y7_1.heavy 612.383 / 787.479 22982.0 36.602699279785156 48 18 10 10 10 4.17094806560395 19.518457750569166 0.0 3 0.9871801774252146 10.88820535662977 22982.0 11.8184374180864 1.0 - - - - - - - 752.5 50 8 VWA5A von Willebrand factor A domain containing 5A 593 76 C20140527_SFK016_02 C20140527_SFK016_02 TB526795.[MT7]-DVPRPILLGASAPLK[MT7].3y3_1.heavy 612.383 / 501.352 170398.0 36.602699279785156 48 18 10 10 10 4.17094806560395 19.518457750569166 0.0 3 0.9871801774252146 10.88820535662977 170398.0 112.70885987815493 0.0 - - - - - - - 739.0 340 4 VWA5A von Willebrand factor A domain containing 5A 595 76 C20140527_SFK016_02 C20140527_SFK016_02 TB526795.[MT7]-DVPRPILLGASAPLK[MT7].3b7_1.heavy 612.383 / 935.58 17182.0 36.602699279785156 48 18 10 10 10 4.17094806560395 19.518457750569166 0.0 3 0.9871801774252146 10.88820535662977 17182.0 45.765412289201485 0.0 - - - - - - - 336.6923076923077 34 13 VWA5A von Willebrand factor A domain containing 5A 597 77 C20140527_SFK016_02 C20140527_SFK016_02 TB328134.[MT7]-ALQDVQIR.2y4_1.heavy 543.823 / 515.33 135025.0 28.945899963378906 50 20 10 10 10 6.2242886285391545 16.066093005630762 0.0 3 0.9900640448582719 12.370786384007165 135025.0 101.75152329107274 0.0 - - - - - - - 1273.2857142857142 270 7 EDC4 enhancer of mRNA decapping 4 599 77 C20140527_SFK016_02 C20140527_SFK016_02 TB328134.[MT7]-ALQDVQIR.2b4_1.heavy 543.823 / 572.316 120171.0 28.945899963378906 50 20 10 10 10 6.2242886285391545 16.066093005630762 0.0 3 0.9900640448582719 12.370786384007165 120171.0 167.59490025702289 0.0 - - - - - - - 1287.0 240 7 EDC4 enhancer of mRNA decapping 4 601 77 C20140527_SFK016_02 C20140527_SFK016_02 TB328134.[MT7]-ALQDVQIR.2y6_1.heavy 543.823 / 758.416 56444.0 28.945899963378906 50 20 10 10 10 6.2242886285391545 16.066093005630762 0.0 3 0.9900640448582719 12.370786384007165 56444.0 136.09705007837636 0.0 - - - - - - - 617.6666666666666 112 9 EDC4 enhancer of mRNA decapping 4 603 77 C20140527_SFK016_02 C20140527_SFK016_02 TB328134.[MT7]-ALQDVQIR.2y7_1.heavy 543.823 / 871.5 81264.0 28.945899963378906 50 20 10 10 10 6.2242886285391545 16.066093005630762 0.0 3 0.9900640448582719 12.370786384007165 81264.0 341.5732138313506 0.0 - - - - - - - 218.92857142857142 162 14 EDC4 enhancer of mRNA decapping 4 605 78 C20140527_SFK016_02 C20140527_SFK016_02 TB328237.[MT7]-STIIISGISK[MT7].2y5_1.heavy 653.913 / 635.385 29393.0 33.27495098114014 42 16 10 6 10 1.8093310047527795 36.97919538190024 0.037403106689453125 3 0.9625711150440999 6.359089484187684 29393.0 52.58996154845414 0.0 - - - - - - - 705.2 58 10 C2CD2 C2 calcium-dependent domain containing 2 607 78 C20140527_SFK016_02 C20140527_SFK016_02 TB328237.[MT7]-STIIISGISK[MT7].2b4_1.heavy 653.913 / 559.357 31744.0 33.27495098114014 42 16 10 6 10 1.8093310047527795 36.97919538190024 0.037403106689453125 3 0.9625711150440999 6.359089484187684 31744.0 76.54267905056759 0.0 - - - - - - - 690.3846153846154 63 13 C2CD2 C2 calcium-dependent domain containing 2 609 78 C20140527_SFK016_02 C20140527_SFK016_02 TB328237.[MT7]-STIIISGISK[MT7].2y6_1.heavy 653.913 / 748.469 25224.0 33.27495098114014 42 16 10 6 10 1.8093310047527795 36.97919538190024 0.037403106689453125 3 0.9625711150440999 6.359089484187684 25224.0 59.800860661453484 0.0 - - - - - - - 774.75 50 8 C2CD2 C2 calcium-dependent domain containing 2 611 78 C20140527_SFK016_02 C20140527_SFK016_02 TB328237.[MT7]-STIIISGISK[MT7].2y7_1.heavy 653.913 / 861.553 19666.0 33.27495098114014 42 16 10 6 10 1.8093310047527795 36.97919538190024 0.037403106689453125 3 0.9625711150440999 6.359089484187684 19666.0 76.14032027108269 0.0 - - - - - - - 263.38461538461536 39 13 C2CD2 C2 calcium-dependent domain containing 2 613 79 C20140527_SFK016_02 C20140527_SFK016_02 EFTU1_ECO24.FESEVYILSK.2y8.peptide 607.82 / 938.52 1597210.0 35.537601470947266 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1597210.0 145.39532729336338 0.0 - - - - - - - 555.0 3194 1 615 79 C20140527_SFK016_02 C20140527_SFK016_02 EFTU1_ECO24.FESEVYILSK.2y6.peptide 607.82 / 722.44 313529.0 35.537601470947266 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 313529.0 896.1475860475861 0.0 - - - - - - - 277.5 627 2 617 79 C20140527_SFK016_02 C20140527_SFK016_02 EFTU1_ECO24.FESEVYILSK.2y5.peptide 607.82 / 623.38 447439.0 35.537601470947266 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 447439.0 501.1659431038116 0.0 - - - - - - - 777.0 894 2 619 80 C20140527_SFK016_02 C20140527_SFK016_02 TB397800.[MT7]-LVEGEEVVRENETR.3b6_1.heavy 601.65 / 801.411 27982.0 27.71014928817749 41 17 10 6 8 3.5391267616305853 28.255557581081643 0.03940010070800781 4 0.9738889113249706 7.620795918560681 27982.0 120.51653465346536 0.0 - - - - - - - 694.375 55 8 MX2 myxovirus (influenza virus) resistance 2 (mouse) 621 80 C20140527_SFK016_02 C20140527_SFK016_02 TB397800.[MT7]-LVEGEEVVRENETR.3y11_2.heavy 601.65 / 659.323 33841.0 27.71014928817749 41 17 10 6 8 3.5391267616305853 28.255557581081643 0.03940010070800781 4 0.9738889113249706 7.620795918560681 33841.0 12.632075783966355 1.0 - - - - - - - 727.2 100 10 MX2 myxovirus (influenza virus) resistance 2 (mouse) 623 80 C20140527_SFK016_02 C20140527_SFK016_02 TB397800.[MT7]-LVEGEEVVRENETR.3b5_1.heavy 601.65 / 672.369 22729.0 27.71014928817749 41 17 10 6 8 3.5391267616305853 28.255557581081643 0.03940010070800781 4 0.9738889113249706 7.620795918560681 22729.0 56.05531953195319 0.0 - - - - - - - 717.1 45 10 MX2 myxovirus (influenza virus) resistance 2 (mouse) 625 80 C20140527_SFK016_02 C20140527_SFK016_02 TB397800.[MT7]-LVEGEEVVRENETR.3y13_2.heavy 601.65 / 773.379 85662.0 27.71014928817749 41 17 10 6 8 3.5391267616305853 28.255557581081643 0.03940010070800781 4 0.9738889113249706 7.620795918560681 85662.0 355.37007920792075 0.0 - - - - - - - 707.0 171 8 MX2 myxovirus (influenza virus) resistance 2 (mouse) 627 81 C20140527_SFK016_02 C20140527_SFK016_02 TB397801.[MT7]-QAVIYESEQTLIK[MT7].2b3_1.heavy 905.514 / 443.273 16226.0 35.15380096435547 48 18 10 10 10 8.79457678457697 11.370643801230978 0.0 3 0.9865780184651481 10.64062391887803 16226.0 17.087353501927332 1.0 - - - - - - - 276.0 34 8 CXorf23 chromosome X open reading frame 23 629 81 C20140527_SFK016_02 C20140527_SFK016_02 TB397801.[MT7]-QAVIYESEQTLIK[MT7].2y8_1.heavy 905.514 / 1091.61 4084.0 35.15380096435547 48 18 10 10 10 8.79457678457697 11.370643801230978 0.0 3 0.9865780184651481 10.64062391887803 4084.0 15.052809667673717 0.0 - - - - - - - 210.72727272727272 8 11 CXorf23 chromosome X open reading frame 23 631 81 C20140527_SFK016_02 C20140527_SFK016_02 TB397801.[MT7]-QAVIYESEQTLIK[MT7].2b4_1.heavy 905.514 / 556.357 12583.0 35.15380096435547 48 18 10 10 10 8.79457678457697 11.370643801230978 0.0 3 0.9865780184651481 10.64062391887803 12583.0 161.60692143150968 0.0 - - - - - - - 143.2 25 10 CXorf23 chromosome X open reading frame 23 633 81 C20140527_SFK016_02 C20140527_SFK016_02 TB397801.[MT7]-QAVIYESEQTLIK[MT7].2y3_1.heavy 905.514 / 517.383 1987.0 35.15380096435547 48 18 10 10 10 8.79457678457697 11.370643801230978 0.0 3 0.9865780184651481 10.64062391887803 1987.0 6.422553041099015 0.0 - - - - - - - 232.88888888888889 3 9 CXorf23 chromosome X open reading frame 23 635 82 C20140527_SFK016_02 C20140527_SFK016_02 TB397809.[MT7]-C[CAM]GLTPLLLGVHEQK[MT7].3b6_1.heavy 618.357 / 786.43 8964.0 37.732200622558594 44 14 10 10 10 1.1127390441537808 51.61805324033456 0.0 3 0.9464640412419429 5.309856008244316 8964.0 16.96010130188754 0.0 - - - - - - - 608.25 17 8 LOC100287399;LOC100288966;POTED;POTEB;POTEC POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C 637 82 C20140527_SFK016_02 C20140527_SFK016_02 TB397809.[MT7]-C[CAM]GLTPLLLGVHEQK[MT7].3y3_1.heavy 618.357 / 548.316 6744.0 37.732200622558594 44 14 10 10 10 1.1127390441537808 51.61805324033456 0.0 3 0.9464640412419429 5.309856008244316 6744.0 10.32580320281485 0.0 - - - - - - - 729.5454545454545 13 11 LOC100287399;LOC100288966;POTED;POTEB;POTEC POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C 639 82 C20140527_SFK016_02 C20140527_SFK016_02 TB397809.[MT7]-C[CAM]GLTPLLLGVHEQK[MT7].3b4_1.heavy 618.357 / 576.293 8452.0 37.732200622558594 44 14 10 10 10 1.1127390441537808 51.61805324033456 0.0 3 0.9464640412419429 5.309856008244316 8452.0 17.54574780351438 0.0 - - - - - - - 734.2 16 10 LOC100287399;LOC100288966;POTED;POTEB;POTEC POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C 641 82 C20140527_SFK016_02 C20140527_SFK016_02 TB397809.[MT7]-C[CAM]GLTPLLLGVHEQK[MT7].3y4_1.heavy 618.357 / 685.375 8622.0 37.732200622558594 44 14 10 10 10 1.1127390441537808 51.61805324033456 0.0 3 0.9464640412419429 5.309856008244316 8622.0 12.669085377013177 0.0 - - - - - - - 711.5555555555555 17 9 LOC100287399;LOC100288966;POTED;POTEB;POTEC POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C 643 83 C20140527_SFK016_02 C20140527_SFK016_02 TB328309.[MT7]-TAVAPSAVNLADPR.2b8_1.heavy 763.426 / 841.49 857.0 30.164299964904785 46 20 10 6 10 14.844721565033307 6.736401188928304 0.03500175476074219 3 0.9949162208888848 17.301544487078292 857.0 3.608421052631579 1.0 - - - - - - - 0.0 1 0 SRRM2 serine/arginine repetitive matrix 2 645 83 C20140527_SFK016_02 C20140527_SFK016_02 TB328309.[MT7]-TAVAPSAVNLADPR.2y10_1.heavy 763.426 / 1039.55 8186.0 30.164299964904785 46 20 10 6 10 14.844721565033307 6.736401188928304 0.03500175476074219 3 0.9949162208888848 17.301544487078292 8186.0 120.63578947368421 0.0 - - - - - - - 195.94117647058823 16 17 SRRM2 serine/arginine repetitive matrix 2 647 83 C20140527_SFK016_02 C20140527_SFK016_02 TB328309.[MT7]-TAVAPSAVNLADPR.2y11_1.heavy 763.426 / 1110.59 3427.0 30.164299964904785 46 20 10 6 10 14.844721565033307 6.736401188928304 0.03500175476074219 3 0.9949162208888848 17.301544487078292 3427.0 22.20490045165453 0.0 - - - - - - - 208.25 6 16 SRRM2 serine/arginine repetitive matrix 2 649 83 C20140527_SFK016_02 C20140527_SFK016_02 TB328309.[MT7]-TAVAPSAVNLADPR.2b4_1.heavy 763.426 / 487.3 10375.0 30.164299964904785 46 20 10 6 10 14.844721565033307 6.736401188928304 0.03500175476074219 3 0.9949162208888848 17.301544487078292 10375.0 46.64235731417072 0.0 - - - - - - - 272.0 20 14 SRRM2 serine/arginine repetitive matrix 2 651 84 C20140527_SFK016_02 C20140527_SFK016_02 TB328040.[MT7]-YVEQSR.2b3_1.heavy 463.247 / 536.284 5373.0 17.75314998626709 44 18 10 6 10 5.470739481374283 18.279064528746193 0.03529930114746094 3 0.9815897490262133 9.081633380199204 5373.0 19.198231768231768 0.0 - - - - - - - 233.85714285714286 10 21 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 653 84 C20140527_SFK016_02 C20140527_SFK016_02 TB328040.[MT7]-YVEQSR.2y4_1.heavy 463.247 / 519.252 7337.0 17.75314998626709 44 18 10 6 10 5.470739481374283 18.279064528746193 0.03529930114746094 3 0.9815897490262133 9.081633380199204 7337.0 32.433410995344715 0.0 - - - - - - - 220.14285714285714 14 21 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 655 84 C20140527_SFK016_02 C20140527_SFK016_02 TB328040.[MT7]-YVEQSR.2y5_1.heavy 463.247 / 618.321 20220.0 17.75314998626709 44 18 10 6 10 5.470739481374283 18.279064528746193 0.03529930114746094 3 0.9815897490262133 9.081633380199204 20220.0 56.21450625499068 0.0 - - - - - - - 202.28571428571428 40 14 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 657 84 C20140527_SFK016_02 C20140527_SFK016_02 TB328040.[MT7]-YVEQSR.2b4_1.heavy 463.247 / 664.342 2484.0 17.75314998626709 44 18 10 6 10 5.470739481374283 18.279064528746193 0.03529930114746094 3 0.9815897490262133 9.081633380199204 2484.0 14.194285714285716 0.0 - - - - - - - 219.0 4 19 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 659 85 C20140527_SFK016_02 C20140527_SFK016_02 TB328245.[MT7]-LAQQIANC[CAM]K[MT7].2y4_1.heavy 667.379 / 636.326 15461.0 26.762800216674805 48 18 10 10 10 6.616848873366734 15.112933952973718 0.0 3 0.987656657584931 11.09681246360708 15461.0 39.5625389976199 0.0 - - - - - - - 298.7 30 10 MID1 midline 1 (Opitz/BBB syndrome) 661 85 C20140527_SFK016_02 C20140527_SFK016_02 TB328245.[MT7]-LAQQIANC[CAM]K[MT7].2y8_1.heavy 667.379 / 1076.56 8452.0 26.762800216674805 48 18 10 10 10 6.616848873366734 15.112933952973718 0.0 3 0.987656657584931 11.09681246360708 8452.0 14.584203771900459 0.0 - - - - - - - 234.0909090909091 16 11 MID1 midline 1 (Opitz/BBB syndrome) 663 85 C20140527_SFK016_02 C20140527_SFK016_02 TB328245.[MT7]-LAQQIANC[CAM]K[MT7].2b4_1.heavy 667.379 / 585.348 8658.0 26.762800216674805 48 18 10 10 10 6.616848873366734 15.112933952973718 0.0 3 0.987656657584931 11.09681246360708 8658.0 20.839150687141974 0.0 - - - - - - - 257.5 17 10 MID1 midline 1 (Opitz/BBB syndrome) 665 85 C20140527_SFK016_02 C20140527_SFK016_02 TB328245.[MT7]-LAQQIANC[CAM]K[MT7].2y3_1.heavy 667.379 / 565.288 5257.0 26.762800216674805 48 18 10 10 10 6.616848873366734 15.112933952973718 0.0 3 0.987656657584931 11.09681246360708 5257.0 11.449621958528105 0.0 - - - - - - - 687.2222222222222 10 9 MID1 midline 1 (Opitz/BBB syndrome) 667 86 C20140527_SFK016_02 C20140527_SFK016_02 SUCC_ECO24.LVQQFTK.2y4.peptide 432.25 / 523.29 622956.0 22.831199645996094 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 622956.0 722.8591016712237 0.0 - - - - - - - 603.2857142857143 1245 7 669 86 C20140527_SFK016_02 C20140527_SFK016_02 SUCC_ECO24.LVQQFTK.2y6.peptide 432.25 / 750.41 900986.0 22.831199645996094 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 900986.0 4130.957522349936 0.0 - - - - - - - 239.83333333333334 1801 12 671 86 C20140527_SFK016_02 C20140527_SFK016_02 SUCC_ECO24.LVQQFTK.2y5.peptide 432.25 / 651.35 2670280.0 22.831199645996094 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2670280.0 7607.276394322976 0.0 - - - - - - - 150.0 5340 3 673 87 C20140527_SFK016_02 C20140527_SFK016_02 TB328043.[MT7]-AAIQDDR.2y4_1.heavy 466.75 / 533.231 14513.0 16.953700065612793 37 12 10 5 10 1.8028435634911024 42.14227404054821 0.04179954528808594 3 0.89203265380407 3.721593695320272 14513.0 41.277717537658845 0.0 - - - - - - - 345.42857142857144 29 14 KIF3C kinesin family member 3C 675 87 C20140527_SFK016_02 C20140527_SFK016_02 TB328043.[MT7]-AAIQDDR.2y5_1.heavy 466.75 / 646.315 12357.0 16.953700065612793 37 12 10 5 10 1.8028435634911024 42.14227404054821 0.04179954528808594 3 0.89203265380407 3.721593695320272 12357.0 70.00532188841203 0.0 - - - - - - - 181.8235294117647 24 17 KIF3C kinesin family member 3C 677 87 C20140527_SFK016_02 C20140527_SFK016_02 TB328043.[MT7]-AAIQDDR.2y6_1.heavy 466.75 / 717.353 35030.0 16.953700065612793 37 12 10 5 10 1.8028435634911024 42.14227404054821 0.04179954528808594 3 0.89203265380407 3.721593695320272 35030.0 74.56287097068761 0.0 - - - - - - - 229.26666666666668 70 15 KIF3C kinesin family member 3C 679 87 C20140527_SFK016_02 C20140527_SFK016_02 TB328043.[MT7]-AAIQDDR.2b5_1.heavy 466.75 / 643.353 82708.0 16.953700065612793 37 12 10 5 10 1.8028435634911024 42.14227404054821 0.04179954528808594 3 0.89203265380407 3.721593695320272 82708.0 362.98213611281426 0.0 - - - - - - - 334.1333333333333 165 15 KIF3C kinesin family member 3C 681 88 C20140527_SFK016_02 C20140527_SFK016_02 TB328459.[MT7]-GLVSTLQSATEQMAATVAGSVR.4y8_1.heavy 581.062 / 760.431 942.0 53.341400146484375 44 16 10 10 8 2.2728712470395274 38.53348879231011 0.0 4 0.9615511705035343 6.273636977519981 942.0 42.112941176470585 0.0 - - - - - - - 0.0 1 0 EDC4 enhancer of mRNA decapping 4 683 88 C20140527_SFK016_02 C20140527_SFK016_02 TB328459.[MT7]-GLVSTLQSATEQMAATVAGSVR.4b7_1.heavy 581.062 / 843.506 N/A 53.341400146484375 44 16 10 10 8 2.2728712470395274 38.53348879231011 0.0 4 0.9615511705035343 6.273636977519981 20.0 0.6 31.0 - - - - - - - 0.0 0 0 EDC4 enhancer of mRNA decapping 4 685 88 C20140527_SFK016_02 C20140527_SFK016_02 TB328459.[MT7]-GLVSTLQSATEQMAATVAGSVR.4y9_1.heavy 581.062 / 831.468 598.0 53.341400146484375 44 16 10 10 8 2.2728712470395274 38.53348879231011 0.0 4 0.9615511705035343 6.273636977519981 598.0 34.58596721311475 1.0 - - - - - - - 0.0 1 0 EDC4 enhancer of mRNA decapping 4 687 88 C20140527_SFK016_02 C20140527_SFK016_02 TB328459.[MT7]-GLVSTLQSATEQMAATVAGSVR.4y6_1.heavy 581.062 / 588.346 405.0 53.341400146484375 44 16 10 10 8 2.2728712470395274 38.53348879231011 0.0 4 0.9615511705035343 6.273636977519981 405.0 15.074735294117646 2.0 - - - - - - - 0.0 1 0 EDC4 enhancer of mRNA decapping 4 689 89 C20140527_SFK016_02 C20140527_SFK016_02 TB328457.[MT7]-VTFPLQPK[MT7]PDVNLTIHR.4y5_1.heavy 566.585 / 639.394 10775.0 36.13100051879883 41 11 10 10 10 1.4863356728918495 52.42324763541953 0.0 3 0.8645205004721817 3.3143309151608804 10775.0 7.566691021539983 1.0 - - - - - - - 310.8 22 5 VWA5A von Willebrand factor A domain containing 5A 691 89 C20140527_SFK016_02 C20140527_SFK016_02 TB328457.[MT7]-VTFPLQPK[MT7]PDVNLTIHR.4y4_1.heavy 566.585 / 526.31 43987.0 36.13100051879883 41 11 10 10 10 1.4863356728918495 52.42324763541953 0.0 3 0.8645205004721817 3.3143309151608804 43987.0 78.36642462372328 0.0 - - - - - - - 1269.5714285714287 87 7 VWA5A von Willebrand factor A domain containing 5A 693 89 C20140527_SFK016_02 C20140527_SFK016_02 TB328457.[MT7]-VTFPLQPK[MT7]PDVNLTIHR.4y9_1.heavy 566.585 / 1064.58 18217.0 36.13100051879883 41 11 10 10 10 1.4863356728918495 52.42324763541953 0.0 3 0.8645205004721817 3.3143309151608804 18217.0 50.11608775930035 0.0 - - - - - - - 222.0 36 9 VWA5A von Willebrand factor A domain containing 5A 695 89 C20140527_SFK016_02 C20140527_SFK016_02 TB328457.[MT7]-VTFPLQPK[MT7]PDVNLTIHR.4y7_1.heavy 566.585 / 852.505 7442.0 36.13100051879883 41 11 10 10 10 1.4863356728918495 52.42324763541953 0.0 3 0.8645205004721817 3.3143309151608804 7442.0 18.549129129129128 0.0 - - - - - - - 232.0909090909091 14 11 VWA5A von Willebrand factor A domain containing 5A 697 90 C20140527_SFK016_02 C20140527_SFK016_02 TB328313.[MT7]-GLLPGLLPAPADK[MT7].2y4_1.heavy 775.481 / 574.332 10658.0 42.28587532043457 32 9 10 3 10 0.6481524884804708 80.30474310983334 0.0771026611328125 3 0.8037895854851205 2.7392397393581103 10658.0 35.355865384615385 0.0 - - - - - - - 677.8571428571429 21 7 EDC4 enhancer of mRNA decapping 4 699 90 C20140527_SFK016_02 C20140527_SFK016_02 TB328313.[MT7]-GLLPGLLPAPADK[MT7].2y5_1.heavy 775.481 / 645.369 1495.0 42.28587532043457 32 9 10 3 10 0.6481524884804708 80.30474310983334 0.0771026611328125 3 0.8037895854851205 2.7392397393581103 1495.0 2.116 1.0 - - - - - - - 239.6875 2 16 EDC4 enhancer of mRNA decapping 4 701 90 C20140527_SFK016_02 C20140527_SFK016_02 TB328313.[MT7]-GLLPGLLPAPADK[MT7].2y6_1.heavy 775.481 / 742.422 22746.0 42.28587532043457 32 9 10 3 10 0.6481524884804708 80.30474310983334 0.0771026611328125 3 0.8037895854851205 2.7392397393581103 22746.0 49.587433643279795 0.0 - - - - - - - 743.8888888888889 45 9 EDC4 enhancer of mRNA decapping 4 703 90 C20140527_SFK016_02 C20140527_SFK016_02 TB328313.[MT7]-GLLPGLLPAPADK[MT7].2y10_1.heavy 775.481 / 1122.66 15532.0 42.28587532043457 32 9 10 3 10 0.6481524884804708 80.30474310983334 0.0771026611328125 3 0.8037895854851205 2.7392397393581103 15532.0 56.15415384615385 0.0 - - - - - - - 282.94117647058823 31 17 EDC4 enhancer of mRNA decapping 4 705 91 C20140527_SFK016_02 C20140527_SFK016_02 TB525906.[MT7]-TQVADAK[MT7].2y4_1.heavy 510.8 / 548.316 29625.0 16.485175609588623 39 14 10 5 10 2.6741669119921982 29.725142563114133 0.04189872741699219 3 0.9332635632197775 4.7504580088092565 29625.0 82.38221110541413 0.0 - - - - - - - 263.2 59 15 ITIH2 inter-alpha (globulin) inhibitor H2 707 91 C20140527_SFK016_02 C20140527_SFK016_02 TB525906.[MT7]-TQVADAK[MT7].2y5_1.heavy 510.8 / 647.385 18309.0 16.485175609588623 39 14 10 5 10 2.6741669119921982 29.725142563114133 0.04189872741699219 3 0.9332635632197775 4.7504580088092565 18309.0 150.60432636774124 0.0 - - - - - - - 147.52941176470588 36 17 ITIH2 inter-alpha (globulin) inhibitor H2 709 91 C20140527_SFK016_02 C20140527_SFK016_02 TB525906.[MT7]-TQVADAK[MT7].2b6_1.heavy 510.8 / 730.385 7366.0 16.485175609588623 39 14 10 5 10 2.6741669119921982 29.725142563114133 0.04189872741699219 3 0.9332635632197775 4.7504580088092565 7366.0 13.614786079444489 1.0 - - - - - - - 242.30769230769232 16 13 ITIH2 inter-alpha (globulin) inhibitor H2 711 91 C20140527_SFK016_02 C20140527_SFK016_02 TB525906.[MT7]-TQVADAK[MT7].2b5_1.heavy 510.8 / 659.348 41955.0 16.485175609588623 39 14 10 5 10 2.6741669119921982 29.725142563114133 0.04189872741699219 3 0.9332635632197775 4.7504580088092565 41955.0 84.54983660130719 0.0 - - - - - - - 213.47058823529412 83 17 ITIH2 inter-alpha (globulin) inhibitor H2 713 92 C20140527_SFK016_02 C20140527_SFK016_02 TB328451.[MT7]-LAQEPLGLEVDQFLEDVR.3y7_1.heavy 739.062 / 906.468 9739.0 53.341400146484375 48 18 10 10 10 2.908905631948895 26.4636161996721 0.0 3 0.98692169708054 10.779837522942405 9739.0 88.25068682410064 0.0 - - - - - - - 107.63636363636364 19 22 GLTSCR2 glioma tumor suppressor candidate region gene 2 715 92 C20140527_SFK016_02 C20140527_SFK016_02 TB328451.[MT7]-LAQEPLGLEVDQFLEDVR.3b4_1.heavy 739.062 / 586.332 49499.0 53.341400146484375 48 18 10 10 10 2.908905631948895 26.4636161996721 0.0 3 0.98692169708054 10.779837522942405 49499.0 472.1984206851228 0.0 - - - - - - - 179.0 98 16 GLTSCR2 glioma tumor suppressor candidate region gene 2 717 92 C20140527_SFK016_02 C20140527_SFK016_02 TB328451.[MT7]-LAQEPLGLEVDQFLEDVR.3y8_1.heavy 739.062 / 1021.49 21089.0 53.341400146484375 48 18 10 10 10 2.908905631948895 26.4636161996721 0.0 3 0.98692169708054 10.779837522942405 21089.0 278.1631387647298 0.0 - - - - - - - 169.35294117647058 42 17 GLTSCR2 glioma tumor suppressor candidate region gene 2 719 92 C20140527_SFK016_02 C20140527_SFK016_02 TB328451.[MT7]-LAQEPLGLEVDQFLEDVR.3b7_1.heavy 739.062 / 853.49 20810.0 53.341400146484375 48 18 10 10 10 2.908905631948895 26.4636161996721 0.0 3 0.98692169708054 10.779837522942405 20810.0 224.65507638072853 0.0 - - - - - - - 133.25 41 20 GLTSCR2 glioma tumor suppressor candidate region gene 2 721 93 C20140527_SFK016_02 C20140527_SFK016_02 TB328311.[MT7]-EYDAYLSYTK[MT7].2y4_1.heavy 770.892 / 642.358 8634.0 32.91170120239258 48 18 10 10 10 4.984107969553601 20.063770811320616 0.0 3 0.9805443474926084 8.833500149529392 8634.0 26.006773042226133 0.0 - - - - - - - 280.8333333333333 17 12 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 723 93 C20140527_SFK016_02 C20140527_SFK016_02 TB328311.[MT7]-EYDAYLSYTK[MT7].2b3_1.heavy 770.892 / 552.242 14215.0 32.91170120239258 48 18 10 10 10 4.984107969553601 20.063770811320616 0.0 3 0.9805443474926084 8.833500149529392 14215.0 87.64452726618273 0.0 - - - - - - - 231.73333333333332 28 15 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 725 93 C20140527_SFK016_02 C20140527_SFK016_02 TB328311.[MT7]-EYDAYLSYTK[MT7].2b4_1.heavy 770.892 / 623.279 9266.0 32.91170120239258 48 18 10 10 10 4.984107969553601 20.063770811320616 0.0 3 0.9805443474926084 8.833500149529392 9266.0 35.19132044037579 0.0 - - - - - - - 225.64285714285714 18 14 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 727 93 C20140527_SFK016_02 C20140527_SFK016_02 TB328311.[MT7]-EYDAYLSYTK[MT7].2b5_1.heavy 770.892 / 786.343 8002.0 32.91170120239258 48 18 10 10 10 4.984107969553601 20.063770811320616 0.0 3 0.9805443474926084 8.833500149529392 8002.0 25.080083060224297 0.0 - - - - - - - 184.08333333333334 16 12 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 729 94 C20140527_SFK016_02 C20140527_SFK016_02 TB526092.[MT7]-LVEGEEVVR.2y8_1.heavy 587.333 / 916.473 139428.0 28.35580062866211 48 18 10 10 10 6.033322341188803 16.57461583269162 0.0 3 0.9849120900131726 10.034604524788918 139428.0 239.8901340829832 0.0 - - - - - - - 755.8571428571429 278 7 MX2 myxovirus (influenza virus) resistance 2 (mouse) 731 94 C20140527_SFK016_02 C20140527_SFK016_02 TB526092.[MT7]-LVEGEEVVR.2b6_1.heavy 587.333 / 801.411 28529.0 28.35580062866211 48 18 10 10 10 6.033322341188803 16.57461583269162 0.0 3 0.9849120900131726 10.034604524788918 28529.0 114.5199972558735 0.0 - - - - - - - 591.3 57 10 MX2 myxovirus (influenza virus) resistance 2 (mouse) 733 94 C20140527_SFK016_02 C20140527_SFK016_02 TB526092.[MT7]-LVEGEEVVR.2y6_1.heavy 587.333 / 688.362 60066.0 28.35580062866211 48 18 10 10 10 6.033322341188803 16.57461583269162 0.0 3 0.9849120900131726 10.034604524788918 60066.0 130.06700591963227 0.0 - - - - - - - 276.5 120 6 MX2 myxovirus (influenza virus) resistance 2 (mouse) 735 94 C20140527_SFK016_02 C20140527_SFK016_02 TB526092.[MT7]-LVEGEEVVR.2y7_1.heavy 587.333 / 817.405 65668.0 28.35580062866211 48 18 10 10 10 6.033322341188803 16.57461583269162 0.0 3 0.9849120900131726 10.034604524788918 65668.0 87.85289411399526 0.0 - - - - - - - 300.7 131 10 MX2 myxovirus (influenza virus) resistance 2 (mouse) 737 95 C20140527_SFK016_02 C20140527_SFK016_02 TB526211.[MT7]-AWC[CAM]PPGFIR.2b3_1.heavy 624.327 / 562.256 111838.0 38.07400131225586 48 18 10 10 10 4.491612612577685 22.26371876327312 0.0 3 0.9818878985831277 9.156305252854068 111838.0 123.09577494378519 0.0 - - - - - - - 442.0 223 1 HMCN2 hemicentin 2 739 95 C20140527_SFK016_02 C20140527_SFK016_02 TB526211.[MT7]-AWC[CAM]PPGFIR.2y8_1.heavy 624.327 / 1032.51 162293.0 38.07400131225586 48 18 10 10 10 4.491612612577685 22.26371876327312 0.0 3 0.9818878985831277 9.156305252854068 162293.0 419.6725011341117 0.0 - - - - - - - 257.6666666666667 324 6 HMCN2 hemicentin 2 741 95 C20140527_SFK016_02 C20140527_SFK016_02 TB526211.[MT7]-AWC[CAM]PPGFIR.2y6_1.heavy 624.327 / 686.398 233503.0 38.07400131225586 48 18 10 10 10 4.491612612577685 22.26371876327312 0.0 3 0.9818878985831277 9.156305252854068 233503.0 444.0688395481585 0.0 - - - - - - - 820.1428571428571 467 7 HMCN2 hemicentin 2 743 95 C20140527_SFK016_02 C20140527_SFK016_02 TB526211.[MT7]-AWC[CAM]PPGFIR.2y7_1.heavy 624.327 / 846.429 89647.0 38.07400131225586 48 18 10 10 10 4.491612612577685 22.26371876327312 0.0 3 0.9818878985831277 9.156305252854068 89647.0 242.68979592594474 0.0 - - - - - - - 693.8571428571429 179 7 HMCN2 hemicentin 2 745 96 C20140527_SFK016_02 C20140527_SFK016_02 TB328318.[MT7]-TPAIPTAVNLADSR.2y6_1.heavy 785.439 / 675.342 327.0 34.59522533416748 30 13 10 1 6 1.7665668292014771 56.60697254527414 0.123199462890625 6 0.9143249753438657 4.185859839745233 327.0 1.5606617647058825 29.0 - - - - - - - 237.8181818181818 7 11 SRRM2 serine/arginine repetitive matrix 2 747 96 C20140527_SFK016_02 C20140527_SFK016_02 TB328318.[MT7]-TPAIPTAVNLADSR.2y10_1.heavy 785.439 / 1043.55 16879.0 34.59522533416748 30 13 10 1 6 1.7665668292014771 56.60697254527414 0.123199462890625 6 0.9143249753438657 4.185859839745233 16879.0 180.52090144288184 0.0 - - - - - - - 249.14285714285714 33 7 SRRM2 serine/arginine repetitive matrix 2 749 96 C20140527_SFK016_02 C20140527_SFK016_02 TB328318.[MT7]-TPAIPTAVNLADSR.2b4_1.heavy 785.439 / 527.331 10128.0 34.59522533416748 30 13 10 1 6 1.7665668292014771 56.60697254527414 0.123199462890625 6 0.9143249753438657 4.185859839745233 10128.0 53.79729638644448 0.0 - - - - - - - 280.2857142857143 20 7 SRRM2 serine/arginine repetitive matrix 2 751 96 C20140527_SFK016_02 C20140527_SFK016_02 TB328318.[MT7]-TPAIPTAVNLADSR.2y7_1.heavy 785.439 / 774.41 980.0 34.59522533416748 30 13 10 1 6 1.7665668292014771 56.60697254527414 0.123199462890625 6 0.9143249753438657 4.185859839745233 980.0 2.32510775602591 9.0 - - - - - - - 286.125 2 16 SRRM2 serine/arginine repetitive matrix 2 753 97 C20140527_SFK016_02 C20140527_SFK016_02 TB525904.[MT7]-LHNMLVSGEIK[MT7].3b4_1.heavy 510.297 / 640.336 9677.0 31.89240074157715 40 14 10 10 6 1.638544894154011 42.18670708059061 0.0 5 0.9427549567545267 5.13333451416546 9677.0 37.41466533871467 1.0 - - - - - - - 664.0 26 7 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 755 97 C20140527_SFK016_02 C20140527_SFK016_02 TB525904.[MT7]-LHNMLVSGEIK[MT7].3b3_1.heavy 510.297 / 509.295 9297.0 31.89240074157715 40 14 10 10 6 1.638544894154011 42.18670708059061 0.0 5 0.9427549567545267 5.13333451416546 9297.0 7.841064799524932 1.0 - - - - - - - 731.8571428571429 19 7 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 757 97 C20140527_SFK016_02 C20140527_SFK016_02 TB525904.[MT7]-LHNMLVSGEIK[MT7].3y9_2.heavy 510.297 / 567.819 N/A 31.89240074157715 40 14 10 10 6 1.638544894154011 42.18670708059061 0.0 5 0.9427549567545267 5.13333451416546 2561.0 2.822914823488594 2.0 - - - - - - - 270.0769230769231 8 13 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 759 97 C20140527_SFK016_02 C20140527_SFK016_02 TB525904.[MT7]-LHNMLVSGEIK[MT7].3y5_1.heavy 510.297 / 677.395 14230.0 31.89240074157715 40 14 10 10 6 1.638544894154011 42.18670708059061 0.0 5 0.9427549567545267 5.13333451416546 14230.0 11.753075571177504 0.0 - - - - - - - 316.22222222222223 28 9 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 761 98 C20140527_SFK016_02 C20140527_SFK016_02 TB526089.[MT7]-LQATAVGPK[MT7].2y4_1.heavy 586.866 / 544.357 29338.0 24.518199920654297 47 17 10 10 10 2.1908718141069436 31.287624813826994 0.0 3 0.9707809190478378 7.202212141092354 29338.0 41.887689275458854 0.0 - - - - - - - 667.75 58 8 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 763 98 C20140527_SFK016_02 C20140527_SFK016_02 TB526089.[MT7]-LQATAVGPK[MT7].2y5_1.heavy 586.866 / 615.395 28287.0 24.518199920654297 47 17 10 10 10 2.1908718141069436 31.287624813826994 0.0 3 0.9707809190478378 7.202212141092354 28287.0 94.5227581531187 0.0 - - - - - - - 675.4285714285714 56 7 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 765 98 C20140527_SFK016_02 C20140527_SFK016_02 TB526089.[MT7]-LQATAVGPK[MT7].2y6_1.heavy 586.866 / 716.442 29951.0 24.518199920654297 47 17 10 10 10 2.1908718141069436 31.287624813826994 0.0 3 0.9707809190478378 7.202212141092354 29951.0 99.88226905927135 0.0 - - - - - - - 242.46153846153845 59 13 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 767 98 C20140527_SFK016_02 C20140527_SFK016_02 TB526089.[MT7]-LQATAVGPK[MT7].2y7_1.heavy 586.866 / 787.479 31090.0 24.518199920654297 47 17 10 10 10 2.1908718141069436 31.287624813826994 0.0 3 0.9707809190478378 7.202212141092354 31090.0 159.13041390903058 0.0 - - - - - - - 233.66666666666666 62 12 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 769 99 C20140527_SFK016_02 C20140527_SFK016_02 TB328319.[MT7]-LIIVLTPDYILR.2y4_1.heavy 786.996 / 564.35 6551.0 51.11310005187988 38 11 10 7 10 0.8449358800730223 70.68827188677375 0.02880096435546875 3 0.8553570688599132 3.205046499413316 6551.0 51.31493223343522 0.0 - - - - - - - 163.63636363636363 13 22 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 771 99 C20140527_SFK016_02 C20140527_SFK016_02 TB328319.[MT7]-LIIVLTPDYILR.2y8_1.heavy 786.996 / 990.562 16080.0 51.11310005187988 38 11 10 7 10 0.8449358800730223 70.68827188677375 0.02880096435546875 3 0.8553570688599132 3.205046499413316 16080.0 84.39402872734115 0.0 - - - - - - - 128.6 32 20 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 773 99 C20140527_SFK016_02 C20140527_SFK016_02 TB328319.[MT7]-LIIVLTPDYILR.2y9_1.heavy 786.996 / 1089.63 10935.0 51.11310005187988 38 11 10 7 10 0.8449358800730223 70.68827188677375 0.02880096435546875 3 0.8553570688599132 3.205046499413316 10935.0 119.40168126266255 0.0 - - - - - - - 154.23809523809524 21 21 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 775 99 C20140527_SFK016_02 C20140527_SFK016_02 TB328319.[MT7]-LIIVLTPDYILR.2y10_1.heavy 786.996 / 1202.71 4002.0 51.11310005187988 38 11 10 7 10 0.8449358800730223 70.68827188677375 0.02880096435546875 3 0.8553570688599132 3.205046499413316 4002.0 71.54747633790357 0.0 - - - - - - - 134.6086956521739 8 23 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 777 100 C20140527_SFK016_02 C20140527_SFK016_02 TB525701.[MT7]-ATEELR.2b3_1.heavy 431.741 / 446.237 10762.0 18.759075164794922 44 18 10 6 10 3.254571934954745 30.72600698297071 0.03170013427734375 3 0.9829280116173389 9.431928886484021 10762.0 20.544052800804916 1.0 - - - - - - - 309.2105263157895 21 19 MX2 myxovirus (influenza virus) resistance 2 (mouse) 779 100 C20140527_SFK016_02 C20140527_SFK016_02 TB525701.[MT7]-ATEELR.2y5_1.heavy 431.741 / 647.336 45839.0 18.759075164794922 44 18 10 6 10 3.254571934954745 30.72600698297071 0.03170013427734375 3 0.9829280116173389 9.431928886484021 45839.0 195.65944234385924 2.0 - - - - - - - 276.4375 91 16 MX2 myxovirus (influenza virus) resistance 2 (mouse) 781 100 C20140527_SFK016_02 C20140527_SFK016_02 TB525701.[MT7]-ATEELR.2b4_1.heavy 431.741 / 575.279 33914.0 18.759075164794922 44 18 10 6 10 3.254571934954745 30.72600698297071 0.03170013427734375 3 0.9829280116173389 9.431928886484021 33914.0 31.597366493750556 0.0 - - - - - - - 1266.6666666666667 67 9 MX2 myxovirus (influenza virus) resistance 2 (mouse) 783 100 C20140527_SFK016_02 C20140527_SFK016_02 TB525701.[MT7]-ATEELR.2b5_1.heavy 431.741 / 688.363 7330.0 18.759075164794922 44 18 10 6 10 3.254571934954745 30.72600698297071 0.03170013427734375 3 0.9829280116173389 9.431928886484021 7330.0 16.62474226804124 1.0 - - - - - - - 272.57894736842104 53 19 MX2 myxovirus (influenza virus) resistance 2 (mouse) 785 101 C20140527_SFK016_02 C20140527_SFK016_02 TB328119.[MT7]-AAITFLK[MT7].2y4_1.heavy 526.341 / 652.415 56181.0 35.537601470947266 46 18 10 10 8 5.023427602363846 19.90672662485343 0.0 4 0.9876449524962825 11.09154382718409 56181.0 148.4663063063063 0.0 - - - - - - - 308.3333333333333 112 9 VWA5A von Willebrand factor A domain containing 5A 787 101 C20140527_SFK016_02 C20140527_SFK016_02 TB328119.[MT7]-AAITFLK[MT7].2y5_1.heavy 526.341 / 765.499 14656.0 35.537601470947266 46 18 10 10 8 5.023427602363846 19.90672662485343 0.0 4 0.9876449524962825 11.09154382718409 14656.0 120.81297297297297 0.0 - - - - - - - 199.8 29 5 VWA5A von Willebrand factor A domain containing 5A 789 101 C20140527_SFK016_02 C20140527_SFK016_02 TB328119.[MT7]-AAITFLK[MT7].2y3_1.heavy 526.341 / 551.367 22206.0 35.537601470947266 46 18 10 10 8 5.023427602363846 19.90672662485343 0.0 4 0.9876449524962825 11.09154382718409 22206.0 27.533850600277137 1.0 - - - - - - - 222.0 91 4 VWA5A von Willebrand factor A domain containing 5A 791 101 C20140527_SFK016_02 C20140527_SFK016_02 TB328119.[MT7]-AAITFLK[MT7].2y6_1.heavy 526.341 / 836.536 19874.0 35.537601470947266 46 18 10 10 8 5.023427602363846 19.90672662485343 0.0 4 0.9876449524962825 11.09154382718409 19874.0 91.90978978978978 0.0 - - - - - - - 230.53846153846155 39 13 VWA5A von Willebrand factor A domain containing 5A 793 102 C20140527_SFK016_02 C20140527_SFK016_02 TB526084.[MT7]-EFQEEIAR.2b3_1.heavy 583.302 / 549.279 27909.0 27.31559944152832 47 17 10 10 10 3.066047338584125 32.61528246533179 0.0 3 0.9718270477701554 7.335357244185405 27909.0 43.66319879534008 0.0 - - - - - - - 666.7272727272727 55 11 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 795 102 C20140527_SFK016_02 C20140527_SFK016_02 TB526084.[MT7]-EFQEEIAR.2b4_1.heavy 583.302 / 678.321 29223.0 27.31559944152832 47 17 10 10 10 3.066047338584125 32.61528246533179 0.0 3 0.9718270477701554 7.335357244185405 29223.0 183.659479351882 0.0 - - - - - - - 277.26666666666665 58 15 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 797 102 C20140527_SFK016_02 C20140527_SFK016_02 TB526084.[MT7]-EFQEEIAR.2b5_1.heavy 583.302 / 807.364 61619.0 27.31559944152832 47 17 10 10 10 3.066047338584125 32.61528246533179 0.0 3 0.9718270477701554 7.335357244185405 61619.0 111.26003300698976 0.0 - - - - - - - 210.23076923076923 123 13 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 799 102 C20140527_SFK016_02 C20140527_SFK016_02 TB526084.[MT7]-EFQEEIAR.2y7_1.heavy 583.302 / 892.452 154978.0 27.31559944152832 47 17 10 10 10 3.066047338584125 32.61528246533179 0.0 3 0.9718270477701554 7.335357244185405 154978.0 508.3394316863256 0.0 - - - - - - - 282.6666666666667 309 12 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 801 103 C20140527_SFK016_02 C20140527_SFK016_02 TNAA_ECO24.GLTFTYEPK.2y7.peptide 528.27 / 885.44 615844.0 32.67689895629883 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 615844.0 1443.6654497959305 0.0 - - - - - - - 273.7142857142857 1231 7 803 103 C20140527_SFK016_02 C20140527_SFK016_02 TNAA_ECO24.GLTFTYEPK.2y6.peptide 528.27 / 784.39 633844.0 32.67689895629883 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 633844.0 1000.1059571724642 0.0 - - - - - - - 756.8888888888889 1267 9 805 103 C20140527_SFK016_02 C20140527_SFK016_02 TNAA_ECO24.GLTFTYEPK.2y5.peptide 528.27 / 637.32 1301980.0 32.67689895629883 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1301980.0 1025.0900394938765 0.0 - - - - - - - 780.5 2603 6 807 104 C20140527_SFK016_02 C20140527_SFK016_02 TB328259.[MT7]-ELLGFVNYK[MT7].2b4_1.heavy 685.9 / 557.341 15171.0 40.462501525878906 45 15 10 10 10 3.845251657978889 26.00610022298546 0.0 3 0.9561844609739987 5.874212580607345 15171.0 22.24205353502377 0.0 - - - - - - - 691.3076923076923 30 13 MX2 myxovirus (influenza virus) resistance 2 (mouse) 809 104 C20140527_SFK016_02 C20140527_SFK016_02 TB328259.[MT7]-ELLGFVNYK[MT7].2y3_1.heavy 685.9 / 568.321 18909.0 40.462501525878906 45 15 10 10 10 3.845251657978889 26.00610022298546 0.0 3 0.9561844609739987 5.874212580607345 18909.0 36.208066072315376 0.0 - - - - - - - 710.5294117647059 37 17 MX2 myxovirus (influenza virus) resistance 2 (mouse) 811 104 C20140527_SFK016_02 C20140527_SFK016_02 TB328259.[MT7]-ELLGFVNYK[MT7].2y6_1.heavy 685.9 / 871.479 42995.0 40.462501525878906 45 15 10 10 10 3.845251657978889 26.00610022298546 0.0 3 0.9561844609739987 5.874212580607345 42995.0 189.64963306295866 0.0 - - - - - - - 737.0 85 8 MX2 myxovirus (influenza virus) resistance 2 (mouse) 813 104 C20140527_SFK016_02 C20140527_SFK016_02 TB328259.[MT7]-ELLGFVNYK[MT7].2y7_1.heavy 685.9 / 984.563 19916.0 40.462501525878906 45 15 10 10 10 3.845251657978889 26.00610022298546 0.0 3 0.9561844609739987 5.874212580607345 19916.0 38.07032310003964 0.0 - - - - - - - 620.8181818181819 39 11 MX2 myxovirus (influenza virus) resistance 2 (mouse) 815 105 C20140527_SFK016_02 C20140527_SFK016_02 TB526036.[MT7]-LSLAEATK[MT7].2y4_1.heavy 560.844 / 592.342 23924.0 29.560999870300293 39 18 9 6 6 6.456938926149427 15.487214784550337 0.03539848327636719 5 0.9879847507594287 11.247607956070791 23924.0 38.43038376907607 0.0 - - - - - - - 272.4 47 15 MX2 myxovirus (influenza virus) resistance 2 (mouse) 817 105 C20140527_SFK016_02 C20140527_SFK016_02 TB526036.[MT7]-LSLAEATK[MT7].2y5_1.heavy 560.844 / 663.379 29662.0 29.560999870300293 39 18 9 6 6 6.456938926149427 15.487214784550337 0.03539848327636719 5 0.9879847507594287 11.247607956070791 29662.0 27.175753922590776 0.0 - - - - - - - 291.9 59 20 MX2 myxovirus (influenza virus) resistance 2 (mouse) 819 105 C20140527_SFK016_02 C20140527_SFK016_02 TB526036.[MT7]-LSLAEATK[MT7].2b4_1.heavy 560.844 / 529.347 20034.0 29.560999870300293 39 18 9 6 6 6.456938926149427 15.487214784550337 0.03539848327636719 5 0.9879847507594287 11.247607956070791 20034.0 27.455745986876977 0.0 - - - - - - - 1375.7142857142858 40 7 MX2 myxovirus (influenza virus) resistance 2 (mouse) 821 105 C20140527_SFK016_02 C20140527_SFK016_02 TB526036.[MT7]-LSLAEATK[MT7].2y7_1.heavy 560.844 / 863.495 35595.0 29.560999870300293 39 18 9 6 6 6.456938926149427 15.487214784550337 0.03539848327636719 5 0.9879847507594287 11.247607956070791 35595.0 64.69290647482015 3.0 - - - - - - - 320.3529411764706 87 17 MX2 myxovirus (influenza virus) resistance 2 (mouse) 823 106 C20140527_SFK016_02 C20140527_SFK016_02 TB525940.[MT7]-VAAGC[CAM]FK[MT7].2y4_1.heavy 520.794 / 655.335 6746.0 25.08930015563965 38 20 0 10 8 6.5099356455957125 15.361134954944577 0.0 4 0.9914630501931744 13.34755006597704 6746.0 23.359610991790284 1.0 - - - - - - - 338.8888888888889 96 9 FRYL FRY-like 825 106 C20140527_SFK016_02 C20140527_SFK016_02 TB525940.[MT7]-VAAGC[CAM]FK[MT7].2y5_1.heavy 520.794 / 726.372 5083.0 25.08930015563965 38 20 0 10 8 6.5099356455957125 15.361134954944577 0.0 4 0.9914630501931744 13.34755006597704 5083.0 35.45899609718021 0.0 - - - - - - - 146.16666666666666 10 12 FRYL FRY-like 827 106 C20140527_SFK016_02 C20140527_SFK016_02 TB525940.[MT7]-VAAGC[CAM]FK[MT7].2y3_1.heavy 520.794 / 598.314 2495.0 25.08930015563965 38 20 0 10 8 6.5099356455957125 15.361134954944577 0.0 4 0.9914630501931744 13.34755006597704 2495.0 2.0279501717554815 1.0 - - - - - - - 285.54545454545456 5 11 FRYL FRY-like 829 106 C20140527_SFK016_02 C20140527_SFK016_02 TB525940.[MT7]-VAAGC[CAM]FK[MT7].2y6_1.heavy 520.794 / 797.41 11737.0 25.08930015563965 38 20 0 10 8 6.5099356455957125 15.361134954944577 0.0 4 0.9914630501931744 13.34755006597704 11737.0 43.9649123259412 0.0 - - - - - - - 338.8333333333333 23 12 FRYL FRY-like 831 107 C20140527_SFK016_02 C20140527_SFK016_02 TB526039.[MT7]-EVTEDLK[MT7].2y5_1.heavy 561.318 / 749.416 8259.0 24.421899795532227 48 18 10 10 10 5.647478794416751 17.7070164652699 0.0 3 0.9838710925437905 9.704528422918408 8259.0 33.80335602723268 0.0 - - - - - - - 239.8181818181818 16 11 EFCAB5 EF-hand calcium binding domain 5 833 107 C20140527_SFK016_02 C20140527_SFK016_02 TB526039.[MT7]-EVTEDLK[MT7].2y3_1.heavy 561.318 / 519.326 4002.0 24.421899795532227 48 18 10 10 10 5.647478794416751 17.7070164652699 0.0 3 0.9838710925437905 9.704528422918408 4002.0 5.707717417559034 2.0 - - - - - - - 688.7272727272727 8 11 EFCAB5 EF-hand calcium binding domain 5 835 107 C20140527_SFK016_02 C20140527_SFK016_02 TB526039.[MT7]-EVTEDLK[MT7].2y6_1.heavy 561.318 / 848.485 8089.0 24.421899795532227 48 18 10 10 10 5.647478794416751 17.7070164652699 0.0 3 0.9838710925437905 9.704528422918408 8089.0 57.09882352941177 0.0 - - - - - - - 188.35714285714286 16 14 EFCAB5 EF-hand calcium binding domain 5 837 107 C20140527_SFK016_02 C20140527_SFK016_02 TB526039.[MT7]-EVTEDLK[MT7].2b5_1.heavy 561.318 / 718.338 14219.0 24.421899795532227 48 18 10 10 10 5.647478794416751 17.7070164652699 0.0 3 0.9838710925437905 9.704528422918408 14219.0 21.280785234899334 1.0 - - - - - - - 184.25 29 12 EFCAB5 EF-hand calcium binding domain 5 839 108 C20140527_SFK016_02 C20140527_SFK016_02 TB526949.[MT7]-VLC[CAM]QFC[CAM]DQDPAQDAVK[MT7].3y7_1.heavy 728.022 / 872.496 30592.0 33.47890090942383 47 17 10 10 10 2.4667782288899405 27.631553421726245 0.0 3 0.9775334468552844 8.21821851351674 30592.0 43.13314013998816 0.0 - - - - - - - 254.25 61 8 MID1 midline 1 (Opitz/BBB syndrome) 841 108 C20140527_SFK016_02 C20140527_SFK016_02 TB526949.[MT7]-VLC[CAM]QFC[CAM]DQDPAQDAVK[MT7].3b4_1.heavy 728.022 / 645.351 23376.0 33.47890090942383 47 17 10 10 10 2.4667782288899405 27.631553421726245 0.0 3 0.9775334468552844 8.21821851351674 23376.0 41.00380327868852 0.0 - - - - - - - 223.8 46 10 MID1 midline 1 (Opitz/BBB syndrome) 843 108 C20140527_SFK016_02 C20140527_SFK016_02 TB526949.[MT7]-VLC[CAM]QFC[CAM]DQDPAQDAVK[MT7].3b5_1.heavy 728.022 / 792.419 14432.0 33.47890090942383 47 17 10 10 10 2.4667782288899405 27.631553421726245 0.0 3 0.9775334468552844 8.21821851351674 14432.0 53.95000903575578 0.0 - - - - - - - 249.45454545454547 28 11 MID1 midline 1 (Opitz/BBB syndrome) 845 108 C20140527_SFK016_02 C20140527_SFK016_02 TB526949.[MT7]-VLC[CAM]QFC[CAM]DQDPAQDAVK[MT7].3y4_1.heavy 728.022 / 576.347 24392.0 33.47890090942383 47 17 10 10 10 2.4667782288899405 27.631553421726245 0.0 3 0.9775334468552844 8.21821851351674 24392.0 48.52427107888392 0.0 - - - - - - - 276.0 48 7 MID1 midline 1 (Opitz/BBB syndrome) 847 109 C20140527_SFK016_02 C20140527_SFK016_02 TB526419.[MT7]-NIIHEEVEK[MT7].3y3_1.heavy 466.933 / 519.326 42086.0 24.009199142456055 48 18 10 10 10 6.808246361660766 14.688070126711242 0.0 3 0.9899272011048469 12.286326898917347 42086.0 52.91887144146644 0.0 - - - - - - - 873.8571428571429 84 7 MX2 myxovirus (influenza virus) resistance 2 (mouse) 849 109 C20140527_SFK016_02 C20140527_SFK016_02 TB526419.[MT7]-NIIHEEVEK[MT7].3y4_1.heavy 466.933 / 648.369 24865.0 24.009199142456055 48 18 10 10 10 6.808246361660766 14.688070126711242 0.0 3 0.9899272011048469 12.286326898917347 24865.0 176.4305716347517 0.0 - - - - - - - 273.46666666666664 49 15 MX2 myxovirus (influenza virus) resistance 2 (mouse) 851 109 C20140527_SFK016_02 C20140527_SFK016_02 TB526419.[MT7]-NIIHEEVEK[MT7].3b3_1.heavy 466.933 / 485.32 70090.0 24.009199142456055 48 18 10 10 10 6.808246361660766 14.688070126711242 0.0 3 0.9899272011048469 12.286326898917347 70090.0 153.8354612766256 0.0 - - - - - - - 758.7142857142857 140 7 MX2 myxovirus (influenza virus) resistance 2 (mouse) 853 109 C20140527_SFK016_02 C20140527_SFK016_02 TB526419.[MT7]-NIIHEEVEK[MT7].3y5_1.heavy 466.933 / 777.411 13117.0 24.009199142456055 48 18 10 10 10 6.808246361660766 14.688070126711242 0.0 3 0.9899272011048469 12.286326898917347 13117.0 185.1415565352697 0.0 - - - - - - - 114.57142857142857 26 7 MX2 myxovirus (influenza virus) resistance 2 (mouse) 855 110 C20140527_SFK016_02 C20140527_SFK016_02 TB526697.[MT7]-DLLLQLEDETLK[MT7].3y3_1.heavy 573.332 / 505.347 N/A N/A - - - - - - - - - 0.0 - - - - - - - APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 857 110 C20140527_SFK016_02 C20140527_SFK016_02 TB526697.[MT7]-DLLLQLEDETLK[MT7].3b4_1.heavy 573.332 / 599.388 N/A N/A - - - - - - - - - 0.0 - - - - - - - APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 859 110 C20140527_SFK016_02 C20140527_SFK016_02 TB526697.[MT7]-DLLLQLEDETLK[MT7].3b5_1.heavy 573.332 / 727.447 N/A N/A - - - - - - - - - 0.0 - - - - - - - APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 861 110 C20140527_SFK016_02 C20140527_SFK016_02 TB526697.[MT7]-DLLLQLEDETLK[MT7].3y5_1.heavy 573.332 / 749.416 N/A N/A - - - - - - - - - 0.0 - - - - - - - APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 863 111 C20140527_SFK016_02 C20140527_SFK016_02 TB526552.[MT7]-LEFPQVLYLDR.2b3_1.heavy 768.931 / 534.304 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP25 ubiquitin specific peptidase 25 865 111 C20140527_SFK016_02 C20140527_SFK016_02 TB526552.[MT7]-LEFPQVLYLDR.2y8_1.heavy 768.931 / 1003.56 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP25 ubiquitin specific peptidase 25 867 111 C20140527_SFK016_02 C20140527_SFK016_02 TB526552.[MT7]-LEFPQVLYLDR.2y9_1.heavy 768.931 / 1150.63 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP25 ubiquitin specific peptidase 25 869 111 C20140527_SFK016_02 C20140527_SFK016_02 TB526552.[MT7]-LEFPQVLYLDR.2b5_1.heavy 768.931 / 759.416 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP25 ubiquitin specific peptidase 25 871 112 C20140527_SFK016_02 C20140527_SFK016_02 CH10_ECO24.SAGGIVLTGSAAAK.2y7.peptide 601.84 / 605.33 920314.0 26.963600158691406 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 920314.0 545.2116538186787 0.0 - - - - - - - 10807.42857142857 1840 7 873 112 C20140527_SFK016_02 C20140527_SFK016_02 CH10_ECO24.SAGGIVLTGSAAAK.2y8.peptide 601.84 / 718.41 1007100.0 26.963600158691406 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1007100.0 13.651904513222963 1.0 - - - - - - - 6056.0 2077 1 875 112 C20140527_SFK016_02 C20140527_SFK016_02 CH10_ECO24.SAGGIVLTGSAAAK.2y9.peptide 601.84 / 817.48 1541040.0 26.963600158691406 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1541040.0 1459.345662056389 0.0 - - - - - - - 8836.0 3082 1 877 113 C20140527_SFK016_02 C20140527_SFK016_02 TB328274.[MT7]-VLLEEGSATVPR.2y8_1.heavy 707.905 / 816.421 46732.0 32.63710021972656 45 15 10 10 10 3.653911365680094 21.746840154379104 0.0 3 0.9544898462417933 5.762981608894364 46732.0 132.09356713549508 0.0 - - - - - - - 665.125 93 8 MX2 myxovirus (influenza virus) resistance 2 (mouse) 879 113 C20140527_SFK016_02 C20140527_SFK016_02 TB328274.[MT7]-VLLEEGSATVPR.2y9_1.heavy 707.905 / 945.464 83659.0 32.63710021972656 45 15 10 10 10 3.653911365680094 21.746840154379104 0.0 3 0.9544898462417933 5.762981608894364 83659.0 136.77322672630697 0.0 - - - - - - - 743.125 167 8 MX2 myxovirus (influenza virus) resistance 2 (mouse) 881 113 C20140527_SFK016_02 C20140527_SFK016_02 TB328274.[MT7]-VLLEEGSATVPR.2y10_1.heavy 707.905 / 1058.55 62275.0 32.63710021972656 45 15 10 10 10 3.653911365680094 21.746840154379104 0.0 3 0.9544898462417933 5.762981608894364 62275.0 234.39305935443338 0.0 - - - - - - - 639.0 124 8 MX2 myxovirus (influenza virus) resistance 2 (mouse) 883 113 C20140527_SFK016_02 C20140527_SFK016_02 TB328274.[MT7]-VLLEEGSATVPR.2y11_1.heavy 707.905 / 1171.63 44854.0 32.63710021972656 45 15 10 10 10 3.653911365680094 21.746840154379104 0.0 3 0.9544898462417933 5.762981608894364 44854.0 123.77890130859119 0.0 - - - - - - - 678.0 89 12 MX2 myxovirus (influenza virus) resistance 2 (mouse) 885 114 C20140527_SFK016_02 C20140527_SFK016_02 TB526554.[MT7]-EYDAYLSYTK[MT7].3b4_1.heavy 514.264 / 623.279 84887.0 32.91170120239258 47 17 10 10 10 2.8806802853921756 34.7140224158496 0.0 3 0.9749700922556502 7.784356139900083 84887.0 287.1580805871036 0.0 - - - - - - - 865.8 169 10 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 887 114 C20140527_SFK016_02 C20140527_SFK016_02 TB526554.[MT7]-EYDAYLSYTK[MT7].3b5_1.heavy 514.264 / 786.343 34230.0 32.91170120239258 47 17 10 10 10 2.8806802853921756 34.7140224158496 0.0 3 0.9749700922556502 7.784356139900083 34230.0 62.75696607036561 0.0 - - - - - - - 268.1818181818182 68 11 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 889 114 C20140527_SFK016_02 C20140527_SFK016_02 TB526554.[MT7]-EYDAYLSYTK[MT7].3y4_1.heavy 514.264 / 642.358 58132.0 32.91170120239258 47 17 10 10 10 2.8806802853921756 34.7140224158496 0.0 3 0.9749700922556502 7.784356139900083 58132.0 161.97868683391712 0.0 - - - - - - - 349.6666666666667 116 9 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 891 114 C20140527_SFK016_02 C20140527_SFK016_02 TB526554.[MT7]-EYDAYLSYTK[MT7].3b3_1.heavy 514.264 / 552.242 70428.0 32.91170120239258 47 17 10 10 10 2.8806802853921756 34.7140224158496 0.0 3 0.9749700922556502 7.784356139900083 70428.0 139.42131538811935 0.0 - - - - - - - 698.5 140 10 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 893 115 C20140527_SFK016_02 C20140527_SFK016_02 TB525842.[MT7]-FLQTAK[MT7].2b3_1.heavy 498.31 / 533.32 19106.0 27.083099365234375 50 20 10 10 10 4.78202214234818 20.911655576503808 0.0 3 0.9936126767962136 15.433750935048792 19106.0 26.004149395582747 0.0 - - - - - - - 793.3076923076923 38 13 MID1 midline 1 (Opitz/BBB syndrome) 895 115 C20140527_SFK016_02 C20140527_SFK016_02 TB525842.[MT7]-FLQTAK[MT7].2y4_1.heavy 498.31 / 591.358 23882.0 27.083099365234375 50 20 10 10 10 4.78202214234818 20.911655576503808 0.0 3 0.9936126767962136 15.433750935048792 23882.0 48.657133863813954 0.0 - - - - - - - 808.0 47 9 MID1 midline 1 (Opitz/BBB syndrome) 897 115 C20140527_SFK016_02 C20140527_SFK016_02 TB525842.[MT7]-FLQTAK[MT7].2y5_1.heavy 498.31 / 704.442 47004.0 27.083099365234375 50 20 10 10 10 4.78202214234818 20.911655576503808 0.0 3 0.9936126767962136 15.433750935048792 47004.0 133.78653766835555 0.0 - - - - - - - 732.75 94 12 MID1 midline 1 (Opitz/BBB syndrome) 899 115 C20140527_SFK016_02 C20140527_SFK016_02 TB525842.[MT7]-FLQTAK[MT7].2b4_1.heavy 498.31 / 634.368 4342.0 27.083099365234375 50 20 10 10 10 4.78202214234818 20.911655576503808 0.0 3 0.9936126767962136 15.433750935048792 4342.0 6.331827563921315 0.0 - - - - - - - 271.5 8 14 MID1 midline 1 (Opitz/BBB syndrome) 901 116 C20140527_SFK016_02 C20140527_SFK016_02 TB526031.[MT7]-SLAPTAAAK[MT7].2y4_1.heavy 559.345 / 504.326 6564.0 21.982999801635742 48 18 10 10 10 6.017199094257946 16.619027961934542 0.0 3 0.981343223258081 9.021246083836775 6564.0 15.434024896265559 0.0 - - - - - - - 695.7777777777778 13 9 ITIH2 inter-alpha (globulin) inhibitor H2 903 116 C20140527_SFK016_02 C20140527_SFK016_02 TB526031.[MT7]-SLAPTAAAK[MT7].2y5_1.heavy 559.345 / 605.374 6925.0 21.982999801635742 48 18 10 10 10 6.017199094257946 16.619027961934542 0.0 3 0.981343223258081 9.021246083836775 6925.0 31.009713968804956 0.0 - - - - - - - 197.71428571428572 13 21 ITIH2 inter-alpha (globulin) inhibitor H2 905 116 C20140527_SFK016_02 C20140527_SFK016_02 TB526031.[MT7]-SLAPTAAAK[MT7].2y6_1.heavy 559.345 / 702.427 86835.0 21.982999801635742 48 18 10 10 10 6.017199094257946 16.619027961934542 0.0 3 0.981343223258081 9.021246083836775 86835.0 242.52399655031036 0.0 - - - - - - - 722.5 173 10 ITIH2 inter-alpha (globulin) inhibitor H2 907 116 C20140527_SFK016_02 C20140527_SFK016_02 TB526031.[MT7]-SLAPTAAAK[MT7].2y7_1.heavy 559.345 / 773.464 13308.0 21.982999801635742 48 18 10 10 10 6.017199094257946 16.619027961934542 0.0 3 0.981343223258081 9.021246083836775 13308.0 129.09496265560165 0.0 - - - - - - - 262.42857142857144 26 14 ITIH2 inter-alpha (globulin) inhibitor H2 909 117 C20140527_SFK016_02 C20140527_SFK016_02 TB397637.[MT7]-SLPLLEGQIR.3y6_1.heavy 423.926 / 715.41 17539.0 38.99992370605469 40 14 10 6 10 1.8564483291234826 38.369579843599865 0.034698486328125 3 0.9455988605817497 5.267076094979596 17539.0 78.41321136934673 0.0 - - - - - - - 190.88888888888889 35 9 MX2 myxovirus (influenza virus) resistance 2 (mouse) 911 117 C20140527_SFK016_02 C20140527_SFK016_02 TB397637.[MT7]-SLPLLEGQIR.3b4_1.heavy 423.926 / 555.362 76201.0 38.99992370605469 40 14 10 6 10 1.8564483291234826 38.369579843599865 0.034698486328125 3 0.9455988605817497 5.267076094979596 76201.0 57.0456658786446 1.0 - - - - - - - 323.6666666666667 152 3 MX2 myxovirus (influenza virus) resistance 2 (mouse) 913 117 C20140527_SFK016_02 C20140527_SFK016_02 TB397637.[MT7]-SLPLLEGQIR.3y4_1.heavy 423.926 / 473.283 70230.0 38.99992370605469 40 14 10 6 10 1.8564483291234826 38.369579843599865 0.034698486328125 3 0.9455988605817497 5.267076094979596 70230.0 165.8201323899284 0.0 - - - - - - - 149.0 140 1 MX2 myxovirus (influenza virus) resistance 2 (mouse) 915 117 C20140527_SFK016_02 C20140527_SFK016_02 TB397637.[MT7]-SLPLLEGQIR.3y5_1.heavy 423.926 / 602.326 61722.0 38.99992370605469 40 14 10 6 10 1.8564483291234826 38.369579843599865 0.034698486328125 3 0.9455988605817497 5.267076094979596 61722.0 89.55415118686793 0.0 - - - - - - - 323.6666666666667 123 3 MX2 myxovirus (influenza virus) resistance 2 (mouse) 917 118 C20140527_SFK016_02 C20140527_SFK016_02 TB525844.[MT7]-YTLQGK[MT7].2b3_1.heavy 499.3 / 522.304 10767.0 23.78969955444336 48 18 10 10 10 3.8816234381564336 25.762416574724394 0.0 3 0.9849830604343603 10.058348284728622 10767.0 45.37264214046823 0.0 - - - - - - - 238.5 21 16 VWA5A von Willebrand factor A domain containing 5A 919 118 C20140527_SFK016_02 C20140527_SFK016_02 TB525844.[MT7]-YTLQGK[MT7].2y4_1.heavy 499.3 / 589.379 16673.0 23.78969955444336 48 18 10 10 10 3.8816234381564336 25.762416574724394 0.0 3 0.9849830604343603 10.058348284728622 16673.0 25.978137534189532 0.0 - - - - - - - 255.58333333333334 33 12 VWA5A von Willebrand factor A domain containing 5A 921 118 C20140527_SFK016_02 C20140527_SFK016_02 TB525844.[MT7]-YTLQGK[MT7].2y5_1.heavy 499.3 / 690.427 34393.0 23.78969955444336 48 18 10 10 10 3.8816234381564336 25.762416574724394 0.0 3 0.9849830604343603 10.058348284728622 34393.0 115.26550873652175 0.0 - - - - - - - 205.75 68 16 VWA5A von Willebrand factor A domain containing 5A 923 118 C20140527_SFK016_02 C20140527_SFK016_02 TB525844.[MT7]-YTLQGK[MT7].2b4_1.heavy 499.3 / 650.363 6355.0 23.78969955444336 48 18 10 10 10 3.8816234381564336 25.762416574724394 0.0 3 0.9849830604343603 10.058348284728622 6355.0 42.5807033184745 0.0 - - - - - - - 202.2 12 10 VWA5A von Willebrand factor A domain containing 5A 925 119 C20140527_SFK016_02 C20140527_SFK016_02 TB526557.[MT7]-SWPIPPPVPAAK[MT7].3y3_1.heavy 516.644 / 433.289 12022.0 36.38679885864258 48 18 10 10 10 7.860716248646547 12.72148705497644 0.0 3 0.9899952496572153 12.328109747369645 12022.0 51.80127853881279 1.0 - - - - - - - 273.5 24 2 C2CD2 C2 calcium-dependent domain containing 2 927 119 C20140527_SFK016_02 C20140527_SFK016_02 TB526557.[MT7]-SWPIPPPVPAAK[MT7].3y6_1.heavy 516.644 / 726.463 5355.0 36.38679885864258 48 18 10 10 10 7.860716248646547 12.72148705497644 0.0 3 0.9899952496572153 12.328109747369645 5355.0 22.747180884914798 1.0 - - - - - - - 164.0 10 2 C2CD2 C2 calcium-dependent domain containing 2 929 119 C20140527_SFK016_02 C20140527_SFK016_02 TB526557.[MT7]-SWPIPPPVPAAK[MT7].3b4_1.heavy 516.644 / 628.357 34754.0 36.38679885864258 48 18 10 10 10 7.860716248646547 12.72148705497644 0.0 3 0.9899952496572153 12.328109747369645 34754.0 28.869771651362605 0.0 - - - - - - - 984.0 69 1 C2CD2 C2 calcium-dependent domain containing 2 931 119 C20140527_SFK016_02 C20140527_SFK016_02 TB526557.[MT7]-SWPIPPPVPAAK[MT7].3y4_1.heavy 516.644 / 530.342 47104.0 36.38679885864258 48 18 10 10 10 7.860716248646547 12.72148705497644 0.0 3 0.9899952496572153 12.328109747369645 47104.0 10.199926889997407 1.0 - - - - - - - 546.0 99 1 C2CD2 C2 calcium-dependent domain containing 2 933 120 C20140527_SFK016_02 C20140527_SFK016_02 TB526559.[MT7]-GLLPGLLPAPADK[MT7].3y6_1.heavy 517.323 / 742.422 N/A N/A - - - - - - - - - 0.0 - - - - - - - EDC4 enhancer of mRNA decapping 4 935 120 C20140527_SFK016_02 C20140527_SFK016_02 TB526559.[MT7]-GLLPGLLPAPADK[MT7].3b6_1.heavy 517.323 / 695.457 N/A N/A - - - - - - - - - 0.0 - - - - - - - EDC4 enhancer of mRNA decapping 4 937 120 C20140527_SFK016_02 C20140527_SFK016_02 TB526559.[MT7]-GLLPGLLPAPADK[MT7].3b5_1.heavy 517.323 / 582.373 N/A N/A - - - - - - - - - 0.0 - - - - - - - EDC4 enhancer of mRNA decapping 4 939 120 C20140527_SFK016_02 C20140527_SFK016_02 TB526559.[MT7]-GLLPGLLPAPADK[MT7].3y4_1.heavy 517.323 / 574.332 N/A N/A - - - - - - - - - 0.0 - - - - - - - EDC4 enhancer of mRNA decapping 4 941 121 C20140527_SFK016_02 C20140527_SFK016_02 TB525800.[MT7]-DFAVVK[MT7].2y4_1.heavy 483.797 / 560.389 30698.0 28.045499801635742 50 20 10 10 10 5.40545627873684 18.499825887661835 0.0 3 0.9916040456050054 13.459316498631123 30698.0 49.756316669923784 0.0 - - - - - - - 783.5 61 8 CERKL ceramide kinase-like 943 121 C20140527_SFK016_02 C20140527_SFK016_02 TB525800.[MT7]-DFAVVK[MT7].2y5_1.heavy 483.797 / 707.457 34522.0 28.045499801635742 50 20 10 10 10 5.40545627873684 18.499825887661835 0.0 3 0.9916040456050054 13.459316498631123 34522.0 128.92336378243604 0.0 - - - - - - - 274.3333333333333 69 12 CERKL ceramide kinase-like 945 121 C20140527_SFK016_02 C20140527_SFK016_02 TB525800.[MT7]-DFAVVK[MT7].2b4_1.heavy 483.797 / 577.31 31229.0 28.045499801635742 50 20 10 10 10 5.40545627873684 18.499825887661835 0.0 3 0.9916040456050054 13.459316498631123 31229.0 56.17706251209905 0.0 - - - - - - - 772.4545454545455 62 11 CERKL ceramide kinase-like 947 121 C20140527_SFK016_02 C20140527_SFK016_02 TB525800.[MT7]-DFAVVK[MT7].2y3_1.heavy 483.797 / 489.352 35265.0 28.045499801635742 50 20 10 10 10 5.40545627873684 18.499825887661835 0.0 3 0.9916040456050054 13.459316498631123 35265.0 74.49060597390888 0.0 - - - - - - - 684.5555555555555 70 9 CERKL ceramide kinase-like 949 122 C20140527_SFK016_02 C20140527_SFK016_02 TB525804.[MT7]-ISPLQK[MT7].2y4_1.heavy 487.318 / 629.41 69227.0 26.482749462127686 40 20 6 6 8 7.823125387171291 12.782615010106376 0.03859901428222656 4 0.99712622986212 23.016129683860385 69227.0 98.04318621966985 0.0 - - - - - - - 628.4285714285714 138 7 KIAA0947 KIAA0947 951 122 C20140527_SFK016_02 C20140527_SFK016_02 TB525804.[MT7]-ISPLQK[MT7].2y5_1.heavy 487.318 / 716.442 69542.0 26.482749462127686 40 20 6 6 8 7.823125387171291 12.782615010106376 0.03859901428222656 4 0.99712622986212 23.016129683860385 69542.0 151.7567555290002 2.0 - - - - - - - 698.3333333333334 199 9 KIAA0947 KIAA0947 953 122 C20140527_SFK016_02 C20140527_SFK016_02 TB525804.[MT7]-ISPLQK[MT7].2b4_1.heavy 487.318 / 555.362 5655.0 26.482749462127686 40 20 6 6 8 7.823125387171291 12.782615010106376 0.03859901428222656 4 0.99712622986212 23.016129683860385 5655.0 22.325926707688566 2.0 - - - - - - - 733.1111111111111 17 9 KIAA0947 KIAA0947 955 122 C20140527_SFK016_02 C20140527_SFK016_02 TB525804.[MT7]-ISPLQK[MT7].2y3_1.heavy 487.318 / 532.357 11416.0 26.482749462127686 40 20 6 6 8 7.823125387171291 12.782615010106376 0.03859901428222656 4 0.99712622986212 23.016129683860385 11416.0 30.866255008783078 0.0 - - - - - - - 298.0 22 13 KIAA0947 KIAA0947 957 123 C20140527_SFK016_02 C20140527_SFK016_02 TB525805.[MT7]-LLSLIK[MT7].2y4_1.heavy 487.846 / 604.415 617.0 38.33290100097656 18 2 0 10 6 0.45451378006283194 99.68285716621075 0.0 5 0.4988199834370494 1.6645017433500546 617.0 0.13927095003571568 28.0 - - - - - - - 727.375 91 8 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 959 123 C20140527_SFK016_02 C20140527_SFK016_02 TB525805.[MT7]-LLSLIK[MT7].2y5_1.heavy 487.846 / 717.499 2734.0 38.33290100097656 18 2 0 10 6 0.45451378006283194 99.68285716621075 0.0 5 0.4988199834370494 1.6645017433500546 2734.0 15.980243312138395 2.0 - - - - - - - 793.625 72 8 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 961 123 C20140527_SFK016_02 C20140527_SFK016_02 TB525805.[MT7]-LLSLIK[MT7].2b4_1.heavy 487.846 / 571.394 3880.0 38.33290100097656 18 2 0 10 6 0.45451378006283194 99.68285716621075 0.0 5 0.4988199834370494 1.6645017433500546 3880.0 2.436488872572158 1.0 - - - - - - - 793.8571428571429 22 7 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 963 123 C20140527_SFK016_02 C20140527_SFK016_02 TB525805.[MT7]-LLSLIK[MT7].2y3_1.heavy 487.846 / 517.383 10053.0 38.33290100097656 18 2 0 10 6 0.45451378006283194 99.68285716621075 0.0 5 0.4988199834370494 1.6645017433500546 10053.0 15.671983491523076 0.0 - - - - - - - 685.6666666666666 40 9 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 965 124 C20140527_SFK016_02 C20140527_SFK016_02 TB526230.[MT7]-LISYAQLTGR.2y8_1.heavy 633.37 / 895.463 218762.0 36.898399353027344 50 20 10 10 10 10.162385271080122 9.840209491424975 0.0 3 0.9931892800554769 14.945796406950377 218762.0 435.0847730334182 0.0 - - - - - - - 233.75 437 8 VWA5A von Willebrand factor A domain containing 5A 967 124 C20140527_SFK016_02 C20140527_SFK016_02 TB526230.[MT7]-LISYAQLTGR.2y9_1.heavy 633.37 / 1008.55 250202.0 36.898399353027344 50 20 10 10 10 10.162385271080122 9.840209491424975 0.0 3 0.9931892800554769 14.945796406950377 250202.0 321.1555429147734 0.0 - - - - - - - 753.8571428571429 500 7 VWA5A von Willebrand factor A domain containing 5A 969 124 C20140527_SFK016_02 C20140527_SFK016_02 TB526230.[MT7]-LISYAQLTGR.2y6_1.heavy 633.37 / 645.368 68047.0 36.898399353027344 50 20 10 10 10 10.162385271080122 9.840209491424975 0.0 3 0.9931892800554769 14.945796406950377 68047.0 180.3805569195136 0.0 - - - - - - - 747.6 136 10 VWA5A von Willebrand factor A domain containing 5A 971 124 C20140527_SFK016_02 C20140527_SFK016_02 TB526230.[MT7]-LISYAQLTGR.2y7_1.heavy 633.37 / 808.431 60792.0 36.898399353027344 50 20 10 10 10 10.162385271080122 9.840209491424975 0.0 3 0.9931892800554769 14.945796406950377 60792.0 193.50139497362704 0.0 - - - - - - - 253.0 121 10 VWA5A von Willebrand factor A domain containing 5A 973 125 C20140527_SFK016_02 C20140527_SFK016_02 TB526806.[MT7]-IINTDNLLTEYQK[MT7].3y3_1.heavy 618.347 / 582.337 96680.0 38.653900146484375 45 15 10 10 10 4.4082513890866935 22.684731693742656 0.0 3 0.9583990633401126 6.0296709254367356 96680.0 103.71872787944605 0.0 - - - - - - - 784.875 193 8 KIAA0947 KIAA0947 975 125 C20140527_SFK016_02 C20140527_SFK016_02 TB526806.[MT7]-IINTDNLLTEYQK[MT7].3b6_1.heavy 618.347 / 815.438 108156.0 38.653900146484375 45 15 10 10 10 4.4082513890866935 22.684731693742656 0.0 3 0.9583990633401126 6.0296709254367356 108156.0 -12.489145496535798 0.0 - - - - - - - 288.8333333333333 216 6 KIAA0947 KIAA0947 977 125 C20140527_SFK016_02 C20140527_SFK016_02 TB526806.[MT7]-IINTDNLLTEYQK[MT7].3b5_1.heavy 618.347 / 701.395 38325.0 38.653900146484375 45 15 10 10 10 4.4082513890866935 22.684731693742656 0.0 3 0.9583990633401126 6.0296709254367356 38325.0 -5.896153846153844 0.0 - - - - - - - 757.875 76 8 KIAA0947 KIAA0947 979 125 C20140527_SFK016_02 C20140527_SFK016_02 TB526806.[MT7]-IINTDNLLTEYQK[MT7].3y5_1.heavy 618.347 / 812.427 96463.0 38.653900146484375 45 15 10 10 10 4.4082513890866935 22.684731693742656 0.0 3 0.9583990633401126 6.0296709254367356 96463.0 108.63964182310664 0.0 - - - - - - - 271.0 192 2 KIAA0947 KIAA0947 981 126 C20140527_SFK016_02 C20140527_SFK016_02 TB397831.[MT7]-SLGWVEMTEEELAPGR.2y5_1.heavy 974.484 / 513.314 3676.0 45.21139907836914 44 14 10 10 10 1.916215586218514 46.786562907087706 0.0 3 0.9307980280528244 4.664082642442655 3676.0 11.73948387096774 1.0 - - - - - - - 230.2 7 15 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 983 126 C20140527_SFK016_02 C20140527_SFK016_02 TB397831.[MT7]-SLGWVEMTEEELAPGR.2b4_1.heavy 974.484 / 588.326 13020.0 45.21139907836914 44 14 10 10 10 1.916215586218514 46.786562907087706 0.0 3 0.9307980280528244 4.664082642442655 13020.0 96.48531073446328 0.0 - - - - - - - 200.64705882352942 26 17 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 985 126 C20140527_SFK016_02 C20140527_SFK016_02 TB397831.[MT7]-SLGWVEMTEEELAPGR.2b6_1.heavy 974.484 / 816.437 6466.0 45.21139907836914 44 14 10 10 10 1.916215586218514 46.786562907087706 0.0 3 0.9307980280528244 4.664082642442655 6466.0 51.41954589864491 0.0 - - - - - - - 197.94117647058823 12 17 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 987 126 C20140527_SFK016_02 C20140527_SFK016_02 TB397831.[MT7]-SLGWVEMTEEELAPGR.2y10_1.heavy 974.484 / 1132.53 5049.0 45.21139907836914 44 14 10 10 10 1.916215586218514 46.786562907087706 0.0 3 0.9307980280528244 4.664082642442655 5049.0 16.40884904022871 0.0 - - - - - - - 268.92857142857144 10 14 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 989 127 C20140527_SFK016_02 C20140527_SFK016_02 TB525808.[MT7]-SLLQTK[MT7].2y4_1.heavy 489.315 / 633.405 34376.0 26.0132999420166 50 20 10 10 10 8.940558201861522 11.184983950910237 0.0 3 0.9910218360205248 13.014968951854172 34376.0 34.30249465431219 0.0 - - - - - - - 668.2222222222222 68 9 VWA5A von Willebrand factor A domain containing 5A 991 127 C20140527_SFK016_02 C20140527_SFK016_02 TB525808.[MT7]-SLLQTK[MT7].2y5_1.heavy 489.315 / 746.489 20345.0 26.0132999420166 50 20 10 10 10 8.940558201861522 11.184983950910237 0.0 3 0.9910218360205248 13.014968951854172 20345.0 89.29476309226933 0.0 - - - - - - - 200.23076923076923 40 13 VWA5A von Willebrand factor A domain containing 5A 993 127 C20140527_SFK016_02 C20140527_SFK016_02 TB525808.[MT7]-SLLQTK[MT7].2b4_1.heavy 489.315 / 586.368 15434.0 26.0132999420166 50 20 10 10 10 8.940558201861522 11.184983950910237 0.0 3 0.9910218360205248 13.014968951854172 15434.0 35.50759178987741 1.0 - - - - - - - 701.625 32 8 VWA5A von Willebrand factor A domain containing 5A 995 127 C20140527_SFK016_02 C20140527_SFK016_02 TB525808.[MT7]-SLLQTK[MT7].2y3_1.heavy 489.315 / 520.321 29966.0 26.0132999420166 50 20 10 10 10 8.940558201861522 11.184983950910237 0.0 3 0.9910218360205248 13.014968951854172 29966.0 66.46556994809094 0.0 - - - - - - - 721.6 59 10 VWA5A von Willebrand factor A domain containing 5A 997 128 C20140527_SFK016_02 C20140527_SFK016_02 TB327998.[MT7]-ILTPVR.2y5_1.heavy 421.783 / 585.372 154071.0 28.684200286865234 48 20 10 10 8 96.00906598646476 1.0415683037068382 0.0 4 0.9998347702517014 96.00907136851323 154071.0 165.67567029977994 0.0 - - - - - - - 287.25 308 4 CERKL ceramide kinase-like 999 128 C20140527_SFK016_02 C20140527_SFK016_02 TB327998.[MT7]-ILTPVR.2b5_1.heavy 421.783 / 668.446 15704.0 28.684200286865234 48 20 10 10 8 96.00906598646476 1.0415683037068382 0.0 4 0.9998347702517014 96.00907136851323 15704.0 28.126986498196963 2.0 - - - - - - - 752.2857142857143 250 7 CERKL ceramide kinase-like 1001 129 C20140527_SFK016_02 C20140527_SFK016_02 TB526238.[MT7]-SLPLLEGQIR.2y8_1.heavy 635.386 / 925.547 N/A N/A - - - - - - - - - 0.0 - - - - - - - MX2 myxovirus (influenza virus) resistance 2 (mouse) 1003 129 C20140527_SFK016_02 C20140527_SFK016_02 TB526238.[MT7]-SLPLLEGQIR.2y9_1.heavy 635.386 / 1038.63 N/A N/A - - - - - - - - - 0.0 - - - - - - - MX2 myxovirus (influenza virus) resistance 2 (mouse) 1005 129 C20140527_SFK016_02 C20140527_SFK016_02 TB526238.[MT7]-SLPLLEGQIR.2y6_1.heavy 635.386 / 715.41 N/A N/A - - - - - - - - - 0.0 - - - - - - - MX2 myxovirus (influenza virus) resistance 2 (mouse) 1007 129 C20140527_SFK016_02 C20140527_SFK016_02 TB526238.[MT7]-SLPLLEGQIR.2y7_1.heavy 635.386 / 828.494 N/A N/A - - - - - - - - - 0.0 - - - - - - - MX2 myxovirus (influenza virus) resistance 2 (mouse) 1009 130 C20140527_SFK016_02 C20140527_SFK016_02 TB526943.[MT7]-VDASETTVNLSENQLNK[MT7].3y7_1.heavy 717.378 / 976.518 8812.0 30.44337558746338 31 13 2 6 10 3.229351797531483 30.965966630343594 0.035900115966796875 3 0.9279334959478 4.569327723398893 8812.0 60.43494345859429 0.0 - - - - - - - 309.94117647058823 17 17 KIAA2022 KIAA2022 1011 130 C20140527_SFK016_02 C20140527_SFK016_02 TB526943.[MT7]-VDASETTVNLSENQLNK[MT7].3b6_1.heavy 717.378 / 747.364 5268.0 30.44337558746338 31 13 2 6 10 3.229351797531483 30.965966630343594 0.035900115966796875 3 0.9279334959478 4.569327723398893 5268.0 38.17036227154047 0.0 - - - - - - - 208.52941176470588 10 17 KIAA2022 KIAA2022 1013 130 C20140527_SFK016_02 C20140527_SFK016_02 TB526943.[MT7]-VDASETTVNLSENQLNK[MT7].3y3_1.heavy 717.378 / 518.342 14272.0 30.44337558746338 31 13 2 6 10 3.229351797531483 30.965966630343594 0.035900115966796875 3 0.9279334959478 4.569327723398893 14272.0 12.060807517525792 0.0 - - - - - - - 840.7777777777778 28 9 KIAA2022 KIAA2022 1015 130 C20140527_SFK016_02 C20140527_SFK016_02 TB526943.[MT7]-VDASETTVNLSENQLNK[MT7].3b4_1.heavy 717.378 / 517.274 3927.0 30.44337558746338 31 13 2 6 10 3.229351797531483 30.965966630343594 0.035900115966796875 3 0.9279334959478 4.569327723398893 3927.0 5.193226656462371 2.0 - - - - - - - 787.6666666666666 72 9 KIAA2022 KIAA2022 1017 131 C20140527_SFK016_02 C20140527_SFK016_02 TB327991.[MT7]-GITLTR.2y4_1.heavy 402.757 / 490.298 57882.0 25.41469955444336 24 8 0 10 6 2.2025844336008475 30.623816840878927 0.0 5 0.7745545693942434 2.5487230294063012 57882.0 83.85190859345424 0.0 - - - - - - - 269.5 115 6 C2CD2 C2 calcium-dependent domain containing 2 1019 131 C20140527_SFK016_02 C20140527_SFK016_02 TB327991.[MT7]-GITLTR.2b3_1.heavy 402.757 / 416.263 41606.0 25.41469955444336 24 8 0 10 6 2.2025844336008475 30.623816840878927 0.0 5 0.7745545693942434 2.5487230294063012 41606.0 20.564476681479917 2.0 - - - - - - - 323.0 646 1 C2CD2 C2 calcium-dependent domain containing 2 1021 131 C20140527_SFK016_02 C20140527_SFK016_02 TB327991.[MT7]-GITLTR.2y5_1.heavy 402.757 / 603.382 53571.0 25.41469955444336 24 8 0 10 6 2.2025844336008475 30.623816840878927 0.0 5 0.7745545693942434 2.5487230294063012 53571.0 206.7596218487395 0.0 - - - - - - - 263.55555555555554 107 9 C2CD2 C2 calcium-dependent domain containing 2 1023 131 C20140527_SFK016_02 C20140527_SFK016_02 TB327991.[MT7]-GITLTR.2b4_1.heavy 402.757 / 529.347 45055.0 25.41469955444336 24 8 0 10 6 2.2025844336008475 30.623816840878927 0.0 5 0.7745545693942434 2.5487230294063012 45055.0 27.620611236193252 2.0 - - - - - - - 431.0 432 3 C2CD2 C2 calcium-dependent domain containing 2 1025 132 C20140527_SFK016_02 C20140527_SFK016_02 TB526412.[MT7]-AENMIQLQFR.2y8_1.heavy 697.373 / 1049.56 9111.0 37.66805076599121 39 14 10 5 10 3.299533770292571 24.568218178085598 0.042499542236328125 3 0.939902140015312 5.008797601579034 9111.0 22.17010117049444 0.0 - - - - - - - 285.42857142857144 18 14 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1027 132 C20140527_SFK016_02 C20140527_SFK016_02 TB526412.[MT7]-AENMIQLQFR.2y5_1.heavy 697.373 / 691.389 11889.0 37.66805076599121 39 14 10 5 10 3.299533770292571 24.568218178085598 0.042499542236328125 3 0.939902140015312 5.008797601579034 11889.0 7.886139227104288 0.0 - - - - - - - 722.5 23 2 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1029 132 C20140527_SFK016_02 C20140527_SFK016_02 TB526412.[MT7]-AENMIQLQFR.2y9_1.heavy 697.373 / 1178.6 5333.0 37.66805076599121 39 14 10 5 10 3.299533770292571 24.568218178085598 0.042499542236328125 3 0.939902140015312 5.008797601579034 5333.0 17.686987384686034 0.0 - - - - - - - 635.2857142857143 10 7 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1031 132 C20140527_SFK016_02 C20140527_SFK016_02 TB526412.[MT7]-AENMIQLQFR.2b4_1.heavy 697.373 / 590.273 13000.0 37.66805076599121 39 14 10 5 10 3.299533770292571 24.568218178085598 0.042499542236328125 3 0.939902140015312 5.008797601579034 13000.0 20.187234042553193 0.0 - - - - - - - 333.0 26 4 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1033 133 C20140527_SFK016_02 C20140527_SFK016_02 TB526028.[MT7]-SLYIQAK[MT7].2y4_1.heavy 555.842 / 603.395 14843.0 27.779799461364746 45 20 10 5 10 11.173683953690084 8.949599828888594 0.04039955139160156 3 0.9972615235553622 23.578094628971236 14843.0 39.00141007796981 0.0 - - - - - - - 322.75 29 4 CXorf23 chromosome X open reading frame 23 1035 133 C20140527_SFK016_02 C20140527_SFK016_02 TB526028.[MT7]-SLYIQAK[MT7].2b3_1.heavy 555.842 / 508.289 17209.0 27.779799461364746 45 20 10 5 10 11.173683953690084 8.949599828888594 0.04039955139160156 3 0.9972615235553622 23.578094628971236 17209.0 27.337418791240477 0.0 - - - - - - - 618.375 34 8 CXorf23 chromosome X open reading frame 23 1037 133 C20140527_SFK016_02 C20140527_SFK016_02 TB526028.[MT7]-SLYIQAK[MT7].2y5_1.heavy 555.842 / 766.458 12584.0 27.779799461364746 45 20 10 5 10 11.173683953690084 8.949599828888594 0.04039955139160156 3 0.9972615235553622 23.578094628971236 12584.0 67.18248050488458 0.0 - - - - - - - 248.3846153846154 25 13 CXorf23 chromosome X open reading frame 23 1039 133 C20140527_SFK016_02 C20140527_SFK016_02 TB526028.[MT7]-SLYIQAK[MT7].2y6_1.heavy 555.842 / 879.542 6561.0 27.779799461364746 45 20 10 5 10 11.173683953690084 8.949599828888594 0.04039955139160156 3 0.9972615235553622 23.578094628971236 6561.0 13.453504864263873 0.0 - - - - - - - 310.77777777777777 13 9 CXorf23 chromosome X open reading frame 23 1041 134 C20140527_SFK016_02 C20140527_SFK016_02 TB525933.[MT7]-LEINEK[MT7].2y4_1.heavy 517.31 / 647.385 14842.0 26.094499588012695 50 20 10 10 10 11.837223047675462 8.447927321909976 0.0 3 0.9973135044199551 23.80521066483825 14842.0 12.6283975631992 0.0 - - - - - - - 740.6666666666666 29 9 GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 1043 134 C20140527_SFK016_02 C20140527_SFK016_02 TB525933.[MT7]-LEINEK[MT7].2y5_1.heavy 517.31 / 776.427 16458.0 26.094499588012695 50 20 10 10 10 11.837223047675462 8.447927321909976 0.0 3 0.9973135044199551 23.80521066483825 16458.0 10.510600358955465 1.0 - - - - - - - 252.5 33 4 GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 1045 134 C20140527_SFK016_02 C20140527_SFK016_02 TB525933.[MT7]-LEINEK[MT7].2b4_1.heavy 517.31 / 614.363 4847.0 26.094499588012695 50 20 10 10 10 11.837223047675462 8.447927321909976 0.0 3 0.9973135044199551 23.80521066483825 4847.0 11.93353795379538 0.0 - - - - - - - 698.5833333333334 9 12 GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 1047 134 C20140527_SFK016_02 C20140527_SFK016_02 TB525933.[MT7]-LEINEK[MT7].2y3_1.heavy 517.31 / 534.3 17266.0 26.094499588012695 50 20 10 10 10 11.837223047675462 8.447927321909976 0.0 3 0.9973135044199551 23.80521066483825 17266.0 49.112177777777774 0.0 - - - - - - - 694.375 34 8 GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 1049 135 C20140527_SFK016_02 C20140527_SFK016_02 TB526029.[MT7]-STETETGSR.2y6_1.heavy 556.271 / 650.31 1033.0 13.026224851608276 43 18 10 7 8 8.958928397327986 11.162049250201079 0.02950000762939453 4 0.9824596308667929 9.304780808218167 1033.0 23.132565347274088 0.0 - - - - - - - 72.85714285714286 2 21 GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 1051 135 C20140527_SFK016_02 C20140527_SFK016_02 TB526029.[MT7]-STETETGSR.2y8_1.heavy 556.271 / 880.401 1206.0 13.026224851608276 43 18 10 7 8 8.958928397327986 11.162049250201079 0.02950000762939453 4 0.9824596308667929 9.304780808218167 1206.0 72.36 1.0 - - - - - - - 61.473684210526315 2 19 GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 1053 135 C20140527_SFK016_02 C20140527_SFK016_02 TB526029.[MT7]-STETETGSR.2b5_1.heavy 556.271 / 692.322 448.0 13.026224851608276 43 18 10 7 8 8.958928397327986 11.162049250201079 0.02950000762939453 4 0.9824596308667929 9.304780808218167 448.0 18.96798905608755 3.0 - - - - - - - 0.0 1 0 GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 1055 135 C20140527_SFK016_02 C20140527_SFK016_02 TB526029.[MT7]-STETETGSR.2y7_1.heavy 556.271 / 779.353 189.0 13.026224851608276 43 18 10 7 8 8.958928397327986 11.162049250201079 0.02950000762939453 4 0.9824596308667929 9.304780808218167 189.0 -1.3117647058823525 4.0 - - - - - - - 0.0 0 0 GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 1057 136 C20140527_SFK016_02 C20140527_SFK016_02 TB397647.[MT7]-DFVEEDNQR.2y5_1.heavy 648.303 / 661.29 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP25 ubiquitin specific peptidase 25 1059 136 C20140527_SFK016_02 C20140527_SFK016_02 TB397647.[MT7]-DFVEEDNQR.2y6_1.heavy 648.303 / 790.333 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP25 ubiquitin specific peptidase 25 1061 136 C20140527_SFK016_02 C20140527_SFK016_02 TB397647.[MT7]-DFVEEDNQR.2b5_1.heavy 648.303 / 764.358 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP25 ubiquitin specific peptidase 25 1063 136 C20140527_SFK016_02 C20140527_SFK016_02 TB397647.[MT7]-DFVEEDNQR.2y7_1.heavy 648.303 / 889.401 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP25 ubiquitin specific peptidase 25 1065 137 C20140527_SFK016_02 C20140527_SFK016_02 TPX_ECO57.DLSDVTLGQFAGK.2y7.peptide 675.85 / 720.4 483042.0 37.85820007324219 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 483042.0 226.78220289734648 0.0 - - - - - - - 852.25 966 8 1067 137 C20140527_SFK016_02 C20140527_SFK016_02 TPX_ECO57.DLSDVTLGQFAGK.2y8.peptide 675.85 / 821.45 1218430.0 37.85820007324219 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1218430.0 329.01434855139956 0.0 - - - - - - - 328.8333333333333 2436 6 1069 137 C20140527_SFK016_02 C20140527_SFK016_02 TPX_ECO57.DLSDVTLGQFAGK.2y6.peptide 675.85 / 607.32 1117530.0 37.85820007324219 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1117530.0 213.08451749935782 0.0 - - - - - - - 727.4285714285714 2235 7 1071 138 C20140527_SFK016_02 C20140527_SFK016_02 TB526810.[MT7]-LVIQQSIDEIAPLK[MT7].3b6_1.heavy 619.043 / 813.495 4656.0 42.704599380493164 43 17 10 6 10 3.341402290087538 29.92755475647328 0.034801483154296875 3 0.9799798982069643 8.707670829341705 4656.0 16.917264154186384 2.0 - - - - - - - 269.42857142857144 66 14 KIAA2022 KIAA2022 1073 138 C20140527_SFK016_02 C20140527_SFK016_02 TB526810.[MT7]-LVIQQSIDEIAPLK[MT7].3y3_1.heavy 619.043 / 501.352 47815.0 42.704599380493164 43 17 10 6 10 3.341402290087538 29.92755475647328 0.034801483154296875 3 0.9799798982069643 8.707670829341705 47815.0 -7.190225563909774 0.0 - - - - - - - 674.25 95 8 KIAA2022 KIAA2022 1075 138 C20140527_SFK016_02 C20140527_SFK016_02 TB526810.[MT7]-LVIQQSIDEIAPLK[MT7].3b4_1.heavy 619.043 / 598.404 10272.0 42.704599380493164 43 17 10 6 10 3.341402290087538 29.92755475647328 0.034801483154296875 3 0.9799798982069643 8.707670829341705 10272.0 33.05991037191038 0.0 - - - - - - - 362.0 20 10 KIAA2022 KIAA2022 1077 138 C20140527_SFK016_02 C20140527_SFK016_02 TB526810.[MT7]-LVIQQSIDEIAPLK[MT7].3y4_1.heavy 619.043 / 572.389 20914.0 42.704599380493164 43 17 10 6 10 3.341402290087538 29.92755475647328 0.034801483154296875 3 0.9799798982069643 8.707670829341705 20914.0 32.545466847090665 0.0 - - - - - - - 694.6 41 10 KIAA2022 KIAA2022 1079 139 C20140527_SFK016_02 C20140527_SFK016_02 TB328261.[MT7]-ASPLSSDSPVK[MT7].2y4_1.heavy 688.387 / 574.368 9293.0 25.680599212646484 48 18 10 10 10 6.630775048359859 15.08119326484093 0.0 3 0.9828361417672193 9.406580265925378 9293.0 10.879609756097562 1.0 - - - - - - - 734.1428571428571 18 7 C2CD2 C2 calcium-dependent domain containing 2 1081 139 C20140527_SFK016_02 C20140527_SFK016_02 TB328261.[MT7]-ASPLSSDSPVK[MT7].2y9_1.heavy 688.387 / 1073.6 6341.0 25.680599212646484 48 18 10 10 10 6.630775048359859 15.08119326484093 0.0 3 0.9828361417672193 9.406580265925378 6341.0 13.611649502893602 1.0 - - - - - - - 337.0 14 12 C2CD2 C2 calcium-dependent domain containing 2 1083 139 C20140527_SFK016_02 C20140527_SFK016_02 TB328261.[MT7]-ASPLSSDSPVK[MT7].2b7_1.heavy 688.387 / 802.406 5029.0 25.680599212646484 48 18 10 10 10 6.630775048359859 15.08119326484093 0.0 3 0.9828361417672193 9.406580265925378 5029.0 33.39224635260051 0.0 - - - - - - - 226.5 10 14 C2CD2 C2 calcium-dependent domain containing 2 1085 139 C20140527_SFK016_02 C20140527_SFK016_02 TB328261.[MT7]-ASPLSSDSPVK[MT7].2y7_1.heavy 688.387 / 863.459 2952.0 25.680599212646484 48 18 10 10 10 6.630775048359859 15.08119326484093 0.0 3 0.9828361417672193 9.406580265925378 2952.0 5.61602634467618 1.0 - - - - - - - 749.7142857142857 5 7 C2CD2 C2 calcium-dependent domain containing 2 1087 140 C20140527_SFK016_02 C20140527_SFK016_02 TB526549.[MT7]-IDMSLAELQSK[MT7].3b9_2.heavy 508.284 / 573.303 6111.0 37.51639938354492 44 14 10 10 10 10.75398312499814 9.298880130055746 0.0 3 0.9473808371762198 5.356331034084841 6111.0 21.562177717285632 0.0 - - - - - - - 272.45454545454544 12 11 CXorf23 chromosome X open reading frame 23 1089 140 C20140527_SFK016_02 C20140527_SFK016_02 TB526549.[MT7]-IDMSLAELQSK[MT7].3b6_1.heavy 508.284 / 775.414 6444.0 37.51639938354492 44 14 10 10 10 10.75398312499814 9.298880130055746 0.0 3 0.9473808371762198 5.356331034084841 6444.0 31.92972972972973 0.0 - - - - - - - 230.53846153846155 12 13 CXorf23 chromosome X open reading frame 23 1091 140 C20140527_SFK016_02 C20140527_SFK016_02 TB526549.[MT7]-IDMSLAELQSK[MT7].3b4_1.heavy 508.284 / 591.293 13332.0 37.51639938354492 44 14 10 10 10 10.75398312499814 9.298880130055746 0.0 3 0.9473808371762198 5.356331034084841 13332.0 32.61928057553957 0.0 - - - - - - - 292.6363636363636 26 11 CXorf23 chromosome X open reading frame 23 1093 140 C20140527_SFK016_02 C20140527_SFK016_02 TB526549.[MT7]-IDMSLAELQSK[MT7].3b5_1.heavy 508.284 / 704.377 7777.0 37.51639938354492 44 14 10 10 10 10.75398312499814 9.298880130055746 0.0 3 0.9473808371762198 5.356331034084841 7777.0 78.00354354354354 0.0 - - - - - - - 210.9 15 10 CXorf23 chromosome X open reading frame 23 1095 141 C20140527_SFK016_02 C20140527_SFK016_02 TB397641.[MT7]-QISLC[CAM]NDQR.2y6_1.heavy 639.323 / 805.362 942.0 24.2367000579834 44 14 10 10 10 2.1015870897899376 47.58308636640674 0.0 3 0.9437617237038646 5.179522473566298 942.0 4.309574468085106 3.0 - - - - - - - 0.0 1 0 KIAA2022 KIAA2022 1097 141 C20140527_SFK016_02 C20140527_SFK016_02 TB397641.[MT7]-QISLC[CAM]NDQR.2y8_1.heavy 639.323 / 1005.48 6123.0 24.2367000579834 44 14 10 10 10 2.1015870897899376 47.58308636640674 0.0 3 0.9437617237038646 5.179522473566298 6123.0 6.372536292082623 0.0 - - - - - - - 753.5714285714286 12 7 KIAA2022 KIAA2022 1099 141 C20140527_SFK016_02 C20140527_SFK016_02 TB397641.[MT7]-QISLC[CAM]NDQR.2y5_1.heavy 639.323 / 692.278 1225.0 24.2367000579834 44 14 10 10 10 2.1015870897899376 47.58308636640674 0.0 3 0.9437617237038646 5.179522473566298 1225.0 4.971485411140583 1.0 - - - - - - - 200.125 2 16 KIAA2022 KIAA2022 1101 141 C20140527_SFK016_02 C20140527_SFK016_02 TB397641.[MT7]-QISLC[CAM]NDQR.2y7_1.heavy 639.323 / 892.394 4051.0 24.2367000579834 44 14 10 10 10 2.1015870897899376 47.58308636640674 0.0 3 0.9437617237038646 5.179522473566298 4051.0 39.43260638297872 0.0 - - - - - - - 167.22222222222223 8 9 KIAA2022 KIAA2022 1103 142 C20140527_SFK016_02 C20140527_SFK016_02 TB526819.[MT7]-AMEIIQQAFINVAK[MT7].3b6_1.heavy 622.025 / 830.456 N/A N/A - - - - - - - - - 0.0 - - - - - - - MX2 myxovirus (influenza virus) resistance 2 (mouse) 1105 142 C20140527_SFK016_02 C20140527_SFK016_02 TB526819.[MT7]-AMEIIQQAFINVAK[MT7].3b4_1.heavy 622.025 / 589.314 N/A N/A - - - - - - - - - 0.0 - - - - - - - MX2 myxovirus (influenza virus) resistance 2 (mouse) 1107 142 C20140527_SFK016_02 C20140527_SFK016_02 TB526819.[MT7]-AMEIIQQAFINVAK[MT7].3y4_1.heavy 622.025 / 575.363 N/A N/A - - - - - - - - - 0.0 - - - - - - - MX2 myxovirus (influenza virus) resistance 2 (mouse) 1109 142 C20140527_SFK016_02 C20140527_SFK016_02 TB526819.[MT7]-AMEIIQQAFINVAK[MT7].3y5_1.heavy 622.025 / 688.447 N/A N/A - - - - - - - - - 0.0 - - - - - - - MX2 myxovirus (influenza virus) resistance 2 (mouse) 1111 143 C20140527_SFK016_02 C20140527_SFK016_02 TB397705.[MT7]-TAAALAPASLTSAR.3y7_1.heavy 482.28 / 705.389 6209.0 31.157400131225586 41 13 10 10 8 0.9738785059298626 62.811046617771936 0.0 4 0.9105525568293846 4.095309785442907 6209.0 31.921877318116977 1.0 - - - - - - - 676.0 15 8 SRRM2 serine/arginine repetitive matrix 2 1113 143 C20140527_SFK016_02 C20140527_SFK016_02 TB397705.[MT7]-TAAALAPASLTSAR.3y6_1.heavy 482.28 / 634.352 12217.0 31.157400131225586 41 13 10 10 8 0.9738785059298626 62.811046617771936 0.0 4 0.9105525568293846 4.095309785442907 12217.0 18.39693842985978 0.0 - - - - - - - 676.0 24 8 SRRM2 serine/arginine repetitive matrix 2 1115 143 C20140527_SFK016_02 C20140527_SFK016_02 TB397705.[MT7]-TAAALAPASLTSAR.3b5_1.heavy 482.28 / 572.352 15822.0 31.157400131225586 41 13 10 10 8 0.9738785059298626 62.811046617771936 0.0 4 0.9105525568293846 4.095309785442907 15822.0 11.6504796581448 0.0 - - - - - - - 684.3333333333334 31 12 SRRM2 serine/arginine repetitive matrix 2 1117 143 C20140527_SFK016_02 C20140527_SFK016_02 TB397705.[MT7]-TAAALAPASLTSAR.3y8_1.heavy 482.28 / 802.442 6008.0 31.157400131225586 41 13 10 10 8 0.9738785059298626 62.811046617771936 0.0 4 0.9105525568293846 4.095309785442907 6008.0 28.02133865779257 0.0 - - - - - - - 307.5 12 14 SRRM2 serine/arginine repetitive matrix 2 1119 144 C20140527_SFK016_02 C20140527_SFK016_02 TB526817.[MT7]-VRQDLEEAQNEQTR.3y7_1.heavy 620.649 / 846.406 35667.0 23.053199768066406 43 13 10 10 10 5.77408153962566 17.31877170658783 0.0 3 0.9252374918832063 4.485148466200259 35667.0 589.5513473205258 0.0 - - - - - - - 206.14285714285714 71 14 KIF3C kinesin family member 3C 1121 144 C20140527_SFK016_02 C20140527_SFK016_02 TB526817.[MT7]-VRQDLEEAQNEQTR.3y6_1.heavy 620.649 / 775.369 41440.0 23.053199768066406 43 13 10 10 10 5.77408153962566 17.31877170658783 0.0 3 0.9252374918832063 4.485148466200259 41440.0 290.8334545454545 0.0 - - - - - - - 184.625 82 16 KIF3C kinesin family member 3C 1123 144 C20140527_SFK016_02 C20140527_SFK016_02 TB526817.[MT7]-VRQDLEEAQNEQTR.3b4_1.heavy 620.649 / 643.364 29276.0 23.053199768066406 43 13 10 10 10 5.77408153962566 17.31877170658783 0.0 3 0.9252374918832063 4.485148466200259 29276.0 198.9631067961165 0.0 - - - - - - - 253.5 58 16 KIF3C kinesin family member 3C 1125 144 C20140527_SFK016_02 C20140527_SFK016_02 TB526817.[MT7]-VRQDLEEAQNEQTR.3y5_1.heavy 620.649 / 647.311 77932.0 23.053199768066406 43 13 10 10 10 5.77408153962566 17.31877170658783 0.0 3 0.9252374918832063 4.485148466200259 77932.0 391.1358621054621 0.0 - - - - - - - 251.86666666666667 155 15 KIF3C kinesin family member 3C 1127 145 C20140527_SFK016_02 C20140527_SFK016_02 TB526952.[MT7]-SDADSGFLGLRPTSVDPALR.3b16_2.heavy 740.058 / 881.94 28501.0 39.181400299072266 44 14 10 10 10 2.5237224719378646 39.62400823067286 0.0 3 0.9379379612683463 4.928074313970063 28501.0 -1.6864497041420101 0.0 - - - - - - - 683.4285714285714 57 7 GLTSCR2 glioma tumor suppressor candidate region gene 2 1129 145 C20140527_SFK016_02 C20140527_SFK016_02 TB526952.[MT7]-SDADSGFLGLRPTSVDPALR.3b6_1.heavy 740.058 / 677.286 2288.0 39.181400299072266 44 14 10 10 10 2.5237224719378646 39.62400823067286 0.0 3 0.9379379612683463 4.928074313970063 2288.0 2.9333333333333336 1.0 - - - - - - - 264.0 4 13 GLTSCR2 glioma tumor suppressor candidate region gene 2 1131 145 C20140527_SFK016_02 C20140527_SFK016_02 TB526952.[MT7]-SDADSGFLGLRPTSVDPALR.3b4_1.heavy 740.058 / 533.232 13939.0 39.181400299072266 44 14 10 10 10 2.5237224719378646 39.62400823067286 0.0 3 0.9379379612683463 4.928074313970063 13939.0 21.13826373626374 0.0 - - - - - - - 138.66666666666666 27 3 GLTSCR2 glioma tumor suppressor candidate region gene 2 1133 145 C20140527_SFK016_02 C20140527_SFK016_02 TB526952.[MT7]-SDADSGFLGLRPTSVDPALR.3y9_1.heavy 740.058 / 955.521 3641.0 39.181400299072266 44 14 10 10 10 2.5237224719378646 39.62400823067286 0.0 3 0.9379379612683463 4.928074313970063 3641.0 2.625721153846154 1.0 - - - - - - - 713.1428571428571 10 7 GLTSCR2 glioma tumor suppressor candidate region gene 2 1135 146 C20140527_SFK016_02 C20140527_SFK016_02 TB525934.[MT7]-TLALAEK[MT7].2y4_1.heavy 517.328 / 604.379 30771.0 27.559600830078125 46 16 10 10 10 2.1252612922632643 47.05303783776466 0.0 3 0.9633654675919326 6.428093713877746 30771.0 36.979841675178754 0.0 - - - - - - - 807.7142857142857 61 14 CERKL ceramide kinase-like 1137 146 C20140527_SFK016_02 C20140527_SFK016_02 TB525934.[MT7]-TLALAEK[MT7].2y5_1.heavy 517.328 / 675.416 21529.0 27.559600830078125 46 16 10 10 10 2.1252612922632643 47.05303783776466 0.0 3 0.9633654675919326 6.428093713877746 21529.0 51.76943139501414 0.0 - - - - - - - 277.77777777777777 43 9 CERKL ceramide kinase-like 1139 146 C20140527_SFK016_02 C20140527_SFK016_02 TB525934.[MT7]-TLALAEK[MT7].2b4_1.heavy 517.328 / 543.362 19681.0 27.559600830078125 46 16 10 10 10 2.1252612922632643 47.05303783776466 0.0 3 0.9633654675919326 6.428093713877746 19681.0 30.013119304847883 0.0 - - - - - - - 830.4545454545455 39 11 CERKL ceramide kinase-like 1141 146 C20140527_SFK016_02 C20140527_SFK016_02 TB525934.[MT7]-TLALAEK[MT7].2y6_1.heavy 517.328 / 788.5 17289.0 27.559600830078125 46 16 10 10 10 2.1252612922632643 47.05303783776466 0.0 3 0.9633654675919326 6.428093713877746 17289.0 94.67962041582919 0.0 - - - - - - - 227.27272727272728 34 11 CERKL ceramide kinase-like 1143 147 C20140527_SFK016_02 C20140527_SFK016_02 TB526403.[MT7]-NTSRPEFIK[MT7].3y3_1.heavy 460.601 / 551.367 30809.0 24.421899795532227 43 13 10 10 10 1.1860780234900177 56.20765695540075 0.0 3 0.9283700046870809 4.583400424755254 30809.0 85.68930147420032 0.0 - - - - - - - 295.5 61 6 CERKL ceramide kinase-like 1145 147 C20140527_SFK016_02 C20140527_SFK016_02 TB526403.[MT7]-NTSRPEFIK[MT7].3y4_1.heavy 460.601 / 680.41 6921.0 24.421899795532227 43 13 10 10 10 1.1860780234900177 56.20765695540075 0.0 3 0.9283700046870809 4.583400424755254 6921.0 23.142297148898635 1.0 - - - - - - - 184.1818181818182 14 11 CERKL ceramide kinase-like 1147 147 C20140527_SFK016_02 C20140527_SFK016_02 TB526403.[MT7]-NTSRPEFIK[MT7].3y8_2.heavy 460.601 / 561.325 31315.0 24.421899795532227 43 13 10 10 10 1.1860780234900177 56.20765695540075 0.0 3 0.9283700046870809 4.583400424755254 31315.0 52.43352649755391 0.0 - - - - - - - 274.375 62 8 CERKL ceramide kinase-like 1149 147 C20140527_SFK016_02 C20140527_SFK016_02 TB526403.[MT7]-NTSRPEFIK[MT7].3y5_1.heavy 460.601 / 777.463 21693.0 24.421899795532227 43 13 10 10 10 1.1860780234900177 56.20765695540075 0.0 3 0.9283700046870809 4.583400424755254 21693.0 134.90419573554558 0.0 - - - - - - - 260.3333333333333 43 12 CERKL ceramide kinase-like 1151 148 C20140527_SFK016_02 C20140527_SFK016_02 TB397702.[MT7]-TLK[MT7]PEGNILR.3y7_1.heavy 476.964 / 798.447 51253.0 27.680599212646484 47 17 10 10 10 2.8383269809473797 28.50264743167553 0.0 3 0.9797208250543764 8.651682176278987 51253.0 373.6116671859583 0.0 - - - - - - - 212.66666666666666 102 12 GLTSCR2 glioma tumor suppressor candidate region gene 2 1153 148 C20140527_SFK016_02 C20140527_SFK016_02 TB397702.[MT7]-TLK[MT7]PEGNILR.3y6_1.heavy 476.964 / 701.394 5302.0 27.680599212646484 47 17 10 10 10 2.8383269809473797 28.50264743167553 0.0 3 0.9797208250543764 8.651682176278987 5302.0 16.0762198777688 0.0 - - - - - - - 245.25 10 12 GLTSCR2 glioma tumor suppressor candidate region gene 2 1155 148 C20140527_SFK016_02 C20140527_SFK016_02 TB397702.[MT7]-TLK[MT7]PEGNILR.3y5_1.heavy 476.964 / 572.352 20128.0 27.680599212646484 47 17 10 10 10 2.8383269809473797 28.50264743167553 0.0 3 0.9797208250543764 8.651682176278987 20128.0 53.909053857350806 0.0 - - - - - - - 730.8888888888889 40 9 GLTSCR2 glioma tumor suppressor candidate region gene 2 1157 148 C20140527_SFK016_02 C20140527_SFK016_02 TB397702.[MT7]-TLK[MT7]PEGNILR.3b7_2.heavy 476.964 / 514.803 26117.0 27.680599212646484 47 17 10 10 10 2.8383269809473797 28.50264743167553 0.0 3 0.9797208250543764 8.651682176278987 26117.0 117.18467806478671 0.0 - - - - - - - 245.5 52 10 GLTSCR2 glioma tumor suppressor candidate region gene 2 1159 149 C20140527_SFK016_02 C20140527_SFK016_02 TB526227.[MT7]-SSVAVNNC[CAM]IR.2y5_1.heavy 632.333 / 676.32 8446.0 22.436500549316406 50 20 10 10 10 8.759882098216172 11.415678759005628 0.0 3 0.9948160594605292 17.13344017168617 8446.0 25.36157023255814 0.0 - - - - - - - 202.30769230769232 16 13 APBB1;APBB2 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65);amyloid beta (A4) precursor protein-binding, family B, member 2 1161 149 C20140527_SFK016_02 C20140527_SFK016_02 TB526227.[MT7]-SSVAVNNC[CAM]IR.2y9_1.heavy 632.333 / 1032.53 18143.0 22.436500549316406 50 20 10 10 10 8.759882098216172 11.415678759005628 0.0 3 0.9948160594605292 17.13344017168617 18143.0 99.43003428053376 0.0 - - - - - - - 746.1428571428571 36 14 APBB1;APBB2 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65);amyloid beta (A4) precursor protein-binding, family B, member 2 1163 149 C20140527_SFK016_02 C20140527_SFK016_02 TB526227.[MT7]-SSVAVNNC[CAM]IR.2y6_1.heavy 632.333 / 775.388 10072.0 22.436500549316406 50 20 10 10 10 8.759882098216172 11.415678759005628 0.0 3 0.9948160594605292 17.13344017168617 10072.0 41.168658946121965 0.0 - - - - - - - 206.05882352941177 20 17 APBB1;APBB2 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65);amyloid beta (A4) precursor protein-binding, family B, member 2 1165 149 C20140527_SFK016_02 C20140527_SFK016_02 TB526227.[MT7]-SSVAVNNC[CAM]IR.2y7_1.heavy 632.333 / 846.425 19081.0 22.436500549316406 50 20 10 10 10 8.759882098216172 11.415678759005628 0.0 3 0.9948160594605292 17.13344017168617 19081.0 70.06160701017906 0.0 - - - - - - - 204.53333333333333 38 15 APBB1;APBB2 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65);amyloid beta (A4) precursor protein-binding, family B, member 2 1167 150 C20140527_SFK016_02 C20140527_SFK016_02 TB526953.[MT7]-SDADSGFLGLRPTSVDPALR.4y9_1.heavy 555.295 / 955.521 2294.0 39.22364902496338 40 14 10 6 10 1.4930722051165108 53.16696775688659 0.033802032470703125 3 0.9363012814381564 4.8636720541735405 2294.0 -1.1002398081534768 0.0 - - - - - - - 247.75 4 8 GLTSCR2 glioma tumor suppressor candidate region gene 2 1169 150 C20140527_SFK016_02 C20140527_SFK016_02 TB526953.[MT7]-SDADSGFLGLRPTSVDPALR.4y12_2.heavy 555.295 / 641.367 17834.0 39.22364902496338 40 14 10 6 10 1.4930722051165108 53.16696775688659 0.033802032470703125 3 0.9363012814381564 4.8636720541735405 17834.0 0.0 0.0 - - - - - - - 391.0 35 4 GLTSCR2 glioma tumor suppressor candidate region gene 2 1171 150 C20140527_SFK016_02 C20140527_SFK016_02 TB526953.[MT7]-SDADSGFLGLRPTSVDPALR.4b4_1.heavy 555.295 / 533.232 10117.0 39.22364902496338 40 14 10 6 10 1.4930722051165108 53.16696775688659 0.033802032470703125 3 0.9363012814381564 4.8636720541735405 10117.0 -0.30626639757820406 0.0 - - - - - - - 521.0 20 1 GLTSCR2 glioma tumor suppressor candidate region gene 2 1173 150 C20140527_SFK016_02 C20140527_SFK016_02 TB526953.[MT7]-SDADSGFLGLRPTSVDPALR.4b6_1.heavy 555.295 / 677.286 19920.0 39.22364902496338 40 14 10 6 10 1.4930722051165108 53.16696775688659 0.033802032470703125 3 0.9363012814381564 4.8636720541735405 19920.0 -0.6367607884922748 0.0 - - - - - - - 347.6666666666667 39 3 GLTSCR2 glioma tumor suppressor candidate region gene 2 1175 151 C20140527_SFK016_02 C20140527_SFK016_02 TB526228.[MT7]-SSVAVNNC[CAM]IR.3b4_1.heavy 421.891 / 489.279 77878.0 22.436500549316406 45 15 10 10 10 2.5525549322682854 30.3931589978502 0.0 3 0.954936935058587 5.791718911763736 77878.0 26.306731318215594 0.0 - - - - - - - 313.0 155 2 APBB1;APBB2 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65);amyloid beta (A4) precursor protein-binding, family B, member 2 1177 151 C20140527_SFK016_02 C20140527_SFK016_02 TB526228.[MT7]-SSVAVNNC[CAM]IR.3b3_1.heavy 421.891 / 418.242 41723.0 22.436500549316406 45 15 10 10 10 2.5525549322682854 30.3931589978502 0.0 3 0.954936935058587 5.791718911763736 41723.0 21.094667805638778 0.0 - - - - - - - 438.0 83 1 APBB1;APBB2 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65);amyloid beta (A4) precursor protein-binding, family B, member 2 1179 151 C20140527_SFK016_02 C20140527_SFK016_02 TB526228.[MT7]-SSVAVNNC[CAM]IR.3y4_1.heavy 421.891 / 562.277 17139.0 22.436500549316406 45 15 10 10 10 2.5525549322682854 30.3931589978502 0.0 3 0.954936935058587 5.791718911763736 17139.0 21.72114619139502 0.0 - - - - - - - 633.375 34 8 APBB1;APBB2 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65);amyloid beta (A4) precursor protein-binding, family B, member 2 1181 151 C20140527_SFK016_02 C20140527_SFK016_02 TB526228.[MT7]-SSVAVNNC[CAM]IR.3y5_1.heavy 421.891 / 676.32 22519.0 22.436500549316406 45 15 10 10 10 2.5525549322682854 30.3931589978502 0.0 3 0.954936935058587 5.791718911763736 22519.0 51.33253517574599 0.0 - - - - - - - 255.9090909090909 45 11 APBB1;APBB2 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65);amyloid beta (A4) precursor protein-binding, family B, member 2 1183 152 C20140527_SFK016_02 C20140527_SFK016_02 TB525965.[MT7]-EPVLAQLR.2y5_1.heavy 535.328 / 600.383 28801.0 32.717498779296875 50 20 10 10 10 4.007061768691887 24.955941728007147 0.0 3 0.9931737714845579 14.928789665248647 28801.0 29.73317522321429 0.0 - - - - - - - 384.0 57 3 EDC4 enhancer of mRNA decapping 4 1185 152 C20140527_SFK016_02 C20140527_SFK016_02 TB525965.[MT7]-EPVLAQLR.2b4_1.heavy 535.328 / 583.357 7104.0 32.717498779296875 50 20 10 10 10 4.007061768691887 24.955941728007147 0.0 3 0.9931737714845579 14.928789665248647 7104.0 7.754583333333333 0.0 - - - - - - - 792.0 14 8 EDC4 enhancer of mRNA decapping 4 1187 152 C20140527_SFK016_02 C20140527_SFK016_02 TB525965.[MT7]-EPVLAQLR.2y6_1.heavy 535.328 / 699.451 6912.0 32.717498779296875 50 20 10 10 10 4.007061768691887 24.955941728007147 0.0 3 0.9931737714845579 14.928789665248647 6912.0 21.439999999999998 1.0 - - - - - - - 778.6666666666666 18 9 EDC4 enhancer of mRNA decapping 4 1189 152 C20140527_SFK016_02 C20140527_SFK016_02 TB525965.[MT7]-EPVLAQLR.2y7_1.heavy 535.328 / 796.504 109059.0 32.717498779296875 50 20 10 10 10 4.007061768691887 24.955941728007147 0.0 3 0.9931737714845579 14.928789665248647 109059.0 274.81136904761905 0.0 - - - - - - - 341.3333333333333 218 9 EDC4 enhancer of mRNA decapping 4 1191 153 C20140527_SFK016_02 C20140527_SFK016_02 TB526678.[MT7]-LFQFDFTGVSNK[MT7].3b4_1.heavy 564.306 / 680.389 N/A N/A - - - - - - - - - 0.0 - - - - - - - GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 1193 153 C20140527_SFK016_02 C20140527_SFK016_02 TB526678.[MT7]-LFQFDFTGVSNK[MT7].3b5_1.heavy 564.306 / 795.416 N/A N/A - - - - - - - - - 0.0 - - - - - - - GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 1195 153 C20140527_SFK016_02 C20140527_SFK016_02 TB526678.[MT7]-LFQFDFTGVSNK[MT7].3b3_1.heavy 564.306 / 533.32 N/A N/A - - - - - - - - - 0.0 - - - - - - - GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 1197 153 C20140527_SFK016_02 C20140527_SFK016_02 TB526678.[MT7]-LFQFDFTGVSNK[MT7].3y5_1.heavy 564.306 / 648.38 N/A N/A - - - - - - - - - 0.0 - - - - - - - GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 1199 154 C20140527_SFK016_02 C20140527_SFK016_02 TB525962.[MT7]-QLSESSK[MT7].2y4_1.heavy 533.803 / 594.321 4477.0 17.016399383544922 48 18 10 10 10 7.427291071974187 13.463859034330241 0.0 3 0.9882141812523525 11.35677504001546 4477.0 10.411778894958186 0.0 - - - - - - - 222.3846153846154 8 13 C2CD2 C2 calcium-dependent domain containing 2 1201 154 C20140527_SFK016_02 C20140527_SFK016_02 TB525962.[MT7]-QLSESSK[MT7].2y5_1.heavy 533.803 / 681.354 14338.0 17.016399383544922 48 18 10 10 10 7.427291071974187 13.463859034330241 0.0 3 0.9882141812523525 11.35677504001546 14338.0 63.24541576248001 0.0 - - - - - - - 135.07692307692307 28 13 C2CD2 C2 calcium-dependent domain containing 2 1203 154 C20140527_SFK016_02 C20140527_SFK016_02 TB525962.[MT7]-QLSESSK[MT7].2b6_1.heavy 533.803 / 776.391 2040.0 17.016399383544922 48 18 10 10 10 7.427291071974187 13.463859034330241 0.0 3 0.9882141812523525 11.35677504001546 2040.0 1.6682228635371286 1.0 - - - - - - - 239.88235294117646 4 17 C2CD2 C2 calcium-dependent domain containing 2 1205 154 C20140527_SFK016_02 C20140527_SFK016_02 TB525962.[MT7]-QLSESSK[MT7].2y6_1.heavy 533.803 / 794.438 19552.0 17.016399383544922 48 18 10 10 10 7.427291071974187 13.463859034330241 0.0 3 0.9882141812523525 11.35677504001546 19552.0 22.01565548474856 0.0 - - - - - - - 687.0 39 8 C2CD2 C2 calcium-dependent domain containing 2 1207 155 C20140527_SFK016_02 C20140527_SFK016_02 TB328018.[MT7]-SAPVSK[MT7].2y4_1.heavy 438.773 / 574.368 68214.0 16.516599655151367 48 18 10 10 10 2.7858254826418833 35.89600304221747 0.0 3 0.989353745531181 11.950274836077199 68214.0 122.0712566526199 0.0 - - - - - - - 762.4285714285714 136 7 C2CD2 C2 calcium-dependent domain containing 2 1209 155 C20140527_SFK016_02 C20140527_SFK016_02 TB328018.[MT7]-SAPVSK[MT7].2y5_1.heavy 438.773 / 645.405 25045.0 16.516599655151367 48 18 10 10 10 2.7858254826418833 35.89600304221747 0.0 3 0.989353745531181 11.950274836077199 25045.0 141.7767079378524 0.0 - - - - - - - 163.05555555555554 50 18 C2CD2 C2 calcium-dependent domain containing 2 1211 155 C20140527_SFK016_02 C20140527_SFK016_02 TB328018.[MT7]-SAPVSK[MT7].2b4_1.heavy 438.773 / 499.3 6511.0 16.516599655151367 48 18 10 10 10 2.7858254826418833 35.89600304221747 0.0 3 0.989353745531181 11.950274836077199 6511.0 34.003288201160544 0.0 - - - - - - - 223.6875 13 16 C2CD2 C2 calcium-dependent domain containing 2 1213 155 C20140527_SFK016_02 C20140527_SFK016_02 TB328018.[MT7]-SAPVSK[MT7].2y3_1.heavy 438.773 / 477.315 7801.0 16.516599655151367 48 18 10 10 10 2.7858254826418833 35.89600304221747 0.0 3 0.989353745531181 11.950274836077199 7801.0 24.459086143955545 0.0 - - - - - - - 272.70588235294116 15 17 C2CD2 C2 calcium-dependent domain containing 2 1215 156 C20140527_SFK016_02 C20140527_SFK016_02 TB526051.[MT7]-NLTYPLK[MT7].2y4_1.heavy 568.849 / 664.415 35216.0 30.543899536132812 48 18 10 10 10 3.444154157247442 29.034705020265328 0.0 3 0.9820591502240659 9.200033687894456 35216.0 20.779460839056878 0.0 - - - - - - - 833.8571428571429 70 7 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1217 156 C20140527_SFK016_02 C20140527_SFK016_02 TB526051.[MT7]-NLTYPLK[MT7].2y5_1.heavy 568.849 / 765.463 21819.0 30.543899536132812 48 18 10 10 10 3.444154157247442 29.034705020265328 0.0 3 0.9820591502240659 9.200033687894456 21819.0 65.04056789224609 0.0 - - - - - - - 691.1111111111111 43 9 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1219 156 C20140527_SFK016_02 C20140527_SFK016_02 TB526051.[MT7]-NLTYPLK[MT7].2b4_1.heavy 568.849 / 636.347 23828.0 30.543899536132812 48 18 10 10 10 3.444154157247442 29.034705020265328 0.0 3 0.9820591502240659 9.200033687894456 23828.0 26.835261633556897 0.0 - - - - - - - 1291.75 47 8 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1221 156 C20140527_SFK016_02 C20140527_SFK016_02 TB526051.[MT7]-NLTYPLK[MT7].2y3_1.heavy 568.849 / 501.352 94836.0 30.543899536132812 48 18 10 10 10 3.444154157247442 29.034705020265328 0.0 3 0.9820591502240659 9.200033687894456 94836.0 93.57651737587553 0.0 - - - - - - - 1243.75 189 8 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1223 157 C20140527_SFK016_02 C20140527_SFK016_02 TB526575.[MT7]-LYQDTHQEYAR.3b6_1.heavy 523.259 / 902.449 N/A N/A - - - - - - - - - 0.0 - - - - - - - KIAA0947 KIAA0947 1225 157 C20140527_SFK016_02 C20140527_SFK016_02 TB526575.[MT7]-LYQDTHQEYAR.3b4_1.heavy 523.259 / 664.342 N/A N/A - - - - - - - - - 0.0 - - - - - - - KIAA0947 KIAA0947 1227 157 C20140527_SFK016_02 C20140527_SFK016_02 TB526575.[MT7]-LYQDTHQEYAR.3y4_1.heavy 523.259 / 538.262 N/A N/A - - - - - - - - - 0.0 - - - - - - - KIAA0947 KIAA0947 1229 157 C20140527_SFK016_02 C20140527_SFK016_02 TB526575.[MT7]-LYQDTHQEYAR.3y5_1.heavy 523.259 / 666.321 N/A N/A - - - - - - - - - 0.0 - - - - - - - KIAA0947 KIAA0947 1231 158 C20140527_SFK016_02 C20140527_SFK016_02 TB328297.[MT7]-EQQATELLAAK[MT7].2b3_1.heavy 745.427 / 530.269 5106.0 30.63360023498535 44 18 10 6 10 4.3846162568220395 22.807013006989983 0.035800933837890625 3 0.9814762488873844 9.053681574105205 5106.0 26.7957430842986 0.0 - - - - - - - 276.0 10 12 KIF3C kinesin family member 3C 1233 158 C20140527_SFK016_02 C20140527_SFK016_02 TB328297.[MT7]-EQQATELLAAK[MT7].2b4_1.heavy 745.427 / 601.306 4350.0 30.63360023498535 44 18 10 6 10 4.3846162568220395 22.807013006989983 0.035800933837890625 3 0.9814762488873844 9.053681574105205 4350.0 16.74404761904762 0.0 - - - - - - - 275.27272727272725 8 11 KIF3C kinesin family member 3C 1235 158 C20140527_SFK016_02 C20140527_SFK016_02 TB328297.[MT7]-EQQATELLAAK[MT7].2b6_1.heavy 745.427 / 831.396 3026.0 30.63360023498535 44 18 10 6 10 4.3846162568220395 22.807013006989983 0.035800933837890625 3 0.9814762488873844 9.053681574105205 3026.0 19.391971830985916 0.0 - - - - - - - 245.9 6 10 KIF3C kinesin family member 3C 1237 158 C20140527_SFK016_02 C20140527_SFK016_02 TB328297.[MT7]-EQQATELLAAK[MT7].2b7_1.heavy 745.427 / 944.481 3782.0 30.63360023498535 44 18 10 6 10 4.3846162568220395 22.807013006989983 0.035800933837890625 3 0.9814762488873844 9.053681574105205 3782.0 5.326760563380282 1.0 - - - - - - - 189.23076923076923 7 13 KIF3C kinesin family member 3C 1239 159 C20140527_SFK016_02 C20140527_SFK016_02 TB328299.[MT7]-LTAFSEVGVPANR.2y12_1.heavy 752.916 / 1247.64 4832.0 35.942501068115234 35 10 10 5 10 3.110558570683951 32.148566801624945 0.0410003662109375 3 0.8491926962937297 3.1371536134419817 4832.0 6.191793278691461 0.0 - - - - - - - 274.57142857142856 9 14 HMCN2 hemicentin 2 1241 159 C20140527_SFK016_02 C20140527_SFK016_02 TB328299.[MT7]-LTAFSEVGVPANR.2y9_1.heavy 752.916 / 928.485 12411.0 35.942501068115234 35 10 10 5 10 3.110558570683951 32.148566801624945 0.0410003662109375 3 0.8491926962937297 3.1371536134419817 12411.0 80.73446738455166 0.0 - - - - - - - 256.3333333333333 24 15 HMCN2 hemicentin 2 1243 159 C20140527_SFK016_02 C20140527_SFK016_02 TB328299.[MT7]-LTAFSEVGVPANR.2y10_1.heavy 752.916 / 1075.55 7578.0 35.942501068115234 35 10 10 5 10 3.110558570683951 32.148566801624945 0.0410003662109375 3 0.8491926962937297 3.1371536134419817 7578.0 13.534262295081968 1.0 - - - - - - - 238.0 15 12 HMCN2 hemicentin 2 1245 159 C20140527_SFK016_02 C20140527_SFK016_02 TB328299.[MT7]-LTAFSEVGVPANR.2y7_1.heavy 752.916 / 712.41 6700.0 35.942501068115234 35 10 10 5 10 3.110558570683951 32.148566801624945 0.0410003662109375 3 0.8491926962937297 3.1371536134419817 6700.0 16.925202974134287 0.0 - - - - - - - 781.1111111111111 13 9 HMCN2 hemicentin 2 1247 160 C20140527_SFK016_02 C20140527_SFK016_02 TB397614.[MT7]-GVTAEQGPQR.2y8_1.heavy 593.818 / 886.438 6413.0 17.99097442626953 39 13 10 6 10 3.3426497994636035 29.916385502318263 0.03350067138671875 3 0.9008601450335347 3.886719357493521 6413.0 48.50291205443283 0.0 - - - - - - - 145.0 12 17 EFCAB5 EF-hand calcium binding domain 5 1249 160 C20140527_SFK016_02 C20140527_SFK016_02 TB397614.[MT7]-GVTAEQGPQR.2y9_1.heavy 593.818 / 985.506 2978.0 17.99097442626953 39 13 10 6 10 3.3426497994636035 29.916385502318263 0.03350067138671875 3 0.9008601450335347 3.886719357493521 2978.0 54.32082443871917 0.0 - - - - - - - 157.41666666666666 5 12 EFCAB5 EF-hand calcium binding domain 5 1251 160 C20140527_SFK016_02 C20140527_SFK016_02 TB397614.[MT7]-GVTAEQGPQR.2y6_1.heavy 593.818 / 714.353 401.0 17.99097442626953 39 13 10 6 10 3.3426497994636035 29.916385502318263 0.03350067138671875 3 0.9008601450335347 3.886719357493521 401.0 1.4008733624454148 7.0 - - - - - - - 144.43478260869566 3 23 EFCAB5 EF-hand calcium binding domain 5 1253 160 C20140527_SFK016_02 C20140527_SFK016_02 TB397614.[MT7]-GVTAEQGPQR.2y7_1.heavy 593.818 / 785.39 2520.0 17.99097442626953 39 13 10 6 10 3.3426497994636035 29.916385502318263 0.03350067138671875 3 0.9008601450335347 3.886719357493521 2520.0 52.34217421282463 1.0 - - - - - - - 103.13333333333334 5 15 EFCAB5 EF-hand calcium binding domain 5 1255 161 C20140527_SFK016_02 C20140527_SFK016_02 TB526577.[MT7]-RNTELETLLAK[MT7].3b6_1.heavy 525.982 / 887.47 32185.0 34.78070068359375 43 13 10 10 10 1.5412040349978389 51.623381039807015 0.0 3 0.906263849970501 3.9990472618611776 32185.0 132.62059948764622 0.0 - - - - - - - 242.71428571428572 64 7 MID1 midline 1 (Opitz/BBB syndrome) 1257 161 C20140527_SFK016_02 C20140527_SFK016_02 TB526577.[MT7]-RNTELETLLAK[MT7].3b5_1.heavy 525.982 / 758.428 25280.0 34.78070068359375 43 13 10 10 10 1.5412040349978389 51.623381039807015 0.0 3 0.906263849970501 3.9990472618611776 25280.0 38.785753424657536 0.0 - - - - - - - 728.4285714285714 50 7 MID1 midline 1 (Opitz/BBB syndrome) 1259 161 C20140527_SFK016_02 C20140527_SFK016_02 TB526577.[MT7]-RNTELETLLAK[MT7].3y4_1.heavy 525.982 / 588.42 52897.0 34.78070068359375 43 13 10 10 10 1.5412040349978389 51.623381039807015 0.0 3 0.906263849970501 3.9990472618611776 52897.0 36.00067927203326 0.0 - - - - - - - 319.0 105 2 MID1 midline 1 (Opitz/BBB syndrome) 1261 161 C20140527_SFK016_02 C20140527_SFK016_02 TB526577.[MT7]-RNTELETLLAK[MT7].3b7_1.heavy 525.982 / 988.518 18376.0 34.78070068359375 43 13 10 10 10 1.5412040349978389 51.623381039807015 0.0 3 0.906263849970501 3.9990472618611776 18376.0 71.61652606624571 0.0 - - - - - - - 254.9 36 10 MID1 midline 1 (Opitz/BBB syndrome) 1263 162 C20140527_SFK016_02 C20140527_SFK016_02 ENO_ECO24.IQLVGDDLFVTNTK.2y8.peptide 781.92 / 937.5 535740.0 41.07789993286133 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 535740.0 136.46232779400071 0.0 - - - - - - - 315.3333333333333 1071 3 1265 162 C20140527_SFK016_02 C20140527_SFK016_02 ENO_ECO24.IQLVGDDLFVTNTK.2y6.peptide 781.92 / 709.39 824916.0 41.07789993286133 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 824916.0 202.0628364890732 0.0 - - - - - - - 697.6666666666666 1649 3 1267 162 C20140527_SFK016_02 C20140527_SFK016_02 ENO_ECO24.IQLVGDDLFVTNTK.2y5.peptide 781.92 / 562.32 1018280.0 41.07789993286133 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1018280.0 212.8197900639075 0.0 - - - - - - - 860.75 2036 4 1269 163 C20140527_SFK016_02 C20140527_SFK016_02 TB328014.[MT7]-GLAPNTR.2y4_1.heavy 436.757 / 487.262 75515.0 18.249099731445312 48 18 10 10 10 5.979006764151145 16.72518596225359 0.0 3 0.9896113158458184 12.097772164944466 75515.0 65.507425207257 0.0 - - - - - - - 676.6666666666666 151 9 CERKL ceramide kinase-like 1271 163 C20140527_SFK016_02 C20140527_SFK016_02 TB328014.[MT7]-GLAPNTR.2y5_1.heavy 436.757 / 558.299 40367.0 18.249099731445312 48 18 10 10 10 5.979006764151145 16.72518596225359 0.0 3 0.9896113158458184 12.097772164944466 40367.0 114.34002463054188 0.0 - - - - - - - 646.2857142857143 80 7 CERKL ceramide kinase-like 1273 163 C20140527_SFK016_02 C20140527_SFK016_02 TB328014.[MT7]-GLAPNTR.2y6_1.heavy 436.757 / 671.383 33060.0 18.249099731445312 48 18 10 10 10 5.979006764151145 16.72518596225359 0.0 3 0.9896113158458184 12.097772164944466 33060.0 198.17 0.0 - - - - - - - 241.66666666666666 66 18 CERKL ceramide kinase-like 1275 163 C20140527_SFK016_02 C20140527_SFK016_02 TB328014.[MT7]-GLAPNTR.2b5_1.heavy 436.757 / 597.348 14384.0 18.249099731445312 48 18 10 10 10 5.979006764151145 16.72518596225359 0.0 3 0.9896113158458184 12.097772164944466 14384.0 99.43619047619049 0.0 - - - - - - - 184.54545454545453 28 22 CERKL ceramide kinase-like 1277 164 C20140527_SFK016_02 C20140527_SFK016_02 TB397813.[MT7]-LVDVPFQVEFPAPK[MT7].4y4_1.heavy 469.272 / 556.357 5404.0 45.68424987792969 43 17 10 6 10 2.820078948997558 35.46000016614662 0.03530120849609375 3 0.9761021965188814 7.967364242997148 5404.0 211.56416576576575 0.0 - - - - - - - 144.77777777777777 10 9 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 1279 164 C20140527_SFK016_02 C20140527_SFK016_02 TB397813.[MT7]-LVDVPFQVEFPAPK[MT7].4y3_2.heavy 469.272 / 230.156 1714.0 45.68424987792969 43 17 10 6 10 2.820078948997558 35.46000016614662 0.03530120849609375 3 0.9761021965188814 7.967364242997148 1714.0 1.4165289256198348 0.0 - - - - - - - 172.6315789473684 3 19 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 1281 164 C20140527_SFK016_02 C20140527_SFK016_02 TB397813.[MT7]-LVDVPFQVEFPAPK[MT7].4b6_1.heavy 469.272 / 815.478 1938.0 45.68424987792969 43 17 10 6 10 2.820078948997558 35.46000016614662 0.03530120849609375 3 0.9761021965188814 7.967364242997148 1938.0 52.37837837837838 0.0 - - - - - - - 158.5 3 8 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 1283 164 C20140527_SFK016_02 C20140527_SFK016_02 TB397813.[MT7]-LVDVPFQVEFPAPK[MT7].4b4_1.heavy 469.272 / 571.357 20125.0 45.68424987792969 43 17 10 6 10 2.820078948997558 35.46000016614662 0.03530120849609375 3 0.9761021965188814 7.967364242997148 20125.0 343.203125 0.0 - - - - - - - 124.22222222222223 40 9 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 1285 165 C20140527_SFK016_02 C20140527_SFK016_02 TB526251.[MT7]-C[CAM]EWELLER.2y4_1.heavy 639.817 / 530.33 6435.0 37.85820007324219 46 16 10 10 10 1.947593849964051 35.54979855743298 0.0 3 0.9647756573226524 6.556284581024862 6435.0 13.135582149417099 0.0 - - - - - - - 754.8 12 10 VWA5A von Willebrand factor A domain containing 5A 1287 165 C20140527_SFK016_02 C20140527_SFK016_02 TB526251.[MT7]-C[CAM]EWELLER.2b4_1.heavy 639.817 / 749.305 8210.0 37.85820007324219 46 16 10 10 10 1.947593849964051 35.54979855743298 0.0 3 0.9647756573226524 6.556284581024862 8210.0 34.51651651651652 0.0 - - - - - - - 314.5 16 12 VWA5A von Willebrand factor A domain containing 5A 1289 165 C20140527_SFK016_02 C20140527_SFK016_02 TB526251.[MT7]-C[CAM]EWELLER.2y6_1.heavy 639.817 / 845.452 7655.0 37.85820007324219 46 16 10 10 10 1.947593849964051 35.54979855743298 0.0 3 0.9647756573226524 6.556284581024862 7655.0 13.137109057740126 0.0 - - - - - - - 1251.7142857142858 15 7 VWA5A von Willebrand factor A domain containing 5A 1291 165 C20140527_SFK016_02 C20140527_SFK016_02 TB526251.[MT7]-C[CAM]EWELLER.2y7_1.heavy 639.817 / 974.494 12204.0 37.85820007324219 46 16 10 10 10 1.947593849964051 35.54979855743298 0.0 3 0.9647756573226524 6.556284581024862 12204.0 50.94162162162162 0.0 - - - - - - - 239.07692307692307 24 13 VWA5A von Willebrand factor A domain containing 5A 1293 166 C20140527_SFK016_02 C20140527_SFK016_02 TB526965.[MT7]-LVEPQSQALLHAQPIISIR.3y7_1.heavy 753.11 / 826.515 27804.0 39.86332416534424 46 20 10 6 10 8.535264138820102 11.716099041994477 0.032299041748046875 3 0.996613887628253 21.20259720043726 27804.0 106.21837632364921 0.0 - - - - - - - 285.7142857142857 55 14 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 1295 166 C20140527_SFK016_02 C20140527_SFK016_02 TB526965.[MT7]-LVEPQSQALLHAQPIISIR.3y6_1.heavy 753.11 / 698.456 56465.0 39.86332416534424 46 20 10 6 10 8.535264138820102 11.716099041994477 0.032299041748046875 3 0.996613887628253 21.20259720043726 56465.0 100.3693995349231 0.0 - - - - - - - 719.6666666666666 112 9 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 1297 166 C20140527_SFK016_02 C20140527_SFK016_02 TB526965.[MT7]-LVEPQSQALLHAQPIISIR.3y8_1.heavy 753.11 / 897.552 49990.0 39.86332416534424 46 20 10 6 10 8.535264138820102 11.716099041994477 0.032299041748046875 3 0.996613887628253 21.20259720043726 49990.0 250.099995101221 0.0 - - - - - - - 625.5714285714286 99 7 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 1299 166 C20140527_SFK016_02 C20140527_SFK016_02 TB526965.[MT7]-LVEPQSQALLHAQPIISIR.3y9_1.heavy 753.11 / 1034.61 50847.0 39.86332416534424 46 20 10 6 10 8.535264138820102 11.716099041994477 0.032299041748046875 3 0.996613887628253 21.20259720043726 50847.0 149.01589285714283 0.0 - - - - - - - 333.35714285714283 101 14 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 1301 167 C20140527_SFK016_02 C20140527_SFK016_02 RBSB_ECOLI.LAATIAQLPDQIGAK.3y7.peptide 503.96 / 728.39 319357.0 36.044898986816406 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 319357.0 193.13587660354307 0.0 - - - - - - - 273.0 638 4 1303 167 C20140527_SFK016_02 C20140527_SFK016_02 RBSB_ECOLI.LAATIAQLPDQIGAK.3y6.peptide 503.96 / 631.34 63653.0 36.044898986816406 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 63653.0 328.7572527472528 0.0 - - - - - - - 273.0 127 9 1305 167 C20140527_SFK016_02 C20140527_SFK016_02 RBSB_ECOLI.LAATIAQLPDQIGAK.3y5.peptide 503.96 / 516.31 48649.0 36.044898986816406 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 48649.0 34.047666679211304 1.0 - - - - - - - 1192.111111111111 101 9 1307 168 C20140527_SFK016_02 C20140527_SFK016_02 TB397817.[MT7]-QFQNYIELVVSELR.3y6_1.heavy 628.011 / 702.414 393.0 54.735599517822266 44 14 10 10 10 3.362695713152345 29.73804605896244 0.0 3 0.9451803254792448 5.246744389857622 393.0 10.639071428571429 0.0 - - - - - - - 0.0 0 0 EFCAB5 EF-hand calcium binding domain 5 1309 168 C20140527_SFK016_02 C20140527_SFK016_02 TB397817.[MT7]-QFQNYIELVVSELR.3b4_1.heavy 628.011 / 662.338 4927.0 54.735599517822266 44 14 10 10 10 3.362695713152345 29.73804605896244 0.0 3 0.9451803254792448 5.246744389857622 4927.0 376.29285714285714 0.0 - - - - - - - 55.68 9 25 EFCAB5 EF-hand calcium binding domain 5 1311 168 C20140527_SFK016_02 C20140527_SFK016_02 TB397817.[MT7]-QFQNYIELVVSELR.3b5_1.heavy 628.011 / 825.401 950.0 54.735599517822266 44 14 10 10 10 3.362695713152345 29.73804605896244 0.0 3 0.9451803254792448 5.246744389857622 950.0 57.185592185592185 0.0 - - - - - - - 0.0 1 0 EFCAB5 EF-hand calcium binding domain 5 1313 168 C20140527_SFK016_02 C20140527_SFK016_02 TB397817.[MT7]-QFQNYIELVVSELR.3b3_1.heavy 628.011 / 548.295 540.0 54.735599517822266 44 14 10 10 10 3.362695713152345 29.73804605896244 0.0 3 0.9451803254792448 5.246744389857622 540.0 3.1798353315036834 0.0 - - - - - - - 0.0 1 0 EFCAB5 EF-hand calcium binding domain 5 1315 169 C20140527_SFK016_02 C20140527_SFK016_02 TB525955.[MT7]-QTQDFK[MT7].2y5_1.heavy 527.792 / 782.417 13828.0 19.275150775909424 39 13 10 6 10 2.1302601459821706 37.538988781709335 0.03140068054199219 3 0.9274297786085987 4.553245665593954 13828.0 50.8904165091027 0.0 - - - - - - - 204.35 27 20 KIAA0947 KIAA0947 1317 169 C20140527_SFK016_02 C20140527_SFK016_02 TB525955.[MT7]-QTQDFK[MT7].2b4_1.heavy 527.792 / 617.301 24083.0 19.275150775909424 39 13 10 6 10 2.1302601459821706 37.538988781709335 0.03140068054199219 3 0.9274297786085987 4.553245665593954 24083.0 53.05333778371161 0.0 - - - - - - - 686.2727272727273 48 11 KIAA0947 KIAA0947 1319 169 C20140527_SFK016_02 C20140527_SFK016_02 TB525955.[MT7]-QTQDFK[MT7].2y3_1.heavy 527.792 / 553.31 5243.0 19.275150775909424 39 13 10 6 10 2.1302601459821706 37.538988781709335 0.03140068054199219 3 0.9274297786085987 4.553245665593954 5243.0 27.719794877970454 0.0 - - - - - - - 228.16 10 25 KIAA0947 KIAA0947 1321 169 C20140527_SFK016_02 C20140527_SFK016_02 TB525955.[MT7]-QTQDFK[MT7].2b5_1.heavy 527.792 / 764.37 2017.0 19.275150775909424 39 13 10 6 10 2.1302601459821706 37.538988781709335 0.03140068054199219 3 0.9274297786085987 4.553245665593954 2017.0 6.138589901827261 0.0 - - - - - - - 691.4285714285714 4 7 KIAA0947 KIAA0947 1323 170 C20140527_SFK016_02 C20140527_SFK016_02 TB526663.[MT7]-QNLESNLTNLIK[MT7].3b6_1.heavy 558.992 / 830.412 85470.0 39.74639892578125 46 16 10 10 10 2.238715045174865 35.56403053746731 0.0 3 0.9668919940128696 6.76379285312172 85470.0 547.3592465753425 0.0 - - - - - - - 232.15384615384616 170 13 MID1 midline 1 (Opitz/BBB syndrome) 1325 170 C20140527_SFK016_02 C20140527_SFK016_02 TB526663.[MT7]-QNLESNLTNLIK[MT7].3b4_1.heavy 558.992 / 629.338 66001.0 39.74639892578125 46 16 10 10 10 2.238715045174865 35.56403053746731 0.0 3 0.9668919940128696 6.76379285312172 66001.0 -4.520616438356164 0.0 - - - - - - - 275.8333333333333 132 6 MID1 midline 1 (Opitz/BBB syndrome) 1327 170 C20140527_SFK016_02 C20140527_SFK016_02 TB526663.[MT7]-QNLESNLTNLIK[MT7].3y4_1.heavy 558.992 / 631.426 83718.0 39.74639892578125 46 16 10 10 10 2.238715045174865 35.56403053746731 0.0 3 0.9668919940128696 6.76379285312172 83718.0 83.14458904109588 0.0 - - - - - - - 1289.875 167 8 MID1 midline 1 (Opitz/BBB syndrome) 1329 170 C20140527_SFK016_02 C20140527_SFK016_02 TB526663.[MT7]-QNLESNLTNLIK[MT7].3b3_1.heavy 558.992 / 500.295 58213.0 39.74639892578125 46 16 10 10 10 2.238715045174865 35.56403053746731 0.0 3 0.9668919940128696 6.76379285312172 58213.0 36.25112204955234 0.0 - - - - - - - 1209.857142857143 116 7 MID1 midline 1 (Opitz/BBB syndrome) 1331 171 C20140527_SFK016_02 C20140527_SFK016_02 TB525952.[MT7]-AGLGAVYTR.2y8_1.heavy 526.304 / 836.463 25581.0 27.083099365234375 46 16 10 10 10 2.082200248842951 38.16818245505816 0.0 3 0.9657400479464102 6.648462493828724 25581.0 124.50876684593483 0.0 - - - - - - - 261.3 51 10 HMCN2 hemicentin 2 1333 171 C20140527_SFK016_02 C20140527_SFK016_02 TB525952.[MT7]-AGLGAVYTR.2y6_1.heavy 526.304 / 666.357 18723.0 27.083099365234375 46 16 10 10 10 2.082200248842951 38.16818245505816 0.0 3 0.9657400479464102 6.648462493828724 18723.0 40.508161368198444 0.0 - - - - - - - 612.125 37 8 HMCN2 hemicentin 2 1335 171 C20140527_SFK016_02 C20140527_SFK016_02 TB525952.[MT7]-AGLGAVYTR.2b5_1.heavy 526.304 / 514.311 12736.0 27.083099365234375 46 16 10 10 10 2.082200248842951 38.16818245505816 0.0 3 0.9657400479464102 6.648462493828724 12736.0 13.417653882439193 0.0 - - - - - - - 381.0 25 2 HMCN2 hemicentin 2 1337 171 C20140527_SFK016_02 C20140527_SFK016_02 TB525952.[MT7]-AGLGAVYTR.2y7_1.heavy 526.304 / 779.441 4898.0 27.083099365234375 46 16 10 10 10 2.082200248842951 38.16818245505816 0.0 3 0.9657400479464102 6.648462493828724 4898.0 13.055386726843237 0.0 - - - - - - - 668.5714285714286 9 7 HMCN2 hemicentin 2 1339 172 C20140527_SFK016_02 C20140527_SFK016_02 TB526669.[MT7]-NIC[CAM]FNIDSEPGK[MT7].3b4_1.heavy 561.287 / 679.335 13719.0 33.33237552642822 46 20 10 6 10 15.104182448591228 6.620682737404766 0.039096832275390625 3 0.9989552473328484 38.17840734810829 13719.0 37.61471897289586 0.0 - - - - - - - 661.0 27 10 ITIH2 inter-alpha (globulin) inhibitor H2 1341 172 C20140527_SFK016_02 C20140527_SFK016_02 TB526669.[MT7]-NIC[CAM]FNIDSEPGK[MT7].3b5_1.heavy 561.287 / 793.378 44661.0 33.33237552642822 46 20 10 6 10 15.104182448591228 6.620682737404766 0.039096832275390625 3 0.9989552473328484 38.17840734810829 44661.0 146.48308490009995 0.0 - - - - - - - 584.3333333333334 89 12 ITIH2 inter-alpha (globulin) inhibitor H2 1343 172 C20140527_SFK016_02 C20140527_SFK016_02 TB526669.[MT7]-NIC[CAM]FNIDSEPGK[MT7].3b3_1.heavy 561.287 / 532.267 39855.0 33.33237552642822 46 20 10 6 10 15.104182448591228 6.620682737404766 0.039096832275390625 3 0.9989552473328484 38.17840734810829 39855.0 45.34011035871299 0.0 - - - - - - - 401.0 79 2 ITIH2 inter-alpha (globulin) inhibitor H2 1345 172 C20140527_SFK016_02 C20140527_SFK016_02 TB526669.[MT7]-NIC[CAM]FNIDSEPGK[MT7].3y5_1.heavy 561.287 / 661.364 12918.0 33.33237552642822 46 20 10 6 10 15.104182448591228 6.620682737404766 0.039096832275390625 3 0.9989552473328484 38.17840734810829 12918.0 7.240479360852198 1.0 - - - - - - - 682.8181818181819 25 11 ITIH2 inter-alpha (globulin) inhibitor H2 1347 173 C20140527_SFK016_02 C20140527_SFK016_02 TB397521.[MT7]-LLQDSLGGNAK[MT7].3b4_1.heavy 468.608 / 614.363 57579.0 31.40329933166504 45 15 10 10 10 2.664983178213324 37.52368901144159 0.0 3 0.9595028580854732 6.1118619706331305 57579.0 84.72014801884367 0.0 - - - - - - - 300.44444444444446 115 9 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 1349 173 C20140527_SFK016_02 C20140527_SFK016_02 TB397521.[MT7]-LLQDSLGGNAK[MT7].3b5_1.heavy 468.608 / 701.395 35248.0 31.40329933166504 45 15 10 10 10 2.664983178213324 37.52368901144159 0.0 3 0.9595028580854732 6.1118619706331305 35248.0 60.07852247586025 0.0 - - - - - - - 578.7777777777778 70 9 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 1351 173 C20140527_SFK016_02 C20140527_SFK016_02 TB397521.[MT7]-LLQDSLGGNAK[MT7].3y4_1.heavy 468.608 / 533.316 33045.0 31.40329933166504 45 15 10 10 10 2.664983178213324 37.52368901144159 0.0 3 0.9595028580854732 6.1118619706331305 33045.0 42.89287871301936 0.0 - - - - - - - 350.5 66 2 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 1353 173 C20140527_SFK016_02 C20140527_SFK016_02 TB397521.[MT7]-LLQDSLGGNAK[MT7].3y5_1.heavy 468.608 / 590.338 101439.0 31.40329933166504 45 15 10 10 10 2.664983178213324 37.52368901144159 0.0 3 0.9595028580854732 6.1118619706331305 101439.0 195.5447772844572 0.0 - - - - - - - 266.6666666666667 202 3 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 1355 174 C20140527_SFK016_02 C20140527_SFK016_02 TB526044.[MT7]-GSDGQDHIR.2y6_1.heavy 564.779 / 725.369 3152.0 14.272799968719482 42 17 10 5 10 4.524371227388029 17.271246593261267 0.04079914093017578 3 0.9783862614762988 8.379383701035708 3152.0 83.50308893544087 0.0 - - - - - - - 75.38461538461539 6 13 KIF3C kinesin family member 3C 1357 174 C20140527_SFK016_02 C20140527_SFK016_02 TB526044.[MT7]-GSDGQDHIR.2y8_1.heavy 564.779 / 927.428 625.0 14.272799968719482 42 17 10 5 10 4.524371227388029 17.271246593261267 0.04079914093017578 3 0.9783862614762988 8.379383701035708 625.0 2.3167785234899334 1.0 - - - - - - - 0.0 1 0 KIF3C kinesin family member 3C 1359 174 C20140527_SFK016_02 C20140527_SFK016_02 TB526044.[MT7]-GSDGQDHIR.2b5_1.heavy 564.779 / 589.27 297.0 14.272799968719482 42 17 10 5 10 4.524371227388029 17.271246593261267 0.04079914093017578 3 0.9783862614762988 8.379383701035708 297.0 7.451866311178823 4.0 - - - - - - - 0.0 0 0 KIF3C kinesin family member 3C 1361 174 C20140527_SFK016_02 C20140527_SFK016_02 TB526044.[MT7]-GSDGQDHIR.2b6_1.heavy 564.779 / 704.297 2825.0 14.272799968719482 42 17 10 5 10 4.524371227388029 17.271246593261267 0.04079914093017578 3 0.9783862614762988 8.379383701035708 2825.0 119.60224719101124 0.0 - - - - - - - 109.8 5 10 KIF3C kinesin family member 3C 1363 175 C20140527_SFK016_02 C20140527_SFK016_02 TB526041.[MT7]-SASLLFGMR.2y8_1.heavy 563.314 / 894.487 N/A N/A - - - - - - - - - 0.0 - - - - - - - APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 1365 175 C20140527_SFK016_02 C20140527_SFK016_02 TB526041.[MT7]-SASLLFGMR.2b4_1.heavy 563.314 / 503.295 N/A N/A - - - - - - - - - 0.0 - - - - - - - APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 1367 175 C20140527_SFK016_02 C20140527_SFK016_02 TB526041.[MT7]-SASLLFGMR.2b5_1.heavy 563.314 / 616.379 N/A N/A - - - - - - - - - 0.0 - - - - - - - APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 1369 175 C20140527_SFK016_02 C20140527_SFK016_02 TB526041.[MT7]-SASLLFGMR.2y7_1.heavy 563.314 / 823.45 N/A N/A - - - - - - - - - 0.0 - - - - - - - APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 1371 176 C20140527_SFK016_02 C20140527_SFK016_02 TB526040.[MT7]-LLPLPLGVR.2y8_1.heavy 561.38 / 864.567 N/A N/A - - - - - - - - - 0.0 - - - - - - - HMCN2 hemicentin 2 1373 176 C20140527_SFK016_02 C20140527_SFK016_02 TB526040.[MT7]-LLPLPLGVR.2y5_1.heavy 561.38 / 541.346 N/A N/A - - - - - - - - - 0.0 - - - - - - - HMCN2 hemicentin 2 1375 176 C20140527_SFK016_02 C20140527_SFK016_02 TB526040.[MT7]-LLPLPLGVR.2b4_1.heavy 561.38 / 581.414 N/A N/A - - - - - - - - - 0.0 - - - - - - - HMCN2 hemicentin 2 1377 176 C20140527_SFK016_02 C20140527_SFK016_02 TB526040.[MT7]-LLPLPLGVR.2y7_1.heavy 561.38 / 751.482 N/A N/A - - - - - - - - - 0.0 - - - - - - - HMCN2 hemicentin 2 1379 177 C20140527_SFK016_02 C20140527_SFK016_02 TB526970.[MT7]-YQAPDIDVQLSSELTDSLR.3b5_1.heavy 765.393 / 719.348 7483.0 44.77262496948242 43 17 10 6 10 2.0114573854175966 33.38968483114784 0.038299560546875 3 0.9717116891577267 7.320314207384118 7483.0 -0.6054207119741095 0.0 - - - - - - - 241.42857142857142 14 7 GLTSCR2 glioma tumor suppressor candidate region gene 2 1381 177 C20140527_SFK016_02 C20140527_SFK016_02 TB526970.[MT7]-YQAPDIDVQLSSELTDSLR.3b3_1.heavy 765.393 / 507.268 10477.0 44.77262496948242 43 17 10 6 10 2.0114573854175966 33.38968483114784 0.038299560546875 3 0.9717116891577267 7.320314207384118 10477.0 -4.029615384615383 0.0 - - - - - - - 243.75 20 8 GLTSCR2 glioma tumor suppressor candidate region gene 2 1383 177 C20140527_SFK016_02 C20140527_SFK016_02 TB526970.[MT7]-YQAPDIDVQLSSELTDSLR.3b7_1.heavy 765.393 / 947.459 10802.0 44.77262496948242 43 17 10 6 10 2.0114573854175966 33.38968483114784 0.038299560546875 3 0.9717116891577267 7.320314207384118 10802.0 -4.154615384615383 0.0 - - - - - - - 260.2 21 10 GLTSCR2 glioma tumor suppressor candidate region gene 2 1385 177 C20140527_SFK016_02 C20140527_SFK016_02 TB526970.[MT7]-YQAPDIDVQLSSELTDSLR.3y9_1.heavy 765.393 / 1007.5 11453.0 44.77262496948242 43 17 10 6 10 2.0114573854175966 33.38968483114784 0.038299560546875 3 0.9717116891577267 7.320314207384118 11453.0 -2.5116228070175417 1.0 - - - - - - - 219.5 22 8 GLTSCR2 glioma tumor suppressor candidate region gene 2 1387 178 C20140527_SFK016_02 C20140527_SFK016_02 TB525815.[MT7]-DFAYVAR.2y4_1.heavy 493.265 / 508.288 23519.0 28.460100173950195 50 20 10 10 10 11.663064333037445 8.574076001341641 0.0 3 0.9981261946304549 28.50573816067198 23519.0 10.92122713482185 0.0 - - - - - - - 654.0 47 7 APBB1;APBB2 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65);amyloid beta (A4) precursor protein-binding, family B, member 2 1389 178 C20140527_SFK016_02 C20140527_SFK016_02 TB525815.[MT7]-DFAYVAR.2y5_1.heavy 493.265 / 579.325 30179.0 28.460100173950195 50 20 10 10 10 11.663064333037445 8.574076001341641 0.0 3 0.9981261946304549 28.50573816067198 30179.0 21.59700743682101 0.0 - - - - - - - 270.4 60 5 APBB1;APBB2 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65);amyloid beta (A4) precursor protein-binding, family B, member 2 1391 178 C20140527_SFK016_02 C20140527_SFK016_02 TB525815.[MT7]-DFAYVAR.2b4_1.heavy 493.265 / 641.305 39440.0 28.460100173950195 50 20 10 10 10 11.663064333037445 8.574076001341641 0.0 3 0.9981261946304549 28.50573816067198 39440.0 102.3923076923077 0.0 - - - - - - - 683.5714285714286 78 14 APBB1;APBB2 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65);amyloid beta (A4) precursor protein-binding, family B, member 2 1393 178 C20140527_SFK016_02 C20140527_SFK016_02 TB525815.[MT7]-DFAYVAR.2y6_1.heavy 493.265 / 726.393 72741.0 28.460100173950195 50 20 10 10 10 11.663064333037445 8.574076001341641 0.0 3 0.9981261946304549 28.50573816067198 72741.0 172.85979395604397 0.0 - - - - - - - 245.8181818181818 145 11 APBB1;APBB2 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65);amyloid beta (A4) precursor protein-binding, family B, member 2 1395 179 C20140527_SFK016_02 C20140527_SFK016_02 TB327985.[MT7]-LLIGGR.2b3_1.heavy 386.762 / 484.362 27219.0 30.470300674438477 50 20 10 10 10 6.028182394197467 16.588748226373635 0.0 3 0.9967704628014229 21.71077237484827 27219.0 52.551185877214266 0.0 - - - - - - - 319.3636363636364 54 11 KIF3C kinesin family member 3C 1397 179 C20140527_SFK016_02 C20140527_SFK016_02 TB327985.[MT7]-LLIGGR.2y4_1.heavy 386.762 / 402.246 80095.0 30.470300674438477 50 20 10 10 10 6.028182394197467 16.588748226373635 0.0 3 0.9967704628014229 21.71077237484827 80095.0 25.635848724644596 0.0 - - - - - - - 1219.5 160 2 KIF3C kinesin family member 3C 1399 179 C20140527_SFK016_02 C20140527_SFK016_02 TB327985.[MT7]-LLIGGR.2y5_1.heavy 386.762 / 515.33 204090.0 30.470300674438477 50 20 10 10 10 6.028182394197467 16.588748226373635 0.0 3 0.9967704628014229 21.71077237484827 204090.0 109.34650134101747 0.0 - - - - - - - 244.0 408 2 KIF3C kinesin family member 3C 1401 179 C20140527_SFK016_02 C20140527_SFK016_02 TB327985.[MT7]-LLIGGR.2b5_1.heavy 386.762 / 598.404 12292.0 30.470300674438477 50 20 10 10 10 6.028182394197467 16.588748226373635 0.0 3 0.9967704628014229 21.71077237484827 12292.0 23.279087141640645 1.0 - - - - - - - 641.0 24 7 KIF3C kinesin family member 3C 1403 180 C20140527_SFK016_02 C20140527_SFK016_02 TB397822.[MT7]-GSYQC[CAM]VDTPC[CAM]PATYR.3y7_1.heavy 640.29 / 864.403 24280.0 26.841999053955078 50 20 10 10 10 15.44041704120761 6.476509004460084 0.0 3 0.9976876532099749 25.659734831949265 24280.0 73.09153708377431 0.0 - - - - - - - 212.8 48 5 HMCN2 hemicentin 2 1405 180 C20140527_SFK016_02 C20140527_SFK016_02 TB397822.[MT7]-GSYQC[CAM]VDTPC[CAM]PATYR.3b4_1.heavy 640.29 / 580.285 20233.0 26.841999053955078 50 20 10 10 10 15.44041704120761 6.476509004460084 0.0 3 0.9976876532099749 25.659734831949265 20233.0 23.341534985603918 0.0 - - - - - - - 390.3333333333333 40 6 HMCN2 hemicentin 2 1407 180 C20140527_SFK016_02 C20140527_SFK016_02 TB397822.[MT7]-GSYQC[CAM]VDTPC[CAM]PATYR.3b5_1.heavy 640.29 / 740.315 8945.0 26.841999053955078 50 20 10 10 10 15.44041704120761 6.476509004460084 0.0 3 0.9976876532099749 25.659734831949265 8945.0 12.432250312661651 1.0 - - - - - - - 266.0 21 10 HMCN2 hemicentin 2 1409 180 C20140527_SFK016_02 C20140527_SFK016_02 TB397822.[MT7]-GSYQC[CAM]VDTPC[CAM]PATYR.3y5_1.heavy 640.29 / 607.32 29072.0 26.841999053955078 50 20 10 10 10 15.44041704120761 6.476509004460084 0.0 3 0.9976876532099749 25.659734831949265 29072.0 22.592608674499502 0.0 - - - - - - - 337.1666666666667 58 6 HMCN2 hemicentin 2 1411 181 C20140527_SFK016_02 C20140527_SFK016_02 TB397726.[MT7]-VILIEC[CAM]TELK[MT7].2y8_1.heavy 753.446 / 1149.63 5321.0 38.41619873046875 44 14 10 10 10 7.655920286710208 13.06178699033589 0.0 3 0.9446561306156915 5.221604932880892 5321.0 20.626666666666665 0.0 - - - - - - - 239.58823529411765 10 17 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1413 181 C20140527_SFK016_02 C20140527_SFK016_02 TB397726.[MT7]-VILIEC[CAM]TELK[MT7].2y5_1.heavy 753.446 / 794.42 8764.0 38.41619873046875 44 14 10 10 10 7.655920286710208 13.06178699033589 0.0 3 0.9446561306156915 5.221604932880892 8764.0 26.30113475177305 0.0 - - - - - - - 250.6 17 15 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1415 181 C20140527_SFK016_02 C20140527_SFK016_02 TB397726.[MT7]-VILIEC[CAM]TELK[MT7].2y6_1.heavy 753.446 / 923.462 19485.0 38.41619873046875 44 14 10 10 10 7.655920286710208 13.06178699033589 0.0 3 0.9446561306156915 5.221604932880892 19485.0 57.34825069217217 0.0 - - - - - - - 337.15384615384613 38 13 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1417 181 C20140527_SFK016_02 C20140527_SFK016_02 TB397726.[MT7]-VILIEC[CAM]TELK[MT7].2y7_1.heavy 753.446 / 1036.55 15885.0 38.41619873046875 44 14 10 10 10 7.655920286710208 13.06178699033589 0.0 3 0.9446561306156915 5.221604932880892 15885.0 35.28491301287208 0.0 - - - - - - - 289.0769230769231 31 13 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1419 182 C20140527_SFK016_02 C20140527_SFK016_02 TB526978.[MT7]-RLAQEPLGLEVDQFLEDVR.3y7_1.heavy 791.096 / 906.468 N/A N/A - - - - - - - - - 0.0 - - - - - - - GLTSCR2 glioma tumor suppressor candidate region gene 2 1421 182 C20140527_SFK016_02 C20140527_SFK016_02 TB526978.[MT7]-RLAQEPLGLEVDQFLEDVR.3b5_1.heavy 791.096 / 742.433 N/A N/A - - - - - - - - - 0.0 - - - - - - - GLTSCR2 glioma tumor suppressor candidate region gene 2 1423 182 C20140527_SFK016_02 C20140527_SFK016_02 TB526978.[MT7]-RLAQEPLGLEVDQFLEDVR.3y8_1.heavy 791.096 / 1021.49 N/A N/A - - - - - - - - - 0.0 - - - - - - - GLTSCR2 glioma tumor suppressor candidate region gene 2 1425 182 C20140527_SFK016_02 C20140527_SFK016_02 TB526978.[MT7]-RLAQEPLGLEVDQFLEDVR.3b8_1.heavy 791.096 / 1009.59 N/A N/A - - - - - - - - - 0.0 - - - - - - - GLTSCR2 glioma tumor suppressor candidate region gene 2 1427 183 C20140527_SFK016_02 C20140527_SFK016_02 TB526976.[MT7]-LMQADLGGTEILAPLQNIYR.3y7_1.heavy 787.43 / 903.505 N/A N/A - - - - - - - - - 0.0 - - - - - - - VWA5A von Willebrand factor A domain containing 5A 1429 183 C20140527_SFK016_02 C20140527_SFK016_02 TB526976.[MT7]-LMQADLGGTEILAPLQNIYR.3b6_1.heavy 787.43 / 816.441 N/A N/A - - - - - - - - - 0.0 - - - - - - - VWA5A von Willebrand factor A domain containing 5A 1431 183 C20140527_SFK016_02 C20140527_SFK016_02 TB526976.[MT7]-LMQADLGGTEILAPLQNIYR.3b5_1.heavy 787.43 / 703.357 N/A N/A - - - - - - - - - 0.0 - - - - - - - VWA5A von Willebrand factor A domain containing 5A 1433 183 C20140527_SFK016_02 C20140527_SFK016_02 TB526976.[MT7]-LMQADLGGTEILAPLQNIYR.3y8_1.heavy 787.43 / 974.542 N/A N/A - - - - - - - - - 0.0 - - - - - - - VWA5A von Willebrand factor A domain containing 5A 1435 184 C20140527_SFK016_02 C20140527_SFK016_02 TB328417.[MT7]-AYPELTLAIFSEISQR.3y7_1.heavy 661.362 / 866.437 10014.0 52.513099670410156 50 20 10 10 10 22.602752333115077 4.424239956542414 0.0 3 0.9927535549504237 14.48896160030324 10014.0 125.04468478889531 0.0 - - - - - - - 122.17391304347827 20 23 FRYL FRY-like 1437 184 C20140527_SFK016_02 C20140527_SFK016_02 TB328417.[MT7]-AYPELTLAIFSEISQR.3b6_1.heavy 661.362 / 819.437 4116.0 52.513099670410156 50 20 10 10 10 22.602752333115077 4.424239956542414 0.0 3 0.9927535549504237 14.48896160030324 4116.0 27.995999911950513 0.0 - - - - - - - 141.9047619047619 8 21 FRYL FRY-like 1439 184 C20140527_SFK016_02 C20140527_SFK016_02 TB328417.[MT7]-AYPELTLAIFSEISQR.3y6_1.heavy 661.362 / 719.368 8421.0 52.513099670410156 50 20 10 10 10 22.602752333115077 4.424239956542414 0.0 3 0.9927535549504237 14.48896160030324 8421.0 85.5240412589262 0.0 - - - - - - - 152.66666666666666 16 24 FRYL FRY-like 1441 184 C20140527_SFK016_02 C20140527_SFK016_02 TB328417.[MT7]-AYPELTLAIFSEISQR.3b4_1.heavy 661.362 / 605.305 6562.0 52.513099670410156 50 20 10 10 10 22.602752333115077 4.424239956542414 0.0 3 0.9927535549504237 14.48896160030324 6562.0 49.99440056607588 0.0 - - - - - - - 164.26923076923077 13 26 FRYL FRY-like 1443 185 C20140527_SFK016_02 C20140527_SFK016_02 TB397722.[MT7]-SAHATAPVNIAGSR.3y6_1.heavy 499.275 / 617.336 8353.0 22.217549324035645 39 13 10 6 10 2.4980251773339126 40.03162214190644 0.034999847412109375 3 0.906641981482285 4.007268600531108 8353.0 13.41933956148618 0.0 - - - - - - - 287.3529411764706 16 17 SRRM2 serine/arginine repetitive matrix 2 1445 185 C20140527_SFK016_02 C20140527_SFK016_02 TB397722.[MT7]-SAHATAPVNIAGSR.3b4_1.heavy 499.275 / 511.275 1770.0 22.217549324035645 39 13 10 6 10 2.4980251773339126 40.03162214190644 0.034999847412109375 3 0.906641981482285 4.007268600531108 1770.0 5.251648351648352 1.0 - - - - - - - 259.6111111111111 3 18 SRRM2 serine/arginine repetitive matrix 2 1447 185 C20140527_SFK016_02 C20140527_SFK016_02 TB397722.[MT7]-SAHATAPVNIAGSR.3y8_1.heavy 499.275 / 813.458 3468.0 22.217549324035645 39 13 10 6 10 2.4980251773339126 40.03162214190644 0.034999847412109375 3 0.906641981482285 4.007268600531108 3468.0 8.012709768221836 0.0 - - - - - - - 251.0 6 22 SRRM2 serine/arginine repetitive matrix 2 1449 185 C20140527_SFK016_02 C20140527_SFK016_02 TB397722.[MT7]-SAHATAPVNIAGSR.3y5_1.heavy 499.275 / 503.294 3256.0 22.217549324035645 39 13 10 6 10 2.4980251773339126 40.03162214190644 0.034999847412109375 3 0.906641981482285 4.007268600531108 3256.0 7.106314086384758 0.0 - - - - - - - 715.6666666666666 6 9 SRRM2 serine/arginine repetitive matrix 2 1451 186 C20140527_SFK016_02 C20140527_SFK016_02 TB526246.[MT7]-DISVQAIAC[CAM]R.2y8_1.heavy 638.844 / 904.467 73366.0 31.11639976501465 50 20 10 10 10 7.414219598794484 13.487596188310837 0.0 3 0.9931004856376255 14.849201140343245 73366.0 235.07807894127876 0.0 - - - - - - - 286.8666666666667 146 15 C2CD2 C2 calcium-dependent domain containing 2 1453 186 C20140527_SFK016_02 C20140527_SFK016_02 TB526246.[MT7]-DISVQAIAC[CAM]R.2y5_1.heavy 638.844 / 590.308 27608.0 31.11639976501465 50 20 10 10 10 7.414219598794484 13.487596188310837 0.0 3 0.9931004856376255 14.849201140343245 27608.0 51.162500082205895 0.0 - - - - - - - 697.3 55 10 C2CD2 C2 calcium-dependent domain containing 2 1455 186 C20140527_SFK016_02 C20140527_SFK016_02 TB526246.[MT7]-DISVQAIAC[CAM]R.2y9_1.heavy 638.844 / 1017.55 53974.0 31.11639976501465 50 20 10 10 10 7.414219598794484 13.487596188310837 0.0 3 0.9931004856376255 14.849201140343245 53974.0 242.91196806063658 0.0 - - - - - - - 278.8333333333333 107 12 C2CD2 C2 calcium-dependent domain containing 2 1457 186 C20140527_SFK016_02 C20140527_SFK016_02 TB526246.[MT7]-DISVQAIAC[CAM]R.2y6_1.heavy 638.844 / 718.367 65628.0 31.11639976501465 50 20 10 10 10 7.414219598794484 13.487596188310837 0.0 3 0.9931004856376255 14.849201140343245 65628.0 131.56020718238926 0.0 - - - - - - - 325.0 131 10 C2CD2 C2 calcium-dependent domain containing 2 1459 187 C20140527_SFK016_02 C20140527_SFK016_02 TB525889.[MT7]-TPQAPASANLVGPR.3b6_1.heavy 508.287 / 710.395 4326.0 27.354799270629883 47 17 10 10 10 4.052726122248754 24.674749041396502 0.0 3 0.9756920800030877 7.899594352872225 4326.0 0.3692176386913229 1.0 - - - - - - - 228.22222222222223 14 9 SRRM2 serine/arginine repetitive matrix 2 1461 187 C20140527_SFK016_02 C20140527_SFK016_02 TB525889.[MT7]-TPQAPASANLVGPR.3y6_1.heavy 508.287 / 655.389 8977.0 27.354799270629883 47 17 10 10 10 4.052726122248754 24.674749041396502 0.0 3 0.9756920800030877 7.899594352872225 8977.0 22.301670404464453 0.0 - - - - - - - 283.75 17 8 SRRM2 serine/arginine repetitive matrix 2 1463 187 C20140527_SFK016_02 C20140527_SFK016_02 TB525889.[MT7]-TPQAPASANLVGPR.3b4_1.heavy 508.287 / 542.305 30392.0 27.354799270629883 47 17 10 10 10 4.052726122248754 24.674749041396502 0.0 3 0.9756920800030877 7.899594352872225 30392.0 69.4513593266636 0.0 - - - - - - - 781.0 60 9 SRRM2 serine/arginine repetitive matrix 2 1465 187 C20140527_SFK016_02 C20140527_SFK016_02 TB525889.[MT7]-TPQAPASANLVGPR.3y8_1.heavy 508.287 / 813.458 7571.0 27.354799270629883 47 17 10 10 10 4.052726122248754 24.674749041396502 0.0 3 0.9756920800030877 7.899594352872225 7571.0 48.85759088187494 0.0 - - - - - - - 207.76923076923077 15 13 SRRM2 serine/arginine repetitive matrix 2 1467 188 C20140527_SFK016_02 C20140527_SFK016_02 TB527015.[MT7]-DVVYGPQPQPLENQLLSEETK[MT7].3y6_1.heavy 891.472 / 850.464 31052.0 38.203399658203125 48 18 10 10 10 5.83180632270076 17.14734585933388 0.0 3 0.9895309620912452 12.051174280337921 31052.0 129.17419145544397 0.0 - - - - - - - 249.85714285714286 62 14 GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 1469 188 C20140527_SFK016_02 C20140527_SFK016_02 TB527015.[MT7]-DVVYGPQPQPLENQLLSEETK[MT7].3b5_1.heavy 891.472 / 678.358 41876.0 38.203399658203125 48 18 10 10 10 5.83180632270076 17.14734585933388 0.0 3 0.9895309620912452 12.051174280337921 41876.0 167.8177529092938 0.0 - - - - - - - 308.0 83 11 GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 1471 188 C20140527_SFK016_02 C20140527_SFK016_02 TB527015.[MT7]-DVVYGPQPQPLENQLLSEETK[MT7].3b7_1.heavy 891.472 / 903.469 37503.0 38.203399658203125 48 18 10 10 10 5.83180632270076 17.14734585933388 0.0 3 0.9895309620912452 12.051174280337921 37503.0 271.3005195456064 0.0 - - - - - - - 182.13333333333333 75 15 GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 1473 188 C20140527_SFK016_02 C20140527_SFK016_02 TB527015.[MT7]-DVVYGPQPQPLENQLLSEETK[MT7].3y5_1.heavy 891.472 / 737.38 49420.0 38.203399658203125 48 18 10 10 10 5.83180632270076 17.14734585933388 0.0 3 0.9895309620912452 12.051174280337921 49420.0 224.75004904802245 0.0 - - - - - - - 269.0769230769231 98 13 GABRE gamma-aminobutyric acid (GABA) A receptor, epsilon 1475 189 C20140527_SFK016_02 C20140527_SFK016_02 TB525793.[MT7]-C[CAM]EAPAK[MT7].2b3_1.heavy 482.262 / 505.22 7071.0 15.553799629211426 46 18 10 10 8 8.87412736000078 11.268713637212347 0.0 4 0.9863504757153926 10.551358481066279 7071.0 53.04403911708532 0.0 - - - - - - - 145.13333333333333 14 15 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 1477 189 C20140527_SFK016_02 C20140527_SFK016_02 TB525793.[MT7]-C[CAM]EAPAK[MT7].2y4_1.heavy 482.262 / 530.342 6182.0 15.553799629211426 46 18 10 10 8 8.87412736000078 11.268713637212347 0.0 4 0.9863504757153926 10.551358481066279 6182.0 36.98885026505606 0.0 - - - - - - - 152.94444444444446 12 18 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 1479 189 C20140527_SFK016_02 C20140527_SFK016_02 TB525793.[MT7]-C[CAM]EAPAK[MT7].2y5_1.heavy 482.262 / 659.385 3202.0 15.553799629211426 46 18 10 10 8 8.87412736000078 11.268713637212347 0.0 4 0.9863504757153926 10.551358481066279 3202.0 13.645712432432433 1.0 - - - - - - - 177.73333333333332 9 15 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 1481 189 C20140527_SFK016_02 C20140527_SFK016_02 TB525793.[MT7]-C[CAM]EAPAK[MT7].2b5_1.heavy 482.262 / 673.31 712.0 15.553799629211426 46 18 10 10 8 8.87412736000078 11.268713637212347 0.0 4 0.9863504757153926 10.551358481066279 712.0 1.4126984126984126 3.0 - - - - - - - 0.0 1 0 APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 1483 190 C20140527_SFK016_02 C20140527_SFK016_02 TB526180.[MT7]-MFFLIEK[MT7].2y4_1.heavy 608.356 / 646.426 N/A N/A - - - - - - - - - 0.0 - - - - - - - MX2 myxovirus (influenza virus) resistance 2 (mouse) 1485 190 C20140527_SFK016_02 C20140527_SFK016_02 TB526180.[MT7]-MFFLIEK[MT7].2b3_1.heavy 608.356 / 570.287 N/A N/A - - - - - - - - - 0.0 - - - - - - - MX2 myxovirus (influenza virus) resistance 2 (mouse) 1487 190 C20140527_SFK016_02 C20140527_SFK016_02 TB526180.[MT7]-MFFLIEK[MT7].2y3_1.heavy 608.356 / 533.341 N/A N/A - - - - - - - - - 0.0 - - - - - - - MX2 myxovirus (influenza virus) resistance 2 (mouse) 1489 190 C20140527_SFK016_02 C20140527_SFK016_02 TB526180.[MT7]-MFFLIEK[MT7].2y6_1.heavy 608.356 / 940.562 N/A N/A - - - - - - - - - 0.0 - - - - - - - MX2 myxovirus (influenza virus) resistance 2 (mouse) 1491 191 C20140527_SFK016_02 C20140527_SFK016_02 TB525790.[MT7]-AINQAGSR.2y5_1.heavy 480.771 / 518.268 5589.0 15.4173002243042 50 20 10 10 10 317.75721326340044 0.3147056803934971 0.0 3 0.9999813518843484 285.78815051214764 5589.0 27.586022727272724 0.0 - - - - - - - 155.69230769230768 11 13 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1493 191 C20140527_SFK016_02 C20140527_SFK016_02 TB525790.[MT7]-AINQAGSR.2b4_1.heavy 480.771 / 571.332 10034.0 15.4173002243042 50 20 10 10 10 317.75721326340044 0.3147056803934971 0.0 3 0.9999813518843484 285.78815051214764 10034.0 121.35275974025973 0.0 - - - - - - - 194.33333333333334 20 12 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1495 191 C20140527_SFK016_02 C20140527_SFK016_02 TB525790.[MT7]-AINQAGSR.2y6_1.heavy 480.771 / 632.311 24996.0 15.4173002243042 50 20 10 10 10 317.75721326340044 0.3147056803934971 0.0 3 0.9999813518843484 285.78815051214764 24996.0 278.36454545454546 0.0 - - - - - - - 162.25 49 16 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1497 191 C20140527_SFK016_02 C20140527_SFK016_02 TB525790.[MT7]-AINQAGSR.2y7_1.heavy 480.771 / 745.395 28649.0 15.4173002243042 50 20 10 10 10 317.75721326340044 0.3147056803934971 0.0 3 0.9999813518843484 285.78815051214764 28649.0 215.2292297979798 0.0 - - - - - - - 173.06666666666666 57 15 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1499 192 C20140527_SFK016_02 C20140527_SFK016_02 TB527010.[MT7]-GGQLQEQLTQQLSQALSSAVAGR.3y11_1.heavy 838.785 / 1046.56 N/A N/A - - - - - - - - - 0.0 - - - - - - - EDC4 enhancer of mRNA decapping 4 1501 192 C20140527_SFK016_02 C20140527_SFK016_02 TB527010.[MT7]-GGQLQEQLTQQLSQALSSAVAGR.3b4_1.heavy 838.785 / 500.295 N/A N/A - - - - - - - - - 0.0 - - - - - - - EDC4 enhancer of mRNA decapping 4 1503 192 C20140527_SFK016_02 C20140527_SFK016_02 TB527010.[MT7]-GGQLQEQLTQQLSQALSSAVAGR.3b5_1.heavy 838.785 / 628.354 N/A N/A - - - - - - - - - 0.0 - - - - - - - EDC4 enhancer of mRNA decapping 4 1505 192 C20140527_SFK016_02 C20140527_SFK016_02 TB527010.[MT7]-GGQLQEQLTQQLSQALSSAVAGR.3b7_1.heavy 838.785 / 885.455 N/A N/A - - - - - - - - - 0.0 - - - - - - - EDC4 enhancer of mRNA decapping 4 1507 193 C20140527_SFK016_02 C20140527_SFK016_02 TB526700.[MT7]-IQPSGGTNINEALLR.2y12_1.heavy 863.982 / 1244.66 4774.0 34.113800048828125 44 14 10 10 10 1.4110478728154252 47.24621180544958 0.0 3 0.9479221509898849 5.384344422392251 4774.0 15.384103687477182 0.0 - - - - - - - 239.53846153846155 9 13 ITIH2 inter-alpha (globulin) inhibitor H2 1509 193 C20140527_SFK016_02 C20140527_SFK016_02 TB526700.[MT7]-IQPSGGTNINEALLR.2y6_1.heavy 863.982 / 715.41 6123.0 34.113800048828125 44 14 10 10 10 1.4110478728154252 47.24621180544958 0.0 3 0.9479221509898849 5.384344422392251 6123.0 15.959129246647121 0.0 - - - - - - - 216.33333333333334 12 12 ITIH2 inter-alpha (globulin) inhibitor H2 1511 193 C20140527_SFK016_02 C20140527_SFK016_02 TB526700.[MT7]-IQPSGGTNINEALLR.2b5_1.heavy 863.982 / 627.358 3321.0 34.113800048828125 44 14 10 10 10 1.4110478728154252 47.24621180544958 0.0 3 0.9479221509898849 5.384344422392251 3321.0 18.12257296561959 0.0 - - - - - - - 285.5 6 8 ITIH2 inter-alpha (globulin) inhibitor H2 1513 193 C20140527_SFK016_02 C20140527_SFK016_02 TB526700.[MT7]-IQPSGGTNINEALLR.2y11_1.heavy 863.982 / 1157.63 5293.0 34.113800048828125 44 14 10 10 10 1.4110478728154252 47.24621180544958 0.0 3 0.9479221509898849 5.384344422392251 5293.0 16.33359965908651 0.0 - - - - - - - 268.1666666666667 10 12 ITIH2 inter-alpha (globulin) inhibitor H2 1515 194 C20140527_SFK016_02 C20140527_SFK016_02 TB526702.[MT7]-RLIIVLTPDYILR.3y6_1.heavy 577.033 / 776.43 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1517 194 C20140527_SFK016_02 C20140527_SFK016_02 TB526702.[MT7]-RLIIVLTPDYILR.3b4_1.heavy 577.033 / 640.463 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1519 194 C20140527_SFK016_02 C20140527_SFK016_02 TB526702.[MT7]-RLIIVLTPDYILR.3b5_1.heavy 577.033 / 739.531 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1521 194 C20140527_SFK016_02 C20140527_SFK016_02 TB526702.[MT7]-RLIIVLTPDYILR.3y4_1.heavy 577.033 / 564.35 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1523 195 C20140527_SFK016_02 C20140527_SFK016_02 TB525989.[MT7]-YIFMVK[MT7].2b3_1.heavy 544.824 / 568.325 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1525 195 C20140527_SFK016_02 C20140527_SFK016_02 TB525989.[MT7]-YIFMVK[MT7].2y4_1.heavy 544.824 / 668.392 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1527 195 C20140527_SFK016_02 C20140527_SFK016_02 TB525989.[MT7]-YIFMVK[MT7].2y5_1.heavy 544.824 / 781.476 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1529 195 C20140527_SFK016_02 C20140527_SFK016_02 TB525989.[MT7]-YIFMVK[MT7].2y3_1.heavy 544.824 / 521.324 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1531 196 C20140527_SFK016_02 C20140527_SFK016_02 TB526706.[MT7]-LIIVLTPDYILRR.3y7_1.heavy 577.033 / 932.531 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1533 196 C20140527_SFK016_02 C20140527_SFK016_02 TB526706.[MT7]-LIIVLTPDYILRR.3b4_1.heavy 577.033 / 583.43 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1535 196 C20140527_SFK016_02 C20140527_SFK016_02 TB526706.[MT7]-LIIVLTPDYILRR.3y4_1.heavy 577.033 / 557.388 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1537 196 C20140527_SFK016_02 C20140527_SFK016_02 TB526706.[MT7]-LIIVLTPDYILRR.3y5_1.heavy 577.033 / 720.451 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1539 197 C20140527_SFK016_02 C20140527_SFK016_02 TB526707.[MT7]-EITFFQTHPYFR.3y6_1.heavy 577.299 / 820.41 46840.0 39.52259826660156 50 20 10 10 10 9.598095754736686 10.418733314954661 0.0 3 0.9931769922719036 14.932316820263987 46840.0 -31.019867549668874 0.0 - - - - - - - 228.72727272727272 93 11 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1541 197 C20140527_SFK016_02 C20140527_SFK016_02 TB526707.[MT7]-EITFFQTHPYFR.3b4_1.heavy 577.299 / 635.352 103350.0 39.52259826660156 50 20 10 10 10 9.598095754736686 10.418733314954661 0.0 3 0.9931769922719036 14.932316820263987 103350.0 -11.977649006622528 0.0 - - - - - - - 251.66666666666666 206 6 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1543 197 C20140527_SFK016_02 C20140527_SFK016_02 TB526707.[MT7]-EITFFQTHPYFR.3y4_1.heavy 577.299 / 582.304 417127.0 39.52259826660156 50 20 10 10 10 9.598095754736686 10.418733314954661 0.0 3 0.9931769922719036 14.932316820263987 417127.0 -3.6536671532846725 0.0 - - - - - - - 201.0 834 1 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1545 197 C20140527_SFK016_02 C20140527_SFK016_02 TB526707.[MT7]-EITFFQTHPYFR.3y5_1.heavy 577.299 / 719.362 57417.0 39.52259826660156 50 20 10 10 10 9.598095754736686 10.418733314954661 0.0 3 0.9931769922719036 14.932316820263987 57417.0 85.48436724565758 0.0 - - - - - - - 251.66666666666666 114 6 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1547 198 C20140527_SFK016_02 C20140527_SFK016_02 TB526274.[MT7]-RQEIAEQK[MT7].3y3_1.heavy 430.585 / 548.316 41813.0 16.353300094604492 45 15 10 10 10 2.484844025096257 32.516963354795166 0.0 3 0.9591650485167286 6.0863551620529215 41813.0 228.2838604532722 0.0 - - - - - - - 225.66666666666666 83 15 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 1549 198 C20140527_SFK016_02 C20140527_SFK016_02 TB526274.[MT7]-RQEIAEQK[MT7].3b4_1.heavy 430.585 / 671.396 16545.0 16.353300094604492 45 15 10 10 10 2.484844025096257 32.516963354795166 0.0 3 0.9591650485167286 6.0863551620529215 16545.0 28.677737052267716 0.0 - - - - - - - 314.05882352941177 33 17 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 1551 198 C20140527_SFK016_02 C20140527_SFK016_02 TB526274.[MT7]-RQEIAEQK[MT7].3y4_1.heavy 430.585 / 619.353 55186.0 16.353300094604492 45 15 10 10 10 2.484844025096257 32.516963354795166 0.0 3 0.9591650485167286 6.0863551620529215 55186.0 49.52048328282548 0.0 - - - - - - - 211.5 110 12 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 1553 198 C20140527_SFK016_02 C20140527_SFK016_02 TB526274.[MT7]-RQEIAEQK[MT7].3b3_1.heavy 430.585 / 558.312 45671.0 16.353300094604492 45 15 10 10 10 2.484844025096257 32.516963354795166 0.0 3 0.9591650485167286 6.0863551620529215 45671.0 87.67573260833473 0.0 - - - - - - - 334.6666666666667 91 6 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 1555 199 C20140527_SFK016_02 C20140527_SFK016_02 TB525876.[MT7]-DTDMNK[MT7].2y4_1.heavy 506.255 / 651.325 1202.0 16.161124229431152 43 18 10 5 10 4.804780187482407 20.812606632978493 0.040500640869140625 3 0.9899626160984621 12.308019251929343 1202.0 4.802004987531172 0.0 - - - - - - - 155.61111111111111 2 18 LOC100287399;LOC100288966;POTEH;POTED;POTEB;POTEC;POTEG;POTEM POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member H;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member G;POTE ankyrin domain family, member M 1557 199 C20140527_SFK016_02 C20140527_SFK016_02 TB525876.[MT7]-DTDMNK[MT7].2y5_1.heavy 506.255 / 752.373 3606.0 16.161124229431152 43 18 10 5 10 4.804780187482407 20.812606632978493 0.040500640869140625 3 0.9899626160984621 12.308019251929343 3606.0 33.7161 0.0 - - - - - - - 135.71428571428572 7 14 LOC100287399;LOC100288966;POTEH;POTED;POTEB;POTEC;POTEG;POTEM POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member H;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member G;POTE ankyrin domain family, member M 1559 199 C20140527_SFK016_02 C20140527_SFK016_02 TB525876.[MT7]-DTDMNK[MT7].2b4_1.heavy 506.255 / 607.251 951.0 16.161124229431152 43 18 10 5 10 4.804780187482407 20.812606632978493 0.040500640869140625 3 0.9899626160984621 12.308019251929343 951.0 3.57576 0.0 - - - - - - - 0.0 1 0 LOC100287399;LOC100288966;POTEH;POTED;POTEB;POTEC;POTEG;POTEM POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member H;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member G;POTE ankyrin domain family, member M 1561 199 C20140527_SFK016_02 C20140527_SFK016_02 TB525876.[MT7]-DTDMNK[MT7].2y3_1.heavy 506.255 / 536.298 6610.0 16.161124229431152 43 18 10 5 10 4.804780187482407 20.812606632978493 0.040500640869140625 3 0.9899626160984621 12.308019251929343 6610.0 33.61594347464671 0.0 - - - - - - - 180.06666666666666 13 15 LOC100287399;LOC100288966;POTEH;POTED;POTEB;POTEC;POTEG;POTEM POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member H;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member G;POTE ankyrin domain family, member M 1563 200 C20140527_SFK016_02 C20140527_SFK016_02 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y7.peptide 661.38 / 836.43 991302.0 45.081000010172524 21 -3 10 6 8 null 0.0 0.0345001220703125 4 0.0 0.0 991302.0 274.09651203985607 1.0 - - - - - - - 262.1111111111111 1982 9 1565 200 C20140527_SFK016_02 C20140527_SFK016_02 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y9.peptide 661.38 / 502.76 1510440.0 45.081000010172524 21 -3 10 6 8 null 0.0 0.0345001220703125 4 0.0 0.0 1510440.0 193.97474739683764 1.0 - - - - - - - 331.0 3128 5 1567 200 C20140527_SFK016_02 C20140527_SFK016_02 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y17.peptide 661.38 / 906.51 1771910.0 45.081000010172524 21 -3 10 6 8 null 0.0 0.0345001220703125 4 0.0 0.0 1771910.0 804.6671918443003 1.0 - - - - - - - 313.75 3543 4 1569 201 C20140527_SFK016_02 C20140527_SFK016_02 TB526502.[MT7]-K[MT7]C[CAM]DELQFAR.3y6_1.heavy 485.594 / 763.41 12227.0 25.972000122070312 45 15 10 10 10 3.2038282905757725 31.212659022381196 0.0 3 0.9597106149015832 6.1277076516622175 12227.0 131.20527188019966 0.0 - - - - - - - 200.4 24 10 KIAA0947 KIAA0947 1571 201 C20140527_SFK016_02 C20140527_SFK016_02 TB526502.[MT7]-K[MT7]C[CAM]DELQFAR.3b3_1.heavy 485.594 / 692.364 6214.0 25.972000122070312 45 15 10 10 10 3.2038282905757725 31.212659022381196 0.0 3 0.9597106149015832 6.1277076516622175 6214.0 47.990247176079734 0.0 - - - - - - - 288.125 12 8 KIAA0947 KIAA0947 1573 201 C20140527_SFK016_02 C20140527_SFK016_02 TB526502.[MT7]-K[MT7]C[CAM]DELQFAR.3y4_1.heavy 485.594 / 521.283 24053.0 25.972000122070312 45 15 10 10 10 3.2038282905757725 31.212659022381196 0.0 3 0.9597106149015832 6.1277076516622175 24053.0 84.83083880824042 0.0 - - - - - - - 613.75 48 8 KIAA0947 KIAA0947 1575 201 C20140527_SFK016_02 C20140527_SFK016_02 TB526502.[MT7]-K[MT7]C[CAM]DELQFAR.3y5_1.heavy 485.594 / 634.367 11024.0 25.972000122070312 45 15 10 10 10 3.2038282905757725 31.212659022381196 0.0 3 0.9597106149015832 6.1277076516622175 11024.0 40.05345155629445 0.0 - - - - - - - 275.5833333333333 22 12 KIAA0947 KIAA0947 1577 202 C20140527_SFK016_02 C20140527_SFK016_02 TB526645.[MT7]-AEIQDQHDEYIR.3y6_1.heavy 554.273 / 832.395 12837.0 24.145000457763672 50 20 10 10 10 6.851221670971219 14.595937017145754 0.0 3 0.9933264740941742 15.098815400195093 12837.0 50.341884690971106 0.0 - - - - - - - 223.25 25 12 KIF3C kinesin family member 3C 1579 202 C20140527_SFK016_02 C20140527_SFK016_02 TB526645.[MT7]-AEIQDQHDEYIR.3b5_1.heavy 554.273 / 701.359 32417.0 24.145000457763672 50 20 10 10 10 6.851221670971219 14.595937017145754 0.0 3 0.9933264740941742 15.098815400195093 32417.0 52.17511873350923 0.0 - - - - - - - 812.2857142857143 64 7 KIF3C kinesin family member 3C 1581 202 C20140527_SFK016_02 C20140527_SFK016_02 TB526645.[MT7]-AEIQDQHDEYIR.3y4_1.heavy 554.273 / 580.309 22993.0 24.145000457763672 50 20 10 10 10 6.851221670971219 14.595937017145754 0.0 3 0.9933264740941742 15.098815400195093 22993.0 100.04146437745032 0.0 - - - - - - - 307.42857142857144 45 14 KIF3C kinesin family member 3C 1583 202 C20140527_SFK016_02 C20140527_SFK016_02 TB526645.[MT7]-AEIQDQHDEYIR.3y5_1.heavy 554.273 / 695.336 42411.0 24.145000457763672 50 20 10 10 10 6.851221670971219 14.595937017145754 0.0 3 0.9933264740941742 15.098815400195093 42411.0 53.68638482910771 0.0 - - - - - - - 251.7 84 10 KIF3C kinesin family member 3C 1585 203 C20140527_SFK016_02 C20140527_SFK016_02 TB526643.[MT7]-AQFLIQEEFNK[MT7].3b4_1.heavy 552.306 / 604.357 36542.0 38.75517559051514 46 20 10 6 10 227.20151969399794 0.44013790107866846 0.036502838134765625 3 0.9931603932724932 14.914165557652098 36542.0 52.65864647168535 0.0 - - - - - - - 251.66666666666666 73 3 USP25 ubiquitin specific peptidase 25 1587 203 C20140527_SFK016_02 C20140527_SFK016_02 TB526643.[MT7]-AQFLIQEEFNK[MT7].3b5_1.heavy 552.306 / 717.442 8731.0 38.75517559051514 46 20 10 6 10 227.20151969399794 0.44013790107866846 0.036502838134765625 3 0.9931603932724932 14.914165557652098 8731.0 -0.24297773654916544 0.0 - - - - - - - 269.5 17 6 USP25 ubiquitin specific peptidase 25 1589 203 C20140527_SFK016_02 C20140527_SFK016_02 TB526643.[MT7]-AQFLIQEEFNK[MT7].3y4_1.heavy 552.306 / 681.369 9809.0 38.75517559051514 46 20 10 6 10 227.20151969399794 0.44013790107866846 0.036502838134765625 3 0.9931603932724932 14.914165557652098 9809.0 -0.7078659793814435 0.0 - - - - - - - 215.66666666666666 19 3 USP25 ubiquitin specific peptidase 25 1591 203 C20140527_SFK016_02 C20140527_SFK016_02 TB526643.[MT7]-AQFLIQEEFNK[MT7].3y5_1.heavy 552.306 / 810.411 5497.0 38.75517559051514 46 20 10 6 10 227.20151969399794 0.44013790107866846 0.036502838134765625 3 0.9931603932724932 14.914165557652098 5497.0 -7.634722222222223 0.0 - - - - - - - 235.1818181818182 10 11 USP25 ubiquitin specific peptidase 25 1593 204 C20140527_SFK016_02 C20140527_SFK016_02 TB525974.[MT7]-SLVSEEK[MT7].2y4_1.heavy 540.313 / 636.332 37799.0 22.436500549316406 50 20 10 10 10 20.784532725160037 4.811270059439357 0.0 3 0.9985478634858528 32.38217967827597 37799.0 127.10732286383777 0.0 - - - - - - - 251.76470588235293 75 17 KIF3C kinesin family member 3C 1595 204 C20140527_SFK016_02 C20140527_SFK016_02 TB525974.[MT7]-SLVSEEK[MT7].2y5_1.heavy 540.313 / 735.401 15889.0 22.436500549316406 50 20 10 10 10 20.784532725160037 4.811270059439357 0.0 3 0.9985478634858528 32.38217967827597 15889.0 45.44248824412033 0.0 - - - - - - - 227.33333333333334 31 15 KIF3C kinesin family member 3C 1597 204 C20140527_SFK016_02 C20140527_SFK016_02 TB525974.[MT7]-SLVSEEK[MT7].2y3_1.heavy 540.313 / 549.3 6517.0 22.436500549316406 50 20 10 10 10 20.784532725160037 4.811270059439357 0.0 3 0.9985478634858528 32.38217967827597 6517.0 24.740706715140327 0.0 - - - - - - - 251.5 13 18 KIF3C kinesin family member 3C 1599 204 C20140527_SFK016_02 C20140527_SFK016_02 TB525974.[MT7]-SLVSEEK[MT7].2y6_1.heavy 540.313 / 848.485 12351.0 22.436500549316406 50 20 10 10 10 20.784532725160037 4.811270059439357 0.0 3 0.9985478634858528 32.38217967827597 12351.0 123.51 0.0 - - - - - - - 139.5 24 16 KIF3C kinesin family member 3C 1601 205 C20140527_SFK016_02 C20140527_SFK016_02 TB526911.[MT7]-K[MT7]PLRVDLILENTSK[MT7].4b8_2.heavy 515.322 / 612.407 35921.0 34.113800048828125 40 14 8 10 8 2.8538209390031293 27.228406545822246 0.0 4 0.9456055783407806 5.267404338141248 35921.0 33.290014947683105 1.0 - - - - - - - 691.1428571428571 100 7 GLTSCR2 glioma tumor suppressor candidate region gene 2 1603 205 C20140527_SFK016_02 C20140527_SFK016_02 TB526911.[MT7]-K[MT7]PLRVDLILENTSK[MT7].4b7_2.heavy 515.322 / 555.865 21409.0 34.113800048828125 40 14 8 10 8 2.8538209390031293 27.228406545822246 0.0 4 0.9456055783407806 5.267404338141248 21409.0 81.06320388349515 0.0 - - - - - - - 294.2857142857143 42 7 GLTSCR2 glioma tumor suppressor candidate region gene 2 1605 205 C20140527_SFK016_02 C20140527_SFK016_02 TB526911.[MT7]-K[MT7]PLRVDLILENTSK[MT7].4b9_2.heavy 515.322 / 668.95 11837.0 34.113800048828125 40 14 8 10 8 2.8538209390031293 27.228406545822246 0.0 4 0.9456055783407806 5.267404338141248 11837.0 42.29141747572815 0.0 - - - - - - - 194.55555555555554 23 9 GLTSCR2 glioma tumor suppressor candidate region gene 2 1607 205 C20140527_SFK016_02 C20140527_SFK016_02 TB526911.[MT7]-K[MT7]PLRVDLILENTSK[MT7].4b6_1.heavy 515.322 / 997.64 2882.0 34.113800048828125 40 14 8 10 8 2.8538209390031293 27.228406545822246 0.0 4 0.9456055783407806 5.267404338141248 2882.0 29.845954692556635 0.0 - - - - - - - 171.66666666666666 5 9 GLTSCR2 glioma tumor suppressor candidate region gene 2 1609 206 C20140527_SFK016_02 C20140527_SFK016_02 TB526445.[MT7]-VLLEEGSATVPR.3y7_1.heavy 472.272 / 687.378 37875.0 32.63710021972656 50 20 10 10 10 41.527061816438135 2.4080682722517066 0.0 3 0.997577523470967 25.06945366118628 37875.0 145.20871921520202 0.0 - - - - - - - 256.14285714285717 75 14 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1611 206 C20140527_SFK016_02 C20140527_SFK016_02 TB526445.[MT7]-VLLEEGSATVPR.3y6_1.heavy 472.272 / 630.357 38456.0 32.63710021972656 50 20 10 10 10 41.527061816438135 2.4080682722517066 0.0 3 0.997577523470967 25.06945366118628 38456.0 97.19498761061946 0.0 - - - - - - - 283.64285714285717 76 14 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1613 206 C20140527_SFK016_02 C20140527_SFK016_02 TB526445.[MT7]-VLLEEGSATVPR.3b4_1.heavy 472.272 / 599.388 114108.0 32.63710021972656 50 20 10 10 10 41.527061816438135 2.4080682722517066 0.0 3 0.997577523470967 25.06945366118628 114108.0 271.19739838123564 0.0 - - - - - - - 395.3333333333333 228 12 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1615 206 C20140527_SFK016_02 C20140527_SFK016_02 TB526445.[MT7]-VLLEEGSATVPR.3y5_1.heavy 472.272 / 543.325 81561.0 32.63710021972656 50 20 10 10 10 41.527061816438135 2.4080682722517066 0.0 3 0.997577523470967 25.06945366118628 81561.0 150.3771130723355 0.0 - - - - - - - 688.7777777777778 163 9 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1617 207 C20140527_SFK016_02 C20140527_SFK016_02 TB526912.[MT7]-RTINILQYVTPTAVGIR.3y7_1.heavy 687.076 / 713.43 23746.0 43.92879867553711 43 13 10 10 10 2.380825141753586 42.002244619420246 0.0 3 0.9135178607775248 4.165991916226629 23746.0 -2.924384236453207 0.0 - - - - - - - 311.3 47 10 XKR6 XK, Kell blood group complex subunit-related family, member 6 1619 207 C20140527_SFK016_02 C20140527_SFK016_02 TB526912.[MT7]-RTINILQYVTPTAVGIR.3b4_1.heavy 687.076 / 629.385 6292.0 43.92879867553711 43 13 10 10 10 2.380825141753586 42.002244619420246 0.0 3 0.9135178607775248 4.165991916226629 6292.0 -0.3489094269870616 0.0 - - - - - - - 309.2857142857143 12 7 XKR6 XK, Kell blood group complex subunit-related family, member 6 1621 207 C20140527_SFK016_02 C20140527_SFK016_02 TB526912.[MT7]-RTINILQYVTPTAVGIR.3y8_1.heavy 687.076 / 814.478 19213.0 43.92879867553711 43 13 10 10 10 2.380825141753586 42.002244619420246 0.0 3 0.9135178607775248 4.165991916226629 19213.0 -2.0266877637130847 0.0 - - - - - - - 308.22222222222223 38 9 XKR6 XK, Kell blood group complex subunit-related family, member 6 1623 207 C20140527_SFK016_02 C20140527_SFK016_02 TB526912.[MT7]-RTINILQYVTPTAVGIR.3b7_1.heavy 687.076 / 983.612 13260.0 43.92879867553711 43 13 10 10 10 2.380825141753586 42.002244619420246 0.0 3 0.9135178607775248 4.165991916226629 13260.0 -1.96153846153846 0.0 - - - - - - - 236.7 26 10 XKR6 XK, Kell blood group complex subunit-related family, member 6 1625 208 C20140527_SFK016_02 C20140527_SFK016_02 TB397747.[MT7]-C[CAM]GADIPSQEADK[MT7].2y8_1.heavy 789.887 / 1031.55 2335.0 21.566025257110596 37 11 10 6 10 1.20799590408196 59.83911064020134 0.03289985656738281 3 0.8791947175494645 3.5143671411342146 2335.0 46.89971489665003 0.0 - - - - - - - 148.16666666666666 4 12 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1627 208 C20140527_SFK016_02 C20140527_SFK016_02 TB397747.[MT7]-C[CAM]GADIPSQEADK[MT7].2b4_1.heavy 789.887 / 548.226 3380.0 21.566025257110596 37 11 10 6 10 1.20799590408196 59.83911064020134 0.03289985656738281 3 0.8791947175494645 3.5143671411342146 3380.0 27.910370344143885 0.0 - - - - - - - 146.30769230769232 6 13 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1629 208 C20140527_SFK016_02 C20140527_SFK016_02 TB397747.[MT7]-C[CAM]GADIPSQEADK[MT7].2b5_1.heavy 789.887 / 661.31 3319.0 21.566025257110596 37 11 10 6 10 1.20799590408196 59.83911064020134 0.03289985656738281 3 0.8791947175494645 3.5143671411342146 3319.0 19.438840073091285 0.0 - - - - - - - 189.65217391304347 6 23 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1631 208 C20140527_SFK016_02 C20140527_SFK016_02 TB397747.[MT7]-C[CAM]GADIPSQEADK[MT7].2y7_1.heavy 789.887 / 918.465 3872.0 21.566025257110596 37 11 10 6 10 1.20799590408196 59.83911064020134 0.03289985656738281 3 0.8791947175494645 3.5143671411342146 3872.0 113.93836065573771 0.0 - - - - - - - 84.25 7 8 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1633 209 C20140527_SFK016_02 C20140527_SFK016_02 TB397744.[MT7]-RNTELETLLAK[MT7].2b8_1.heavy 788.469 / 1101.6 3523.0 34.80105018615723 36 11 10 5 10 1.0233091433014665 64.97056171158368 0.040699005126953125 3 0.8505149025298023 3.151364835612871 3523.0 11.528072826356205 0.0 - - - - - - - 203.07692307692307 7 13 MID1 midline 1 (Opitz/BBB syndrome) 1635 209 C20140527_SFK016_02 C20140527_SFK016_02 TB397744.[MT7]-RNTELETLLAK[MT7].2b7_1.heavy 788.469 / 988.518 1321.0 34.80105018615723 36 11 10 5 10 1.0233091433014665 64.97056171158368 0.040699005126953125 3 0.8505149025298023 3.151364835612871 1321.0 5.521396048228121 2.0 - - - - - - - 264.0 2 10 MID1 midline 1 (Opitz/BBB syndrome) 1637 209 C20140527_SFK016_02 C20140527_SFK016_02 TB397744.[MT7]-RNTELETLLAK[MT7].2b9_1.heavy 788.469 / 1214.69 881.0 34.80105018615723 36 11 10 5 10 1.0233091433014665 64.97056171158368 0.040699005126953125 3 0.8505149025298023 3.151364835612871 881.0 1.0013636363636365 11.0 - - - - - - - 220.0 2 16 MID1 midline 1 (Opitz/BBB syndrome) 1639 209 C20140527_SFK016_02 C20140527_SFK016_02 TB397744.[MT7]-RNTELETLLAK[MT7].2b6_1.heavy 788.469 / 887.47 1321.0 34.80105018615723 36 11 10 5 10 1.0233091433014665 64.97056171158368 0.040699005126953125 3 0.8505149025298023 3.151364835612871 1321.0 4.003030303030303 0.0 - - - - - - - 227.85714285714286 2 14 MID1 midline 1 (Opitz/BBB syndrome) 1641 210 C20140527_SFK016_02 C20140527_SFK016_02 TB397887.[MT7]-LTAFSEVGVPANRTELSMLEPDPR.4b8_1.heavy 694.113 / 949.511 6886.0 41.9200496673584 39 13 10 6 10 1.238214111513152 53.84098440389851 0.037097930908203125 3 0.921603808970323 4.378606854655791 6886.0 24.910184331797232 0.0 - - - - - - - 664.2857142857143 13 7 HMCN2 hemicentin 2 1643 210 C20140527_SFK016_02 C20140527_SFK016_02 TB397887.[MT7]-LTAFSEVGVPANRTELSMLEPDPR.4b4_1.heavy 694.113 / 577.347 4901.0 41.9200496673584 39 13 10 6 10 1.238214111513152 53.84098440389851 0.037097930908203125 3 0.921603808970323 4.378606854655791 4901.0 9.19651515151515 0.0 - - - - - - - 728.5833333333334 9 12 HMCN2 hemicentin 2 1645 210 C20140527_SFK016_02 C20140527_SFK016_02 TB397887.[MT7]-LTAFSEVGVPANRTELSMLEPDPR.4b5_1.heavy 694.113 / 664.379 2792.0 41.9200496673584 39 13 10 6 10 1.238214111513152 53.84098440389851 0.037097930908203125 3 0.921603808970323 4.378606854655791 2792.0 6.029336096840341 0.0 - - - - - - - 754.4166666666666 5 12 HMCN2 hemicentin 2 1647 210 C20140527_SFK016_02 C20140527_SFK016_02 TB397887.[MT7]-LTAFSEVGVPANRTELSMLEPDPR.4b6_1.heavy 694.113 / 793.421 6638.0 41.9200496673584 39 13 10 6 10 1.238214111513152 53.84098440389851 0.037097930908203125 3 0.921603808970323 4.378606854655791 6638.0 20.385516454871293 0.0 - - - - - - - 666.625 13 8 HMCN2 hemicentin 2 1649 211 C20140527_SFK016_02 C20140527_SFK016_02 TB397888.[MT7]-AEVQHQLHVAVGSLQESILAQVQR.4y5_1.heavy 696.886 / 601.342 7900.0 42.131500244140625 47 17 10 10 10 2.3560776624295254 29.15492844884453 0.0 3 0.9782719794054032 8.35723805172504 7900.0 17.047148721700605 0.0 - - - - - - - 653.1666666666666 15 12 EDC4 enhancer of mRNA decapping 4 1651 211 C20140527_SFK016_02 C20140527_SFK016_02 TB397888.[MT7]-AEVQHQLHVAVGSLQESILAQVQR.4y4_1.heavy 696.886 / 530.305 5056.0 42.131500244140625 47 17 10 10 10 2.3560776624295254 29.15492844884453 0.0 3 0.9782719794054032 8.35723805172504 5056.0 17.66219686060552 0.0 - - - - - - - 666.1538461538462 10 13 EDC4 enhancer of mRNA decapping 4 1653 211 C20140527_SFK016_02 C20140527_SFK016_02 TB397888.[MT7]-AEVQHQLHVAVGSLQESILAQVQR.4b8_2.heavy 696.886 / 544.292 4866.0 42.131500244140625 47 17 10 10 10 2.3560776624295254 29.15492844884453 0.0 3 0.9782719794054032 8.35723805172504 4866.0 20.590481312853356 0.0 - - - - - - - 312.0 9 16 EDC4 enhancer of mRNA decapping 4 1655 211 C20140527_SFK016_02 C20140527_SFK016_02 TB397888.[MT7]-AEVQHQLHVAVGSLQESILAQVQR.4y6_1.heavy 696.886 / 714.426 7079.0 42.131500244140625 47 17 10 10 10 2.3560776624295254 29.15492844884453 0.0 3 0.9782719794054032 8.35723805172504 7079.0 21.432063599135617 1.0 - - - - - - - 324.92857142857144 14 14 EDC4 enhancer of mRNA decapping 4 1657 212 C20140527_SFK016_02 C20140527_SFK016_02 TB526538.[MT7]-LTAFSEVGVPANR.3b6_1.heavy 502.28 / 793.421 17270.0 35.922000885009766 48 18 10 10 10 6.301941616589653 15.868125426099365 0.0 3 0.9873124982639557 10.944957124304102 17270.0 191.88077622288924 0.0 - - - - - - - 289.6666666666667 34 9 HMCN2 hemicentin 2 1659 212 C20140527_SFK016_02 C20140527_SFK016_02 TB526538.[MT7]-LTAFSEVGVPANR.3y6_1.heavy 502.28 / 613.342 41709.0 35.922000885009766 48 18 10 10 10 6.301941616589653 15.868125426099365 0.0 3 0.9873124982639557 10.944957124304102 41709.0 82.80260625412905 0.0 - - - - - - - 271.625 83 8 HMCN2 hemicentin 2 1661 212 C20140527_SFK016_02 C20140527_SFK016_02 TB526538.[MT7]-LTAFSEVGVPANR.3b4_1.heavy 502.28 / 577.347 14663.0 35.922000885009766 48 18 10 10 10 6.301941616589653 15.868125426099365 0.0 3 0.9873124982639557 10.944957124304102 14663.0 10.396862343601157 2.0 - - - - - - - 304.0 32 5 HMCN2 hemicentin 2 1663 212 C20140527_SFK016_02 C20140527_SFK016_02 TB526538.[MT7]-LTAFSEVGVPANR.3b5_1.heavy 502.28 / 664.379 8364.0 35.922000885009766 48 18 10 10 10 6.301941616589653 15.868125426099365 0.0 3 0.9873124982639557 10.944957124304102 8364.0 28.46052340528741 0.0 - - - - - - - 217.375 16 8 HMCN2 hemicentin 2 1665 213 C20140527_SFK016_02 C20140527_SFK016_02 TB525864.[MT7]-AELEEK[MT7].2y4_1.heavy 503.787 / 662.384 9933.0 20.125874519348145 47 20 10 7 10 47.64718725515948 2.0987597749365885 0.027698516845703125 3 0.9993948971583747 50.167894181043685 9933.0 79.55 0.0 - - - - - - - 130.7826086956522 19 23 DOCK1;KIAA0947 dedicator of cytokinesis 1;KIAA0947 1667 213 C20140527_SFK016_02 C20140527_SFK016_02 TB525864.[MT7]-AELEEK[MT7].2y5_1.heavy 503.787 / 791.427 7681.0 20.125874519348145 47 20 10 7 10 47.64718725515948 2.0987597749365885 0.027698516845703125 3 0.9993948971583747 50.167894181043685 7681.0 21.335446685878964 1.0 - - - - - - - 140.10526315789474 15 19 DOCK1;KIAA0947 dedicator of cytokinesis 1;KIAA0947 1669 213 C20140527_SFK016_02 C20140527_SFK016_02 TB525864.[MT7]-AELEEK[MT7].2b4_1.heavy 503.787 / 587.316 6699.0 20.125874519348145 47 20 10 7 10 47.64718725515948 2.0987597749365885 0.027698516845703125 3 0.9993948971583747 50.167894181043685 6699.0 23.779999999999998 0.0 - - - - - - - 298.5 13 24 DOCK1;KIAA0947 dedicator of cytokinesis 1;KIAA0947 1671 213 C20140527_SFK016_02 C20140527_SFK016_02 TB525864.[MT7]-AELEEK[MT7].2y3_1.heavy 503.787 / 549.3 8951.0 20.125874519348145 47 20 10 7 10 47.64718725515948 2.0987597749365885 0.027698516845703125 3 0.9993948971583747 50.167894181043685 8951.0 51.38259954566885 0.0 - - - - - - - 243.16666666666666 17 24 DOCK1;KIAA0947 dedicator of cytokinesis 1;KIAA0947 1673 214 C20140527_SFK016_02 C20140527_SFK016_02 TB526821.[MT7]-LVDVPFQVEFPAPK[MT7].3b6_1.heavy 625.36 / 815.478 N/A N/A - - - - - - - - - 0.0 - - - - - - - APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 1675 214 C20140527_SFK016_02 C20140527_SFK016_02 TB526821.[MT7]-LVDVPFQVEFPAPK[MT7].3b4_1.heavy 625.36 / 571.357 N/A N/A - - - - - - - - - 0.0 - - - - - - - APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 1677 214 C20140527_SFK016_02 C20140527_SFK016_02 TB526821.[MT7]-LVDVPFQVEFPAPK[MT7].3y4_1.heavy 625.36 / 556.357 N/A N/A - - - - - - - - - 0.0 - - - - - - - APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 1679 214 C20140527_SFK016_02 C20140527_SFK016_02 TB526821.[MT7]-LVDVPFQVEFPAPK[MT7].3b7_1.heavy 625.36 / 943.537 N/A N/A - - - - - - - - - 0.0 - - - - - - - APBB1 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) 1681 215 C20140527_SFK016_02 C20140527_SFK016_02 TB526531.[MT7]-RNVTLQNIIDR.3b4_1.heavy 495.959 / 615.37 45754.0 32.79679870605469 47 17 10 10 10 2.777698792397863 28.1316150497835 0.0 3 0.9729864210711033 7.491844843122465 45754.0 90.76386747394633 0.0 - - - - - - - 348.42857142857144 91 14 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1683 215 C20140527_SFK016_02 C20140527_SFK016_02 TB526531.[MT7]-RNVTLQNIIDR.3b5_1.heavy 495.959 / 728.453 36974.0 32.79679870605469 47 17 10 10 10 2.777698792397863 28.1316150497835 0.0 3 0.9729864210711033 7.491844843122465 36974.0 53.66568632102034 0.0 - - - - - - - 302.5 73 10 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1685 215 C20140527_SFK016_02 C20140527_SFK016_02 TB526531.[MT7]-RNVTLQNIIDR.3y4_1.heavy 495.959 / 516.314 65949.0 32.79679870605469 47 17 10 10 10 2.777698792397863 28.1316150497835 0.0 3 0.9729864210711033 7.491844843122465 65949.0 70.85945054781514 0.0 - - - - - - - 1170.857142857143 131 7 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1687 215 C20140527_SFK016_02 C20140527_SFK016_02 TB526531.[MT7]-RNVTLQNIIDR.3y5_1.heavy 495.959 / 630.357 121556.0 32.79679870605469 47 17 10 10 10 2.777698792397863 28.1316150497835 0.0 3 0.9729864210711033 7.491844843122465 121556.0 186.8925983117494 0.0 - - - - - - - 1198.7142857142858 243 7 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1689 216 C20140527_SFK016_02 C20140527_SFK016_02 TB526534.[MT7]-VNC[CAM]QEVESLK[MT7].3b4_1.heavy 498.601 / 646.31 23194.0 28.684200286865234 44 14 10 10 10 1.30458678264977 45.89291748790065 0.0 3 0.9402179557701777 5.022145527489929 23194.0 54.62218235071226 0.0 - - - - - - - 662.7142857142857 46 7 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1691 216 C20140527_SFK016_02 C20140527_SFK016_02 TB526534.[MT7]-VNC[CAM]QEVESLK[MT7].3b5_1.heavy 498.601 / 775.352 31564.0 28.684200286865234 44 14 10 10 10 1.30458678264977 45.89291748790065 0.0 3 0.9402179557701777 5.022145527489929 31564.0 116.48619047619047 0.0 - - - - - - - 218.66666666666666 63 12 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1693 216 C20140527_SFK016_02 C20140527_SFK016_02 TB526534.[MT7]-VNC[CAM]QEVESLK[MT7].3b3_1.heavy 498.601 / 518.251 17345.0 28.684200286865234 44 14 10 10 10 1.30458678264977 45.89291748790065 0.0 3 0.9402179557701777 5.022145527489929 17345.0 38.1664725478409 0.0 - - - - - - - 696.8181818181819 34 11 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1695 216 C20140527_SFK016_02 C20140527_SFK016_02 TB526534.[MT7]-VNC[CAM]QEVESLK[MT7].3y4_1.heavy 498.601 / 620.374 49313.0 28.684200286865234 44 14 10 10 10 1.30458678264977 45.89291748790065 0.0 3 0.9402179557701777 5.022145527489929 49313.0 49.05920833086716 0.0 - - - - - - - 347.22222222222223 98 9 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1697 217 C20140527_SFK016_02 C20140527_SFK016_02 TB525776.[MT7]-SFQIFR.2y4_1.heavy 471.27 / 563.33 2825.0 36.21609878540039 48 18 10 10 10 3.207039668908785 31.18140413711366 0.0 3 0.9804225119498838 8.805880674436326 2825.0 10.199725095329844 0.0 - - - - - - - 289.8888888888889 5 9 FRY;FRYL furry homolog (Drosophila);FRY-like 1699 217 C20140527_SFK016_02 C20140527_SFK016_02 TB525776.[MT7]-SFQIFR.2b3_1.heavy 471.27 / 507.268 8692.0 36.21609878540039 48 18 10 10 10 3.207039668908785 31.18140413711366 0.0 3 0.9804225119498838 8.805880674436326 8692.0 29.486471246690872 0.0 - - - - - - - 326.0 17 10 FRY;FRYL furry homolog (Drosophila);FRY-like 1701 217 C20140527_SFK016_02 C20140527_SFK016_02 TB525776.[MT7]-SFQIFR.2y5_1.heavy 471.27 / 710.398 7715.0 36.21609878540039 48 18 10 10 10 3.207039668908785 31.18140413711366 0.0 3 0.9804225119498838 8.805880674436326 7715.0 41.50830388359579 0.0 - - - - - - - 152.2 15 10 FRY;FRYL furry homolog (Drosophila);FRY-like 1703 217 C20140527_SFK016_02 C20140527_SFK016_02 TB525776.[MT7]-SFQIFR.2b4_1.heavy 471.27 / 620.352 4998.0 36.21609878540039 48 18 10 10 10 3.207039668908785 31.18140413711366 0.0 3 0.9804225119498838 8.805880674436326 4998.0 11.892024787202352 0.0 - - - - - - - 736.4444444444445 9 9 FRY;FRYL furry homolog (Drosophila);FRY-like 1705 218 C20140527_SFK016_02 C20140527_SFK016_02 TB526823.[MT7]-YLIIENFIPPEEK[MT7].3b6_1.heavy 631.692 / 890.51 N/A N/A - - - - - - - - - 0.0 - - - - - - - KIF3C kinesin family member 3C 1707 218 C20140527_SFK016_02 C20140527_SFK016_02 TB526823.[MT7]-YLIIENFIPPEEK[MT7].3y4_1.heavy 631.692 / 646.353 N/A N/A - - - - - - - - - 0.0 - - - - - - - KIF3C kinesin family member 3C 1709 218 C20140527_SFK016_02 C20140527_SFK016_02 TB526823.[MT7]-YLIIENFIPPEEK[MT7].3b3_1.heavy 631.692 / 534.341 N/A N/A - - - - - - - - - 0.0 - - - - - - - KIF3C kinesin family member 3C 1711 218 C20140527_SFK016_02 C20140527_SFK016_02 TB526823.[MT7]-YLIIENFIPPEEK[MT7].3y5_1.heavy 631.692 / 743.406 N/A N/A - - - - - - - - - 0.0 - - - - - - - KIF3C kinesin family member 3C 1713 219 C20140527_SFK016_02 C20140527_SFK016_02 TB526533.[MT7]-EQQATELLAAK[MT7].3b6_1.heavy 497.287 / 831.396 45773.0 30.651500701904297 46 16 10 10 10 2.22267600424448 36.8478705871781 0.0 3 0.9601283969061464 6.159945278012123 45773.0 134.28599964808717 0.0 - - - - - - - 335.3333333333333 91 12 KIF3C kinesin family member 3C 1715 219 C20140527_SFK016_02 C20140527_SFK016_02 TB526533.[MT7]-EQQATELLAAK[MT7].3b4_1.heavy 497.287 / 601.306 28728.0 30.651500701904297 46 16 10 10 10 2.22267600424448 36.8478705871781 0.0 3 0.9601283969061464 6.159945278012123 28728.0 80.84344229765013 0.0 - - - - - - - 697.7142857142857 57 7 KIF3C kinesin family member 3C 1717 219 C20140527_SFK016_02 C20140527_SFK016_02 TB526533.[MT7]-EQQATELLAAK[MT7].3y4_1.heavy 497.287 / 546.373 43953.0 30.651500701904297 46 16 10 10 10 2.22267600424448 36.8478705871781 0.0 3 0.9601283969061464 6.159945278012123 43953.0 59.456664693170715 0.0 - - - - - - - 255.5 87 6 KIF3C kinesin family member 3C 1719 219 C20140527_SFK016_02 C20140527_SFK016_02 TB526533.[MT7]-EQQATELLAAK[MT7].3b3_1.heavy 497.287 / 530.269 27770.0 30.651500701904297 46 16 10 10 10 2.22267600424448 36.8478705871781 0.0 3 0.9601283969061464 6.159945278012123 27770.0 57.166738036835326 0.0 - - - - - - - 725.1428571428571 55 7 KIF3C kinesin family member 3C 1721 220 C20140527_SFK016_02 C20140527_SFK016_02 TB525867.[MT7]-AAWWGK[MT7].2y4_1.heavy 503.789 / 720.395 19707.0 32.97849941253662 46 20 10 6 10 9.280223967037058 10.775602006502812 0.037601470947265625 3 0.9982690872388862 29.659383269616225 19707.0 103.88501030927836 0.0 - - - - - - - 246.23076923076923 39 13 LOC100287399;LOC100288966;POTEH;POTED;POTEB;POTEC;POTEG;POTEE;POTEM;POTEI;POTEJ;POTEF POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member H;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member G;POTE ankyrin domain family, member E;POTE ankyrin domain family, member M;POTE ankyrin domain family, member I;POTE ankyrin domain family, member J;POTE ankyrin domain family, member F 1723 220 C20140527_SFK016_02 C20140527_SFK016_02 TB525867.[MT7]-AAWWGK[MT7].2y5_1.heavy 503.789 / 791.432 19028.0 32.97849941253662 46 20 10 6 10 9.280223967037058 10.775602006502812 0.037601470947265625 3 0.9982690872388862 29.659383269616225 19028.0 76.01391752577318 0.0 - - - - - - - 264.54545454545456 38 11 LOC100287399;LOC100288966;POTEH;POTED;POTEB;POTEC;POTEG;POTEE;POTEM;POTEI;POTEJ;POTEF POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member H;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member G;POTE ankyrin domain family, member E;POTE ankyrin domain family, member M;POTE ankyrin domain family, member I;POTE ankyrin domain family, member J;POTE ankyrin domain family, member F 1725 220 C20140527_SFK016_02 C20140527_SFK016_02 TB525867.[MT7]-AAWWGK[MT7].2b4_1.heavy 503.789 / 659.342 3689.0 32.97849941253662 46 20 10 6 10 9.280223967037058 10.775602006502812 0.037601470947265625 3 0.9982690872388862 29.659383269616225 3689.0 5.958178694158075 2.0 - - - - - - - 300.7 7 20 LOC100287399;LOC100288966;POTEH;POTED;POTEB;POTEC;POTEG;POTEE;POTEM;POTEI;POTEJ;POTEF POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member H;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member G;POTE ankyrin domain family, member E;POTE ankyrin domain family, member M;POTE ankyrin domain family, member I;POTE ankyrin domain family, member J;POTE ankyrin domain family, member F 1727 220 C20140527_SFK016_02 C20140527_SFK016_02 TB525867.[MT7]-AAWWGK[MT7].2y3_1.heavy 503.789 / 534.316 47278.0 32.97849941253662 46 20 10 6 10 9.280223967037058 10.775602006502812 0.037601470947265625 3 0.9982690872388862 29.659383269616225 47278.0 33.81814982097875 0.0 - - - - - - - 716.0 94 8 LOC100287399;LOC100288966;POTEH;POTED;POTEB;POTEC;POTEG;POTEE;POTEM;POTEI;POTEJ;POTEF POTE ankyrin domain family member B-like;POTE ankyrin domain family member D-like;POTE ankyrin domain family, member H;POTE ankyrin domain family, member D;POTE ankyrin domain family, member B;POTE ankyrin domain family, member C;POTE ankyrin domain family, member G;POTE ankyrin domain family, member E;POTE ankyrin domain family, member M;POTE ankyrin domain family, member I;POTE ankyrin domain family, member J;POTE ankyrin domain family, member F 1729 221 C20140527_SFK016_02 C20140527_SFK016_02 TB526723.[MT7]-ELNK[MT7]PVQGPLAHR.4y5_1.heavy 437.511 / 593.352 8882.0 23.78969955444336 47 17 10 10 10 2.4134385223851176 28.09617178055808 0.0 3 0.9705766534376555 7.177045153472133 8882.0 33.10637249368965 0.0 - - - - - - - 246.66666666666666 17 9 VWA5A von Willebrand factor A domain containing 5A 1731 221 C20140527_SFK016_02 C20140527_SFK016_02 TB526723.[MT7]-ELNK[MT7]PVQGPLAHR.4y4_1.heavy 437.511 / 496.299 17457.0 23.78969955444336 47 17 10 10 10 2.4134385223851176 28.09617178055808 0.0 3 0.9705766534376555 7.177045153472133 17457.0 50.27762522213187 0.0 - - - - - - - 354.0 34 8 VWA5A von Willebrand factor A domain containing 5A 1733 221 C20140527_SFK016_02 C20140527_SFK016_02 TB526723.[MT7]-ELNK[MT7]PVQGPLAHR.4y6_1.heavy 437.511 / 650.373 15160.0 23.78969955444336 47 17 10 10 10 2.4134385223851176 28.09617178055808 0.0 3 0.9705766534376555 7.177045153472133 15160.0 73.62297650130549 0.0 - - - - - - - 250.72727272727272 30 11 VWA5A von Willebrand factor A domain containing 5A 1735 221 C20140527_SFK016_02 C20140527_SFK016_02 TB526723.[MT7]-ELNK[MT7]PVQGPLAHR.4b6_2.heavy 437.511 / 485.302 21056.0 23.78969955444336 47 17 10 10 10 2.4134385223851176 28.09617178055808 0.0 3 0.9705766534376555 7.177045153472133 21056.0 14.693715429120243 1.0 - - - - - - - 663.6666666666666 45 9 VWA5A von Willebrand factor A domain containing 5A 1737 222 C20140527_SFK016_02 C20140527_SFK016_02 TB526631.[MT7]-NWVGILATNTQK[MT7].3y3_1.heavy 544.982 / 520.321 83957.0 38.76430130004883 48 18 10 10 10 5.231196633915386 19.116085094502203 0.0 3 0.9869605287892406 10.795911939568237 83957.0 -3.868986175115211 0.0 - - - - - - - 325.0 167 1 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1739 222 C20140527_SFK016_02 C20140527_SFK016_02 TB526631.[MT7]-NWVGILATNTQK[MT7].3b4_1.heavy 544.982 / 601.321 241566.0 38.76430130004883 48 18 10 10 10 5.231196633915386 19.116085094502203 0.0 3 0.9869605287892406 10.795911939568237 241566.0 -1.8872343749999985 0.0 - - - - - - - 1193.0 483 1 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1741 222 C20140527_SFK016_02 C20140527_SFK016_02 TB526631.[MT7]-NWVGILATNTQK[MT7].3b5_1.heavy 544.982 / 714.406 172470.0 38.76430130004883 48 18 10 10 10 5.231196633915386 19.116085094502203 0.0 3 0.9869605287892406 10.795911939568237 172470.0 -7.947926267281119 0.0 - - - - - - - 922.0 344 2 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1743 222 C20140527_SFK016_02 C20140527_SFK016_02 TB526631.[MT7]-NWVGILATNTQK[MT7].3b3_1.heavy 544.982 / 544.3 54127.0 38.76430130004883 48 18 10 10 10 5.231196633915386 19.116085094502203 0.0 3 0.9869605287892406 10.795911939568237 54127.0 -0.11231332444049213 0.0 - - - - - - - 1519.0 108 1 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1745 223 C20140527_SFK016_02 C20140527_SFK016_02 TB526630.[MT7]-LTTELIMHIQK[MT7].3b6_1.heavy 538.988 / 815.5 19032.0 37.943599700927734 36 18 0 10 8 3.2035516319298423 24.99455217564156 0.0 4 0.9849190411580193 10.036922689441612 19032.0 63.06430876046559 0.0 - - - - - - - 267.5 38 12 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1747 223 C20140527_SFK016_02 C20140527_SFK016_02 TB526630.[MT7]-LTTELIMHIQK[MT7].3y3_1.heavy 538.988 / 532.357 52670.0 37.943599700927734 36 18 0 10 8 3.2035516319298423 24.99455217564156 0.0 4 0.9849190411580193 10.036922689441612 52670.0 85.38910811693776 1.0 - - - - - - - 309.8 426 5 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1749 223 C20140527_SFK016_02 C20140527_SFK016_02 TB526630.[MT7]-LTTELIMHIQK[MT7].3b4_1.heavy 538.988 / 589.331 51785.0 37.943599700927734 36 18 0 10 8 3.2035516319298423 24.99455217564156 0.0 4 0.9849190411580193 10.036922689441612 51785.0 77.2386440677966 0.0 - - - - - - - 802.375 103 8 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1751 223 C20140527_SFK016_02 C20140527_SFK016_02 TB526630.[MT7]-LTTELIMHIQK[MT7].3b5_1.heavy 538.988 / 702.415 53887.0 37.943599700927734 36 18 0 10 8 3.2035516319298423 24.99455217564156 0.0 4 0.9849190411580193 10.036922689441612 53887.0 72.75419847838356 0.0 - - - - - - - 312.0 107 11 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1753 224 C20140527_SFK016_02 C20140527_SFK016_02 TB526725.[MT7]-EAFQSVVLPAFEK[MT7].3b4_1.heavy 584.997 / 620.316 16940.0 42.37072563171387 46 20 10 6 10 5.783032574182688 17.291965541821792 0.03530120849609375 3 0.9914879146440142 13.367058240433527 16940.0 -1.6923076923076916 0.0 - - - - - - - 308.0 33 5 EDC4 enhancer of mRNA decapping 4 1755 224 C20140527_SFK016_02 C20140527_SFK016_02 TB526725.[MT7]-EAFQSVVLPAFEK[MT7].3b5_1.heavy 584.997 / 707.348 22407.0 42.37072563171387 46 20 10 6 10 5.783032574182688 17.291965541821792 0.03530120849609375 3 0.9914879146440142 13.367058240433527 22407.0 -1.2731250000000003 0.0 - - - - - - - 205.33333333333334 44 3 EDC4 enhancer of mRNA decapping 4 1757 224 C20140527_SFK016_02 C20140527_SFK016_02 TB526725.[MT7]-EAFQSVVLPAFEK[MT7].3y4_1.heavy 584.997 / 638.363 15631.0 42.37072563171387 46 20 10 6 10 5.783032574182688 17.291965541821792 0.03530120849609375 3 0.9914879146440142 13.367058240433527 15631.0 -1.421000000000003 0.0 - - - - - - - 323.4 31 5 EDC4 enhancer of mRNA decapping 4 1759 224 C20140527_SFK016_02 C20140527_SFK016_02 TB526725.[MT7]-EAFQSVVLPAFEK[MT7].3y5_1.heavy 584.997 / 735.416 49356.0 42.37072563171387 46 20 10 6 10 5.783032574182688 17.291965541821792 0.03530120849609375 3 0.9914879146440142 13.367058240433527 49356.0 -4.578478664192957 0.0 - - - - - - - 134.75 98 4 EDC4 enhancer of mRNA decapping 4 1761 225 C20140527_SFK016_02 C20140527_SFK016_02 TB526638.[MT7]-IYGNQDTSSQLK[MT7].3b6_1.heavy 547.961 / 835.407 21884.0 25.185199737548828 44 14 10 10 10 2.279575310814445 30.34344932658495 0.0 3 0.9410871071439721 5.059430760947459 21884.0 80.61231521052436 0.0 - - - - - - - 323.75 43 12 ITIH2 inter-alpha (globulin) inhibitor H2 1763 225 C20140527_SFK016_02 C20140527_SFK016_02 TB526638.[MT7]-IYGNQDTSSQLK[MT7].3b4_1.heavy 547.961 / 592.321 40737.0 25.185199737548828 44 14 10 10 10 2.279575310814445 30.34344932658495 0.0 3 0.9410871071439721 5.059430760947459 40737.0 69.26185116509322 0.0 - - - - - - - 351.85714285714283 81 7 ITIH2 inter-alpha (globulin) inhibitor H2 1765 225 C20140527_SFK016_02 C20140527_SFK016_02 TB526638.[MT7]-IYGNQDTSSQLK[MT7].3y4_1.heavy 547.961 / 619.39 42442.0 25.185199737548828 44 14 10 10 10 2.279575310814445 30.34344932658495 0.0 3 0.9410871071439721 5.059430760947459 42442.0 97.16075842471426 0.0 - - - - - - - 365.42857142857144 84 7 ITIH2 inter-alpha (globulin) inhibitor H2 1767 225 C20140527_SFK016_02 C20140527_SFK016_02 TB526638.[MT7]-IYGNQDTSSQLK[MT7].3y5_1.heavy 547.961 / 706.422 28800.0 25.185199737548828 44 14 10 10 10 2.279575310814445 30.34344932658495 0.0 3 0.9410871071439721 5.059430760947459 28800.0 55.42234304027236 0.0 - - - - - - - 676.5714285714286 57 7 ITIH2 inter-alpha (globulin) inhibitor H2 1769 226 C20140527_SFK016_02 C20140527_SFK016_02 TB397859.[MT7]-TC[CAM]VTC[CAM]EVSYC[CAM]DEC[CAM]LK[MT7].3y6_1.heavy 737.993 / 968.43 9906.0 30.26277446746826 41 15 10 6 10 1.529486487133286 45.720581095522206 0.035900115966796875 3 0.9533925512029685 5.694207949865816 9906.0 26.67909090909091 0.0 - - - - - - - 238.21428571428572 19 14 MID1 midline 1 (Opitz/BBB syndrome) 1771 226 C20140527_SFK016_02 C20140527_SFK016_02 TB397859.[MT7]-TC[CAM]VTC[CAM]EVSYC[CAM]DEC[CAM]LK[MT7].3b6_1.heavy 737.993 / 895.377 8858.0 30.26277446746826 41 15 10 6 10 1.529486487133286 45.720581095522206 0.035900115966796875 3 0.9533925512029685 5.694207949865816 8858.0 36.1015160692326 0.0 - - - - - - - 205.23076923076923 17 13 MID1 midline 1 (Opitz/BBB syndrome) 1773 226 C20140527_SFK016_02 C20140527_SFK016_02 TB397859.[MT7]-TC[CAM]VTC[CAM]EVSYC[CAM]DEC[CAM]LK[MT7].3b4_1.heavy 737.993 / 606.304 4953.0 30.26277446746826 41 15 10 6 10 1.529486487133286 45.720581095522206 0.035900115966796875 3 0.9533925512029685 5.694207949865816 4953.0 12.70996681355938 0.0 - - - - - - - 702.75 9 8 MID1 midline 1 (Opitz/BBB syndrome) 1775 226 C20140527_SFK016_02 C20140527_SFK016_02 TB397859.[MT7]-TC[CAM]VTC[CAM]EVSYC[CAM]DEC[CAM]LK[MT7].3y4_1.heavy 737.993 / 693.372 5525.0 30.26277446746826 41 15 10 6 10 1.529486487133286 45.720581095522206 0.035900115966796875 3 0.9533925512029685 5.694207949865816 5525.0 6.783434673796334 0.0 - - - - - - - 718.2307692307693 11 13 MID1 midline 1 (Opitz/BBB syndrome) 1777 227 C20140527_SFK016_02 C20140527_SFK016_02 TB328395.[MT7]-AMEIIQQAFINVAK[MT7].2b8_1.heavy 932.534 / 1029.55 3407.0 49.399048805236816 47 20 10 7 10 6.563391074581758 15.236026447863669 0.029399871826171875 3 0.9901045097205367 12.396095981653573 3407.0 9.392731829573934 0.0 - - - - - - - 267.39285714285717 6 28 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1779 227 C20140527_SFK016_02 C20140527_SFK016_02 TB328395.[MT7]-AMEIIQQAFINVAK[MT7].2y4_1.heavy 932.534 / 575.363 4420.0 49.399048805236816 47 20 10 7 10 6.563391074581758 15.236026447863669 0.029399871826171875 3 0.9901045097205367 12.396095981653573 4420.0 33.715348837209305 0.0 - - - - - - - 179.46153846153845 8 26 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1781 227 C20140527_SFK016_02 C20140527_SFK016_02 TB328395.[MT7]-AMEIIQQAFINVAK[MT7].2b4_1.heavy 932.534 / 589.314 11849.0 49.399048805236816 47 20 10 7 10 6.563391074581758 15.236026447863669 0.029399871826171875 3 0.9901045097205367 12.396095981653573 11849.0 88.28268153230417 0.0 - - - - - - - 211.08 23 25 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1783 227 C20140527_SFK016_02 C20140527_SFK016_02 TB328395.[MT7]-AMEIIQQAFINVAK[MT7].2b7_1.heavy 932.534 / 958.515 2609.0 49.399048805236816 47 20 10 7 10 6.563391074581758 15.236026447863669 0.029399871826171875 3 0.9901045097205367 12.396095981653573 2609.0 25.445340347521125 0.0 - - - - - - - 171.03571428571428 5 28 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1785 228 C20140527_SFK016_02 C20140527_SFK016_02 TB397757.[MT7]-NWVGILATNTQK[MT7].2y5_1.heavy 816.969 / 735.412 5340.0 38.773000717163086 41 15 10 6 10 1.8364758633115839 43.392554182924314 0.03479766845703125 3 0.9582196763589657 6.016621235171254 5340.0 30.7326886372312 0.0 - - - - - - - 630.2857142857143 10 7 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1787 228 C20140527_SFK016_02 C20140527_SFK016_02 TB397757.[MT7]-NWVGILATNTQK[MT7].2b4_1.heavy 816.969 / 601.321 9442.0 38.773000717163086 41 15 10 6 10 1.8364758633115839 43.392554182924314 0.03479766845703125 3 0.9582196763589657 6.016621235171254 9442.0 25.50965095533308 0.0 - - - - - - - 662.4444444444445 18 9 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1789 228 C20140527_SFK016_02 C20140527_SFK016_02 TB397757.[MT7]-NWVGILATNTQK[MT7].2y9_1.heavy 816.969 / 1089.64 14936.0 38.773000717163086 41 15 10 6 10 1.8364758633115839 43.392554182924314 0.03479766845703125 3 0.9582196763589657 6.016621235171254 14936.0 63.61227676216041 0.0 - - - - - - - 278.53333333333336 29 15 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1791 228 C20140527_SFK016_02 C20140527_SFK016_02 TB397757.[MT7]-NWVGILATNTQK[MT7].2y7_1.heavy 816.969 / 919.533 12150.0 38.773000717163086 41 15 10 6 10 1.8364758633115839 43.392554182924314 0.03479766845703125 3 0.9582196763589657 6.016621235171254 12150.0 39.24418604651163 0.0 - - - - - - - 259.3529411764706 24 17 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1793 229 C20140527_SFK016_02 C20140527_SFK016_02 TB328392.[MT7]-LWAYLTINQLLAER.2b3_1.heavy 924.529 / 515.31 29493.0 53.746498107910156 42 12 10 10 10 3.160388544353341 31.641679051985484 0.0 3 0.8934063503975873 3.7459438827036275 29493.0 136.2169591906332 0.0 - - - - - - - 223.5 58 18 ITIH2 inter-alpha (globulin) inhibitor H2 1795 229 C20140527_SFK016_02 C20140527_SFK016_02 TB328392.[MT7]-LWAYLTINQLLAER.2b4_1.heavy 924.529 / 678.373 16287.0 53.746498107910156 42 12 10 10 10 3.160388544353341 31.641679051985484 0.0 3 0.8934063503975873 3.7459438827036275 16287.0 254.16527136329017 0.0 - - - - - - - 168.71428571428572 32 21 ITIH2 inter-alpha (globulin) inhibitor H2 1797 229 C20140527_SFK016_02 C20140527_SFK016_02 TB328392.[MT7]-LWAYLTINQLLAER.2y9_1.heavy 924.529 / 1057.6 18211.0 53.746498107910156 42 12 10 10 10 3.160388544353341 31.641679051985484 0.0 3 0.8934063503975873 3.7459438827036275 18211.0 132.30260169395393 0.0 - - - - - - - 260.2352941176471 36 17 ITIH2 inter-alpha (globulin) inhibitor H2 1799 229 C20140527_SFK016_02 C20140527_SFK016_02 TB328392.[MT7]-LWAYLTINQLLAER.2y10_1.heavy 924.529 / 1170.68 8404.0 53.746498107910156 42 12 10 10 10 3.160388544353341 31.641679051985484 0.0 3 0.8934063503975873 3.7459438827036275 8404.0 52.191842633480526 0.0 - - - - - - - 204.5 16 22 ITIH2 inter-alpha (globulin) inhibitor H2 1801 230 C20140527_SFK016_02 C20140527_SFK016_02 TB526437.[MT7]-LISY[MT7]AQLTGR.3y6_1.heavy 470.617 / 645.368 9705.0 31.63356653849284 42 17 10 5 10 3.260129832662595 27.16527615902126 0.04089927673339844 3 0.9731050284782237 7.508421223486976 9705.0 13.537851392200116 0.0 - - - - - - - 267.90909090909093 19 11 VWA5A von Willebrand factor A domain containing 5A 1803 230 C20140527_SFK016_02 C20140527_SFK016_02 TB526437.[MT7]-LISY[MT7]AQLTGR.3y4_1.heavy 470.617 / 446.272 9895.0 31.63356653849284 42 17 10 5 10 3.260129832662595 27.16527615902126 0.04089927673339844 3 0.9731050284782237 7.508421223486976 9895.0 8.877094111607432 0.0 - - - - - - - 842.4285714285714 19 7 VWA5A von Willebrand factor A domain containing 5A 1805 230 C20140527_SFK016_02 C20140527_SFK016_02 TB526437.[MT7]-LISY[MT7]AQLTGR.3y8_1.heavy 470.617 / 1039.57 N/A 31.63356653849284 42 17 10 5 10 3.260129832662595 27.16527615902126 0.04089927673339844 3 0.9731050284782237 7.508421223486976 0.0 0.0 4.0 - - - - - - - 0.0 0 0 VWA5A von Willebrand factor A domain containing 5A 1807 230 C20140527_SFK016_02 C20140527_SFK016_02 TB526437.[MT7]-LISY[MT7]AQLTGR.3y8_2.heavy 470.617 / 520.286 35964.0 31.63356653849284 42 17 10 5 10 3.260129832662595 27.16527615902126 0.04089927673339844 3 0.9731050284782237 7.508421223486976 35964.0 79.16915117219078 0.0 - - - - - - - 742.0 71 10 VWA5A von Willebrand factor A domain containing 5A 1809 231 C20140527_SFK016_02 C20140527_SFK016_02 TB328394.[MT7]-VRQDLEEAQNEQTR.2y10_1.heavy 930.47 / 1217.58 1355.0 23.043924808502197 35 9 10 6 10 2.4738143290148615 40.423405599652526 0.03709983825683594 3 0.8183521490275413 2.8506414508364037 1355.0 30.288235294117648 0.0 - - - - - - - 118.6 2 5 KIF3C kinesin family member 3C 1811 231 C20140527_SFK016_02 C20140527_SFK016_02 TB328394.[MT7]-VRQDLEEAQNEQTR.2b7_1.heavy 930.47 / 1014.53 1524.0 23.043924808502197 35 9 10 6 10 2.4738143290148615 40.423405599652526 0.03709983825683594 3 0.8183521490275413 2.8506414508364037 1524.0 35.32094117647058 0.0 - - - - - - - 127.33333333333333 3 6 KIF3C kinesin family member 3C 1813 231 C20140527_SFK016_02 C20140527_SFK016_02 TB328394.[MT7]-VRQDLEEAQNEQTR.2b4_1.heavy 930.47 / 643.364 6350.0 23.043924808502197 35 9 10 6 10 2.4738143290148615 40.423405599652526 0.03709983825683594 3 0.8183521490275413 2.8506414508364037 6350.0 24.5 0.0 - - - - - - - 160.9 12 10 KIF3C kinesin family member 3C 1815 231 C20140527_SFK016_02 C20140527_SFK016_02 TB328394.[MT7]-VRQDLEEAQNEQTR.2y7_1.heavy 930.47 / 846.406 2032.0 23.043924808502197 35 9 10 6 10 2.4738143290148615 40.423405599652526 0.03709983825683594 3 0.8183521490275413 2.8506414508364037 2032.0 33.77519248172642 0.0 - - - - - - - 148.25 4 8 KIF3C kinesin family member 3C 1817 232 C20140527_SFK016_02 C20140527_SFK016_02 TB526539.[MT7]-VILIEC[CAM]TELK[MT7].3y3_1.heavy 502.633 / 533.341 28336.0 38.41619873046875 50 20 10 10 10 18.24738392676493 5.480237627560509 0.0 3 0.9992815282630575 46.03959765768295 28336.0 43.87176684881603 0.0 - - - - - - - 219.77777777777777 56 9 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1819 232 C20140527_SFK016_02 C20140527_SFK016_02 TB526539.[MT7]-VILIEC[CAM]TELK[MT7].3b4_1.heavy 502.633 / 583.43 41954.0 38.41619873046875 50 20 10 10 10 18.24738392676493 5.480237627560509 0.0 3 0.9992815282630575 46.03959765768295 41954.0 -3.0567577413479015 0.0 - - - - - - - 298.14285714285717 83 7 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1821 232 C20140527_SFK016_02 C20140527_SFK016_02 TB526539.[MT7]-VILIEC[CAM]TELK[MT7].3b5_1.heavy 502.633 / 712.472 20648.0 38.41619873046875 50 20 10 10 10 18.24738392676493 5.480237627560509 0.0 3 0.9992815282630575 46.03959765768295 20648.0 65.35288029211078 0.0 - - - - - - - 219.8181818181818 41 11 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1823 232 C20140527_SFK016_02 C20140527_SFK016_02 TB526539.[MT7]-VILIEC[CAM]TELK[MT7].3y4_1.heavy 502.633 / 634.389 26798.0 38.41619873046875 50 20 10 10 10 18.24738392676493 5.480237627560509 0.0 3 0.9992815282630575 46.03959765768295 26798.0 89.30196528874771 0.0 - - - - - - - 279.54545454545456 53 11 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1825 233 C20140527_SFK016_02 C20140527_SFK016_02 TB526829.[MT7]-TINILQYVTPTAVGIR.3y7_1.heavy 635.043 / 713.43 N/A N/A - - - - - - - - - 0.0 - - - - - - - XKR6 XK, Kell blood group complex subunit-related family, member 6 1827 233 C20140527_SFK016_02 C20140527_SFK016_02 TB526829.[MT7]-TINILQYVTPTAVGIR.3b6_1.heavy 635.043 / 827.511 N/A N/A - - - - - - - - - 0.0 - - - - - - - XKR6 XK, Kell blood group complex subunit-related family, member 6 1829 233 C20140527_SFK016_02 C20140527_SFK016_02 TB526829.[MT7]-TINILQYVTPTAVGIR.3b4_1.heavy 635.043 / 586.368 N/A N/A - - - - - - - - - 0.0 - - - - - - - XKR6 XK, Kell blood group complex subunit-related family, member 6 1831 233 C20140527_SFK016_02 C20140527_SFK016_02 TB526829.[MT7]-TINILQYVTPTAVGIR.3y8_1.heavy 635.043 / 814.478 N/A N/A - - - - - - - - - 0.0 - - - - - - - XKR6 XK, Kell blood group complex subunit-related family, member 6 1833 234 C20140527_SFK016_02 C20140527_SFK016_02 TB328399.[MT7]-YLIIENFIPPEEK[MT7].2y4_1.heavy 947.034 / 646.353 5672.0 47.13937568664551 43 17 10 6 10 4.114293897291496 24.305507213724223 0.03130340576171875 3 0.977652930475504 8.240242226744652 5672.0 4.146332384889318 1.0 - - - - - - - 669.2 15 15 KIF3C kinesin family member 3C 1835 234 C20140527_SFK016_02 C20140527_SFK016_02 TB328399.[MT7]-YLIIENFIPPEEK[MT7].2b3_1.heavy 947.034 / 534.341 16849.0 47.13937568664551 43 17 10 6 10 4.114293897291496 24.305507213724223 0.03130340576171875 3 0.977652930475504 8.240242226744652 16849.0 55.21610825944937 0.0 - - - - - - - 834.0 33 7 KIF3C kinesin family member 3C 1837 234 C20140527_SFK016_02 C20140527_SFK016_02 TB328399.[MT7]-YLIIENFIPPEEK[MT7].2y5_1.heavy 947.034 / 743.406 36387.0 47.13937568664551 43 17 10 6 10 4.114293897291496 24.305507213724223 0.03130340576171875 3 0.977652930475504 8.240242226744652 36387.0 144.6128037872051 0.0 - - - - - - - 130.2 72 10 KIF3C kinesin family member 3C 1839 234 C20140527_SFK016_02 C20140527_SFK016_02 TB328399.[MT7]-YLIIENFIPPEEK[MT7].2b7_1.heavy 947.034 / 1037.58 10000.0 47.13937568664551 43 17 10 6 10 4.114293897291496 24.305507213724223 0.03130340576171875 3 0.977652930475504 8.240242226744652 10000.0 47.319215241872655 0.0 - - - - - - - 222.6 20 10 KIF3C kinesin family member 3C 1841 235 C20140527_SFK016_02 C20140527_SFK016_02 TB526831.[MT7]-QPSFC[CAM]DLLIIVEGK[MT7].3b6_1.heavy 636.357 / 879.379 N/A N/A - - - - - - - - - 0.0 - - - - - - - ZBTB41 zinc finger and BTB domain containing 41 1843 235 C20140527_SFK016_02 C20140527_SFK016_02 TB526831.[MT7]-QPSFC[CAM]DLLIIVEGK[MT7].3y4_1.heavy 636.357 / 576.347 N/A N/A - - - - - - - - - 0.0 - - - - - - - ZBTB41 zinc finger and BTB domain containing 41 1845 235 C20140527_SFK016_02 C20140527_SFK016_02 TB526831.[MT7]-QPSFC[CAM]DLLIIVEGK[MT7].3y5_1.heavy 636.357 / 689.431 N/A N/A - - - - - - - - - 0.0 - - - - - - - ZBTB41 zinc finger and BTB domain containing 41 1847 235 C20140527_SFK016_02 C20140527_SFK016_02 TB526831.[MT7]-QPSFC[CAM]DLLIIVEGK[MT7].3b7_1.heavy 636.357 / 992.463 N/A N/A - - - - - - - - - 0.0 - - - - - - - ZBTB41 zinc finger and BTB domain containing 41 1849 236 C20140527_SFK016_02 C20140527_SFK016_02 TB525852.[MT7]-AREQEAR.2b3_1.heavy 502.274 / 501.29 N/A N/A - - - - - - - - - 0.0 - - - - - - - EDC4 enhancer of mRNA decapping 4 1851 236 C20140527_SFK016_02 C20140527_SFK016_02 TB525852.[MT7]-AREQEAR.2y5_1.heavy 502.274 / 632.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - EDC4 enhancer of mRNA decapping 4 1853 236 C20140527_SFK016_02 C20140527_SFK016_02 TB525852.[MT7]-AREQEAR.2b6_1.heavy 502.274 / 829.428 N/A N/A - - - - - - - - - 0.0 - - - - - - - EDC4 enhancer of mRNA decapping 4 1855 236 C20140527_SFK016_02 C20140527_SFK016_02 TB525852.[MT7]-AREQEAR.2b5_1.heavy 502.274 / 758.391 N/A N/A - - - - - - - - - 0.0 - - - - - - - EDC4 enhancer of mRNA decapping 4 1857 237 C20140527_SFK016_02 C20140527_SFK016_02 TB526524.[MT7]-FYNQVSTPLLR.2b3_1.heavy 741.415 / 569.284 7199.0 37.41230010986328 41 16 10 5 10 3.515076253069847 22.77445650704228 0.04119873046875 3 0.9661311360243422 6.686958329558508 7199.0 15.622158423658071 0.0 - - - - - - - 775.2857142857143 14 7 ITIH2 inter-alpha (globulin) inhibitor H2 1859 237 C20140527_SFK016_02 C20140527_SFK016_02 TB526524.[MT7]-FYNQVSTPLLR.2b4_1.heavy 741.415 / 697.343 16281.0 37.41230010986328 41 16 10 5 10 3.515076253069847 22.77445650704228 0.04119873046875 3 0.9661311360243422 6.686958329558508 16281.0 21.461670892755638 0.0 - - - - - - - 841.8 32 10 ITIH2 inter-alpha (globulin) inhibitor H2 1861 237 C20140527_SFK016_02 C20140527_SFK016_02 TB526524.[MT7]-FYNQVSTPLLR.2y9_1.heavy 741.415 / 1027.59 14842.0 37.41230010986328 41 16 10 5 10 3.515076253069847 22.77445650704228 0.04119873046875 3 0.9661311360243422 6.686958329558508 14842.0 59.64142044306257 0.0 - - - - - - - 221.69230769230768 29 13 ITIH2 inter-alpha (globulin) inhibitor H2 1863 237 C20140527_SFK016_02 C20140527_SFK016_02 TB526524.[MT7]-FYNQVSTPLLR.2y6_1.heavy 741.415 / 686.42 20158.0 37.41230010986328 41 16 10 5 10 3.515076253069847 22.77445650704228 0.04119873046875 3 0.9661311360243422 6.686958329558508 20158.0 102.27571296472573 0.0 - - - - - - - 283.1111111111111 40 9 ITIH2 inter-alpha (globulin) inhibitor H2 1865 238 C20140527_SFK016_02 C20140527_SFK016_02 TB526000.[MT7]-DLQESISR.2b3_1.heavy 546.294 / 501.279 N/A 24.565900802612305 46 20 10 10 6 4.515022190220236 17.468455109598693 0.0 5 0.9926091878509241 14.346581907778063 5373.0 1.4165390077701456 8.0 - - - - - - - 901.4 19 5 USP25 ubiquitin specific peptidase 25 1867 238 C20140527_SFK016_02 C20140527_SFK016_02 TB526000.[MT7]-DLQESISR.2y5_1.heavy 546.294 / 591.31 5200.0 24.565900802612305 46 20 10 10 6 4.515022190220236 17.468455109598693 0.0 5 0.9926091878509241 14.346581907778063 5200.0 9.776239907727795 2.0 - - - - - - - 693.5714285714286 16 7 USP25 ubiquitin specific peptidase 25 1869 238 C20140527_SFK016_02 C20140527_SFK016_02 TB526000.[MT7]-DLQESISR.2y6_1.heavy 546.294 / 719.368 7020.0 24.565900802612305 46 20 10 10 6 4.515022190220236 17.468455109598693 0.0 5 0.9926091878509241 14.346581907778063 7020.0 21.750391137133825 0.0 - - - - - - - 212.8181818181818 14 11 USP25 ubiquitin specific peptidase 25 1871 238 C20140527_SFK016_02 C20140527_SFK016_02 TB526000.[MT7]-DLQESISR.2y7_1.heavy 546.294 / 832.452 10573.0 24.565900802612305 46 20 10 10 6 4.515022190220236 17.468455109598693 0.0 5 0.9926091878509241 14.346581907778063 10573.0 38.398199096556745 0.0 - - - - - - - 260.0 21 14 USP25 ubiquitin specific peptidase 25 1873 239 C20140527_SFK016_02 C20140527_SFK016_02 TB527008.[MT7]-LFIPERDLIPSGTYMEDLTR.3y17_2.heavy 837.441 / 996.988 13046.0 45.66659927368164 41 13 10 10 8 2.091734026833964 38.0602933853885 0.0 4 0.9144362064826396 4.188619810044086 13046.0 -2.0707936507936537 0.0 - - - - - - - 252.0 26 9 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1875 239 C20140527_SFK016_02 C20140527_SFK016_02 TB527008.[MT7]-LFIPERDLIPSGTYMEDLTR.3b3_1.heavy 837.441 / 518.346 5483.0 45.66659927368164 41 13 10 10 8 2.091734026833964 38.0602933853885 0.0 4 0.9144362064826396 4.188619810044086 5483.0 -1.7406349206349194 1.0 - - - - - - - 243.0 16 7 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1877 239 C20140527_SFK016_02 C20140527_SFK016_02 TB527008.[MT7]-LFIPERDLIPSGTYMEDLTR.3y19_2.heavy 837.441 / 1127.06 11470.0 45.66659927368164 41 13 10 10 8 2.091734026833964 38.0602933853885 0.0 4 0.9144362064826396 4.188619810044086 11470.0 -2.275793650793652 0.0 - - - - - - - 315.0 22 7 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1879 239 C20140527_SFK016_02 C20140527_SFK016_02 TB527008.[MT7]-LFIPERDLIPSGTYMEDLTR.3y10_1.heavy 837.441 / 1172.53 2143.0 45.66659927368164 41 13 10 10 8 2.091734026833964 38.0602933853885 0.0 4 0.9144362064826396 4.188619810044086 2143.0 -0.396851851851852 0.0 - - - - - - - 238.0 4 9 IL1RAPL2 interleukin 1 receptor accessory protein-like 2 1881 240 C20140527_SFK016_02 C20140527_SFK016_02 TB525853.[MT7]-GTQVTPTR.2y5_1.heavy 502.286 / 573.336 10458.0 16.033899307250977 50 20 10 10 10 10.255023445003062 9.75131851587592 0.0 3 0.997719678981827 25.83936356218618 10458.0 48.357619207435135 0.0 - - - - - - - 223.4 20 15 XKR6 XK, Kell blood group complex subunit-related family, member 6 1883 240 C20140527_SFK016_02 C20140527_SFK016_02 TB525853.[MT7]-GTQVTPTR.2b4_1.heavy 502.286 / 530.305 13251.0 16.033899307250977 50 20 10 10 10 10.255023445003062 9.75131851587592 0.0 3 0.997719678981827 25.83936356218618 13251.0 48.7782874015748 0.0 - - - - - - - 235.71428571428572 26 14 XKR6 XK, Kell blood group complex subunit-related family, member 6 1885 240 C20140527_SFK016_02 C20140527_SFK016_02 TB525853.[MT7]-GTQVTPTR.2y6_1.heavy 502.286 / 701.394 6803.0 16.033899307250977 50 20 10 10 10 10.255023445003062 9.75131851587592 0.0 3 0.997719678981827 25.83936356218618 6803.0 57.72337935507783 0.0 - - - - - - - 160.83333333333334 13 18 XKR6 XK, Kell blood group complex subunit-related family, member 6 1887 240 C20140527_SFK016_02 C20140527_SFK016_02 TB525853.[MT7]-GTQVTPTR.2y7_1.heavy 502.286 / 802.442 8732.0 16.033899307250977 50 20 10 10 10 10.255023445003062 9.75131851587592 0.0 3 0.997719678981827 25.83936356218618 8732.0 89.8757293825114 0.0 - - - - - - - 139.8125 17 16 XKR6 XK, Kell blood group complex subunit-related family, member 6 1889 241 C20140527_SFK016_02 C20140527_SFK016_02 TB526736.[MT7]-K[MT7]FYNQVSTPLLR.3y7_1.heavy 585.345 / 785.488 18839.0 33.410573959350586 44 18 10 6 10 3.093765546673613 25.37921883880628 0.03910064697265625 3 0.9874206499449798 10.992005903112753 18839.0 15.969466120522076 0.0 - - - - - - - 584.4 37 10 ITIH2 inter-alpha (globulin) inhibitor H2 1891 241 C20140527_SFK016_02 C20140527_SFK016_02 TB526736.[MT7]-K[MT7]FYNQVSTPLLR.3y6_1.heavy 585.345 / 686.42 68403.0 33.410573959350586 44 18 10 6 10 3.093765546673613 25.37921883880628 0.03910064697265625 3 0.9874206499449798 10.992005903112753 68403.0 24.723628547861225 0.0 - - - - - - - 335.6666666666667 136 6 ITIH2 inter-alpha (globulin) inhibitor H2 1893 241 C20140527_SFK016_02 C20140527_SFK016_02 TB526736.[MT7]-K[MT7]FYNQVSTPLLR.3b4_1.heavy 585.345 / 841.481 13701.0 33.410573959350586 44 18 10 6 10 3.093765546673613 25.37921883880628 0.03910064697265625 3 0.9874206499449798 10.992005903112753 13701.0 42.65338503641461 0.0 - - - - - - - 624.4 27 10 ITIH2 inter-alpha (globulin) inhibitor H2 1895 241 C20140527_SFK016_02 C20140527_SFK016_02 TB526736.[MT7]-K[MT7]FYNQVSTPLLR.3b5_1.heavy 585.345 / 969.54 9570.0 33.410573959350586 44 18 10 6 10 3.093765546673613 25.37921883880628 0.03910064697265625 3 0.9874206499449798 10.992005903112753 9570.0 24.072962316639533 0.0 - - - - - - - 633.1428571428571 19 7 ITIH2 inter-alpha (globulin) inhibitor H2 1897 242 C20140527_SFK016_02 C20140527_SFK016_02 TB526009.[MT7]-LSTYFGK[MT7].2y4_1.heavy 552.321 / 658.368 15473.0 33.430124282836914 44 18 10 6 10 4.157418328863865 24.053388927865697 0.03910064697265625 3 0.9869284184805424 10.782614728643313 15473.0 25.563788229564494 0.0 - - - - - - - 687.7777777777778 30 9 ITIH2 inter-alpha (globulin) inhibitor H2 1899 242 C20140527_SFK016_02 C20140527_SFK016_02 TB526009.[MT7]-LSTYFGK[MT7].2y5_1.heavy 552.321 / 759.416 6089.0 33.430124282836914 44 18 10 6 10 4.157418328863865 24.053388927865697 0.03910064697265625 3 0.9869284184805424 10.782614728643313 6089.0 12.16735481883253 0.0 - - - - - - - 698.8571428571429 12 7 ITIH2 inter-alpha (globulin) inhibitor H2 1901 242 C20140527_SFK016_02 C20140527_SFK016_02 TB526009.[MT7]-LSTYFGK[MT7].2b4_1.heavy 552.321 / 609.336 5690.0 33.430124282836914 44 18 10 6 10 4.157418328863865 24.053388927865697 0.03910064697265625 3 0.9869284184805424 10.782614728643313 5690.0 9.52856674026847 0.0 - - - - - - - 778.6 11 10 ITIH2 inter-alpha (globulin) inhibitor H2 1903 242 C20140527_SFK016_02 C20140527_SFK016_02 TB526009.[MT7]-LSTYFGK[MT7].2y6_1.heavy 552.321 / 846.448 26354.0 33.430124282836914 44 18 10 6 10 4.157418328863865 24.053388927865697 0.03910064697265625 3 0.9869284184805424 10.782614728643313 26354.0 40.74937246780706 0.0 - - - - - - - 887.2222222222222 52 9 ITIH2 inter-alpha (globulin) inhibitor H2 1905 243 C20140527_SFK016_02 C20140527_SFK016_02 TB526007.[MT7]-IIDPNDLR.2y5_1.heavy 550.315 / 614.326 373079.0 32.83539962768555 46 18 10 10 8 2.459993093939332 31.341406683601697 0.0 4 0.9848272991588165 10.006455539040195 373079.0 178.0662360724911 0.0 - - - - - - - 776.75 746 4 CXorf23 chromosome X open reading frame 23 1907 243 C20140527_SFK016_02 C20140527_SFK016_02 TB526007.[MT7]-IIDPNDLR.2b6_1.heavy 550.315 / 812.427 102905.0 32.83539962768555 46 18 10 10 8 2.459993093939332 31.341406683601697 0.0 4 0.9848272991588165 10.006455539040195 102905.0 430.13685866540317 0.0 - - - - - - - 312.55555555555554 205 9 CXorf23 chromosome X open reading frame 23 1909 243 C20140527_SFK016_02 C20140527_SFK016_02 TB526007.[MT7]-IIDPNDLR.2y6_1.heavy 550.315 / 729.353 37958.0 32.83539962768555 46 18 10 10 8 2.459993093939332 31.341406683601697 0.0 4 0.9848272991588165 10.006455539040195 37958.0 74.33965128018778 1.0 - - - - - - - 690.3333333333334 290 9 CXorf23 chromosome X open reading frame 23 1911 243 C20140527_SFK016_02 C20140527_SFK016_02 TB526007.[MT7]-IIDPNDLR.2y7_1.heavy 550.315 / 842.437 73101.0 32.83539962768555 46 18 10 10 8 2.459993093939332 31.341406683601697 0.0 4 0.9848272991588165 10.006455539040195 73101.0 82.48050748352983 1.0 - - - - - - - 310.4 230 5 CXorf23 chromosome X open reading frame 23 1913 244 C20140527_SFK016_02 C20140527_SFK016_02 TB525780.[MT7]-QIIGTK[MT7].2b3_1.heavy 474.31 / 499.336 10399.0 22.401500701904297 50 20 10 10 10 5.0527946751191255 19.791027823160533 0.0 3 0.9905575706765356 12.690483603395416 10399.0 31.355821534312433 0.0 - - - - - - - 384.05555555555554 20 18 MID1 midline 1 (Opitz/BBB syndrome) 1915 244 C20140527_SFK016_02 C20140527_SFK016_02 TB525780.[MT7]-QIIGTK[MT7].2y4_1.heavy 474.31 / 562.368 33811.0 22.401500701904297 50 20 10 10 10 5.0527946751191255 19.791027823160533 0.0 3 0.9905575706765356 12.690483603395416 33811.0 85.87852931824703 0.0 - - - - - - - 306.61538461538464 67 13 MID1 midline 1 (Opitz/BBB syndrome) 1917 244 C20140527_SFK016_02 C20140527_SFK016_02 TB525780.[MT7]-QIIGTK[MT7].2y5_1.heavy 474.31 / 675.452 24969.0 22.401500701904297 50 20 10 10 10 5.0527946751191255 19.791027823160533 0.0 3 0.9905575706765356 12.690483603395416 24969.0 68.06767182915426 0.0 - - - - - - - 720.5714285714286 49 7 MID1 midline 1 (Opitz/BBB syndrome) 1919 244 C20140527_SFK016_02 C20140527_SFK016_02 TB525780.[MT7]-QIIGTK[MT7].2b5_1.heavy 474.31 / 657.405 2677.0 22.401500701904297 50 20 10 10 10 5.0527946751191255 19.791027823160533 0.0 3 0.9905575706765356 12.690483603395416 2677.0 5.510321167883212 4.0 - - - - - - - 636.4444444444445 5 9 MID1 midline 1 (Opitz/BBB syndrome) 1921 245 C20140527_SFK016_02 C20140527_SFK016_02 TB525781.[MT7]-SVMNVVR.2y5_1.heavy 474.774 / 618.339 26815.0 27.197900772094727 48 18 10 10 10 5.172637704917159 19.332496436960785 0.0 3 0.9857878085694243 10.339895358582895 26815.0 24.58318788409562 0.0 - - - - - - - 672.2857142857143 53 7 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1923 245 C20140527_SFK016_02 C20140527_SFK016_02 TB525781.[MT7]-SVMNVVR.2b4_1.heavy 474.774 / 576.293 38854.0 27.197900772094727 48 18 10 10 10 5.172637704917159 19.332496436960785 0.0 3 0.9857878085694243 10.339895358582895 38854.0 58.20878278304648 0.0 - - - - - - - 717.5555555555555 77 9 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1925 245 C20140527_SFK016_02 C20140527_SFK016_02 TB525781.[MT7]-SVMNVVR.2y6_1.heavy 474.774 / 717.408 33491.0 27.197900772094727 48 18 10 10 10 5.172637704917159 19.332496436960785 0.0 3 0.9857878085694243 10.339895358582895 33491.0 96.85372907153729 0.0 - - - - - - - 672.4285714285714 66 7 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1927 245 C20140527_SFK016_02 C20140527_SFK016_02 TB525781.[MT7]-SVMNVVR.2b5_1.heavy 474.774 / 675.362 25611.0 27.197900772094727 48 18 10 10 10 5.172637704917159 19.332496436960785 0.0 3 0.9857878085694243 10.339895358582895 25611.0 57.9870161031663 0.0 - - - - - - - 719.2857142857143 51 7 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1929 246 C20140527_SFK016_02 C20140527_SFK016_02 TB525687.[MT7]-VWGVGR.2b3_1.heavy 409.244 / 487.279 42748.0 28.427099227905273 50 20 10 10 10 8.39416545033775 11.913036571846028 0.0 3 0.9990536462260631 40.11449737267631 42748.0 84.32358649789029 0.0 - - - - - - - 842.3333333333334 85 9 APBB1;APBB2 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65);amyloid beta (A4) precursor protein-binding, family B, member 2 1931 246 C20140527_SFK016_02 C20140527_SFK016_02 TB525687.[MT7]-VWGVGR.2y5_1.heavy 409.244 / 574.31 254490.0 28.427099227905273 50 20 10 10 10 8.39416545033775 11.913036571846028 0.0 3 0.9990536462260631 40.11449737267631 254490.0 889.9440684842584 0.0 - - - - - - - 285.85714285714283 508 7 APBB1;APBB2 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65);amyloid beta (A4) precursor protein-binding, family B, member 2 1933 246 C20140527_SFK016_02 C20140527_SFK016_02 TB525687.[MT7]-VWGVGR.2b4_1.heavy 409.244 / 586.347 20953.0 28.427099227905273 50 20 10 10 10 8.39416545033775 11.913036571846028 0.0 3 0.9990536462260631 40.11449737267631 20953.0 63.02311366848072 1.0 - - - - - - - 322.93333333333334 41 15 APBB1;APBB2 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65);amyloid beta (A4) precursor protein-binding, family B, member 2 1935 246 C20140527_SFK016_02 C20140527_SFK016_02 TB525687.[MT7]-VWGVGR.2b5_1.heavy 409.244 / 643.368 12635.0 28.427099227905273 50 20 10 10 10 8.39416545033775 11.913036571846028 0.0 3 0.9990536462260631 40.11449737267631 12635.0 23.969974617063322 0.0 - - - - - - - 706.8571428571429 25 7 APBB1;APBB2 amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65);amyloid beta (A4) precursor protein-binding, family B, member 2 1937 247 C20140527_SFK016_02 C20140527_SFK016_02 TB526320.[MT7]-K[MT7]LQEAAVK[MT7].3y3_1.heavy 440.285 / 461.32 26223.0 20.443399906158447 45 18 10 7 10 3.5807447146881466 22.318541840332472 0.029600143432617188 3 0.9814445509970638 9.045921101638843 26223.0 34.64420731707317 0.0 - - - - - - - 764.9285714285714 52 14 KIAA0947 KIAA0947 1939 247 C20140527_SFK016_02 C20140527_SFK016_02 TB526320.[MT7]-K[MT7]LQEAAVK[MT7].3y4_1.heavy 440.285 / 532.357 22171.0 20.443399906158447 45 18 10 7 10 3.5807447146881466 22.318541840332472 0.029600143432617188 3 0.9814445509970638 9.045921101638843 22171.0 36.913093901349505 0.0 - - - - - - - 636.8571428571429 44 7 KIAA0947 KIAA0947 1941 247 C20140527_SFK016_02 C20140527_SFK016_02 TB526320.[MT7]-K[MT7]LQEAAVK[MT7].3b4_2.heavy 440.285 / 394.249 30565.0 20.443399906158447 45 18 10 7 10 3.5807447146881466 22.318541840332472 0.029600143432617188 3 0.9814445509970638 9.045921101638843 30565.0 87.89427954483136 0.0 - - - - - - - 741.9090909090909 61 11 KIAA0947 KIAA0947 1943 247 C20140527_SFK016_02 C20140527_SFK016_02 TB526320.[MT7]-K[MT7]LQEAAVK[MT7].3y5_1.heavy 440.285 / 661.4 8625.0 20.443399906158447 45 18 10 7 10 3.5807447146881466 22.318541840332472 0.029600143432617188 3 0.9814445509970638 9.045921101638843 8625.0 41.65399009458553 0.0 - - - - - - - 153.69565217391303 17 23 KIAA0947 KIAA0947 1945 248 C20140527_SFK016_02 C20140527_SFK016_02 TB526424.[MT7]-C[CAM]RGQQEITNR.3b6_1.heavy 469.241 / 903.422 2283.0 15.644800186157227 42 15 9 10 8 3.213457306077755 31.11913135141567 0.0 4 0.9580566450542957 6.004833871312207 2283.0 68.73542522694697 0.0 - - - - - - - 101.44444444444444 4 9 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1947 248 C20140527_SFK016_02 C20140527_SFK016_02 TB526424.[MT7]-C[CAM]RGQQEITNR.3b3_1.heavy 469.241 / 518.263 7077.0 15.644800186157227 42 15 9 10 8 3.213457306077755 31.11913135141567 0.0 4 0.9580566450542957 6.004833871312207 7077.0 33.46378662133787 0.0 - - - - - - - 265.72727272727275 14 11 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1949 248 C20140527_SFK016_02 C20140527_SFK016_02 TB526424.[MT7]-C[CAM]RGQQEITNR.3y4_1.heavy 469.241 / 503.294 23649.0 15.644800186157227 42 15 9 10 8 3.213457306077755 31.11913135141567 0.0 4 0.9580566450542957 6.004833871312207 23649.0 139.92483876540368 1.0 - - - - - - - 228.41176470588235 57 17 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1951 248 C20140527_SFK016_02 C20140527_SFK016_02 TB526424.[MT7]-C[CAM]RGQQEITNR.3y5_1.heavy 469.241 / 632.336 12875.0 15.644800186157227 42 15 9 10 8 3.213457306077755 31.11913135141567 0.0 4 0.9580566450542957 6.004833871312207 12875.0 70.48357664233578 0.0 - - - - - - - 199.52631578947367 25 19 MX2 myxovirus (influenza virus) resistance 2 (mouse) 1953 249 C20140527_SFK016_02 C20140527_SFK016_02 TB526422.[MT7]-LLQDSLGGNAK[MT7].2y5_1.heavy 702.408 / 590.338 13273.0 31.40329933166504 44 14 10 10 10 1.405219761983693 47.442164186871366 0.0 3 0.9451344281587426 5.244528899411619 13273.0 59.763246073298426 0.0 - - - - - - - 293.6923076923077 26 13 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 1955 249 C20140527_SFK016_02 C20140527_SFK016_02 TB526422.[MT7]-LLQDSLGGNAK[MT7].2b4_1.heavy 702.408 / 614.363 20626.0 31.40329933166504 44 14 10 10 10 1.405219761983693 47.442164186871366 0.0 3 0.9451344281587426 5.244528899411619 20626.0 42.115916230366494 0.0 - - - - - - - 722.8571428571429 41 7 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 1957 249 C20140527_SFK016_02 C20140527_SFK016_02 TB526422.[MT7]-LLQDSLGGNAK[MT7].2y10_1.heavy 702.408 / 1146.62 9072.0 31.40329933166504 44 14 10 10 10 1.405219761983693 47.442164186871366 0.0 3 0.9451344281587426 5.244528899411619 9072.0 17.261068452907008 0.0 - - - - - - - 245.35714285714286 18 14 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 1959 249 C20140527_SFK016_02 C20140527_SFK016_02 TB526422.[MT7]-LLQDSLGGNAK[MT7].2y7_1.heavy 702.408 / 790.454 16329.0 31.40329933166504 44 14 10 10 10 1.405219761983693 47.442164186871366 0.0 3 0.9451344281587426 5.244528899411619 16329.0 31.06214659685864 0.0 - - - - - - - 235.33333333333334 32 15 KIF3C;KIF3B kinesin family member 3C;kinesin family member 3B 1961 250 C20140527_SFK016_02 C20140527_SFK016_02 TB526289.[MT7]-STIIISGISK[MT7].3b4_1.heavy 436.278 / 559.357 101369.0 33.27495098114014 46 20 10 6 10 10.555246351855144 9.47396173111814 0.037403106689453125 3 0.996003051351051 19.51431562108098 101369.0 228.76221653800425 0.0 - - - - - - - 290.3636363636364 202 11 C2CD2 C2 calcium-dependent domain containing 2 1963 250 C20140527_SFK016_02 C20140527_SFK016_02 TB526289.[MT7]-STIIISGISK[MT7].3y4_1.heavy 436.278 / 548.352 39111.0 33.27495098114014 46 20 10 6 10 10.555246351855144 9.47396173111814 0.037403106689453125 3 0.996003051351051 19.51431562108098 39111.0 139.7804932481706 1.0 - - - - - - - 307.0769230769231 89 13 C2CD2 C2 calcium-dependent domain containing 2 1965 250 C20140527_SFK016_02 C20140527_SFK016_02 TB526289.[MT7]-STIIISGISK[MT7].3b3_1.heavy 436.278 / 446.273 113841.0 33.27495098114014 46 20 10 6 10 10.555246351855144 9.47396173111814 0.037403106689453125 3 0.996003051351051 19.51431562108098 113841.0 142.6159106453058 0.0 - - - - - - - 308.45454545454544 227 11 C2CD2 C2 calcium-dependent domain containing 2 1967 250 C20140527_SFK016_02 C20140527_SFK016_02 TB526289.[MT7]-STIIISGISK[MT7].3y5_1.heavy 436.278 / 635.385 53179.0 33.27495098114014 46 20 10 6 10 10.555246351855144 9.47396173111814 0.037403106689453125 3 0.996003051351051 19.51431562108098 53179.0 140.185329512894 0.0 - - - - - - - 266.22222222222223 106 9 C2CD2 C2 calcium-dependent domain containing 2 1969 251 C20140527_SFK016_02 C20140527_SFK016_02 TB526283.[MT7]-LFFVDTGSK[MT7].2y4_1.heavy 651.371 / 536.316 N/A N/A - - - - - - - - - 0.0 - - - - - - - GLTSCR2 glioma tumor suppressor candidate region gene 2 1971 251 C20140527_SFK016_02 C20140527_SFK016_02 TB526283.[MT7]-LFFVDTGSK[MT7].2y8_1.heavy 651.371 / 1044.55 N/A N/A - - - - - - - - - 0.0 - - - - - - - GLTSCR2 glioma tumor suppressor candidate region gene 2 1973 251 C20140527_SFK016_02 C20140527_SFK016_02 TB526283.[MT7]-LFFVDTGSK[MT7].2y6_1.heavy 651.371 / 750.411 N/A N/A - - - - - - - - - 0.0 - - - - - - - GLTSCR2 glioma tumor suppressor candidate region gene 2 1975 251 C20140527_SFK016_02 C20140527_SFK016_02 TB526283.[MT7]-LFFVDTGSK[MT7].2y7_1.heavy 651.371 / 897.48 N/A N/A - - - - - - - - - 0.0 - - - - - - - GLTSCR2 glioma tumor suppressor candidate region gene 2